UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

———————
FORM 10-K
———————

þANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 20112014
Commission file number:  000-51354

AEMETIS, INC.
(Exact name of registrant as specified in its charter)
 
Nevada 26-1407544
(State or other jurisdiction of  incorporation or organization) (I.R.S. Employer  Identification Number)

20400 Stevens Creek Blvd., Suite 700
Cupertino, CA 95014
(Address of principal executive offices)

Registrant’s telephone number (including area code):(408) 213-0940

Securities registered under Section 12(g) of the Exchange Act:

Common Stock, Par Value $0.001
(Title of class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.      YesoNoþ
 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  YesoNoþ
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or Section 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes oþ No þo
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes   þNoo
 
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.   Yes   þo Noo þ
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):
 
Large accelerated filero
Accelerated filer
oþ
Non-accelerated filer
o
Smaller reporting companyþ
(Do not check if a smaller reporting company)
Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yeso Noþ
 
The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant was approximately $15,363,775$100,884,800 as ofJuneof June 30, 2011,2014 based on the average bid and asked price on the OTC MarketsreportedNASDAQ Markets reported for such date.  This calculation does not reflect a determination that certain persons are affiliates of the registrant for any other purpose.
 
The number of shares outstanding of the registrant’s Common Stock on October 25, 2012March 5, 2015 was 170,548,50720,771,914 shares.
 
DOCUMENTS INCORPORATED BY REFERENCE
 
NonePortions of the Proxy Statement for the Registrant’s 2015 Annual Meeting of Stockholders are incorporated by reference in Part III of this Form 10-K.
 


 
 

 
 
TABLE OF CONTENTS
 
 Page
PART I
 
Special Note Regarding Forward-Looking Statements13
Explanatory Note1
  
Item 1.Business13
  
Item 1A.Risk Factors911
  
Item 2.Properties1521
  
Item 3.Legal Proceedings1622
  
Item 4.Mine Safety Disclosures1623
PART II
PART II
Item 5.Market for Registrant'sRegistrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities1724
  
Item 6.Selected Financial InformationData1827
  
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations1827
Item 7A.Quantitative and Qualitative Disclosures about Market Risk51
  
Item 8.Financial Statements and Supplementary Data5141
  
Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure51
41
  
Item 9A.Controls and Procedures52
41
  
Item 9B.Other Information5344
PART III
PART III
  
Item 10.Directors, Executive Officers and Corporate Governance54
44
  
Item 11.Executive Compensation60
44
  
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters63
44
  
Item 13.Certain Relationships and Related Transactions, and Director Independence66
44
  
Item 14.Principal Accounting Fees and Services66
44
PART IV
PART IV
Item 15.Exhibits and Financial Statement Schedules67
44
  
Index to Financial Statements6850
  
SIGNATURESSignatures7186
 
 
2

 
 
PART I
 
SPECIAL NOTE REGARDING FORWARD—LOOKINGFORWARD-LOOKING STATEMENTS
 
On one or more occasions, we may make forward-looking statements in this Annual Report on Form 10-K, including statements regarding our assumptions, projections, expectations, targets, intentions or beliefs about future events.events or other statements that are not historical facts.  Forward-looking statements in this Annual Report on Form 10-K, include without limitation, statements regarding trends in demand for renewable fuels; trends in market conditions with respect to prices for inputs for our products verses prices for our products; our ability to leverage approved feedstock pathways; our ability to leverage our location and infrastructure; our ability to incorporate lower-cost, non-food advanced biofuels feedstock at the Keyes plant; our ability to adopt value-add byproduct processing systems; our ability to expand into alternative markets for  biodiesel and its byproducts, including continuing to expand our sales into international markets; the impact of changes in regulatory policies on our performance, including the Indian government’s recent changes to tax policies, diesel prices and related subsidies; our ability to continue to develop new, and to maintain and protect  new and existing, intellectual property rights; our ability to adopt, develop and commercialize new technologies; our ability to refinance our senior debt on more commercial terms or at all; our ability to continue to fund operations; our ability to sell additional notes under our EB-5 note program and our expectations regarding the release of funds from escrow under our EB-5 note program; our ability to improve margins; our ability to raise the expected costs to complete our fractionation unit; and our ability to raise additional capital.  Words or phrases such as “anticipates,” “may,” “will,” “should,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “targets,” “will likely result,” “will continue” or similar expressions are intended to identify forward-looking statements.  These forward-looking statements are only ourbased on current assumptions and predictions and involveare subject to numerous assumptions, risks and uncertainties,uncertainties.  Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, but not limited to those listedwithout limitation, the risks set forth under the caption “Risk Factors” below, andwhich are incorporated herein by reference as well as those business risks and factors described elsewhere in this report and in our other filings with the Securities and Exchange Commission filings.(the “SEC”).
 
We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. However, your attention is directed to any further disclosures made on related subjects in our subsequent annual and periodic reports filed with the Securities and Exchange Commission on Forms 10-K, 10-Q and 8-K and Proxy Statements on Schedule 14A.
 
We obtained the market data used in this report from internal company reports and industry publications.  Industry publications generally state that the information contained in those publications has been obtained from sources believed to be reliable, but their accuracy and completeness are not guaranteed and their reliability cannot be assured.  Although we believe market data used in this 10-K is reliable, it has not been independently verified. Similarly, while we believe internal company reports are reliable, we have not had the content of these reports independently verified.
 
Unless the context requires otherwise, references to “we,” “us,” “our,” and “the Company” refer specifically to Aemetis, Inc. and its subsidiaries.
 
EXPLANATORY NOTE
This annual report on Form 10-K is a comprehensive filing for the fiscal years ended December 31, 2010 and 2011 and the interim periods within 2011.  It is being filed by us in order to become current in our filing obligations under the Securities Exchange Act of 1934, as amended.  This is our first periodic filing since the third quarter of 2010, although we have made certain filings on Form 8-K.  Included in this report are the audited financial statements for the years ended December 31, 2010 and 2011 as well as unaudited quarterly financial information for the 2011 interim periods.
This annual report should be read together and in connection with the other reports filed by us with the SEC for a comprehensive description of our current financial condition and operating results.  In the interest of complete and accurate disclosure, we have included current information in this annual report for all material events and developments that have taken place through the date of filing of this annual report with the SEC.
ITEMItem 1.  BUSINESSBusiness
 
General
 
We areAemetis is an international renewable fuels and specialty chemicalbiochemicals company focused on the production of advanced fuels and chemicals andthrough the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products and convertby conversion of first-generation ethanol and biodiesel plants into advanced biorefineries.
Aemetis operates in threetwo reportable geographic segments:  “North America”, “India”, and “Other.“India.”  For revenue and other information regarding Aemetis’ operating segments, see Note 11.13- Segment Information, of the Notes to Consolidated Financial Statements in Part II, Item 8 of this Form 10-K, which is incorporated herein by reference.10-K.
 
1

Aemetis was incorporated in Nevada in 2006.
 
2010 Highlights
In 2010, we were primarily engaged in three activities: (i) fundraising for the retrofit ofWe own and operate a 55 million gallon per year (MGY)capacity ethanol plantproduction facility located in Keyes, California, pursuantCalifornia.  The facility produces its own combined heat and power (CHP) through the use of a natural gas-powered steam turbine, and is designed to a Project Agreementreuse 100% of its process water with Cilion, Inc.; (ii) owningzero water discharge.  In addition to ethanol, the Keyes plant produces Wet Distillers Grains (WDG), corn oil, and operatingCondensed Distillers Soluables (CDS), all of which are sold to local dairies and feedlots for animal consumption.  The primary feedstock for the production of low carbon fuel ethanol at the Keyes facility is yellow dent corn specified as number two.  The corn is procured from various Midwestern grain facilities and shipped, via Union Pacific Rail Road, to an unloading facility adjacent to the plant.
The Company owns and operates a biodiesel production facility in Kakinada, India with a nameplate capacity of 50 million gallons per year which is equal to 150,000 metric tons per year;year.  We believe this facility is one of the largest biodiesel production facilities in India on a nameplate capacity basis.  Our objective is to continue to capitalize on the substantial growth potential of the industry in India and (iii) continuing to developestablished markets in the EU and US.
3

Strategy
Key elements of our proprietary, patented and patent pending microbial and enzyme technology.strategy include:
 
North America
 
RetrofitLeverage Approved Feedstock Pathways. When economically advantageous, we will also utilize grain sorghum (“milo”) as a lower carbon, advanced feedstock for the production of EPA-approved advanced biofuels. Aemetis has been approved to use the grain sorghum Pathway (in combination with landfill gas and CHP) for the production of Advanced Biofuels and associated higher value D5 RINs. While Aemetis has processed a significant amount of grain sorghum through the Keyes CA Ethanol Plantfacility during 2013, economics in 2014 favored the use of corn over milo.  This was largely due to the significant export demand for milo by China. These conditions continued into 2015.
 
In December 2009, we enteredLeverage the Keyes plant infrastructure and location.  As milo becomes price-competitive with corn, Aemetis Keyes has the brokerage and infrastructure relationships in place to incorporate this feedstock into a Project Agreement with Cilion, Inc.production without delay. Through its strategic location near the Port of Stockton and adjacent access to retrofit, re-startthe Union Pacific railroad, the Aemetis Keyes facility can, and operate a 55 MGY ethanol plant inhas, procured grain sorghum from both international and domestic sources.  Additionally, the Keyes California.  In December 2009 wefacility has ready access to biogas through its existing infrastructure for the production of Advanced Biofuels under the approved EPA Pathway.  We have also entered into a three year (subsequently extendedmulti-year contract with Chromatin, Inc., an advanced grain sorghum seed and technology provider, to establish a five year) Lease Agreementmulti-thousand acre local grain sorghum growing program with Cilion,farmers in California’s Central Valley.  In 2014, Aemetis was awarded a $3 million dollar matching grant from the termCalifornia Energy Commission for the acquisition of which would begin upon substantial completionmilo for the production of lower carbon fuel ethanol, and to fully develop the in-state grain sorghum growing program.
Leverage technology for the development and production of additional Advanced Biofuels and renewable chemicals. In July 2011, we acquired Zymetis, Inc., a biochemical research and development firm, with several patents pending and in-process R&D utilizing the Z-microbe™ to produce renewable chemicals and advanced fuels from renewable feedstocks. Aemetis now has nine granted patents for the production of advanced biofuels.  Our objective is to continue to commercialize this technology and expand the production of advanced biofuel technologies and other bio-chemicals in the United States.
Diversify and expand revenue and cash flow by continuing to develop and adopt value-added byproduct processing systems.  During April 2012, we installed a corn oil extraction unit at the Keyes plant and began extracting corn oil for sale into the livestock feed market beginning in May 2012.  During 2014, we installed a second corn oil extraction system to further improve corn oil yields from this process. During the fourth quarter of 2014, we entered into an agreement to construct a liquid CO2 facility at the Keyes plant.  We continue to evaluate and, as allowed by available financing and incremental profitability, adopt additional value-added processes that increase the value of the retrofit.  During 2010, substantiallyethanol, distillers grain, corn oil and CO2 produced at the Keyes plant, including, as described further below, adding liquefied CO2 processing capability.
Joint venture or license Aemetis technologies to other ethanol and biodiesel plants.  After developing and commercially demonstrating technologies at the Keyes and/or India plants, we plan to explore and evaluate opportunities for joint ventures or to license our technologies to the other approximately 200 ethanol plants and hundreds of biodiesel plants in the US, as well as plants in Brazil, Argentina, India and elsewhere.
Evaluate and pursue technology acquisition opportunities.  We intend to evaluate and pursue opportunities to acquire technologies and processes that result in accretive value opportunities as financial resources and business prospects make the acquisition of these technologies advisable. In addition, we may also seek to acquire companies or form licensing agreements or joint ventures with companies that offer prospects for the adoption of accretive technologies.
Acquire additional biofuels production facilities. There are approximately 200 ethanol plants in the US that could be upgraded to expand revenues and improve cash flow using technology commercially deployed or licensed by Aemetis.  On an opportunistic basis, we will evaluate the benefit of acquiring ownership of a portion of or all of our activities in North America were focused on fundraising and retrofitting the Keyesother or biodiesel production facilities, or entering into joint-venture or licensing agreements with other ethanol, plant.  We took possession of the plant in the second quarter of 2010 and began the retrofit shortly thereafter.  On October 29, 2010 and March 9, 2011 the parties amended the Project Agreement and the Lease Agreement to, among other things, extend the date by which substantial completion of the retrofit was required, extend the term of the Lease, and waive certain defaults under the Project Agreement.  On April 1, 2011 the retrofit was substantially completed and the Lease term began.  The plant became operational in the second quarter of 2011.  We raised a total of $8.0 million in debt financing to retrofit the plant with an initial raise of $4.5 million in 2010 and an additional raise of $3.5 million in early 2011.  For more information regarding this debt financing, see Note 5. Notes Payable of the Notes to Consolidated Financial Statements in Part II, Item 8 of this Form 10-K, which is incorporated herein by reference.renewable diesel, or renewable jet fuel facilities.
4

 
India
 
Capitalize on recent policy changes by the Government of India, particularly those to reduce the subsidies on diesel and to reduce restrictions on sales of fuel into the transportation markets.  We plan to expand our marketing channels for the traditional bulk and transportation biodiesel markets, which are becoming more economically attractive as a result of the reduction of government subsidies on petroleum diesel (biodiesel is not subsidized in India) and policies to further open sales into the bulk fuel markets.
Expand alternative market demand for biodiesel and its byproducts.  We plan to create additional demand for our biodiesel and its byproducts by developing additional alternative markets.  In 2011, we began selling biodiesel to textile manufacturers for use as an anti-static chemical.  In the first quarter of 2012, we completed glycerin refining and oil pre-treatment units and began selling refined glycerin to manufacturers of paints and adhesives.  In 2012, our India subsidiary received an Indian Pharmacopeia license, which enables the sale of refined glycerin to the pharmaceutical industry in India.
Continue to develop international markets.  We expect to increase sales by selling our biodiesel into international markets during the summer months, when biodiesel use in Europe increases with the onset of warmer weather.  In 2014 and 2013, we had sales of $4.5 million and $11.6 million into the European market, respectively.  During 2014, we received the certifications necessary to meet the ISCC standard, allowing for further access to European markets for our biodiesel products.
Diversify and expand our products.  In 2012, we completed a glycerin refinery, enabling the upgrade of crude glycerin to refined glycerin using glycerin from our own and operatebiodiesel production (the byproduct of biodiesel production is crude glycerin) or crude glycerin purchased from domestic or foreign sources.  In 2014, we completed the construction of a biodiesel manufacturingdistillation column, which allows us to produce a high-quality biodiesel product meeting European Union standards.
Diversify our feedstocks from India and international sources.  We designed our Kakinada plant in Kakinada, India with a nameplate capacitythe capability to produce biodiesel from multiple feedstocks.  In 2009, we began to produce biodiesel from NRPO.  In 2012, we completed an oil pre-treatment unit, which enables us to convert crude palm oil into NRPO, which can either be sold or used to produce biodiesel.  During 2014, we further diversified our feedstock with the introduction of 150,000 metric tonsanimal oils and fats, which we used for the production of biodiesel (approximately 50 million gallons) and 18,000 metric tons of glycerin (approximately 3.8 million gallons) per annum.  Ourto be sold into the European markets.  The plant is capable of producing biodiesel from multiple feedstocks. In 2010, our primary feedstock was non-edible refined palmused cooking oil (NRPO)(UCO), a byproductwhich can be supplied from China, the Middle East and other foreign markets, as well as domestic India suppliers.
Develop and commercially deploy technologies to produce high-margin products. The technology applicable to the Keyes ethanol plant for the upgrade of palmcorn oil fractionation and a non-edible feedstock, which we sourced from suppliersinto valuable, high-margin products also applies to the Kakinada plant in India.  In 2010,By using the existing equipment, process controls, utilities and personnel at the India plant, we sold 7,598 metric tons of biodieselplan to produce high-value products more quickly and at an average price of $849 per ton, which represented 80% of our consolidated 2010 revenue.a lower capital and operating cost than greenfield projects.
 
Crude glycerin is a natural byproduct of the biodiesel production process.  In 2010, we produced and sold 1,046 metric tons of crude glycerin at an average price of $350 per metric ton.
The following table sets forth information about our production and sales of biodiesel, crude glycerin and NRPO in 2010 and 2009.
  2010  2009  % Change 
Biodiesel         
Tons Sold(1)
  7,598   13,349   (43%)
Average Sales Price/Ton
 $849  $658   29%
Crude Glycerin            
Tons Sold
  1,046   1,964   (47%)
Average Sales Price/Ton
 $350  $237   48%
NRPO            
Tons Sold
  1,434   -   (100%)
Average Sales Price/Ton
 $923   -   100%
(1)1 metric ton is equal to 1,000 kilograms (approximately 2,205 pounds).
Biodiesel production declined in 2010 due to high feedstock prices.  Although production declined markedly, revenues decreased slightly to $8.1 million in 2010 from $9.2 million in 2009 as a result of higher average sales prices.
2

20112014 Highlights
 
North America
 
In the second quarter of 2011, we successfully completed the retrofit of the Keyes, CA ethanol plant and in late April 2011 began operating the plant pursuant to a 5-year lease agreement with Cilion, Inc.  The Keyes plant is a dry mill ethanol production facility currently utilizing corn as feedstock.  In addition, the plant produces high quality wet distillers grains (WDG) and a small amount of condensed distillers soluble (CDS) as byproducts of the ethanol production process, which are sold as a high protein, livestock feed supplement.
The plant is located adjacent to the Union Pacific Railroad and Highway 99, two major transportation arteries in California’s Central Valley region, providing convenient transportation to and from the plant for inbound feedstock and outbound feed and fuel.
During 2011,2014, we produced threefour products at the Keyes plant:  denatured ethanol, WDG, corn oil, and CDS.  In 2011 weWe sold 100% of the ethanol and WDG we produced to J.D. Heiskell pursuant to a Purchase Agreement established with J.D. Heiskell.  J.D. Heiskell in turn sells 100% of our ethanol to Kinergy and 100% of our WDG to A.L. Gilbert, a local feed and grain business. Corn oil is sold directly by Aemetis to local animal feedlots (primarily poultry) as well as feed mills for use in various animal feed products. Small amounts of CDS were sold to various local third parties.parties as an animal feed supplement.  Ethanol pricing for sales to J.D. Heiskell is determined pursuant to a marketing agreement between the Company and Kinergy Marketing LLC, and is generally based on daily and monthly pricing for ethanol delivered to Los Angeles, California,the San Francisco Bay Area as published by the Oil Price Information Service (OPIS), as well as quarterly contracts negotiated by Kinergy with localnumerous fuel blenders.  The price for WDG is determined monthly pursuant to a marketing agreement between the Company and A.L. Gilbert Co., and is generally determined in reference to the local price of dry distillers grains (DDG), corn, and corn.
The following table sets forth information about our production and sales of ethanol and WDG in 2011.
  2011 
Ethanol   
Gallons Sold (in 000s)
  37,389 
Average Sales Price/Gallon
 $2.89 
WDG    
Tons Sold (in 000s)
  274 
Average Sales Price/Ton
 $85.37 
During 2011 we continued to spend research and development dollars exploring the viability of commercializing our integrated cellulose and starch ethanol technology and in July 2011, we acquired Zymetis, Inc., a biochemical research and development firm, with several patents pending and in-process R&D utilizing the Z-microbe™ (a marine organism originally discovered consuming plant cellulose at a high rate in the Chesapeake Bay) to produce renewable chemicals and advanced fuels from renewable feedstocks.
India
The market for biodiesel in 2011 was very challenging and as a result the Company’s production of biodiesel and crude glycerin remained static although revenues increased as a result of an increase in average sale prices.  In 2011, our primary feedstock for the production of biodiesel continued to be NRPO, a byproduct of palm oil fractionation and a non-edible feedstock, which we sourced from suppliers in India.
In response to difficult market conditions, during 2011, the Company took the opportunity to perform routine maintenance and to complete the plant’s glycerin refining and oil pretreatment units. The glycerin refining and oil pre-treatment units were completed in the firstquarter of 2012.  The glycerin refining unit enables us to produce and sell refined glycerin and the oil pre-treatment unit enables us to refine crude palm oil into refined palm oil.  In addition, in the first quarter of 2012, our India subsidiary received an Indian Pharmacopeia license, which enables it to sell refined glycerin to the pharmaceutical industry in India.  In the third quarter of 2011, in order to develop a market for our refined glycerin, we imported 1,000 metric tons of refined glycerin, which we sold in 2011 and 2012.  In 2011, we did not produce any refined glycerin.
In 2011, the Company began to explore other markets for its products and developed a customer base in the textile industry for its biodiesel and in the paints and adhesives market for its refined glycerin.protein feedstuffs.
 
 
35

 
 
The following table sets forth information about our production and sales of ethanol and WDG for 2014 compared with 2013:
  2014  2013  % Change 
Ethanol         
Gallons Sold (in 000s)
  60,197   42,390   42%
Average Sales Price/Gallon
 $2.54  $2.62   (3)%
WDG            
Tons Sold (in 000s)
  408   301   36%
Average Sales Price/Ton
 $91.81  $100.47   (9)%

On January 15, 2013 our ethanol production facility was idled due to unfavorable market conditions and to conduct maintenance on the plant for the first time since commencing ethanol production in April 2011.  In April 2013, we restarted our ethanol production facility and ran the plant on a continual basis through the rest of the year.
India
The market for biodiesel showed signs of improving during early 2014 upon completion of our biodiesel distillation facility and receipt of the certifications necessary to meet the ISCC standard which opened sales channels into the European Union.  The Company’s production of biodiesel in 2014 decreased compared to 2013 due to the rising price of NRPO resulting in uncompetitive pricing for sales into European markets.  In 2014, we expanded our feedstock to include oils and fats as well as NRPO, a byproduct of palm oil refining and a non-edible feedstock, which we sourced principally from suppliers in India.
In 2014, we produced four products at the India plant:  biodiesel, crude glycerin, refined glycerin, and NRPO / Stearin.  Crude glycerin held in inventory or produced as a by-product of the biodiesel production was further processed into refined glycerin and crude palm oil was further processed into refined palm oil for sale to customers.  During portions of 2013 and 2014, we were able to utilize our refining unit to refine crude palm oil into NRPO and subsequently sell the NRPO at a more attractive margin than converting NRPO into biodiesel or earn a fixed fee for processing the NRPO.  Additionally, crude glycerin was purchased on the open market and further processed to fill the demand for refined glycerin.
The following table sets forth information about our production and sales of biodiesel, crude and refined glycerin and NRPO in 20112014 and 2010.2013:
 
 2011  2010  % Change  2014  2013  % Change 
Biodiesel                  
Tons sold (1)
  8,636   7,598   14%  9,036   19,354   (53)%
Average Sales Price/Ton
 $1,001  $849   18% $985  $929   6%
Crude Glycerin            
Tons sold
  23   1,046   (98%)
Average Sales Price/Ton
 $643  $350   84%
Refined Glycerin                        
Tons sold
  772   -   -   2,236   4,913   (54)%
Average Sales Price/Ton
 $787   -   -  $933  $940   (1)%
NRPO Stearin            
NRPO / Stearin            
Tons Sold
  588   1,434   (59%)  -   8,227   (100)%
Average Sales Price/Ton
 $1,024  $923   11%  -  $980   (100)%
CPO            
Tons Sold
  -   2,000   (100)%
Average Sales Price/Ton
  -  $958   (100)%

(1)1 metric ton is equal to 1,000 kilograms (approximately 2,204 pounds).
 
The plant was originally designed to include four production units:  biodiesel, refined glycerin, oil refining and fractionation.  To date, the biodiesel, refined glycerin and oil refining units have been completed.  In order to complete the fractionation unit, the Company will need to purchase and install additional equipment forat an additional cost of approximately $2 million.
 
Strategy
During 2014 the Indian government completed their plan to eliminate subsidies for diesel and allowed the domestic price to float to the market price. Our goalbiodiesel pricing is indexed to the price of petroleum diesel, and as such, the increase in the price of petroleum diesel is expected to favorably impact the profitability of our Indian operations.  During 2013, the Company began construction of a biodiesel distillation column allowing for the biodiesel produced at the Kakinada plant to be a leadermore readily adopted by customers in the production of advanced fuelsEuropean Union due to its higher purity levels, and specialty chemicals from renewable sourcesbegan certification requirements necessary to meet increasing market demandthe European Union International Sustainability and Carbon Certification (“ISCC”) standard.  The biodiesel distillation column and the ISCC certification were completed in January 2014, allowing for such products, andfurther access to reduce overall dependence on petroleum-based fuels and chemicals in an environmentally responsible manner.
India
The Company owns and operates aEuropean markets for our biodiesel production facility in Kakinada, India with a nameplate capacity of 150,000 metric tons per year. This facility is one of the largest biodiesel production facilities in India on a nameplate capacity basis. Our objective is to continue to capitalize on the substantial growth potential of the industry. Key elements of our strategy include the following:
●  
Expand market demand for biodiesel and its byproducts. We plan to create additional demand for biodiesel and its byproducts by looking for alternative markets.  In 2011, we began selling biodiesel to textile manufacturers.  In addition, in the fourth quarter of 2011 we completed glycerin refining and oil pre-treatment units and began selling refined glycerin to manufacturers of paints and adhesives.  In 2012, our India subsidiary received an Indian Pharmacopeia license, which enables it to sell refined glycerin to the pharmaceutical industry in India.  We also expect to increase sales by selling our biodiesel into the international market during the summer months when biodiesel use in Europe and the United States increases with the onset of warmer weather.  In 2011, we had two sales in the aggregate amount of $6.86 million and in 2010 we had no sales, respectively, into the European market.
●  
Diversify our feedstocks. We designed our Kakinada plant with the capability of producing biodiesel from multiple-feedstocks. In 2009 we began to produce biodiesel from NRPO.  In 2011 we completed an oil pre-treatment unit, which enables us to convert crude palm oil into refined palm oil, which can either be sold or used to produce biodiesel.
North America
In 2007, we acquired patent-pending enzyme technology to enable the production of ethanol from a combination of starch and cellulose, or from cellulose alone, and in July 2011, we acquired Zymetis, Inc., a biochemical research and development firm, with several patents pending and in-process R&D utilizing the Z-microbe™ to produce renewable chemicals and advanced fuels from renewable feedstocks.  Our objective is to continue to look for ways to commercialize this technology to expand the production of cellulosic ethanol and other bio-chemicals in the United States.products.
 
 
46

 
 
Competition
 
North America
 
In 2011,2014, there were overapproximately 200 operating commercial corn ethanol production facilities in operation in the U.S. with a combined production of nearly 13.5 billion gallons,approximately 14.033 BGY and operating capacity of 15.6 BGY, according to the Renewable Fuels Association (RFA).  The production of ethanol is a commoditycommodity-based business, and producers compete on the basis of price.  We sell ethanol into the Northern California market; however, since insufficient production capacity exists in California to supply the state’s total fuel demand (in excess of one billion gallons), we compete with ethanol transported into California from the Midwest.  Similarly, our co-products, principally WDG and corn oil, are sold into California markets and compete with distillers grains and corn oil transported into the California markets as well as alternative feed products including corn.
 
India
 
With respect to biodiesel sold as fuel, we compete primarily with the producers of petroleum diesel, which are the three state-controlled oil companies:  Indian Oil Corporation, Bharat Petroleum and Hindustan Petroleum, and two private oil companies:  Reliance Petroleum and Essar Oil, all of whom have significantly larger market shares than us,we do and control a significant share of the distribution network.  These competitors may also purchase our product for blending and further sales to their customers.  We compete primarily on the basis of price.  The price of biodiesel is indexed to the price of petroleum diesel, which, is setduring 2014, was allowed to float to market pricing by the Indian government.  In addition,Prior to 2014, the Indian government subsidized state-controlled oil companies are subsidized by the India government creating a disparity between the cost of oil on the open market and the price we cancould obtain from sales of biodiesel.  In September 2012,2014, the Indian government provided partial relief by raisingeliminated its subsidization of the priceState-controlled oil float. We believe the elimination of diesel by 5 rupee per liter.  Ifsubsidies and the Indian government werelifting of certain restrictions to significantly reduce diesel prices, or ifthe sale of bulk fuels will have a positive effect on our oil company competitors were to significantlymargins and will increase production of petroleum diesel, ourthe business, operating results and financial condition could be adversely affected.of our India segment during 2015.  With respect to international markets, principally the European markets, we compete with biodiesel from Europe, Argentina, Indonesia and Malaysia, some of which subsidize their biodiesel industry using government payment and taxation programs to promote the sales of their products into these markets.
 
With respect to biodiesel sold for manufacturing purposes, we compete with specialty chemical manufacturers selling products into the textile industries primarily on the basis of price,price; and with respect to crude and refined glycerin, we compete with other glycerin producers and refiners selling products into the personal care, paints and adhesive markets primarily on the basis of price and product quality.
 
Customers
 
North America
 
One hundred percent (100%)All of our ethanol and WDG are sold to J.D. Heiskell pursuant to a Purchase Agreement.purchase agreement.  J.D. Heiskell in turn sells 100%all of our ethanol to Kinergy and 100%all of theour WDG to A.L. Gilbert.  Kinergy markets and sells our ethanol to petroleum refiners and blenders in Northern California.  A.L. Gilbert markets and sells our WDG to approximately 200 dairy and feeding operators in Northern California.
 
India
 
For the fiscal years ended December 31, 2011During 2014, three customers in paints and 2010, no single customerpersonal care products industries within India accounted for more than80% of our refined glycerin sales and, three customers from India and one customer from Europe accounted for 80% of biodiesel sales.  During 2013, three customers in paints and personal care products industries within India accounted for 79% of our refined glycerin sales, two customers in edible oils and products industry within India accounted for 97% of our refined palm oil sales, one customer from European continent accounted for 69% of biodiesel sales. Three customers and two customers exceeded 10% of our total revenues. The level of sales to any customer may vary from quarter to quarter.during the year ended 2014 and 2013, respectively.
 
Pricing
India
In India the price of biodiesel is based on the price of petroleum diesel, which is established by the India government.  Biodiesel sold into Europe is based on the spot market price. We sell our biodiesel primarily to resellers, distributors and refiners on an as-needed basis. We have no long-term sales contracts.
 
North America
 
We sell 100% of the ethanol and WDG we produce to J.D. Heiskell.  Ethanol pricing is determined pursuant to a marketing agreement between the Company and Kinergy Marketing LLC, and is generally based on daily and monthly pricing for ethanol delivered to Los Angeles,the San Francisco Bay area in California, as published by the Oil Price Information Service (OPIS), as well as the terms of quarterly contracts negotiated by Kinergy with local fuel blenders.blenders and available premiums for fuel with low Carbon Intensity (CI) as provided by California’s Low Carbon Fuel Standard (LCFS).  The price for WDG is determined monthly pursuant to a marketing agreement between the Company and A.L. Gilbert Co., and is generally determined in reference to the price of dry distillers grains (DDG), corn, and corn.other protein feedstuffs.
 
 
57

 
India
In India, the price of biodiesel is based on the price of petroleum diesel, which floats with changes in the price determined by the international markets.  Biodiesel sold into Europe is based on the spot market price.  We sell our biodiesel primarily to resellers, distributors and refiners on an as-needed basis.  We have no long-term sales contracts.  Our biodiesel pricing is indexed to the price of petroleum diesel, and the increase in the price of petroleum diesel is expected to favorably impact the profitability of our India operations.
 
Raw Materials and Suppliers
 
North America
 
In March 2011, weWe entered into a Corn Procurement and Working Capital Agreement with J.D. Heiskell.  Pursuant toHeiskell in March 2011 which we amended in May 2013 (the “Heiskell Agreement”). Under the agreementHeiskell Agreement, we agreed to procure whole yellow dent corn from J.D. Heiskell.  We have the ability to obtain corn from other sources subject to certain conditions, however, in 20112014, all of our corn requirements were purchased from Heiskell.  Title to the corn and risk of loss passespass to us when the corn is deposited in the weigh bin.ground for production at our Keyes facility.  We also purchased grain sorghum from J.D. Heiskell during 2014.  The initial term of the Heiskell Agreement expired on December 31, 2011 and2013, but the agreement is automatically renewed for additional one-year terms, currentlyterms. The current term is set to expire on December 31, 2012.2015.
 
India
 
Surrounding our plant in Kakinada, India, are a number of edible oil processing facilities that produce NRPO as a byproduct.  In 2010, 100%2013, all of our biodiesel was produced from NRPO, which we obtained from sources surrounding the plant.  The receiving capabilities of the plant allow for import of feedstock using the local port at Kakinada.  During 2014 and 2013 we imported crude palm oil for further processing into refined palm oil and imported crude glycerin for further processing into refined glycerin.  In addition to feedstock, our plant requires quantities of methanol and chemical catalysts for use in the biodiesel production process.  These chemicals are also readily available and sourced from a number of suppliers surrounding the plant.  We are not dependent on sole source or limited source suppliers for any of our raw materials or chemicals.
 
Sales and Marketing
 
North America
 
As part of our obligations under the Corn Procurement and Working Capital Agreement, in March 2011, we entered into a Purchase Agreementpurchase agreement with Heiskell, pursuant to which we granted Heiskell exclusive rights to purchase 100% of the ethanol and WDG we produce at prices based upon the price established by the Company pursuant to marketing agreements with Kinergy and A.L. Gilbert.  In turn, Heiskell agreed to resell all the ethanol to Kinergy (or any other purchaser we designate) and all of the WDG to A.L. Gilbert.
 
In March 2011, we entered into a WDG Purchase and Sale Agreement with A.L. Gilbert Company, pursuant to which A.L. Gilbert agreed to market on an exclusive basis all of the WDG we produce.  The initial term of the Agreement expired on December 31, 2011 and is automatically renewed for additional one-year terms, currently to December 31, 2012.2015.
 
In October 2010, we entered into an exclusive marketing agreement with Kinergy Marketing LLC to market and sell our ethanol.  The initial term of the Agreement expiresexpired on August 31, 2013, andbut the agreement is automatically renewed for additional one-year terms. The current term is set to expire on August 31, 2015.
 
India
 
We sell our biodiesel and crude glycerin (i) to end-users utilizing our own sales force and independent sales agents;agents and (ii) to brokers who resell the product to end-users.  We pay a sales commission on sales arranged by independent sales agents.
 
8

Commodity Risk Management Practices
 
North America
 
The cost of corn and the price of ethanol are volatile and are reasonably well correlated.the correlation of these commodities form the basis for the profit margin at our Keyes Plant. We are, therefore, exposed to moderate commodity price risk.  Our risk management strategy is to purchaseoperate in the physical market by purchasing corn and sellselling ethanol on a daily basis at the then prevailing market price.  We monitor these prices weeklydaily to test for an overall positive variable contribution margin. We periodically explore methods of mitigating the volatility of our commodity prices however, we have yet to engage in any hedging or forward purchase activity. In addition, we are actively pursuingand during the identification and adoptionfourth quarter of technologies and processes2014 entered into a contract that would lessenfixed our dependencepricing on the traditionaltransportation and corn basis components of price as a measure to limit the risk of a rapidly rising transportation cost component.  In second half of 2013, we purchased grain sorghum as a substitute for corn with generally positive economic results.  We intend to opportunistically purchase grain sorghum and ethanol commodity markets atuse it to produce lower carbon advanced biofuel, when market conditions present favorable conditions.  Similarly, with the Keyes plant.EPA certification received in August 2013, we intend to opportunistically purchase the combination of grain sorghum and biogas to generate Advanced Biofuel RIN credits, when market conditions present favorable margins.
 
India
 
The cost of NRPO and the price of biodiesel are volatile and are generally uncorrelated.  We therefore are therefore, exposed to ongoing and substantial commodity price risk.  Our risk management strategy is to produce biodiesel in India only when we believe we can generate positive gross margins and to idle the plant during periods of low or negative gross margins.  In addition, in 20112013, we begancontinued to look for customersdevelop markets and expand our customer base outside of the fuels market.
6

  During 2014, we introduced animal oil and fats as a means of further diversifying our feedstock and improving margins.
 
In addition, to minimize our commodity risk, we have modified the processes within our facility to utilize lower cost NRPO, which enables us to reduce our feedstock costs; however, ourcosts.  Our ability to mitigate the risk of falling biodiesel prices is more limited.  The price of our biodiesel is generally indexed to the price of petroleum diesel, which is set by the Indian government.  There is no establishedDuring January 2014 the Indian government fully lifted subsidies for diesel by increasing the sales price of diesel to the market for biodiesel futures.price.
 
We have in the past, and may in the future, use forward purchase contracts and other hedging strategies,strategies; however, the extent to which we engage in these risk management strategies may vary substantially from time to time depending on our working capital provider’s interest to fund these transactions, market conditions and other factors.
 
Research and Development
 
In July 2011, we acquired Zymetis, Inc., a biochemical research and development firm, with several patents pending and in-process R&D utilizing the Z-microbe™ (a marine organism originally discovered consuming plant cellulose at a high rate in the Chesapeake Bay) to produce renewable chemicals and advanced fuels from renewable feedstocks. Our R&D efforts consist of working with third parties to develop and commercialize our cellulosic ethanolexisting microbial technology, to evaluate third party technologies, and to expand the production of cellulosic ethanol and other renewable bio-chemicals in the United States and the pursuit of patents around this technology.States. The primary objective of this development activity is to optimize the production of ethanol using either our proprietary, patent-pending enzyme technology for large-scale commercial production.production or the evaluation of third party technologies which have promise for large-scale commercial adoption at one of our operating facilities.  Our innovations are protected by fourissued and tenseveral issued or pending patents.  We are in the process of filing additional patents that will further strengthen the Company’s portfolio.  Some core intellectual property has been exclusively and indefinitely licensed from the University of Maryland.  R&D expense was $576,625$0.5 million in 2011each of 2014 and $322,561 in 2010.2013.
 
Patents and Trademarks
 
We have filed a number of trademark applications within the U.S.  We do not consider the success of our business, as a whole, to be dependent on these trademarks.  In addition, we hold nine patents and have three patent applications pendingapplied for five additional patents in the United States in connection with our cellulosic ethanol technologyStates.  We also hold related patents and 4 issued and 10 pendinghave applied for patents in connection withmajor foreign jurisdictions.  Our patents cover the Z-microbe technology acquired from Zymetis, Inc.and production of cellulosic ethanol.  We intend to develop, maintain and secure further intellectual property rights and pursue new patents to expand upon our current patent base.
 
It is possible thatWe have acquired exclusive rights to patented technology in support of the Company will not receive patents for every application it files. Furthermore, when patents are issued, the issued patents may not adequately protect our technology from infringement or prevent others from claiming thatdevelopment and commercialization of our products, infringe the patents of third parties. The Company’s failureand we also rely on trade secrets and proprietary technology in developing potential products.  We continue to protect ourplace significant emphasis on securing global intellectual property could materially harmrights and we are pursuing new patents to expand upon our business. In addition, the Company’s competitors may independently develop similar or superior technology or design around our patents. It is possible that litigation may be necessarystrong foundation for commercializing products in development.
The company has received, and in the future to enforce the Company’s intellectual property rights, to protect its trade secrets or to determine the validity and scope of the proprietary rights of others. Litigation could result in substantial costs and diversion of resources and could materially harm the Company’s business.
The Company may receive in the future, notice ofadditional, claims of infringement of other parties’ proprietary rights.  See Item 3. Legal Proceedings, below.  Infringement or other claims could be asserted or prosecuted against the Company in the future, and it is possible that future assertions or prosecutions could harm our business.  Any such claims, with or without merit, could be time-consuming, result in costly litigation and diversion of technical and management personnel, cause delays in the development of our products, or require the Company to develop non-infringing technology or enter into royalty or licensing arrangements.  Such royalty or licensing arrangements, if required, may require the Company to license back its technology or may not be available on terms acceptable to the Company, or at all. For these reasons, infringement claims could materially harm the Company’s business.
9

 
Environmental and Regulatory Matters
India
We are subject to national, state and local environmental laws, regulations and permits, including with respect to the generation, storage, handling, use, transportation and disposal of hazardous materials, and the health and safety of our employees. These laws may require us to make operational changes to limit actual or potential impacts to the environment. A violation of these laws, regulations or permits can result in substantial fines, natural resource damages, criminal sanctions, permit revocations and/or facility shutdowns. In addition, environmental laws and regulations (and interpretations thereof) change over time, and any such changes, more vigorous enforcement policies or the discovery of currently unknown conditions may require substantial additional environmental expenditures.
7

 
North America
 
We are subject to extensive federal, state and local environmental laws, regulations and permit conditions, (and interpretations thereof), including those relating to the discharge of materials into the air, water and ground, the generation, storage, handling, use, transportation and disposal of hazardous materials, and the health and safety of our employees.  These laws, regulations, and permits require us to incur, on an annual basis, significant capital costs.  These include, but are not limited to, testing and other costs, including costsmonitoring plant emissions, and where necessary, obtaining and maintaining mitigation processes to obtain and maintain expensive pollution control equipment.comply with regulations.  They may also require us to make operational changes to limit actual or potential impacts to the environment.  A significant violation of these laws, regulations, permits or permitlicense conditions could result in substantial fines, natural resource damages, criminal sanctions, permit revocations and/or facility shutdowns.  In addition, environmental laws and regulations (and interpretations thereof) change over time, and any such changes, more vigorous enforcement policies or the discovery of currently unknown conditions may require substantial additional environmental expenditures.
 
We are also subject to potential liability for the investigation and cleanup of environmental contamination at each of the properties that we may own or operate and at off-site locations where we arrangedarrange for the disposal of hazardous wastes.  If significant contamination is identified at our properties in the future, costs to investigate and remediate this contamination as well as any costs to investigate or remediate associated natural resource damagesdamage could be significant.  If any of these sites are subject to investigation and/or remediation requirements, we may be responsible under the Comprehensive Environmental Response, Compensation and Liability Act of 1980 (“CERCLA”) or other environmental laws for all or part of the costs of such investigation and/or remediation, and for damagesdamage to natural resources.  We may also be subject to related claims by private parties alleging property damage or personal injury due to exposure to hazardous or other materials at or from such properties.  While costs to address contamination or related third-party claims could be significant, based upon currently available information, we are not aware of any material contamination or any such third party claims.  WeBased on our current assessment of the environmental and regulatory risks, we have not accrued any amounts for environmental matters as of December 31, 2011.2014.  The ultimate costs of any liabilities that may be identified or the discovery of additional contaminants could materially adversely impact our results of operation or financial condition.
 
In addition, the hazardsproduction and risks associated with producing and transportingtransportation of our products (such as fires, natural disasters, explosions, and abnormal pressures) may result in spills or releases of hazardous substances, orwhich could result in claims from governmental authorities or third parties relating to actual or alleged personal injury, property damage, or damagesdamage to natural resources.  We maintain insurance coverage against some, but not all, potential losses caused by our operations.  Our general and umbrella liability policy coverage includes, but is not limited to, physical damage to assets, employer’s liability, comprehensive general liability, automobile liability and workers’ compensation.  We do not carry environmental insurance.  We believe that our insurance is adequate for our industry, but losses could occur for uninsurable or uninsured risks or in amounts in excess of existing insurance coverage.  The occurrence of events which result in significant personal injury or damage to our property, natural resources or third parties that is not covered by insurance could have a material adverse impact on our results of operations and financial condition.
 
Our air emissions are subject to the federal Clean Air Act, and similar State laws, which generally require us to obtain and maintain air emission permits for our ongoing operations as well as for any expansion of existing facilities or any new facilities.  Obtaining and maintaining those permits requires us to incur costs, and any future more stringent standards may result in increased costs and may limit or interfere with our operating flexibility.  These costs could have a material adverse effect on our financial condition and results of operations.  Because other ethanol manufacturers in the U.S. are and will continue to be subject to similar laws and restrictions, we do not currently believe that our costs to comply with current or future environmental laws and regulations will adversely affect our competitive position with other U.S. ethanol producers.  However, because ethanol is produced and traded internationally, these costs could adversely affect us in our efforts to compete with foreign producers who are not subject to such stringent requirements.
 
New laws or regulations relating to the production, disposal or emissionsemission of carbon dioxide and other greenhouse gassesgases may require us to incur significant additional costs with respect to ethanol plants that we build or acquire.  In particular,For example, in 2007, Illinois and four other Midwestern Statesstates entered into the Midwestern Greenhouse Gas Reduction Accord, which program directs participating states to develop a multi-sector cap-and-trade mechanism to help achieve reductions in greenhouse gases, including carbon dioxide.  In addition,We currently conduct our North American commercial activities exclusively in California, however, it is possible that other states in which we conduct or plan to conduct business could join this accord or require other costly carbon dioxide emissions reductions.  Climate Changechange legislation is being considered in Washington, D.C. this year which may significantly impact the biofuels industry'sindustry’s emissions regulations, as will the Renewable Fuel Standard, CaliforniaCalifornia’s Low Carbon Fuel Standard, and other potentially significant changes in existing transportation fuels regulations.
 
10

India
We are subject to national, state and local environmental laws, regulations and permits, including with respect to the generation, storage, handling, use, transportation and disposal of hazardous materials, and the health and safety of our employees.  These laws may require us to make operational changes to limit actual or potential impacts to the environment.  A violation of these laws, regulations or permits can result in substantial fines, natural resource damages, criminal sanctions, permit revocations and/or facility shutdowns.  In addition, environmental laws and regulations (and interpretations thereof) change over time, and any such changes, more vigorous enforcement policies or the discovery of currently unknown conditions may require substantial additional environmental expenditures.
Employees
 
At December 31, 2010,2014, we had a total of 69131 full-time equivalent employees, comprised of 12 full-time equivalent employees in our corporate offices, 13 full-time equivalent employees at our plant in Keyes, California and 44 full-time equivalent employees in India.
At December 31, 2011, we had a total of 112 full-time equivalent employees, comprised of 1615 full-time equivalent employees in our corporate offices, 45 full-time equivalent employees at our plant in Keyes, California, threetwo full-time equivalent employees in our Maryland research and development facility and 4869 full-time equivalent employees in India. None of
We believe that our employees are highly-skilled, and our success will depend in part upon our ability to retain our employees and attract new qualified employees, many of whom are in great demand. We have never had a work stoppage or strike, and no employees are presently represented by a union.labor union or covered by a collective bargaining agreement. We believe our relations with our employees are good.
 
8

Available Information
 
We file reports with the Securities and Exchange Commission (“SEC”). We make available on our website under “Investor Relations,” free of charge, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports as soon as reasonably practicable after we electronically file such materials with or furnish them to the SEC. Our website address is www.aemetis.com. Our website address is provided as an inactive textual reference only, and the contents of that website are not incorporated in or otherwise to be regarded as part of this report. You can also read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549. You may also obtain additional information about the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains an Internet site (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including us.
ITEM 1A.  RISK FACTORS
Item 1A.  Risk Factors
 
We operate in an evolving industry that presents numerous risks that are beyond our control that are driven by factors that cannot be predicted.  Should any of the riskrisks described in this section or in the documents incorporated by reference in this report actually occur, our business, results of operations, financial condition, or stock price could be materially and adversely affected.  Investors should carefully consider the riskrisks factors discussed below, in addition to the other information in this report, before making any investment in our securities.
 
Risks Related to our Overall Business
 
We are currently profitable, but historically, we have incurred significant losses, and may never achieve profitability.losses.  If we continue to incur losses, we may have to curtail our operations, which may prevent us from successfully operating and expanding our business.
 
We haveare currently reporting a history ofprofitable year during 2014, but incurred significant losses.losses in the past.  Historically, we have relied upon cash from debt and equity financing activities to fund substantially all of the cash requirements of our activities and have incurred significant losses and experienced negative cash flow.activities.  As of December 31, 2011,2014, we had an accumulated deficit of $65,526,029.approximately $87.1 million.  For our fiscal years ended December 31, 20112014, 2013 and 2010,2012, we incurredreported a net income of $7.1 million, net loss of $18,296,359$24.4 million and $8,425,253, respectively. We cannot predict whennet loss of $4.3 million, respectively, primarily comprised of interest and fees related to our senior debt.  Despite recent profitability and positive cash flow from operations, we will become profitable or if we ever will become profitable. We may continue to incur losses for an indeterminate period of time and may nevernot achieve or sustainconsistent profitability.  An extended period of losses andor negative cash flow may prevent us from successfully operating and expanding our business.  Even if we are able to achieve profitability, we may be unable to sustain or increase our profitability on a quarterly or annual basis.
 
We are dependent upon our working capital arrangementsagreements with J.D. Heiskell and Secunderabad Oils Limited.
 
Our ability to operate our Keyes plant depends on maintaining our working capital arrangementagreement with J.D. Heiskell (Heiskell), and our ability to operate our biodiesel plant in India depends on maintaining our working capital arrangementagreement with Secunderabad Oils Limited.  The Heiskell agreement provides for an initial term of one year with automatic one-year renewals; provided, however, that Heiskell may terminate the agreement by notice 90 days prior to the end of the initial term or any renewal term.  The current term extends through March 8, 2013.December 31, 2015.  In addition, the agreement may be terminated at any time upon default.a default, such as payment default, bankruptcy, acts of fraud or material breach under one of our related agreements with Heiskell.  The Secunderabad agreement may be terminated at any time by either party upon written notice.  If we are unable to maintain these strategic relationships, we will be required to locate alternative sources of working capital and corn procurement logistics,or sorghum supply, which we may be unable to do in a timely manner or at all.  If we are unable to maintain our current working capital arrangements or locate alternative sources of working capital, our ability to operate our plants will be negatively affected.
 
11

Disruptions in ethanol production infrastructure may adversely affect our business, results of operations and financial condition.
Our business depends on the continuing availability of rail, road, port, storage and distribution infrastructure. In particular, due to limited storage capacity at the Keyes Plant and other considerations related to production efficiencies, the Keyes Plant depends on just-in-time delivery of corn and grain sorghum. The delivery and transformation of feedstock requires a significant and uninterrupted supply of corn and grain sorghum, principally delivered by rail, as well as other raw materials and energy, primarily electricity and natural gas. The prices of rail, electricity and natural gas have fluctuated significantly in the past and may fluctuate significantly in the future. The national rail system, as well as local electricity and gas utilities may not be able to reliably supply the rail logistics, electricity and natural gas that the Keyes Plant will need or may not be able to supply those resources on acceptable terms. Any disruptions in the ethanol production infrastructure, whether caused by labor difficulties, earthquakes, storms, other natural disasters or human error or malfeasance or other reasons, could prevent timely deliveries of corn, grain sorghum or other raw materials and energy and may require the Keyes Plants to halt production which could have a material adverse effect on our business, results of operations and financial condition.
Our results from operations are primarily dependent on the spread between the feedstock and energy we purchase and the fuel, animal feed and other products we sell.
 The results of our ethanol production business in the U.S. are significantly affected by the spread between the cost of the corn and natural gas that we purchase and the price of the ethanol, distillers grains and corn oil that we sell.    Similarly, in India our biodiesel business is primarily dependent on the price difference between the costs of the feedstock we purchase (principally NRPO and crude glycerin) and the products we sell (principally distilled biodiesel and refined glycerin).  The markets for ethanol, biodiesel, distiller grains, corn oil and glycerin are highly volatile and subject to significant fluctuations.  Any decrease in the spread between prices of the commodities we buy and sell, whether as a result of an increase in feedstock prices or a reduction in ethanol or biodiesel prices, would adversely affect our financial performance and cash flow and may cause us to suspend production at either of our plants.
 The price of ethanol is volatile and subject to large fluctuations, and increased ethanol production may cause a decline in ethanol prices or prevent ethanol prices from rising, either of which could adversely impact our results of operations, cash flows and financial condition.
 The market price of ethanol is volatile and subject to large fluctuations. The market price of ethanol is dependent upon many factors, including the supply of ethanol and the demand for gasoline, which is in turn dependent upon the price of petroleum which is also highly volatile and difficult to forecast.  Fluctuations in the market price of ethanol may cause our profitability or losses to fluctuate significantly.  In addition, domestic ethanol production capacity increased significantly in the last decade.  Demand for ethanol may not increase commensurate with increases in supply, which could lead to lower ethanol prices. Demand for ethanol could be impaired due to a number of factors, including regulatory developments and reduced United States gasoline consumption. Reduced gasoline consumption has occurred in the past and could occur in the future as a result of increased gasoline or oil prices.
Decreasing gasoline prices may negatively impact the selling price of ethanol which could reduce our ability to operate profitably.

The price of ethanol tends to change in relation to the price of gasoline. Recently, as a result of a number of factors including the current world economy, the price of gasoline has decreased. In correlation to the decrease in the price of gasoline, the price of ethanol has also decreased. Decreases in the price of ethanol reduce our revenue. Our profitability depends on a favorable spread between our corn and natural gas costs and the price we receive for our ethanol. If ethanol prices fall during times when corn and/or natural gas prices are high, we may not be able to operate profitably.
We may be unable to execute on the Company’sour business plan.
 
The value of our long-lived assets is based on our ability to execute our business plan principally in India and Keyes, California and generate sufficient cash flow to justify the carrying value of this asset.our assets.  Should we fall short of our cash flow projections, we may be required to write down the value of these assets under the accounting rules and further degradereduce the value of our business.assets.  We can make no assurances that our future cash flows will develop and provide us with sufficient cash to maintain the value of these assets, thus avoiding future impairment to our asset carrycarrying values.  As a result, we may need to write down the carrying value of the Company’sour long-lived assets.
 
In addition, we planintend to implement our ownmodify or aadapt third party’s technologyparty technologies at the Keyes ethanol plant and at the India biodiesel plant for the production of advanced fuelsto accommodate alternative feedstocks and specialty chemicals.improve operations.  After we design and engineer a specific integrated upgrade to either or both plants to allow us to produce products other than their existing products, we may not receive permission from the regulatory agencies to install the process at either plant.one or both plants.  Additionally, even if we are able to install and begin operations of an integrated advanced fuels and/or specialty chemicalbio-chemical plant, we cannot give assuranceassure you that the technology will work and produce cost effective products because we have never designed, engineered nor built this technology into an existing bio-refinery.  Similarly, our plans to add a CO­­2­ conversion unit at the Keyes plant may not be successful as a result of financing, issues in the design or construction process, or our ability to sell liquid CO­­2 at cost effective prices.  Any inability to execute on the Company’sour business plan may have a material adverse effect on our operations, financial position, and ability to pay dividends and continue as a going concern.
 
12

 We are dependent on, and vulnerable to any difficulties of, our principal suppliers and customers.
 We buy all of the feedstock for the Keyes plant from one supplier, J.D. Heiskell.  Under our Agreements with Heiskell, we are only permitted to purchase feedstock from other suppliers upon the satisfaction of certain conditions.  In addition, we have contracted to sell all of the WDG, CDS, corn oil and ethanol we produce at the Keyes Plant to Heiskell.  Heiskell, in turn, sells all ethanol produced at the Keyes plant to Kinergy Marketing and all WDG and syrup to A.L. Gilbert.  If Heiskell were to fail to deliver adequate feedstock to our plant or fail to purchase all the product we produce, if Kinergy were to fail to purchase all of the ethanol we produce, if A.L. Gilbert were to fail to purchase all of the WDG and syrup we produce, or if any of them were otherwise to default on our agreements with them or fail to perform as expected, we may be unable to find replacement suppliers or purchasers, or both, in a reasonable time or on favorable terms, any of which could materially adversely affect our results from operations and financial results.
We are currently in default on our term loan with the State Bank of India.
 
On October 7, 2009,March 10, 2011, one of our subsidiaries, Universal Biofuels Pvt. Ltd. (UBPL)(“UBPL”), received a demand notice from the State Bank of India under the Agreement of Loan for Overall Limit dated as of June 26, 2008.  The notice informsinformed UBPL that an event of default hashad occurred for failure to make an installment payment on the loan due incommencing June 2009 and demandsdemanded repayment of the entire outstanding indebtedness of 19.60 crores (approximately $4$3.2 million) together with all accrued interest thereon and any applicable fees and expenses by October 10, 2009.expenses.  Upon the occurrence and during the continuance of an Event of Default,the default, interest accrues at the default interest rate of 2% above the State Bank of India Advance Rate pursuant to the Agreement of Loan for Overall Limit.agreement. The State Bank of India has filed a legal case before the Debt Recovery Tribunal (DRT)(“DRT”), Hyderabad, for recovery of approximately $5$5.9 million against the companyCompany and also impleaded Andhra Pradesh Industrial Infrastructure Corporation (APIIC)(“APIIC”) to expedite the process of registration of Factory land forthe sale deed of the property on which counter replythe UBPL facility is yet to be filed by APIIC.  In the case thatlocated.   If the Company is unable to prevail with itsin this legal case, DRT may pass a Decreedecree for recovery of the amount due, amount, which will impact operations of the company including action up tomay include seizing company property for recovery of their dues.property. Interest continues to accrue at the default rate in the amount of approximately $48,000$66,000 per month during the continuance of default.  If the DRT were to issue an order to seize our India plant and we were unable to successfully stay the order, our operations and financial position would be adversely affected.
 
9

We may be unable to repay or refinance our Third Eye Capital Notes upon maturity.
 
On Under our note facilities with Third Eye Capital Corporation, we owe approximately $57.6 million, excluding debt discounts, as of December 31, 2014.  Our indebtedness and interests payments under these note facilities are currently substantial and may adversely affect our cash flow, cash position and stock price.  These notes are currently due in July 6, 2012, we entered into an amended and restated note purchase agreement for a term note2015 although the maturity can be extended to January 2016 upon payment of certain fees.  We have been able to extend our indebtedness in the amount of $15 million, a revolving facility in the amount of $18 million and a revenue participation note in the amount of $10 million.  These three facilities have varying maturities over the next two years.  Wepast, but we may not be able to continue to extend the maturity of these notes,notes.  We may not have sufficient cash available at the time of maturity to repay this indebtedness,indebtedness.  We have defaultsdefault covenants that may accelerate the maturities orof these notes.  We may not have sufficient assets or cash flow available to support refinancing these notes at market rates or on terms that are satisfactory to us, or at all.us.  If we are unable to extend the maturity of the notes or refinance on terms satisfactory to us, we may be forced to refinance on terms that are materially less favorable, seek funds through other means such as a sale of some of our assets, or otherwise significantly alter our operating plan, any of which could have a material adverse effect on our business, financial condition, and results of operation.operations. Additionally, if we are unable to amend our current note purchase agreement with Third Eye Capital, our ability to pay dividends could be restrained.
 
Our business is affected by greenhouse gasdependent on external financing and climate change regulation.cash from operations to service debt and provide future growth.
 
The operationsadoptions of new technologies at our Keyes plant emits carbon dioxide into the atmosphere.  In 2010, the EPA released its final regulationsethanol and biodiesel plants, along with working capital, are financed in part through debt facilities.  We may need to seek additional financing to continue or grow our operations.  However, generally unfavorable credit market conditions may make it difficult to obtain necessary capital or additional debt financing on RFS2.  We believe the EPA’s final RFS2 regulations grandfather the Keyes facilitycommercially viable terms or at all.  If we operate at its current capacity. Compliance with future legislationare unable to pay our debt we may requirebe forced to delay or cancel capital expenditures, sell assets, restructure our indebtedness, seek additional financing, or file for bankruptcy protection.  Debt levels or debt service requirements may limit our ability to borrow additional capital, make us vulnerable to take action unknownincreases in prevailing interest rates, subject our assets to liens, limit our ability to adjust to changing market conditions, or place us at this time that coulda competitive disadvantage to our competitors.  Should we be costly, require the use of working capital, whichunable to generate enough cash from our operations or secure additional financing to fund our operations and debt service requirements, we may be required to postpone or cancel growth projects, reduce our operations, or may not be available, preventing us from operating as planned, which mayunable to meet our debt repayment schedules.  Any one of these events would likely have a material adverse effect on our operations and cash flow.financial position.
 
13

There can be no assurance that our existing cash flow from operations will be sufficient to sustain operations and to the extent that we are dependent on credit facilities to fund operations or service debt there can be no assurances that we will be successful at securing funding from our senior lender or significant shareholders. Should the Company require additional financing, there can be no assurances that the additional financing will be available on terms satisfactory to the Company.  Our ability to identify and enter into commercial arrangements with feedstock suppliers in India depends on maintaining our operations agreement with Secunderabad Oil Limited, who is currently providing us with working capital for our Kakinada facility.  If we are unable to maintain this strategic relationship, our business may be negatively affected.  In addition, the ability of Secunderabad to continue to provide us with working capital depends in part on the financial strength of Secunderabad and its banking relationships.  If Secunderabad is unable or unwilling to continue to provide us with working capital, our business may be negatively affected.  Our ability to enter into commercial arrangements with feedstock suppliers in California depends on maintaining our operations agreement with J.D. Heiskell, who is currently providing us with working capital for our California ethanol plant.  If we are unable to maintain this strategic relationship, our business may be negatively affected.  In addition, the ability of J.D. Heiskell to continue to provide us with working capital depends in part on the financial strength of J.D. Heiskell and its banking relationships.  If J.D. Heiskell is unable or unwilling to continue to provide us with working capital, our business may be negatively affected.  There is no assurance that UBPL or the Company will be able to obtain alternative funding in the event the State Bank of India demands payment and immediate acceleration would have a significant adverse impact on UBPL or the Company’s near term liquidity and our ability to operate our biodiesel plant.  Our consolidated financial statements do not include any adjustments to the classification or carrying values of our assets or liabilities that might be necessary as a result of the outcome of this uncertainty.
 We may not receive the funds we expect under our EB-5 program
The EB-5 program allows for the issuance of up to 72 subordinated convertible promissory notes, each in the amount of $0.5 million due and payable four years from the date of the note for a total aggregate principal amount of up to $36.0 million. Deposits held in escrow pending investor approval by the U.S. Citizenship and Immigration Services were $22.0 million at December 31, 2014. While $22 million of EB-5 program funds have been received into escrow as of December 31, 2014, the release of those funds to us is subject to the approval of the USCIS, which could take a year or more to obtain.  Additionally, the USCIS could deny approval of the loans, and then we would not receive some or all of the subscribed funds.  If the USCIS takes longer to approve the release of funds in escrow, or does not approve the loans at all, it would have a material adverse effect on our cash flows available for operations, and thus could have a material adverse effect on our results of operations.
 We face competition for our bio-chemical and transportation fuels products from providers of petroleum-based products and from other companies seeking to provide alternatives to these products, many of whom have greater resources and experience than we do, and if we cannot compete effectively against these companies we may not be successful.
Our renewable products compete with both the traditional, largely petroleum-based bio-chemical and fuels products that are currently being used in our target markets and with the alternatives to these existing products that established enterprises and new companies are seeking to produce.  The oil companies, large chemical companies and well-established agricultural products companies with whom we compete are much larger than we are, and have, in many cases, well developed distribution systems and networks for their products.
In the transportation fuels market, we compete with independent and integrated oil refiners, advanced biofuels companies and biodiesel companies. Refiners compete with us by selling traditional fuel products and some are also pursuing hydrocarbon fuel production using non-renewable feedstocks, such as natural gas and coal, as well as processes using renewable feedstocks, such as vegetable oil and biomass. We also expect to compete with companies that are developing the capacity to produce diesel and other transportation fuels from renewable resources in other ways.
 With the emergence of many new companies seeking to produce chemicals and fuels from alternative sources, we may face increasing competition from alternative fuels and chemicals companies. As they emerge, some of these companies may be able to establish production capacity and commercial partnerships to compete with us. If we are unable to establish production and sales channels that allow us to offer comparable products at attractive prices, we may not be able to compete effectively with these companies.
 The high concentration of our sales within the ethanol production industry could result in a significant reduction in sales and negatively affect our profitability if demand for ethanol declines.
 We expect our US operations are to be substantially focused on the production of ethanol and its co-products for the foreseeable future. We may be unable to shift our business focus away from the production of ethanol to other renewable fuels or competing products. Accordingly, an industry shift away from ethanol or the emergence of new competing products may reduce the demand for ethanol. A downturn in the demand for ethanol could materially and adversely affect our sales and profitability.
14

Our operations are subject to environmental, health, and safety laws, regulations, and liabilities.
 
Our operations are subject to various federal, state and local environmental laws and regulations, including those relating to the discharge of materials into the air, water and ground, the generation, storage, handling, use, transportation and disposal of hazardous materials, access to and impacts on water supply, and the health and safety of our employees.  In addition, our operations and sales in India subject us to risks associated with foreign laws, policies, and regulations.  Some of these laws and regulations require our facilities to operate under permits or licenses that are subject to renewal or modification.  These laws, regulations and permits can require expensive emissions testing and pollution control equipment or operational changes to limit actual or potential impacts to the environment.  A violation of these laws and regulations or permitpermits or license conditions can result in substantial fines, natural resource damages, criminal sanctions, permit revocations and facility shutdowns.  We may not be at all times in compliance with these laws, regulations, permits or permitslicenses or we may not have all permits or licenses required to operate our business.  We may be subject to legal actions brought by environmental advocacy groups and other parties for actual or alleged violations of environmental laws, permits or permits.licenses.  In addition, we may be required to make significant capital expenditures on an ongoing basis to comply with increasingly stringent environmental laws, regulations, permit and permits.license requirements.
 
We may be liable for the investigation and cleanup of environmental contamination at the Keyes plant and at off-site locations where we arrange for the disposal of hazardous substances.  If thesehazardous substances have been or are disposed of or released at sites that undergo investigation or remediation by regulatory agencies, we may be responsible under CERCLA or other environmental laws for all or part of the costs of investigation and remediation, and for damage to natural resources.  We also may be subject to related claims by private parties alleging property damage and personal injury due to exposure to hazardous or other materials at or from those properties. Some of these matters may require us to expend significant amounts for investigation, cleanup or other costs.
 
New laws, new interpretations of existing laws, increased governmental enforcement of environmental laws or other developments could require us to make additional significant expenditures.  Continued government and public emphasis on environmental issues can be expected to result in increased future investments for environmental controls at our production facilities.  Environmental laws and regulations applicable to our operations now or in the future, more vigorous enforcement policies and discovery of currently unknown conditions may require substantial expenditures that could have a negative impact on our results of operations and financial condition.  For example, carbon dioxide is a co-product of the ethanol manufacturing process and may be released into the atmosphere.
 
Emissions of carbon dioxide resulting from the manufacturing processethanol are not currently subject to applicable permit requirements.  If new laws or regulations are passed relating to the production, disposal or emissions of carbon dioxide, we may be required to incur significant costs to comply with such new laws or regulations.
 
10

 Our business is affected by greenhouse gas and climate change regulation.
 
Our business The operations at our Keyes plant will result in the emission of carbon dioxide into the atmosphere.  In March 2010, the EPA released its final regulations on the Renewable Fuels Standard Program, or RFS2.  We believe the EPA’s final RFS2 regulations grandfather the Keyes facility we operate at its current capacity, however, compliance with future legislation may suffer if we cannot maintain necessary permitsrequire us to take action unknown to us at this time that could be costly, and require the use of working capital, which may or licenses.
Our operations require licenses, permits and in some cases renewals of these licenses and permitsmay not be available, preventing us from various governmental authorities.  Our ability to obtain, sustain, or renew such licenses and permits on acceptable, commercially viable terms are subject to change,operating as among other things, the regulations and policies of applicable governmental authorities may change.  Any inability to obtain, renew, or the loss of any of these licenses or permitsplanned, which may have a material adverse effect on our operations and financial condition.cash flow.
 
A change in government policies may cause a decline in the demand for our products.
 
The domestic ethanol industry is highly dependent upon a myriad of federal and state regulations and pending legislation, and any changes in legislation or regulation could adversely affect our results of operations and financial position.  Other federal and state programs benefiting ethanol generally are subject to U.S. government obligations under international trade agreements, including those under the World Trade Organization Agreement on Subsidies and Countervailing Measures, and may be the subject of challenges, in whole or in part.  Growth and demand for ethanol and biodiesel is largely driven by federal and state government mandates or blending requirements, such as the Renewable Fuel Standard (RFS).  Any change in government policies which negatively affects our business, maycould have a material adverse effect our business and the results of our operations.
 
Ethanol can be imported into the United States duty-free from some countries, which may undermine the domestic ethanol industry.  Production costs for ethanol in these countries can be significantly less than in the United States and the import of lower price or lower carbon value ethanol from these countries may reduce the demand for domestic ethanol and depress the price at which we sell our ethanol.
 
Waivers of the RFS minimum levels of renewable fuels included in gasoline could have a material adverse effect on our results of operations.  Under the Energy Policy Act, the U.S. Department of Energy, in consultation with the Secretary of Agriculture and the Secretary of Energy, may waive the renewable fuels mandate with respect to one or more states if the Administrator of the Environmental Protection Agency determines that implementing the requirements would severely harm the economy or the environment of a state, a region or the nation, or that there is inadequate supply to meet the requirement.  Any waiver of the RFS with respect to one or more states would reduce demand for ethanol and could cause our results of operations to decline and our financial condition to suffer.
 
We are subject to anti-corruption laws in the jurisdictions in which we operate, including the U.S. Foreign Corrupt Practices Act, or the FCPA. Our failure to comply with these laws could result in penalties, which could harm our reputation and have a material adverse effect on our business, results of operations and financial condition.
15

 
We are subject In November 2013, the EPA initially proposed a waiver to the FCPA, which generally prohibits companiesRFS by reducing the RFS for 2014 from the previous requirement of 18.15 billion gallons to a revised level of 15.21 billion gallons.  The EPA proposal represents a reduction of approximately 16% from the original RFS fuel volume for 2014. The EPA subsequently indicated that they would release the requirements in late fall, and their intermediaries from making improper paymentsthen again pushed the final rule release date to foreign officials for the purpose of obtaining or keeping business and/or other benefits, along with various other anticorruption laws. Although we have implemented policies and procedures designed to ensure that we, our employees and other intermediaries comply with the FCPA and other anticorruption laws to which we are subject, there is no assurance that such policies or procedures will work effectively allearly 2015. As of the time or protect us against liability underdate of this report, the FCPA or other laws for actions taken by our employees and other intermediaries with respectEPA has yet to our business or any businesses that we may acquire. We have manufacturing operations in India, which poses elevated risks of anti-corruption violations, and we export our products for sale internationally. This puts us in frequent contact with persons who may be considered “foreign officials” underrelease the FCPA, resulting in an elevated risk of potential FCPA violations. If we are not in compliance withfinal determination on the FCPA and other laws governing the conduct of business with government entities (including local laws), we may be subject to criminal and civil penalties and other remedial measures, which could have an adverse impact on our business, financial condition, results of operations and liquidity. Any investigation of any potential violations of the FCPA or other anticorruption laws by U.S. or foreign authorities could harm our reputation and have an adverse impact on our business, financial condition and results of operations.revised 2014 RFS requirements.
 
We may encounter unanticipated difficulties in converting the Keyes plant to accommodate alternative feedstocks, new chemicals used in the fermentation and distillation process, or new mechanical production equipment.
 
In order to improve the operations of the Keyes plant and execute on our business plan, we intend to modify the plant to accommodate alternative feedstocks and new chemical and/or mechanical production processes.  We may not be able successfully to implement these modifications, and they may not function as we expect them to.  These modifications may cost significantly more to complete than our estimates.  The plant may not operate at nameplate capacity once the changes are complete.  If any of these risks materialize, they could have a material adverse impact on our results of operation and financial position.
 
11

We may be subject to liabilities and losses that may not be covered by insurance.
 
Our employees and facilities are subject to the hazards associated with producing ethanol and biodiesel.  Operating hazards can cause personal injury and loss of life, damage to, or destruction of, property, plant and equipment and environmental damage.  We maintain insurance coverage in amounts and against the risks that we believe are consistent with industry practice.  However, we could sustain losses for uninsurable or uninsured risks, or in amounts in excess of existing insurance coverage.  Events that result in significant personal injury or damage to our property or to property owned by third parties or other losses that are not fully covered by insurance could have a material adverse effect on our results of operations and financial position.
 
Insurance liabilities are difficult to assess and quantify due to unknown factors, including the severity of an injury, the determination of our liability in proportion to other parties, the number of incidents not reported and the effectiveness of our safety program.  If we were to experience insurance claims or costs above our coverage limits or that are not covered by our insurance, we might be required to use working capital to satisfy these claims rather than to maintain or expand our operations.  To the extent that we experience a material increase in the frequency or severity of accidents or workers’ compensation claims, or unfavorable developments on existing claims, our operating results and financial condition could be materially and adversely affected.
 
Our success depends in part on recruiting and retaining key personnel and, if we fail to do so, it may be more difficult for us to execute our business is dependent on external financing and cash from operations.strategy.
 
The construction, repairs, Our success depends on our continued ability to attract, retain and upgrades ofmotivate highly qualified management, manufacturing and scientific personnel, in particular our ethanolChairman and biodiesel plants, along with working capital, were financedChief Executive Officer, Eric McAfee.  We do not maintain any key man insurance. Competition for qualified personnel in part through debt facilities.  We may need to seek additional financing to continue or grow our operations.  However, our recent financial performancethe renewable fuel and generally unfavorable credit market conditions may make it difficult to obtain necessary capital or additional debt financingbio-chemicals manufacturing fields is intense.  Our future success will depend on, commercially viable terms or at all.  If we are unable to pay our debt we may be forced to delay or cancel capital expenditures, sell assets, restructure our indebtedness, seek additional financing, or file for bankruptcy.  Debt levels or debt service requirements may limitamong other factors, our ability to borrow additional capital, make us vulnerableretain our current key personnel and attract and retain qualified future key personnel, particularly executive management.  Failure to increases in prevailing interest rates, subject our assets to liens, limit our ability to adjust to changing market conditions,attract or place us at a competitive disadvantage to our competitors because of our leverage.  Should we be unable to generate enough cash from our operations or secure additional financing to fund our operations and debt service requirements, we may be required to postpone or cancel growth projects, reduce our operations, or may be unable to meet our debt repayment schedules.  Any one of these events mayretain key personnel could have a material adverse effect on our operationsbusiness and financial position.results of operations.
 
The result of our operations is primarily dependent on the spread between the feedstock and energy we purchase and the fuel and co-products we sell.
The results of our ethanol production business are significantly affected by the spread between the cost of the corn and natural gas that we purchase and the price of the ethanol and distiller grains that we sell.  Our biodiesel business is primarily dependent on the price difference between the costs of the feedstock we purchase (principally, NRPO and crude glycerin) and the products we sell (principally; biodiesel and glycerin).  In addition, the markets for ethanol, biodiesel, distiller grains, and glycerin are highly volatile and subject to significant fluctuations.  Any decrease in the spread between prices of the commodities we buy and sell, whether as a result of an increase in feedstock prices or a reduction in ethanol or biodiesel prices, would adversely affect our financial performance and cash flow and may cause us to cease production at either of our plants.
Our operations subject us to risks associated with foreign laws, policies, regulations, and markets.
 
Our sales and manufacturing operations in foreign countries are subject to the laws, policies, regulations, and markets of the countrycountries in which we operate.  As a result, our foreign manufacturing operations and sales are subject to inherent risks associated with the countries in which we operate.  Risks involving our foreign operations include differences or unexpected changes in regulatory requirements, political and economic instability, terrorism and civil unrest, work stoppages or strikes, natural disasters, interruptions in transportation, restrictions on the export or import of technology, difficulties in staffing and managing international operations, variations in tariffs, quotas, taxes, and other market barriers, longer payment cycles, changes in economic conditions in the international markets in which our products are sold, and greater fluctuations in sales to customers in developing countries.  If we are unable to effectively manage the risks associated with our foreign operations, our business may experience a material adverse effect on the results of our operations or financial condition.
 
 We could be adversely affected by violations of the U.S. Foreign Corrupt Practices Act.
 Our operations in countries outside the United States, including our operations in India, are subject to anti-corruption laws and regulations, including restrictions imposed by the U.S. Foreign Corrupt Practices Act (the “FCPA”). The FCPA and similar anti-corruption laws in other jurisdictions generally prohibit companies and their intermediaries from making improper payments to government officials for the purpose of obtaining or retaining business. We operate in parts of the world that have experienced governmental corruption to some degree and, in certain circumstances; strict compliance with anti-corruption laws may conflict with local customs and practices.
16

 Our employees and agents interact with government officials on our behalf, including interactions necessary to obtain licenses and other regulatory approvals necessary to operate our business. These interactions create a risk that actions may occur that could violate the FCPA or other similar laws.
 Although we have policies and procedures designed to promote compliance with local laws and regulations as well as U.S. laws and regulations, including the FCPA, there can be no assurance that all of our employees, consultants, contractors and agents will abide by our policies. If we are found to be liable for violations of the FCPA or similar anti-corruption laws in other jurisdictions, either due to our own acts or out of inadvertence, or due to the acts or inadvertence of others, we could suffer from criminal or civil penalties which could have a material and adverse effect on our results of operations, financial condition and cash flows.
A substantial portion of our assets and operations are located in India, and we are subject to regulatory, economic and political uncertainties in India.
Certain of our principal operating subsidiaries are incorporated in India, and a substantial portion of our assets are located in India. We intend to continue to develop and expand our facilities in India.  The Indian government has exercised and continues to exercise significant influence over many aspects of the Indian economy. India’s government has traditionally maintained an artificially low price for certain commodities, including diesel fuel, through subsidies, but has recently begun to reduce such subsidies, which benefits us.  We cannot assure you that liberalization policies will continue. Various factors, such as changes in the current federal government, could trigger significant changes in India’s economic liberalization and deregulation policies and disrupt business and economic conditions in India generally and our business in particular.  Our financial performance may be adversely affected by general economic conditions and economic and fiscal policy in India, including changes in exchange rates and controls, interest rates and taxation policies, as well as social stability and political, economic or diplomatic developments affecting India in the future.
 Currency fluctuations among the Indian Rupee and the U.S. dollar could have a material adverse effect on our results of operations.
 A substantial portion of our revenues are denominated in Rupees. We report our financial results in U.S. dollars. The exchange rates among the Rupee and the U.S. dollar have changed substantially in recent years and may fluctuate substantially in the future.  We do not currently engage in any formal currency hedging of our foreign currency exposure, and our results of operations may be adversely affected if the Rupee fluctuates significantly against the U.S. dollar.
We are a holding company and there are significant limitations on our ability to receive distributions from our subsidiaries.
 
We conduct substantially all of our operations through subsidiaries and are dependent on cash distributions, dividends or other intercompany transfers of funds from our subsidiaries to finance our operations. Our subsidiaries have not made significant distributions to the Company and may not have funds legally available for dividends or distributions in the future.  In addition, we may enter into credit, or other, agreements that would contractually restrictThe ability of our subsidiaries from paying dividends, making distributions, or making intercompany loans to our parent company ortransfer funds to any other subsidiary.  In particular, ourus will be dependent upon their respective abilities to achieve sufficient cash flows after satisfying their respective cash requirements, including subsidiary-level debt service on their respective credit agreements. Our current credit agreement, may requirethe Third Eye Capital Note Purchase Agreement, as amended from time to time, described in the Notes to Consolidated Condensed Financial Statements, requires us to obtain the prior consent of Third Eye Capital, as the lender for dividendsAdministrative Agent of the Note holders, to make cash distributions or otherany intercompany fund transfers. If the amountThe ability of our Indian operating subsidiary to transfer funds to us is restricted by Indian laws and maybe adversely affected by US tax laws.  Under Indian laws, our capital we are ablecontributions, or future capital contributions, to raise from financing activities, together with our revenues from operations that are available for distribution, are not sufficient to satisfy our ongoing working capital and corporate overhead requirements needs, evenIndian operation cannot be remitted back to the extentUS. Remittance of funds by our Indian subsidiary to us may subject us to significant tax liabilities under US tax laws.
 Our Chief Executive Officer has outside business interests which could require time and attention.
 Eric McAfee, our Chairman and Chief Executive Officer, has outside business interests which include his ownership of McAfee Capital.  In addition, Mr. McAfee’s employment agreement requires his devotion of reasonable business efforts and time to the Company.  Furthermore, Mr. McAfee is prohibited from engaging in any competitive employment, occupational or consulting services.  Although Mr. McAfee’s employment agreement requires that we reducehe devote reasonable business efforts to our operations accordingly, we may be requiredcompany, this agreement also permits him to cease operations.devote time to his outside business interests consistent with past practice.  As a result, these outside business interests could interfere with Mr. McAfee’s ability to devote time to our business and affairs.
 
 
1217

 
 
Our business may be subject to natural forces beyond our control.
 
Earthquakes, floods, droughts, tsunamis, and other unfavorable weather conditions may affect our operations.  Natural catastrophes may have a detrimental effect on our supply and distribution channels, causing a delay or prevention of our receipt of raw materials from our suppliers or delivery of finished goods to our customers.  In addition, weather conditions may adversely impact the planting, growth, harvest, storage, and general availability of any number of the products we may process at our facilities or sell to our customers.  The severity of these occurrences, should they ever occur, will determine the extent to which and if our business is materially and adversely affected.
 
Our ability to utilize our NOL carryforwards may be limited.
Under the Internal Revenue Code of 1986, as amended (the “Code”), a corporation is generally allowed a deduction in any taxable year for net operating losses (“NOL”) carried over from prior taxable years. As of December 31, 2014, we have U.S. federal NOL carryforwards of approximately $117 million. Such U.S. federal NOL carryforwards expire on various dates between 2027 and 2032. We also have state NOL carryforwards as of December 31, 2014 of approximately $114 million, which expire on various dates between 2027 and 2032.

Our ability to deduct these NOL carryforwards and certain other tax attributes against future taxable income could be limited if we experience an "ownership change," as defined in Section 382 of the Code. In general, an  ownership change may result from one or more transactions increasing the aggregate ownership of certain persons (or groups of persons) in our stock by more than 50 percentage points over a testing period (generally three years). Future direct or indirect changes in the ownership of our stock, including sales or acquisitions of our stock by certain stockholders and purchases and issuances of our stock by us, some of which are not in our control, could result in an ownership change. Any resulting limitation on the use of our NOL carryforwards could result in the payment of taxes above the amounts currently estimated and could have a negative effect on our future results of operations and financial position.
We are subject to covenants and other operating restrictions under the terms of our debt, which may restrict our ability to engage in some business transactions.
 Our debt facilities contain covenants restricting our ability, among others, to:
 ●incur additional debt;
 ●make certain capital expenditures;
 ●incur or permit liens to exist;
 ●enter into transactions with affiliates;
 ●guarantee the debt of other entities, including joint ventures;
 ●pay dividends;
 ●merge or consolidate or otherwise combine with another company; and
 ●transfer, sell or lease our assets. 
These restrictions may limit our ability to engage in business transactions that may be beneficial to the Company, or may restrict our ability to execute our business plan.
Operational difficulties at our facilities may negatively impact our business.
 
Our operations may experience unscheduled downtimes due to technical or structural failure, political and economic instability, terrorism and civil unrest, natural disasters, and other operational hazards inherent to our operations.  These hazards may cause personal injury or loss of life, severe damage to or destruction of property, equipment, or the environment, and may result in the suspension of operations andor the imposition of civil or criminal penalties.  Our insurance may not be adequate to cover thesuch potential hazards described and we may not be able to renew our insurance on commercially reasonable terms or at all.  In addition, any reduction in the yield or quality of the products we produce could negatively impact our ability to market our products.  Any decrease in the quality, reduction in volume, or cessation of our operations due to these hazards would have a material adverse effect on the results of our business and financial condition.
 
Our success depends on our ability to manage the growth of our operations.
 
Our strategy envisions a period of rapid growth that may impose a significant burden on our administrative and operational resources and personnel, which if not effectively managed, could impair our growth.  The growth of our business will require significant investments of capital and management’s close attention.  If we are unable to successfully manage our growth, our sales may not increase commensurately with capital expenditures and investments.  Our ability to effectively manage our growth will require us to substantially expand the capabilities of our administrative and operational resources and to attract, train, manage and retain qualified management, technicians and other personnel; we may be unable to do so.personnel.  In addition to our plans to adopt technologies that expand our operations and product offerings at our biodiesel and ethanol plants, we may seek to enter into strategic business relationships with companies to expand our operations.  If we are unable to successfully manage our growth, we may be unable to achieve our business goals, which may have a material adverse effect on the results of our operations and financial condition.
 
18

Our mergers, acquisitions, partnerships, and joint ventures may not be as beneficial as we anticipate.
 
We have increased our operations through mergers, acquisitions, partnerships, and joint ventures and intend to continue to explore these opportunities in the future.  The anticipated benefits of these transactions may take longer to realize than expected, may never be fully realized, or even realized at all.  Furthermore, partnerships and joint ventures generally involve restrictive covenants on the parties involved, which may limit our ability to manage these agreements in a manner that is in our best interest.  Future mergers, acquisitions, partnerships, and joint ventures may involve the issuance of debt or equity, or a combination of the two, as payment for or financing of the business or assets involved, which may dilute ownership interest in our business.  Any failure to adequately evaluate and address the risks of and execute on our mergers, acquisitions, partnerships, and joint ventures could have an adverse material effect on our business, results of operations, and financial position.  In connection with such acquisitions and strategic transactions, we may incur unanticipated expenses, fail to realize anticipated benefits, have difficulty incorporating the acquired businesses, our management may become distracted from our core business, and we may disrupt relationships with current and new employees, customers and vendors, incur significant debt, or have to delay or not proceed with announced transactions.  The occurrence of any of these events could have an adverse effect on our business.
 
Our business may be significantly disrupted upon the occurrence of a catastrophic event or cyberattack.
Our Keyes and India plants are highly automated and rely extensively on the availability of our network infrastructure and our internal technology systems. The failure of our systems due to a catastrophic event, such as an earthquake, fire, flood, tsunami, weather event, telecommunications failure, power failure, cyberattack or war, could adversely impact our business, financial results and financial condition. We have developed disaster recovery plans and maintain backup systems in order to reduce the potential impact of a catastrophic event, however there can be no assurance that these plans and systems would enable us to return to normal business operations.
We may be unable to protect our intellectual property.
 
We rely on a combination of patents, trademarks, trade name, confidentiality agreements, and other contractual restrictions on disclosure to protect our intellectual property rights.  We also enter into confidentiality agreements with our employees, consultants, and corporate partners, and control access to and distribution of our confidential information.  These measures may not preclude the disclosure of our confidential or proprietary information.  Despite efforts to protect our proprietary rights, unauthorized parties may attempt to copy or otherwise obtain and use our proprietary information.  Monitoring unauthorized use of our confidential information is difficult, and we cannot be certain that the steps we have taken to prevent unauthorized use of our confidential information, particularly in foreign countries where the laws may not protect proprietary rights as fully as in the U.S., will be effective.
 
 Companies in our industry aggressively protect and pursue their intellectual property rights.  From time to time, we receive notices from competitors and other operating companies, as well as notices from “non-practicing entities,” or NPEs, that claim we have infringed upon, misappropriated or misused other parties’ proprietary rights.  Our success and future revenue growth will depend, in part, on our ability to protect our intellectual property.  It is possible that competitors or other unauthorized third parties may obtain, copy, use or disclose our technologies and processes, or confidential employee, customer or supplier data.  Any of our existing or future patents may be challenged, invalidated or circumvented.
We may not be able to successfully develop and commercialize our technologies, which may require us to curtail or cease our research and development activities.
 
Since 2007, we have been developing patent-pending enzyme technology to enable the production of ethanol from a combination of starch and cellulose, or from cellulose alone, and in July 2011, we acquired Zymetis, Inc., a biochemical research and development firm, with several patents pending and in-process R&D utilizing the Z-microbe™ to produce renewable chemicals and advanced fuels from renewable feedstocks.  Although, the viability of our technology has been demonstrated in the lab, there can be no assurance that we will be able to commercialize our technology.  To date, we have not completed a large-scale commercial prototype of our technology and are uncertain at this time when completion of a commercial scale prototype will occur.  Commercialization risks include economic financial feasibility at commercial scale, availability of funding to complete large-scale commercial prototype, ability of Z-microbeTM to function at commercial scale and ability to obtain regulatory approvals, and market acceptance of product.
 
 
1319

 
 
Risks related to ownership of our stock
 
There can be no assurance that a liquid public market for ourFuture sales and issuances of rights to purchase common stock will continue to exist.
Although our sharesby us, could result in additional dilution of common stock are quoted on the OTC Markets electronic over-the-counter trading system, a very limited number of shares trade on a regular basis and there may not be a significant market in such stock.  There can be no assurance that a regular and established market will be developed and maintained for our common stock.  There can also be no assurance as to the strength or liquidity of any market for our common stock or the prices at which holders may be able to sell their shares.
It is likely that there will be significant volatility in the trading pricepercentage ownership of our stock.
Market prices for our common stock will be influenced by many factorsstockholders and will be subject to significant fluctuations in response to variations in our operating results and other factors.  Because our business is the operation of our biodiesel plant and the future development and operation of next-generation cellulosic ethanol plants, factors that could affect our future stock price, and create volatility incause our stock price include the price and demand for ethanol and biodiesel, the price and availability of oil and gasoline, the political situationto fall.
We may issue equity or convertible securities in the Middle East, U.S. energy policies, federalfuture.  To the extent we do so, our stockholders may experience substantial dilution.  We may sell common stock, convertible securities, or other equity securities in one or more transactions at prices and state regulatory changes that affect the price of ethanolin a manner we determine from time to time.  If we sell common stock, convertible securities, or biodiesel,other equity securities in more than one transaction, investors may be materially diluted by subsequent sales and the existence or discontinuation of legislative incentives for renewable fuels.  Our stock price will also be affected by the trading price of the stock of our competitors, investor perceptions of us, interest rates, general economic conditions and those specific to the ethanol or biodiesel industry, developments with regardnew investors could gain rights superior to our operations and activities, our future financial condition, and changes in our management.existing stockholders.
 
Our stock may have risks associated with low priced stocks.
Although our common stock currentlyprice is quoted and traded on the OTC Bulletin Board, the price at which the stock will trade in the future cannot currently be estimated.  Since December 15, 2008, our common stock has traded below $5.00 per share.  As a result, trading in our common stock may be subject to the requirements of certain rules promulgated under the Exchange Act of 1934, as amended (the “Exchange Act”), which require additional disclosure by broker-dealers in connection with any trades involving a stock defined as a penny stock (generally, any non-Nasdaq equity security that has a market price share of less than $5.00 per share, subject to certain exceptions) and a two business day “cooling off period” before broker and dealers can effect transactions in penny stocks.  For these types of transactions, the broker-dealer must make a special suitability determination for the purchaser and have received the purchaser’s written consent to the transaction before the sale.  The broker-dealer also must disclose the commissions payable to the broker-dealer, current bid and offer quotations for the penny stock and, if the broker-dealer is the sole market-maker, the broker-dealer must disclose this fact and the broker-dealer’s presumed control over the market.  These, and the other burdens imposed upon broker-dealers by the penny stock requirements, could discourage broker-dealers from effecting transactions in our common stock,highly volatile, which could severely limit the market liquidityresult in substantial losses for investors purchasing shares of our common stock and the ability of holdersin litigation against us.
The market price of our common stock has fluctuated significantly in the past and may continue to fluctuate significantly in the future. The market price of our common stock may continue to fluctuate in response to one or more of the following factors, many of which are beyond our control:
fluctuations in the market prices of ethanol and its co-products including WDG and corn oil;
the cost of key inputs to the production of ethanol, including corn and natural gas;
the volume and timing of the receipt of orders for ethanol from major customers;
competitive pricing pressures;
our ability to produce, sell and deliver ethanol on a cost-effective and timely basis;
the announcement, introduction and market acceptance of one or more alternatives to ethanol;
losses resulting from adjustments to the fair values of our outstanding warrants to purchase our common stock;
changes in market valuations of companies similar to us;
stock market price and volume fluctuations generally;
regulatory developments or increased enforcement;
fluctuations in our quarterly or annual operating results;
additions or departures of key personnel;
our inability to obtain financing; and
our financing activities and future sales of our common stock or other securities.
Demand for ethanol could be adversely affected by a slow down in overall demand for oxygenote and gasoline additive products. The levels of our ethanol production and purchases for resale will be based upon forecasted demand. Accordingly, any inaccuracy in forecasting anticipated revenues and expenses could adversely affect our business. The failure to receive anticipated orders or to complete delivery in any quarterly period could adversely affect our results of operations for that period. Quarterly results are not necessarily indicative of future performance for any particular period, and we may not experience revenue growth or profitability on a quarterly or an annual basis.
The price at which you purchase shares of our common stock may not be indicative of the price that will prevail in the trading market. You may be unable to sell it.your shares of common stock at or above your purchase price, which may result in substantial losses to you and which may include the complete loss of your investment. In the past, securities class action litigation has often been brought against a company following periods of high stock price volatility. We may be the target of similar litigation in the future. Securities litigation could result in substantial costs and divert management’s attention and our resources away from our business.
 
Any of the risks described above could have a material adverse effect on our results of operations or the price of our common stock, or both.

We do not intend to pay dividends.
 
We have not paid any cash dividends on any of our securities since inception and we do not anticipate paying any cash dividends on any of our securities in the foreseeable future.
 
20

Our principal shareholders hold a substantial amount of our common stock.
 
Eric A. McAfee, our Chief Executive Officer and Chairman of the Board, Laird Q. Cagan, a former board member, in the aggregate, beneficially own 29.26%29% of our commonstockcommon stock outstanding.  In addition, the other members of our Board of Directors and management, in the aggregate, excluding Eric McAfee, beneficially own approximately 4.33%4.6% of our common stock.  Our lender, Third Eye Capital, acting as principal and an agent, beneficially owns 14.61%16.8% of our common stock.  As a result, these shareholders, acting together, will be able to influence many matters requiring shareholder approval, including the election of directors and approval of mergers and acquisitions and other significant corporate transactions.  See “Security Ownership of Certain Beneficial Owners and Management.”  The interests of these shareholders may differ from yours and this concentration of ownership enables these shareholders to exercise influence over many matters requiring shareholder approval, may have the effect of delaying, preventing or deterring a change in control, and could deprive you of an opportunity to receive a premium for your securities as part of a sale of the company and may affect the market price of our securities.
14

 
Rule 144 will not be available to holders of restricted shares during any period in which the Company has failed to comply with its reporting obligations under the Exchange Act.
 
From time to time the Company has issued shares in transactions exempt from registration.  Shares issued pursuant to exemptions from registration are “restricted securities” within the meaning of Rule 144 under the Securities Act of 1933.  As restricted shares, these shares may be resold only pursuant to an effective registration statement or pursuant to Rule 144 or other applicable exemption from registration under the Securities Act.  However, Rule 144 is not available with respect to restricted shares acquired from an issuer that is or was at any time in its past a shell company if the former shell company has failed to file all reports that it is required to file under the Exchange Act during the 12 months preceding the sale.  If at any time the Company fails to comply with its reporting obligations under the Exchange Act, Rule 144 will not be available to holders of restricted shares, which may limit your ability to sell your restricted shares.
 
The conversion of convertible securities and the exercise of outstanding options and warrants to purchase our common stock could substantially dilute your investment and reduce the voting power of your shares, impede our ability to obtain additional financing and cause us to incur additional expenses.
Our Series B convertible preferred stock is convertible into our common stock.  As of December 31, 2014, there were 1.7 million shares of our Series B convertible Preferred Stock outstanding, convertible into shares of our common stock on 10 to 1 ratio.  Certain of our financing arrangements, such as our Subordinated Notes, our line of credit with Laird Cagan, our arrangements with Third Eye Capital and as part of working capital arrangements with JD Heiskell are convertible into, or contain the right to purchase shares of our common stock at fixed prices.  As of December 31, 2014, there were outstanding warrants to purchase 42 thousand shares of our common stock.  Additionally, there are outstanding warrants and options to acquire our common stock issued to employees, directors and others.  As of December 31, 2014, there were outstanding warrants and options to purchase 1.4 million shares of our common stock.
Such securities allow their holders an opportunity to profit from a rise in the market price of our common stock such that conversion of the securities will result in dilution of the equity interests of our common stockholders.  The terms on which we may obtain additional financing may be adversely affected by the existence and potentially dilutive impact of our outstanding convertible and other promissory notes, Series B convertible preferred stock, options and warrants. In addition, holders of our outstanding promissory notes and certain warrants have registration rights with respect to the common stock underlying those notes and warrants, the registration of which involves substantial expense.
ITEM 2.  PROPERTIES
Item 2.  Properties
 
North America
 
Corporate Office.Our corporate headquarters are located at 20400 Stevens Creek Blvd., Suite 700, Cupertino, California.CA. The Cupertino facility office space consists of 9,238 rentable square feet.  We occupy this facility under aOur lease that commenced June 16, 2009 and endswas set to expire on May 31, 2012 with an option to extend the lease for an additional three years.  On February 22, 2012,2015; however, we extended the lease in February 2015 for an additional three-year period untilfive years ending on May 31, 2015.2020.  From July 2009 through July 2012, we sublet office space consisting of 3,104 rentable square feet to Nevo Energy, formerly Solargen, Energy,Inc., then from June 1, 2013 through present, we sublet office space consisting of 3,104 rentable square feet to Splunk Inc., at a monthly rent rate equal to the rent charged to us by our landlord.
 
Ethanol Plant in Keyes, CA.  In 2009 we entered into a Project Agreement and Lease Agreement with Cilion, Inc. pursuant to which we agreed, through our wholly-owned subsidiary AE Advanced Fuels Keyes, Inc., to retrofit and restart a 55 million gallon per year name plate capacity ethanol plant in Keyes, CA and upon substantial completion of the retrofit to lease theWe leased Keyes plant for a term of 60 monthsfrom April 2011 until June 2012 at a monthly rent of $250,000.  The lease commenced on April 1, 2011.$250,000 per month.  On July 6, 2012, we acquired Cilion, Inc., including the Keyes, CA ethanol plant, for an aggregate purchase price of (a) $16.5 million of cashandcash and (b) 20 million shares of Aemetis common stock and (c) the right to receive an additional cash amount of $5 million plus interest at the rate of 3% per annum, payable upon the satisfaction by the Company of certain conditions.  See Note 15. Subsequent Events, of the Notes to Consolidated Financial Statements in Part II, Item 8 of this Form 10-K.  Our tangible and intangible assets, including the Keyes, CA ethanol plant, are subject to perfected first liens and mortgages as further described in Note 15. Subsequent Events,5 Notes Payable, of the Notes to Consolidated Financial Statements in Part II, Item 8 of this Form 10-K.
 
AemetisWe productively utilizesutilize the majority of the space in these facilities.
 
Other Properties. In 2011 we also owned approximately 200 acres of land in Sutton, Nebraska.  The land in Sutton, Nebraska was sold in March 2012.  See Note 15. Subsequent Events, of the Notes to Consolidated Financial Statements in Part II, item 8 of this Form 10-K.
21

 
India
 
Biodiesel Plant in Kakinada, India.We own and operate a biodiesel  Our Indian plant with a nameplate capacity of 50 MGYis situated on approximately 32,000 square meters of land in Kakinada, India.  The property is located 7.5 kilometers from the local seaport with connectivity through a third-party pipeline to the port jetty.  The pipeline facilitates the importing of raw materials and exporting finished product.  Our tangible and intangible assets, including the Kakinada plant, are subject to liens as further described in Note 5 Notes Payable, of the Notes to Consolidated Financial Statements in Part II, Item 8 of this Form 10-K.
 
India Administrative Office.Our principal administrative, sales and marketing facilities are located in approximately 1,000 square feet of office space in Hyderabad, India which we lease on a month to month rental arrangement.
 
AemetisWe productively utilizesutilize the majority of the space in these facilities.
 
15

ITEM 3.  LEGAL PROCEEDINGS
Item 3.  Legal Proceedings
 
On March 28, 2008, the Cordillera Fund, L.P.10, 2011, one of our subsidiaries, Universal Biofuels Pvt. Ltd. (“Cordillera”) filed a complaint in the Clark County District Court of the State of Nevada against American Ethanol, Inc. and the Company. The complaint seeks a judicial declaration that Cordillera has a right to payment from the Company for its American Ethanol shares at fair market value pursuant to Nevada’s Dissenters’ Rights Statute, a judicial declaration that Cordillera is not a holder of Series B preferred stock in the Company under the provisions of the statute; and a permanent injunction compelling the Company to apply the Dissenters’ Rights Statute to Cordillera’s shares and reimburse Cordillera for attorney’s fees and costs.
On June 2, 2008 the case was transferred to the Second Judicial Court of the State of Nevada, located in Washoe County, Nevada. On February 17, 2009, a jury trial commenced on the sole issue of whether Cordillera timely delivered its notice of Dissenters’ Rights to the Company. On February 17, 2009, the jury delivered its verdict in favor of Cordillera. The remaining issue in the lawsuit concerned the fair market value of the shares of stock held by Cordillera. On or about October 7, 2009, the Court entered a judgment awarding damages to Cordillera for the fair market value of the shares of stock.  The amount of this liability has been reflected in the financial statements.  On October 19, 2009, the Company filed a Notice of Appeal of the judgment.  The judgment was affirmed on May 5, 2011.
On May 1, 2009 our transfer agent, Corporate Stock Transfer, Inc. (“CST”UBPL”), filed a Complaint for Interpleader in the United States District Court for the District of Colorado. The interpleader action was based on the Company’s and CST’s refusal to remove the restrictive legend from a certificate representing 5.6 million shares of the Company's restricted common stock (the “Certificate”) held by Surendra Ajjarapu and sought a judicial determination as to whether the legend could be lawfully removed from the Certificate. On July 1, 2009, Ajjarapu answered the Complaint for Interpleader, and cross-claimed against the Company for breach of fiduciary duty, conversion, violation of Section 10(b) and Rule 10b-5 of the Exchange Act and injunctive relief.   On October 24, 2011 the Company entered into a settlement agreement with the Ajjarapus and this matter was dismissed with prejudice.
On October 7, 2009, UBPL received a demand notice from the State Bank of India.India under the Agreement of Loan for Overall Limit dated as of June 26, 2008. The notice informed UBPL that an event of default hashad occurred for failure to make an installment payment on the loan due in September,commencing June 2009 and demandsdemanded repayment of the entire outstanding indebtedness of 19.60 crorescrore rupees (approximately $4$3.2 million) together with all accrued interest thereon and any applicable fees and expenses by October 10, 2009.expenses.  Upon the occurrence and during the continuance of an Event of Default, interest accrues at the default interest rate of 2% above the State Bank of India Advance Rate. The default period began on July 1, 2009 when the principal payment was deemed past due; and we have accrued interest at the default rate since the beginning of the default period.  Additional provisions of the loan agreement give the bank the right to disclose or publish our company name and the names of our directors as defaulter in any medium or media. In addition, since the bank demanded payment of the balance, in July 2009, we have classified the entire loan amount as current. On March 12, 2011, the State Bank of India has filed a legal case before the Debt Recovery Tribunal (DRT)(“DRT”), Hyderabad, for recovery of approximately $5$5.0 million against the companyCompany and also impleaded Andhra Pradesh Industrial Infrastructure Corporation (APIIC)(“APIIC”) to expedite the process of registration of Factorythe factory land for which counter reply is yet to be filed by APIIC. UBPL asserts that the State Bank of India did not provide the committed funding of the working capital loan and only funded a portion of the term loan, thus requiring the Company to enter into a working capital facility at unfavorable terms which served to hinder the business from developing at the planned rate. The State Bank of India has additionally required the personal guarantee of our Executive Officer and the registration of the land underlying the factory as conditions prior to restructure of the loan. Payments have recently been made against the facility; however, the State Bank of India has rejected these payments as a good faith effort. In January 2014, the Company made payment of $162 thousand (1 crore rupees) against principal on the facility which was accepted by the State Bank of India. UBPL filed for a stay against further collection efforts pending the development of sufficient business in a domestic or international market that would allow UBPL to make meaningful repayments against the facility.  In May 2014, the Company obtained an interim stay subject to payments of 1 crore rupees (approximately $0.2 million) by each of May 15, 2014 and June 15, 2014. In the caseevent that the Company is unable to prevail with itsin the aforementioned legal case, DRT may pass a Decreedecree for recovery of the amount due, amount, which will impact operations of the company including action up tocould include seizing company property for recovery of their dues.amounts due.

On August 4, 2013, GS Cleantech Corporation, a subsidiary of Greenshift Corporation (“Greenshift”), filed a complaint in the United States District for the Eastern District of California – Fresno Division against the Company and its subsidiary, AAFK. The case was transferred to the Southern District of Indiana and joined as tag-along defendants to a pending Multidistrict Litigation with over a dozen original defendants. The complaint alleges infringement of patent rights assigned to Greenshift that pertain to certain corn oil extraction processes that the Company employs and seeks royalties, damages, treble damages, and attorney’s fees, along with injunctions precluding the Company from infringing its patent rights. The corn oil extraction process we use is licensed to us by Valicor Separation Technologies LLC, formerly called Solution Recovery Services LLC (“SRS”). The process provider has no obligations to indemnify us. On September 12, 2013, the Company, along with its subsidiary, filed its answer and counterclaims. In response to a motion for summary judgment filed by the original defendants, on October 23, 2014, the Court ruled that all the claims of all the patents at issue in the case are invalid. Further, in a January 16, 2015 decision, the District Court for the Southern District of Indiana ruled in favor of a stipulated motion for partial summary judgment for Company, along with its subsidiary, finding that all of the GS Cleantech patents in the suit were invalid and, therefore, not infringed.  GS Cleantech has said it will appeal this decision when the remaining claim in the suit has been decided. Regardless of when it may be appealed, we believe that the likelihood of Greenshift succeeding on appeal of the invalidity determination is small since the Court’s findings included summary judgments on several grounds for each allegedly infringed patent. If Greenshift successfully appeals the District Court’s findings of invalidity, damages may be $1 million or more.
 
22


The only remaining claim alleges that GS Cleantech inequitably conducted itself before the United States Patent Office when obtaining the patents at issue. A trial in the District Court for the Southern District of Indiana on that single issue is anticipated but has not yet been scheduled. If the Defendants, including Company and its subsidiary, succeed in proving inequitable conduct, the patents at issue will be invalidated such that no damages will be awarded to GS Cleantech for infringement and the Court will be asked to determine whether GS Cleantech’s behavior makes this an “exceptional case”. A finding that this is an exceptional case would allow the Court to award to Company and its subsidiary the attorneys’ fees each has expended to date for defense in this case. It is unknown whether GS Cleantech would appeal such a ruling.

On August 21, 2012, UBS Securities Inc.LLC (“UBS”) filed a complaint in the United States District Court for the Southern District of New York against the Company.  The complaint seeksCompany for damages based on a breach of contract theory.theory in connection with the Cilion acquisition transaction (“UBS Federal Action”). UBS filed a motion for, and the District Court approved, a judgment against the Company in the liquidated amount of $2.3 million. UBS filed post-judgment discovery requests and pursued the enforcement of the judgment. Subsequently, on March 13, 2014, UBS also filed a complaint against one of our subsidiaries, Aemetis Advanced Fuels Keyes, Inc. in the state court in the State of New York, alleging breach of the same contract involved in the UBS Federal Action. The Company filed its answer onand AAFK entered into a settlement agreement with UBS in September 25, 2012.  Because of2014 and complied with the early stage of the action, we are unable to state whether an unfavorable outcome is either probable or remote or the amount of or range of potential loss if the outcome should be unfavorable.  The Company intends to defend itself vigorously.agreement by December 31, 2014.
 
ITEMItem 4.  MINE SAFETY DISCLOSURES.Mine Safety Disclosures.
 
Not Applicable.
 
 
1623

 
 
PART II
 
ITEMItem 5.  MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES MARKET INFORMATIONMarket for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
 
OurMarket Information
Aemetis’ common stock became qualified for quotationis traded on the Over-the-CounterNASDAQ Stock Market under the symbol “AMTX.”  Prior to trading on NASDAQ, between November 15, 2011 and June 5, 2014 our common stock was traded on the OTC Bulletin Board under the symbol AEBF in“AMTX.”  Between November 15, 2011 and December 7, 2007, and continued to trade on the Over-the-Counter Bulletin Board until September 24, 2010. Thereafter, the Company commenced tradingour common stock traded on the OTC Market as an OTC Pink companyBulletin Board under the symbol AMTX, where it continues“AEBF.”  Prior to trade today. There is, at present, a very low public market for the Company’s common shares, and there is no assurance that any such market will develop, or if developed, that such market will be sustained. The Company’s common shares therefore are not a suitable investment for persons who may have to liquidate their investment on a timely basis and are therefore only appropriate for those investors who are able to make a long-term investment in the Company.
Although quotations for the Company’sDecember 7, 2007, our common stock appeartraded on the OTC Markets, there is no established trading market forBulletin Board under the common stock.  Since January 2007, transactions in the common stock can only be described as sporadic. Consequently, the Company is of the opinion that any published prices cannot be attributed to a liquid and active trading market and, therefore, is not indicative of any meaningful market value.symbol “MWII.”
 
The following table sets forth the high and low bidsale prices for ourof the Company’s common stock for each fullthe quarterly period during fiscal 2010 and 2011reporting periods indicated, as adjusted for the 1 for 10 stock split, which became effective after the close of trading on the OTC Bulletin Board through September 24, 2010 and on the OTC Market thereafter. The source of these quotations is OTCMarkets.com. The bid prices are inter-dealer prices, without retail markup, markdown or commission, and may not reflect actual transactions.May 15, 2014:
 
Quarter Ending High Bid  Low Bid 
March 31, 2010 $0.33  $0.18 
June 30, 2010 $0.23  $0.05 
September 30, 2010 $0.10  $0.05 
December 31, 2010 $0.15  $0.06 
March 31, 2011 $0.16  $0.08 
June 30, 2011 $0.28  $0.10 
September 30, 2011 $1.01  $0.25 
December 31, 2011 $0.95  $0.34 
Quarter Ending High  Low 
2014      
December 31 $8.99  $3.99 
September 30 $13.29  $6.05 
June 30 $11.20  $4.30 
March 31 $7.30  $1.80 
2013        
December 31 $3.20  $1.50 
September 30 $4.50  $3.00 
June 30 $5.90  $2.50 
March 31 $8.30  $4.30 
2012        
December 31 $7.30  $3.50 
September 30 $8.20  $3.70 
June 30 $8.50  $3.70 
March 31 $10.00  $5.30 

Shareholders of Record
 
According to the records of Aemetis’ transfer agent, Aemetis had 351420 stockholders of record as of September 12, 2012March 5, 2015.  This figure does not include "street name" holders or beneficial holders of our common stock whose shares are held of record by banks, brokers and it believes there are a substantially greater number of non-objecting beneficial holders. other financial institutions.

24

Dividends
Aemetis has never declared or paid any cash dividends on its common stock.  Aemetis currently expects to retain any future earnings for use in the operation and expansion of its business and to reduce its outstanding debt and does not anticipate paying any cash dividends in the foreseeable future.  Information with respect to restrictions on paying dividends is set forth in Note 5 “Notes Payable”Notes Payable of the Notes to Consolidated Financial Statements in Part II, Item 8 of this Form 10-K.
 
Securities Authorized For Issuance under Equity Compensation Plans
The Company’s shareholders approved the Company’s Amended and Restated 2007 Stock Plan (“2007 Stock Plan”) at the Company’s 2010 Annual Shareholders Meeting.   On July 1, 2011, the Company acquired the Zymetis 2006 Stock Plan (“2006 Stock Plan”) pursuant to the acquisition of Zymetis, Inc. and gave Zymetis option holders the right to convert shares into Aemetis common stock at the same terms as the 2006 Plan.  Additional information regarding the 2007 Stock Plan, 2006 Stock Plan and other compensatory warrants may be found under the caption “Securities Authorized for Issuance under Equity Compensation Plans,” in the Proxy Statement, which is hereby incorporated by reference.
Sales of Unregistered Equity Securities
 
Details surrounding major equity securities transactions can be found in our regular Form 8-K disclosures. In addition to transactions already disclosed, on FebruaryOn October 3, 2010, the Company2014, we issued 600,0001,033 shares of our common stock to Mr. Laird Cagan as a fee forwarrant holder pursuant to a loan provided by Mr. Caganwarrants exercise at a price of $0.1 per share and issued 1,360 shares of our common stock to Aemetis’ wholly-owned subsidiary, AE Advanced Fuels Keyes, Inc., in the amounta warrant holder pursuant to a warrants exercise at a price of $1,600,000.  See Note 5 “Notes Payable”, of the Notes to Consolidated Financial Statements in Part II, item 8 of this Form 10-K.$5.00 per share.
 
On March 30, 2010 and August 10, 2010 shareholders converted 55,500 and 100,000November 13, 2014, we issued 20 thousand shares respectively, fromof our common stock as a result of a Series B Preferred stockinvestor exercising their right to common stock.
From October 14, 2010 to November 4, 2010 Third Eye Capital acting as a principal and as an agent for purchasers received 2,250,000 common shares of stock as inducement to enter into note purchase agreements.
17

On July 7, 2010 and November 4, 2010, the Company issued 155,000 common shares to six consultants for services rendered.
On December 15, 2010, the Company issued warrants exercisable for 950,856 shares of common stock to officers, directors and employees of the Company.  The warrants are exercisable at $0.13 perconvert each share and expire on December 15, 2015.
From March 9, 2011 to December 30, 2011 Third Eye Capital acting as a principal and as an agent for note purchasers received 4,589,360 common shares of stock as inducement to enter into note purchase agreements.
On July 19, 2011, a shareholder converted 50,000 shares of Series B Preferred to 0.10 of a share of common stock to common stock.at a $0.001 par value cost per share.
 
On November 16, 2011, the Company24, 2014, we issued 30,00016,667 shares pursuantof our common stock as a result of a Series B investor exercising their right to the exerciseconvert each share of outstanding options from the 2007 Stock Plan and on December 14, 201. The Company issued 5,585 shares pursuantSeries B Preferred to the exercise0.10 of outstanding options from the 2006 Stock Plan.a share of common stock at a $0.001 par value cost per share.
 
These securities were issued pursuant to an exemptionEach of these issuances was exempt from registration provided by eitherunder Section 4(2) of the Securities Act of 1933, as amended, or Regulation D or Regulation S, as promulgated thereunder.sales of securities not involving any public offering.
 
Performance Graph
The graph below compares the cumulative five-year total return to shareholders of our common stock (AMTX) alongside the cumulative total return of the NASDAQ Composite Index (IXIC) and NASDAQ Clean Edge Green Energy Index (CELS).
The total cumulative return assumes dividends were reinvested at each year-end and is based on an original $100 investment at the respective closing prices on December 31, 2009.  Note that historic stock price performance is not necessarily indicative of future stock price performance.
25



Year Ended December 31 2009  2010  2011  2012  2013  2014 
Aemetis, Inc. $100  $79  $368  $368  $168  $305 
NASDAQ Composite Index $100  $117  $115  $133  $184  $209 
NASDAQ Clean Edge Green Energy Index $100  $102  $60  $59  $112  $108 

26

ITEMItem 6.  SELECTED FINANCIAL DATASelected Financial Data
 
Not ApplicableThe following selected financial data are derived from the Company’s consolidated financial statements and should be read in conjunction with “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Item 8. Financial Statements and Supplementary Data.”
 
Year Ended December 31 (In thousands, except per share data) 2014  2013  2012  2011  2010 
Net operating revenues $207,683  $177,514  $189,048  $141,858  $8,132 
Income/(loss) from continuing operations  7,133   (24,437)  (4,282)  (18,296)  (8,564)
Basic income/(loss) from continuing operations (per share)  0.35   (1.28)  (0.28)  (1.77)  (0.98)
Diluted income/(loss) from continuing operations (per share)  0.34   (1.28)  (0.28)  (1.77)  (0.98)
                     
Total assets  89,176   97,142   96,872   27,218   21,594 
Long-term obligations  64,832   73,792   35,522   19,993   12,744 
Redeemable preferred stock  2,641   2,540   2,438   2,320   2,222 
In July 2012 we acquired 100 percent ownership interest, through merger with Cilion, Inc., in the Keyes, California 55 million gallon per year name-plate capacity dry mill ethanol production facility, which produces corn ethanol, wet distillers grains (WDG), condensed distillers solubles (CDS) and corn oil. The aggregate purchase price for Cilion, Inc. included (a) $16.5 million of cash; (b) 20 million shares of Aemetis common stock; and, (c) the right to receive an additional cash amount of $5 million plus interest at the rate of 3% per annum, payable upon the satisfaction by the Company of certain conditions.
In July 2011, we acquired Zymetis, Inc., a biochemical research and development firm with several patents pending and in-process R&D utilizing the Z-microbe™ to produce renewable chemicals and advanced fuels from renewable feedstocks. Goodwill and intangible assets increased as a result of our acquisition of Zymetis, Inc.
ITEMItem 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONSManagement’s Discussion and Analysis of Financial Condition and Results of Operations
 
Our Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is provided in addition to the accompanying consolidated financial statements and notes to assist readers in understanding our results of operations, financial condition, and cash flows.  MD&A is organized as follows:
 
 
Overview.  Discussion of our business and overall analysis of financial and other highlights affecting us, to provide context for the remainder of MD&A.
 
 
Results of Operations.AnOperations.  An analysis of our financial results comparing the twelve months ended December 31, 2011 to the twelve months ended December 31, 20102014, 2013 and comparing the twelve months ended December 31, 2010 to the twelve months ended December 31, 2009.2012.
 
 
Quarterly Changes in Financial Position. An analysis of our financial position comparing the quarter end position to the December 31, 2010 financial position.
Quarterly Results of Operations. An analysis of our financial results comparing the quarterly three month period of 2011 to the respective quarterly period of 2010.  Also the analysis of the six months ended June 30, 2011 compared to the six months ended June 30, 2010 and the analysis of the nine months ended September 30, 2011 compared to the nine months ended September 30, 2010.
Liquidity and Capital Resources.  An analysis of changes in our balance sheets and cash flows and discussion of our financial condition.
 
 
Critical Accounting Estimates.  Accounting estimates that we believe are important to understanding the assumptions and judgments incorporated in our reported financial results and forecasts.
 
The following discussion should be read in conjunction with our consolidated financial statements and accompanying notes included elsewhere in this report.  The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs.  TheOur actual results could differ materially from those discussed in the forward-looking statements.  Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Report, particularly under “Part I, Item 1A.  Risk Factors,"” and in other reports we file with the SEC.  All references to years relate to the calendar year ended December 31 of the particular year.
 
18

Overview
 
Our goalAemetis is to be a leader in the production ofan advanced renewable fuels and specialty chemicals and inbiochemicals company focused on the acquisition, development and commercialization of innovative technologies that are substitutes forreplace traditional petroleum-based products and non-food feedstockby the conversion of traditionalfirst generation ethanol and biodiesel plants using our operating ethanol and biodiesel facilities. To fund our operations, since our inception in 2005 we have raised approximately $48.9 million through the sale of preferred and common stock and approximately $30 million in debt.into advanced biorefineries.  We have used these funds to (i) constructown and operate a biodiesel plant in Kakinada, India, (ii) construct a glycerin refining and vegetable oil pretreatment facility at our Kakinada plant, (iii) develop and expand our technology portfolio of proprietary, patented and patent-pending technology, (iv) retrofit and operate an ethanol  plant in Keyes, California where we manufacture and (v) acquire Cilion, Inc.produce ethanol, wet distillers’ grain (WDG), condensed distillers solubles (CDS) and corn oil and manufacturing and refining facility in Kakinada, India where we manufacture and produce fatty acid methyl ester (biodiesel), crude and refined glycerin and refined palm oil.  In September 2013, we received approval by the former owner ofUS Environmental Protection Agency to produce ethanol using grain sorghum and biogas as well as approval for the Keyes CA plant.plant to use existing combined heat and power systems to generate higher value Advanced Biofuel Renewable Identification Numbers (RIN’s).  In addition, we are continuing to research the viability of commercializing our microbial technology, which would enable us to produce renewable industrial biofuels and biochemicals and our integrated starch-cellulose technology, which would enable us to produce ethanol from non-food feedstock.
27

 
North America
 
In the second quarter of 2011,2012, we successfully completed the retrofit ofacquired the Keyes, CA ethanol plant and inwhich we had previously been operating since April 2011 began operating the plant pursuant to a 5-year lease agreement with Cilion, Inc.  The Keyes plant is a dry mill ethanol production facility currently utilizing corn and grain sorghum as feedstock.  In addition, the plant produces high quality wet distillers grains (WDG) and a small amount of condensed distillers soluble (CDS) as byproducts of the ethanol production process, which are sold as a high protein, livestock feed supplements.feedstocks.
 
During 2011, we produced threeWe produce four products at the Keyes plant:  denatured ethanol, WDG, corn oil and CDS.  In 20112014, we sold 100% of the ethanol and WDG we produced to J.D. Heiskell pursuant to a Purchase Agreement established with J.D. Heiskell.  Corn oil was sold to J.D. Heiskell and other local animal feedlots (primarily poultry). Small amounts of CDS were sold to various local third parties. Ethanol pricing is determined pursuant to a marketing agreement between us and Kinergy Marketing LLC, and is generally based on daily and monthly pricing for ethanol delivered to Los Angeles,the San Francisco Bay Area, California, as published by the Oil Price Information Service (OPIS), as well as quarterly contracts negotiated by Kinergy with local fuel blenders.  The price for WDG is determined monthly pursuant to a marketing agreement between usthe Company and A.L. Gilbert Co., and is generally determined in reference to the price of dry distillers grains (DDG) and corn.North American revenue is dependent on the price of ethanol and wet distiller’s grains.  Ethanol pricing is influenced by national inventory levels, corn prices and gasoline prices. Distiller’s grains is influenced by the price of corn, the supply of dry distiller’s grains, and demand from the local dairy and feed markets.  Our revenue is further influenced by our decision to operate the plant at any capacity level, maintenance requirements, and the influences of the underlying biological processes.  During 2014, the most significant factor impacting revenue has been the price received for ethanol.
 
On July 6, 2012,January 15, 2013, we entered intotemporarily idled the corn grinding and ethanol production activities at our Keyes, California plant due to unfavorable market conditions for corn ethanol production, while we undertook efforts perform maintenance and to restart the plant as an Agreementadvanced biofuel producer.  This action was in keeping with the Company’s plan to move to advanced biofuel feedstocks and Planinputs using a recently approved combined grain sorghum and biogas EPA pathway for a significant portion of Merger with Cilion, Inc. pursuant to which we acquired Cilion for an aggregate of (a) $16.5 million, (b) 20 million shares of Aemetis common stock and (c) the obligation to pay an additional cash amount of $5 million plus interestour operational capacity.  Operations at the rate of 3% per annum, which is payable uponethanol plant were restarted in April 2013.  In September 2013, we received approval by the satisfaction by us of certain conditions set forth inUS Environmental Protection Agency to produce ethanol using grain sorghum and biogas along with the Merger Agreement.Keyes plant existing combined heat and power (CHP) system to generate higher value Advanced Biofuel Renewable Identification Numbers (RIN’s).
 
India
 
During the twelve months ended December 31, 2011,2014, 2013 and 2012, we also continued to operateoperated our biodiesel plant in India and increase revenues.India.  However, during 2011  our India operations continued to bewere constrained by limitedfunds available from our working capital partner and by diesel price supports bysubsidies from the India government.  During 2014, the India government eliminated subsidies for diesel and increased the sales price of diesel to the market prices. Our abilitybiodiesel pricing is indexed to sell biodiesel in India is also hampered by a disparity between the Indian national biofuels policy and State of Andhra Pradesh tax policy. Until the State of Andhra Pradesh adopts the national biofuels policy, the price of biodiesel will continuepetroleum diesel, and as such, the increase in the price of petroleum diesel is expected to be less attractive than petroleum-based diesel. We cannot predict when or iffavorably impact the State of Andhra Pradesh will adopt the national biofuels policy.
We believe, however, that we can increase sales and profitability of our India plant by diversifyingoperations.
We continue to diversify our feedstock, our product lines and our customer base.  As a result, inIn early 2012, we completed the construction of glycerin and oil refining units, which enable us to produce and sell refined glycerin and refined palm oil.  During 2013, we further increased sales with expanded orders from international customers. In anticipationaddition, we commissioned biodiesel distillation capacity for the biodiesel plant in February 2014 and this allows the India plant to produce quality biodiesel which meets or exceeds international standards.  During 2014, we further diversified our feedstock with the introduction of animal oils and fats, which we used for the completionproduction of our glycerin refining unit, in 2011 we purchased refined glycerin and resold itbiodiesel to be sold into the India domestic market to begin developing a customer base.European markets.
 
In addition, we have begun to develop a base of industrial customers who use fatty acid methyl ester (biodiesel) as a specialty chemical for commercial manufacturing.
 
19

North America Segment
 
Revenue
 
Substantially all of our North America revenues during the period covered by this Reportyears ended December 31, 2014, 2013, and 2012 were from sales of ethanol and WDG.  During the twelve months ended December 31, 2011,2014, 2013, 2012, we produced and sold 37,388,84960.2 million gallons, 42.4 million gallons, and 53.0 million gallons of ethanol and 273,533408 thousand tons, 301 thousand tons, and 380 thousand tons of WDG, compared to none during the twelve months ended December 31, 2010.respectively.
 
Cost of Goods Sold
 
Substantially all of our cornfeedstock is procured by J.D. Heiskell.  Our cost of cornfeedstock includes rail, truck, or ship transportation, local basis costs and a handling fee paid to J.D. Heiskell.  Cost of goods sold also includes chemicals, plant overhead and out bound transportation.  Plant overhead includes direct and indirect costs associated with the operation of the ethanol plant, including the cost of electricity and natural gas, maintenance, insurance, rental, direct labor, depreciation and freight.  Transportation includes the costs of in-bound delivery of corn by rail, inbound delivery of grain sorghum by ship, rail, and truck, and out-bound shipments of ethanol and wet distillers grainWDG by truck.  In 2011,2014, transportation cost for ethanol and WDG was approximately $0.09 per gallon.
 
Pursuant to a Corn Procurement and Working Capital Agreement with J.D. Heiskell, we purchase all of our corn and grain Sorghum from Heiskell.  Title to the corn or grain sorghum passes to us when the corn is deposited into the weigh binground for processing at our facility and entered into the production process.  The credit termsterm of the corn or grain sorghum purchased from J.D. Heiskell is five days.  J.D. Heiskell purchases our ethanol and WDG on one-day terms.
 
The price of corn is established by J.D Heiskell based on Chicago Board of Trade (CBOT) pricing including transportation and basis, plus a handling fee.  We establish pricing for WDG and ethanol pursuant to marketing agreements with Kinergy and A.L. Gilbert.  Ethanol prices are based on daily OPIS published rates, while the price of WDG is based on a percentage of dry distiller grains and corn prices.  J.D. Heiskell is contractually obligated to sell all of the ethanol to Kinergy Marketing LLC, who in turn sells the ethanol to local blenders and all of the WDG to A.L Gilbert who in turn sells the WDG to local dairies and feedlots.
 
28

Sales, Marketing and General Administrative Expenses (SG&A)
 
SG&A expenses consist of employee compensation, professional services, travel, depreciation, taxes, insurance, rent and utilities, including license and permit fees, penalties and interest, and sales and marketing fees.  Our single largest expense is employee compensation, including related stock compensation, followed by sales and marketing fees paid in connection with the marketing and sale of ethanol and WDG.
 
In October 2010, we entered into an exclusive marketing agreement with Kinergy Marketing LLC to market and sell our ethanol and an agreement with A.L. Gilbert to market and sell our WDG.  The agreements expire on August 31, 20132015 and December 31, 2012,2015, respectively, and are automatically renewed for additional one-year terms.  Pursuant to these agreements, our marketing costs for ethanol and WDG are approximatelyless than 2% of sales.
 
Research and Development Expenses (R&D)
 
In 2010,2014, 2013, and 2012, substantially all of our R&D expenses were related to the operation of our integrated celluloseresearch and starch ethanol commercial demonstration facilitydevelopment activities in Butte, MT.  In 2011, substantially all of our R&D expenses were attributable to our industrial biotechnology research team in Maryland acquired in July 2011 as a result of the acquisition of Zymetis, Inc. and for the operation and subsequent closing of our facility in Butte, MT. In 2011, certain costs related to establishing a demonstration plant in Keyes, CA were included as well.
20

Maryland.
 
India Segment
 
Revenue
 
Substantially all of our India segment revenues during the period covered by this Reportyears ended December 31, 2014, 2013 and 2012 were from sales of biodiesel, refined palm oil, and refined glycerin.  During the twelve months ended December 31, 2011,2014, we sold 8,6369 thousand metric tons of biodiesel and 7722.2 thousand metric tons of refined glycerin. During the twelve months ended December 31, 2013, we sold 19.3 thousand metric tons of biodiesel, 4.9 thousand metric tons of refined glycerin compared to 7,598and 3.7 thousand metric tons of refined palm oil. We sold 4.1 thousand metric tons of biodiesel, and 1,0462.3 thousand metric tons of cruderefined glycerin, and 7 thousand metric tons of refined palm oil during the twelve months ended December 31, 2010.  In 2011,2012.
During 2014, we purchased 1,000completed upgrades to the plant for the distillation of biodiesel and testing of waste fats and oils for the production of distilled biodiesel for sales into international markets. During 2013, we sold 4 thousand metric tons of processed natural refined glycerin of which 772palm oil (NRPO) to customers.  During 2012, we commissioned our pre-treatment unit, began producing and sold 7 thousand  metric tons were resold in 2011of processed NRPO to develop a market for refined glycerin in advancecustomers.  During the portion of the completion of our glycerin refining unit.
During the latter part of 2010 and2013, we were able to refine crude palm oil into the early months of 2011, NRPO prices increased to the point where biodiesel production was uneconomical.  Asat a result, we resold the feedstock we held in inventory rathermore attractive margin than producingconverting stearin into biodiesel.
 
Cost of Goods Sold
 
Cost of goods sold consists primarily of feedstock oil, chemicals, direct costs (principally labor and labor related costs), and factory overhead.  Depending upon the costs of these inputs in comparison to the sales price of biodiesel and glycerin, our gross margins mayat any given time can vary from positive to negative.  Factory overhead includes direct and indirect costs associated with the plant, including the cost of repairs and maintenance, consumables, maintenance, on-site security, insurance, depreciation and inbound freight.
 
We purchase NRPO, a non-edible feedstock, for our biodiesel unit from neighboring natural oil processing plants at a discount to refined palm oil.  NRPOIn addition, we purchase waste fats and oils from other processing plants in India. Raw material is received by truck and title passes when the NRPOisgoods are received at our facility.  Credit terms vary by vendor; however, we generally receive 15 days of credit on the purchases. We purchase crude glycerin in the international market on letters of credit or advance payment terms.
 
Sales, Marketing and General Administrative Expenses (SG&A)
 
SG&A expenses consist of employee compensation, professional services, travel, depreciation, taxes, insurance, rent and utilities, including licenses and permits, penalties, and sales and marketing fees.  Pursuant to an operating agreement with Secunderabad Oils Limited, we receive operational support and working capital.  We compensate Secunderabad Oils Limited with a percentage of the profits and losses generated from operations.  Payments of interest are identified as interest income while payments of profit and losses are identified as compensation for the operational support component of this agreement.  We therefore include the portion of profit or losses paid to Secunderabad Oils Limited as a component of SG&A and our SG&A component will vary based on the profits earned by operations.  In addition, we market our biodiesel and glycerin through our internal sales staff, commissioned agents and brokers.  Commissions paid to agents are included as a component of SG&A.
 
29

Research and Development Expenses (R&D)
 
Our India segment has no research and development activities.
 
21

Results of Operations
 
Year Ended December 31, 20112014 Compared to Year Ended December 31, 20102013
 
Revenues
 
Our revenues are derived primarily from sales of ethanol and WDG in North America and biodiesel and glycerin in India.
 
Fiscal Year Ended December 31 (in thousands) 
  2011  2010  Increase/(Decrease) 
North America $131,946   -  $131,946 
India  9,912  $8,132   1,780 
Total $141,858  $8,132  $133,726 
Fiscal Year Ended December 31 (in thousands)
  2014  2013  Inc/(dec)  % change 
             
North America $195,416  $144,698  $50,718   35.1%
India  12,267   32,816   (20,549)  -62.6%
Total $207,683  $177,514  $30,169   17.0%

North America.  The increase in revenues in North America segment for the year ended December 31, 2014 reflects the full year operation of the Keyes, CA plant compared to the operation of the Keyes, CA plant for only 9 months in 2013. The full year of operation of our plant increased gallons sold in ethanol and WDG by 42% and 36%, respectively, while the average price decreased by 3% and 9%, respectively to $2.54 per gallon and $91.81 per ton. For the year ended December 31, 2014, we generated approximately 78% of revenues from sales of ethanol, and 19% of revenues from sales of WDG and 3% of revenues from corn oil and syrup sales compared to 77% of revenues from sales of ethanol, and 21% of revenues from sales of WDG and 2% of revenues from corn oil and syrup sales for the year ended December 31, 2013.  For the year ended December 31, 2014, plant operations averaged 109% of nameplate capacity compared to 103% for the nine months of operations in 2013.

India.  The decrease in revenues in the India segment for the year ended December 31, 2014 reflects (i) commission of distilled-biodiesel unit which commenced using the waste fats and oils instead of NRPO, reduced the production and sales while the distilled biodiesel unit was being commissioned; and only one international sale during the year ended December 31, 2014 compared to several international sales in the year ended December 31, 2013. We sold 9 thousand metric tons of biodiesel and 2.2 thousand metric tons of refined glycerin in 2014, respectively, which were decreased of 53% and 54%, respectively, compared to 2013 while the average price per metric ton of biodiesel and refined glycerin increased by 8% to $985 per metric ton and 1% to $933 per metric ton respectively in 2014 compared to 2013. In addition, we processed 7 thousand tons of NRPO for a customer and recognized fees and by-product of $1.3 million for the year ended December 31, 2014. During the year ended December 31, 2013, we sold 8.2 thousand metric tons of RPO/Stearin and 2 thousand metric tons of CPO which made up of 1% of our total India revenue in 2013. For the year ended December 31, 2014, we generated approximately 55% of revenue from sales of biodiesel (methyl ester), 14% of revenue from sales of glycerin and 31% of revenue from sales of NRPO and crude palm oil, compared to 55% of revenue from sales of biodiesel (methyl ester), 14% of revenue from sales of glycerin and 31% of revenue from sales of NRPO and crude palm oil for the year ended December 31, 2013.
Cost of Goods Sold
Fiscal Year Ended December 31 (in thousands)
  2014  2013  Inc/(dec)  % change 
             
North America $158,719  $130,498  $28,221   21.6%
India  11,820   28,722   (16,902)  -58.8%
Total $170,539  $159,220  $11,319   7.1%
North America.  We ground 21.4 million bushels of corn during the year ended December 31, 2014 compared to 15.0 million bushels of corn during the year ended December 31, 2013.  Our cost of feedstock on a per bushel basis decreased by 20% for the year ended December 31, 2014 as compared to 2013.  The increase in costs of goods sold from 2013 to 2014 reflects the 35% increase in revenues over full twelve months of operations during the year ended December 31, 2014 compared to idling of the Keyes, CA plant from January 15, 2013 through April 22, 2013 during the year ended December 31, 2013.
30

India.  The decrease in cost of goods sold reflects the decrease in sales of biodiesel and refined glycerin in 2014. The cost of NRPO decreased on an average of 10% per ton basis in 2014 compared to 2013. We processed 9 thousand metric tons of NRPO and waste oils and fats, and 3.4 thousand metric tons of crude glycerin during the year ended December 31, 2014 to produce 9.6 thousand metric tons of biodiesel and 4.7 thousand metric tons of refined glycerin compared to the processing of 4 thousand metric tons of refined palm oil (RPO) and 3.9 thousand metric tons of crude glycerin during the year ended December 31, 2013 to produce 19.8 metric tons of biodiesel and 5.0 thousand metric tons of refined glycerin during the 2013.
Gross Profit

Fiscal Year Ended December 31 (in thousands)

  2014  2013  Inc/(dec)  % change 
             
North America $36,697  $14,200  $22,497   158.4%
India  447   4,094   (3,647)  -89.1%
Total $37,144  $18,294  $18,850   103.0%
North America.  Gross profit increased by 158.4% in the year ended December 31, 2014 compared to the year ended December 31, 2013 due to corn prices falling faster than ethanol prices. Corn prices decreased by 20% while ethanol prices decreased by 3% during the year ended December 31, 2014 compared to the year ended December 31, 2013.

India.  The decrease of 89% in gross profit was attributable to the decrease of 63% in overall revenues in the year ended December 31, 2014 compared to the year ended December 31, 2013.  We had only one international shipment of distilled biodiesel as well as domestic sales of biodiesel and refined glycerin in the year ended December 31, 2014 compared to one large domestic sale of biodiesel and sales of refined glycerin, and crude and refined palm oil sales in the year ended December 31, 2013.

Operating Expenses
R&D
Fiscal Year Ended December 31 (in thousands)

  2014  2013  Inc/(dec)  % change 
             
North America $459  $539  $(80)  -14.8%
India  -   -   -   - 
Total $459  $539  $(80)  -14.8%

The decrease in R&D expenses in our North America segment for the year ended December 31, 2014 compared to the year ended December 31, 2013 is due to a decrease in depreciation and amortization of $169 thousand and a decrease in taxes, utilities, and other of $23 thousand offset by an increase of professional fees and lab equipment of $44 thousand and an increase in salaries of $68 thousand.
SG&A
Fiscal Year Ended December 31 (in thousands)
  2014  2013  Inc/(dec)  % change 
             
North America $11,619  $12,428  $(809)  -6.5%
India  976   2,847   (1,871)  -65.7%
Total $12,595  $15,275  $(2,680)  -17.5%

31

Selling, General and Administrative Expenses (SG&A). SG&A expenses consist primarily of salaries and related expenses for employees, marketing expenses related to sales of ethanol and WDG in North America and biodiesel and other products in India, as well as professional fees, other corporate expenses, and related facilities expenses.
 
North America.  SG&A expenses as a percentage of revenue in the year ended December 31, 2014 decreased to 6% as compared to 9% in the corresponding period of 2013. The decrease in SG&A in the year ended December 31, 2014 was primarily attributable to: (i) reclassification of fixed costs from cost of goods sold to SG&A in early 2013 related to idling of the plant of approximately $2.5 million, (ii) decrease in 2014 stock compensation expense of approximately $0.5 million, and $0.1 million decrease in other expenses, offset by (iii) increase in marketing fees of $0.8 million, and (iv) increases of $0.9 million in consultant and financial advisory fees, $0.3 million in legal fees, and $0.3 million in engineering services during year ended December 31, 2014.
India.  SG&A expenses as a percentage of revenue in the year ended December 31, 2014 decreased slightly to 8% as compared to 9% in the year ended December 31, 2013.Our single largest expense in SG&A is the operational support fees paid to Secunderabad Oils Limited based on the working capital provided.  These fees are computed as a percentage of operating profits.  During the 2014, the working capital support decreased by 32% hence decreasing the overall SG&A expenses.  In addition, the 63% decrease in revenues resulted in decreased marketing, travel, and other miscellaneous expense of $1.1 million.
Other Income/Expense
Fiscal Year Ended December 31 (in thousands)
   2014  2013  Inc/(dec)  % change 
North America            
 Interest expense $9,018  $10,684  $(1,666)  -15.6%
 Amortization expense  6,038   12,467   (6,429)  -51.6%
 Loss on debt extinguishment  1,346   3,709   (2,363)  -63.7%
 Other (income) expense  (471)  (980)  509   -51.9%
                  
India                
 Interest expense  1,034   1,124   (90)  -8.0%
 Other (income) expense  (14)  (93)  79   -84.9%
 Total $16,951  $26,911  $(9,960)  -37.0%
Other Income/Expense.  Other (income) expense consisted primarily of interest, amortization and extinguishment expense attributable to debt facilities acquired by our parent company, our subsidiaries Universal Biofuels Pvt. Ltd. (UBPL), International Biofuels, Inc., Aemetis Advanced Fuels Keyes, Inc., Aemetis Facilities Keyes, Aemetis Technologies and AE Advanced Fuels and interest accrued on the judgments obtained by Cordillera Fund, UBS and Kiefer. The debt facilities include stock or warrants issued as fees. The fair value of stock and warrants are amortized as amortization expense, except when the extinguishment accounting method is applied, in which case refinanced debt costs are recorded as extinguishment expense. In addition, the other (income) expense consists of scrap sales from UBPL and gain or loss on sale of equipment in the North America entities.

North America.  Interest expense was lower in the year ended December 31, 2014 due to $23.9 million in principal and $6.6 million in interest payments on our senior notes and sub debt. The decrease in amortization expense is due to debt issuance costs present during the prior period becoming fully amortized in the year  2014. The debt extinguishment costs were higher in 2013 as there were multiple sub debt notes that were amended in the 2013 period causing a larger loss on extinguishment, while only three sub debt notes were refinanced during the year ended December 31, 2014. The decrease in other income was due to gain on sales of assets during the year ended December 31, 2013 compared to a loss on sale of assets offset by gain on settlement of liabilities in the year ended December 31, 2014.

India.  Interest expense decreased slightly as a result of principal and interest payments of $0.5 million and $0.8 million for the SBI term loan and working capital loan respectively during the year ended December 31, 2014. The decrease in other income was caused primarily by a decrease in foreign exchange gains as there were multiple international shipments in the year ended December 31, 2013, but only one international shipment in the year ended December 31, 2014.

32


Year Ended December 31, 2013 Compared to Year Ended December 31, 2012
Revenues
Fiscal Year Ended December 31 (in thousands)
  2013  2012  Inc/(dec)  % change 
             
North America $144,698  $175,501  $(30,803)  -17.6%
India  32,816   13,547   19,269   142.2%
Total $177,514  $189,048  $(11,534)  -6.1%

North America.  The decrease in revenues in the North America segment for the year ended December 31, 20112013 reflects the operation of the Keyes, CA plant beginning April 2011.  Wefor only 9 months in 2013 compared to full year of operation in 2012. The shorter operation cycle in 2013 reduced our gallons sold in ethanol and WDG by 20% and 2% respectively, while the average price of  ethanol increased by 5% to $2.63 per gallon and of WDG decreased by 3% to $100.47 per ton. For the year ended December 31, 2013, we generated 82%approximately 77% of revenuerevenues from sales of ethanol, 21% of revenues from sales of WDG and 2% of revenues from corn oil and syrup sales compared to 76% of revenues from sales of ethanol and 18%22% of revenuerevenues from sales of WDG.WDG for the year ended December 31, 2012.  For the eightyear ended December 31, 2013, plant operations averaged 103% of nameplate capacity for nine months of operations compared to 96% for the twelve months of operations in 2011 plant2012 due to a decision by management to slow down production averaged 101%during the last quarter of nameplate capacity.2012 in response to unfavorable market conditions.

India.  The increase in revenues in the India segment for the year ended December 31, 20112013 reflects (i) an increase in the amount of biodiesel produced and sold as a result of two largeconsistent sales into the domestic market and several sales to one international customer during the year ended December 31, 2013 compared to no international sales ($6.8 million) induring the second halfyear ended December 31, 2012, (ii) continuing stronger sales of the year, (ii) the resalerefined glycerin unit (iii) a decrease in sales of feedstock inventory ($602,590);natural refined palm oil (NRPO) and (iii) the resalean increase in sales of  crude palm oil.  We sold 19.4 thousand metric tons of biodiesel, and 4.9 thousand metric tons of refined glycerin ($607,145).in 2013, which were increases of 369% and 115%, respectively, compared to 2012; while the prices of biodiesel and refined glycerin decreased by 26% to $913 per metric ton and 4% to $939 per metric ton respectively in 2013 compared to 2012. In addition, we sold 8.2 thousand metric tons of RPO/Stearin in 2013 compared to 6.5 thousand metric tons in 2012 while average price decreased by 140% from 2012 to 2013. Also, we sold 2 thousand metric tons of CPO in 2013 which made up of 1% of our total India revenue in 2013. For the year ended December 31, 2013, we generated approximately 55% of revenue from sales of biodiesel (methyl ester), 14% of revenue from sales of glycerin and 31% of revenue from sales of NRPO and crude palm oil, compared to 31% of revenue from sales of biodiesel, 16% of revenue from sales of glycerin and 53% of revenue from sales of NRPO for the year ended December 31, 2012.
 
Cost of Goods Sold
 
Fiscal Year Ended December 31 (in thousands) 
  2011  2010  Increase/(Decrease) 
North America $127,722   -  $127,722 
India  9,494  $8,254   1,240 
Total $137,216  $8,254  $128,962 
Fiscal Year Ended December 31 (in thousands)
  2013  2012  Inc/(dec)  % change 
             
North America $130,498  $183,784  $(53,286)  -29.0%
India  28,722   14,191   14,531   102.4%
Total $159,220  $197,975  $(38,755)  -19.6%
 
North AmericaAmerica.  .We ground 15.0 million bushels of corn and grain sorghum during the year ended December 31, 2013 compared to 18.6 million bushels of corn during the twelve months ended December 31, 2012.  Our cost of feedstock on a per ton basis decreased by 14% for the twelve months ended December 31, 2013 as compared to 2012.  The increasedecrease in costs of goods sold inbetween the North America segment fortwelve months ended December 31, 2013 and 2012 reflects the idling of the Keyes, CA plant from January 15, 2013 through April 22, 2013 compared to twelve months of operations during the year ended December 31, 2011 reflects the operation of the Keyes, CA plant beginning in April 2011.  For the year ended December 31, 2011, we ground 380,774 tons of corn.2012 as well as decreased feedstock costs.
 
India.  The increase in costscost of goods sold inreflects the India segment is primarily attributable to an increase in productionsales of biodiesel and refined glycerin revenue in 2013. In addition, the second halfaverage cost of 2011.  ForNRPO increased  21% per ton in 2013 compared to 2012. Even though, the cost of goods sold increased, gross margins were positive in 2013 due to higher volume sales in biodiesel and refined glycerin compared to 2012 which had negative gross margins due to higher raw material costs and lower finished goods prices in 2012.  We processed 4 thousand metric tons of refined palm oil (RPO) and 3.9 thousand metric tons of crude glycerin during the twelve months ended December 31, 2013 to produce 19.8 thousand metric tons of biodiesel and 5.0 thousand metric tons of refined glycerin compared to the processing of 4.7 thousand metric tons of refined palm oil and 1.3 thousand metric tons of crude glycerin to produce 4.0 thousand metric tons of biodiesel and 2.3 thousand metric tons of refined glycerin during the 2012.
33

Gross Profit (Loss)

Fiscal Year Ended December 31 (in thousands)

  2013  2012  Inc/(dec)  % change 
             
North America $14,200  $(8,283) $22,483   -271.4%
India  4,094   (644)  4,738   -735.6%
Total $18,294  $(8,927) $27,221   -304.9%
North America.  Gross profit increased by 271.4% in the year ended December 31, 2011, we processed 9,302 metric tons of NRPO.2013 compared to the year ended December 31, 2012 due to decreases in corn prices by 14%.

India.  The increase in gross profit was attributable to the increase in overall revenues and volume in the year ended December 31, 2013 compared to the year ended December 31, 2012.
 
Operating Expenses
 
R&D
 
Fiscal Year Ended December 31 (in thousands) 
  2011  2010  Increase/(Decrease) 
North America $577  $323  $254 
India  -   -   - 
Total $577  $323  $254 
Fiscal Year Ended December 31 (in thousands)
 
22

  2013  2012  Inc/(dec)  % change 
             
North America $539  $620  $(81)  -13.1%
India  -   -   -   - 
Total $539  $620  $(81)  -13.1%
 
The increasedecrease in R&D expense in our North America segment in 2011 reflects2013 primarily came from lower legal costs compared to 2012 offset by the increase in amortization expense in 2013.  Legal costs in 2012 related principally to the acquisition of acquiring and operating our research and development facilityZymetis in College Park, Maryland.2012.
 
SG&A
 
Fiscal Year Ended December 31 (in thousands) 
  2011  2010  Increase/(Decrease) 
North America $7,843  $4,006  $3,837 
India  739   396   343 
Other  (11)  308   (319)
Total $8,571  $4,710  $3,861 
Fiscal Year Ended December 31 (in thousands)
  2013  2012  Inc/(dec)  % change 
             
North America $12,428  $10,922  $1,506   13.8%
India  2,847   691   2,156   312.0%
Total $15,275  $11,613  $3,662   31.5%
Selling, General and Administrative Expenses (SG&A). SG&A expenses consist primarily of salaries and related expenses for employees, marketing expenses related to sales of ethanol and WDG in North America and biodiesel and other products in India, as well as professional fees, other corporate expenses, and related facilities expenses.
 
North America.  SG&A expenses as a percentage of revenue in the year ended December 31, 2013 increased to 9% as compared to 6% in the corresponding period of 2012. The increase in SG&A in the year ended December 31, 20112013 was primarily attributable to: (i) reclassification of fixed costs from cost of goods sold to (i) an increaseSG&A in early 2013 related to idling of the plant of approximately $2.5 million, (ii) stock compensation expense related to an increaseof approximately $0.7 million, (iii) $0.2 million in managementpayroll expense, and administrative personnel at the Keyes plant; and (ii) an increase(iv) $0.2 million in ethanol and WDG sales and marketing expenses.  Compensation expense rose from approximately $1.1 millionother miscellaneous expense.  These increases for the year ended December 31, 2010 to approximately $2.72013 compared with 2012 were offset by decreases in (i) financial advisory service fees of $1.9 million forand (ii) marketing fees of $0.3 million.
34

India.  SG&A expenses as a percentage of revenue in the year ended December 31, 2011.  The number of management and administrative employees at our Keyes plant rose during the two-year period2013 increased to 9% as we were hiring plant personnel latecompared to 5% in the year of 2010 and for the first two months of 2011, while having the full complement of employees during the balance of the fiscal year of 2011.  In addition, retrofit and restart costs in the amount of approximately $3.0 million were charged to SG&A.  Marketing fees of approximately $2.0 million were incurred during the year ended December 31, 2011 in connection with sales of ethanol and WDG.
India.2012. Our single largest expense in SG&A is the operational support fees paid to Secunderabad Oils Limited.  These fees are computed as a percentage of operating profits.  For the years ended December 31, 20112013 and 2010,2012, we incurred approximately $115,000$0.9 million and $135,000, respectively$0.1 million in operational support fees.fees and incurred salary and related expenses of approximately $0.4 million and $0.2million, respectively.  Additionally, during the year ended December 31, 2013, year- over-year spending increased by $0.5 million due to increases in commission, travelling, and selling expenses.

Other.  Resources associated with the Biofuels Marketing subsidiary were reassigned to other segments during 2010 resulting in a decrease in Other SG&A.

Other Income/Expense
 
Other income (expense) consisted of the following items:
Fiscal
Interest expense is attributable to debt facilities acquired by our parent company, our subsidiaries Universal Biofuels Pvt. Ltd., International Biofuels, Inc., AE Advanced Fuels Keyes, Inc. and interest accrued on the complaint filed by Cordillera Fund, L.P. These debt facilities included revenue participation fees, warrants issued as fees and the payment of other fees and discount fees, which are amortized as part of interest expense. Currently, the debt facility for Universal Biofuels Pvt. Ltd. accrues interest at the default rate of interest. We incurred interest expense of approximately $13.6 million for the twelve months ended December 31, 2011 ($4.0 million from India loans and $9.6 million from North America loans) compared to $4.0 million for the twelve months ended December 31, 2010 ($1.8 million from India loans and $2.2 million from North America loans).  We capitalized interest in the amount of approximately $185,000 and $54,000, respectively, during the twelve months ended December 31, 2011 and 2010.
Other income decreased year-over-year by approximately $550,000 mainly related to the extinguishment of certain liabilities.
During 2011, we realized a loss of approximately $401,000 on the sale of land holdings in Danville, IL and a loss of approximately $34,000 from extinguishment of debt was included in other expense.
23

Year Ended December 31 2010 Compared to Year Ended December 31, 2009(in thousands)
 
Revenues
   2013  2012  Inc/(dec)  % change 
North America            
 Interest expense $10,684  $9,113  $1,571   17.2%
 Amortization expense  12,467   7,544   4,923   65.3%
 Loss on debt extinguishment  3,709   9,069   (5,360)  -59.1%
 Gain on Bargain Purchase  -   (42,336  42,336   -100%
 Other (income) expense  (980)  (258)  (722)  279.8%
                  
India                 
 Interest expense  1,124   1,001   123   12.3%
 Other (income) expense  (93)  70   (163)  -232.9%
 Total $26,911  $(15,797) $42,708   -270.4%
 
During
Other Income/Expense.  Other (income) expense consisted primarily of interest, amortization and extinguishment expense attributable to debt facilities acquired by our parent company, our subsidiaries Universal Biofuels Pvt. Ltd. (UBPL), International Biofuels, Inc., Aemetis Advanced Fuels Keyes, Inc., Aemetis Facilities Keyes, Aemetis Technologies and AE Advanced Fuels and interest accrued on the judgments obtained by Cordillera Fund, UBS and Kiefer. The debt facilities include stock or warrants issued as fees. The fair value of stock and warrants are amortized as amortization expense, except when the extinguishment accounting method is applied, in which case refinanced debt costs are recorded as extinguishment expense. In addition, the other (income) expense consists of scrap sales from UBPL and gain or loss on sale of equipment in the North America entities.

North America.  Interest expense was higher in the year ended December 31, 20102013 due to no payments of interest or principal payments on our revenues were derived primarily from salessenior notes or sub debt. In addition, we drew on the revolving loan under our senior debt facility and other notes as acquisition funding in 2012. The increase in amortization expense is due to increase in discount issuance costs on refinancing of biodieselsenior debt and glycerin in India.
Fiscal Year Ended December 31 (in thousands) 
  2010  2009  Increase/(Decrease) 
North America  -   -   - 
India $8,132  $9,175  $(1,043)
Total $8,132  $9,175  $(1,043)
India.  The decrease in revenuessub debts in the India segmentfourth quarter of 2012. The debt extinguishment costs were higher in 2012 as we drew and refinanced the senior debt, the senior debt was extinguished and we recognized higher loss compared to only sub debt notes being extinguished in 2013. On July 6, 2012 we acquired Cilion, Inc. through a merger. The excess of the fair value of the assets acquired gave rise to a gain on bargain purchase accounting of $42.3 million for the year ended December 31, 2010 reflects (i) a decrease in the amount of biodiesel produced and sold.  During 2010, we had no international sales compared to one international sale (approximately $2.9 million) in 2009.  In addition, the market for biodiesel declined in 2010 as a result of the2012. The increase in feedstock costs.
Costother income was due to gain on sales of Goods Sold
Fiscal Year Ended December 31 (in thousands) 
  2010  2009  Increase/(Decrease) 
North America  -   -   - 
India $8,254  $9,047  $(793)
Total $8,254  $9,047  $(793)
India.  The decreaseequipment held for sale in costs2013 of goods sold in the India segment is primarily attributable to a 43% decrease in the amount$0.2 million and gain on settlement of biodiesel sold offset by an increase in feedstock prices.  Forpast liabilities of $0.6 million during the year ended December 31, 2010, we processed 7,555 metric tons2013 compared to gain on sales of NRPO.equipment of $0.1 million and gain on land sale of $0.2 million during the year ended December 31, 2012.
Operating Expenses
R&D
Fiscal Year Ended December 31 (in thousands) 
  2010  2009  
Increase/
Decrease
 
North America $323  $539  $(216)
India  -   -   - 
Total $323  $539  $(216)
24

The decrease in R&D in our North America segment in 2010 reflects the shut down of the Butte, MT facility and storage of the equipment in June 2010 prior to moving the equipment to the Keyes plant.
SG&A
Fiscal Year Ended December 31 (in thousands) 
  2010  2009  Increase/Decrease 
North America $4,006  $4,260  $(254)
India  396   1,843   (1,447)
Other  308   157   151 
Total $4,710  $6,260  $(1,550)

North AmericaIndia.  Interest expense increased slightly as a result of no payments toward principal and interest for the SBI term loan and working capital loan respectively during year ended December 31, 2013. The decreaseincrease in SG&Aother income was caused primarily by an increase in foreign exchange gains as there were multiple international shipments in the year ended December 31, 2010 was primarily attributable2013 compared to a decreasenone in professional expense related to non-recurring litigation, advisory services and accounting fees in 2009 partially offset by an increase in rent associated with Cilion plant.the year ended December 31, 2012.
 
India.  The decrease in SG&A in 2010 reflects the (i) conversion of our plant from an export-only facility to a facility that sells our products into India (a decrease of approximately $539,000), which eliminated a differential duty imposed by the government of India; (ii) lower operational support fees paid to Secunderabad Oils Limited (a decrease of approximately $62,000);Liquidity and (iii) decrease in ancillary support provided by us to our India subsidiary (a decrease of approximately $288,000).Capital Resources
 
Other.  The 2010 increase in Other SG&A resulted from the addition of one headcountCash and increased travel in operation of the Biofuels Marketing subsidiary.Cash Equivalents

Other Income/Expense
Other income (expense) consisted of the following items:
Interest expense is attributable to debt facilities acquired by our parent company, our subsidiaries Universal Biofuels Pvt. Ltd., International Biofuels, Inc., AE Advanced Fuels Keyes, Inc. and interest accrued on the complaint filed by Cordillera Fund, L.P. These debt facilities included warrants issued as fees and the payment of other fees and discount fees, which are amortized as part of interest expense. Currently, the debt facility for Universal Biofuels Pvt. Ltd. accrues interestCash and cash equivalents were $0.3 million at the default rate of interest. We incurred interest expense of approximately $4 million for the twelve months ended December 31, 2010 ($1.8 million from India loans and $2.2 million from North America loans) compared to approximately $2.7 million for the twelve months ended December 31, 2009 ($672,000 from India loans and $2.0 million from North America loans).  The North America interest expense increase resulted principally from the higher levels ofborrowings made to sustain the business and the additional funding to begin the retrofit of the Keyes, CA plant.We capitalized interest in the amount of approximately $54,000 and zero, respectively, during the twelve months ended December 31, 2010 and 2009.
Other income increased mainly from approximately $514,000 from the extinguishment of certain liabilities.
During 2009, we recorded an impairment write down of approximately $2,086,350. We wrote down $1,766,355 against our Sutton, Nebraska construction-in-progress after evaluating the fair value of our development assets and wrote down $319,995 against our land holdings in Danville, Illinois after securing an appraisal of the land.
25

Quarterly Changes in Financial Position
  December 31, 2010  March 31, 2011  June 30, 2011  September 30, 2011 
Assets            
Current assets:            
Cash and cash equivalents $683,016  $238,117  $558,620  $213,136 
Accounts receivable, net  113,583   1,767,206   1,698,284   809,377 
Inventories  666,854   191,377   2,815,791   4,959,904 
Prepaid expenses  228,040   110,980   106,536   338,251 
Other current assets  390,891   251,847   407,381   647,865 
Total current assets  2,082,384   2,559,527   5,586,612   6,968,533 
                 
Property, plant and equipment, net  16,404,550   17,968,594   17,917,729   16,809,133 
Assets held for sale  2,885,000   2,885,000   885,000   885,000 
Goodwill and intangible assets  -   -   -   2,767,994 
Other assets  222,101   392,225   551,869   683,874 
Total assets $21,594,035  $23,805,346  $24,941,210  $28,114,534 
                 
Liabilities and stockholders' deficit                
Current liabilities:                
Accounts payable $4,689,420  $5,999,380  $10,426,911  $14,508,738 
Current portion of long term secured notes  2,793,427   2,993,427   3,149,015   3,274,021 
Secured notes, net of discount for issuance costs  5,306,742   5,517,928   5,710,260   5,400,230 
Short term notes and unsecured working capital lines of credit  547,596   -   -   1,631,756 
Mandatorily redeemable Series B convertible preferred stock  2,221,872   2,247,041   2,273,091   2,299,182 
Other current liabilities  2,741,103   2,798,420   3,434,826   3,563,810 
Total current liabilities  18,300,160   19,556,196   24,994,103   30,677,737 
                 
Long term liabilities:                
Long term portion of secured notes, net of discounts for issuance costs  8,168,980   12,279,895   12,949,687   13,906,726 
Long term debt (related party), net of discounts for issuance costs  4,574,603   5,244,589   6,146,437   3,867,863 
Total long term liabilities:  12,743,583   17,524,484   19,096,124   17,774,589 
                 
Stockholders' deficit:                
Series B convertible preferred stock  3,165   3,165   3,165   3,115 
Common Stock  90,342   92,092   92,792   129,463 
Additional paid-in capital  38,557,376   38,973,006   39,483,563   44,436,634 
Accumulated deficit  (47,229,670)  (51,492,962)  (57,861,871)  (63,312,346)
Accumulated other comprehensive income  (870,921)  (850,635)  (866,666)  (1,594,658)
Total stockholders' deficit  (9,449,708)  (13,275,334)  (19,149,017)  (20,337,792)
                 
Total liabilities and stockholders' deficit $21,594,035  $23,805,346  $24,941,210  $28,114,534 
We ended each of the quarters of 2011 with limited cash and were required to raise additional working capital through the extension of vendor credit for operating the plants and additional loans from our senior lender.  Obtaining working capital through commercial banks or through other means is a significant challenge.  Our senior lender has a lien on substantially all of our assets.  Unless we are able to raise equity capital or attract subordinated debt, we are dependent on our North America senior lender and our India working capital partner to fund operational cash shortfalls or other working capital requirements.
26

March 31, 2011 Compared to December 31, 2010
Assets.  During the three months ended March 31, 2011, property, plant and equipment increased by approximately $1.5 million.  During the first quarter2014, of 2011, we  completed the retrofit of the Keyes plant and capitalized those costs that added utility to the facility as leasehold improvements.  This purchase of property, plant and equipmentwhich $0.2 million was financed through additional borrowings from our senior lender and from extending terms with our trade vendors.
The $1.59 million sequential accounts receivable increase resulted from unfunded borrowing obligations in the first quarter of 2011. Our biodiesel sales during the three months ended March 31, 2011 declined to zero from $176,000 in the first quarter of 2010.  As a result we were able to collect our outstanding receivables for the India segment during the first quarter of 2011.  Additionally, because of the decline in biodiesel prices, we elected to sell approximately $527,000 of NRPO rather than produce biodiesel, resulting in lower levels of inventory at the end of the period. We applied the proceeds to repay all amounts due to Secunderabad Oils Limited under our operating agreement.
Liabilities.  Current liabilities increased during the period, as we completed the retrofit of our leased ethanol production facility in Keyes, CA.  We sold additional notes in the principal amount of $3.5 million and used approximately half of the funding to complete work through March 31, 2011.  In India, we used the proceeds from the sale of inventory to reduce the amount outstanding under our operating agreement with Secunderabad Oils Limited.
Equity.  We issued 1,750,000 shares of common stock pursuant to the sale of the additional notes.  The issuance of this equity resulted in an increase to additional paid in capital.
June 30, 2011 Compared to December 31, 2010
Assets.  Total assets increased during the six-month period ending June 30, 2011. The restart of the Keyes plant in April 2011 resulted in an increase in working capital in the form of increased inventories and accounts receivable (including a receivable under the California Ethanol Producers Incentive Program).  The increase in the asset component of working capital was offset by a related increase in accounts payable obtained pursuant to the credit terms of the Corn Procurement and Working Capital Agreement with J.D. Heiskell and trade credit provided by vendors. Property, plant and equipment increased as a result of the completion of the retrofit activities and the related capitalization of certain leasehold improvements associated with the restart.  These capitalized retrofit costs were offset by the sale of property in Danville, IL, which we carried on our books at a value of approximately $2.0 million.  We used approximately $650,000 of these proceeds to continue the construction of the refined glycerin and oil processing units at our plant in India.  Other assets increased as a result of deposits associated with the restart of the Keyes plant, principally the deposit for natural gas.
Liabilities. Total current liabilities increased during the period as a result of an increase in accounts payable and the amount of outstanding secured notes used to fund the restart of the Keyes plant in April 2011. Other accrued liabilities increased primarily due to natural gas obligations at the Keyes ethanol plant. The commencement of production allowed us to obtain favorable terms with vendors resulting in the extension of credit from trade creditors.  To complete the retrofit and restart, we sold $3.5 million in senior notes and by June 30, 2011 had used the full amount of this borrowing.  We used approximately $900,000 from the sale of the land in Danville, IL to repay obligations to our senior lender.  The India segment continued to sell feedstock inventories and use the proceeds from these sales to repay amounts owed to Secunderabad Oils Limited under our operating agreement.
Equity.  We issued 1,750,000 shares of common stock pursuant to the sale of the $3.5 million in additional notes.  We issued an additional 700,000 shares of common stock to cure certain defaults under the secured term notes held by Third Eye Capital.  The issuance of this equity resulted in an increase to additional paid in capital.
27

September 30, 2011 Compared to December 31, 2010
Assets.  Total assets increased during the nine-month period ending September 30, 2011. Inventories and accounts receivable rose as a result of the operation of the Keyes plant as well as an increase in the cost of corn, the key component of ethanol production at the Keyes plant.  Inventories rose in India as a result of the purchase of refined glycerin for resale as well as resumed production of biodiesel to fulfill an international order. Goodwill and intangible assets increased as a result of our acquisition of Zymetis, Inc. in the third quarter of 2011.  We recognized a decrease in assets held for sale as a result of the sale of property in Danville, IL.
Liabilities.  Liabilities increased during the period primarily as a result of increased accounts payable, secured notes, and other current liabilities primarily from retrofit of the Keyes plant and the commencement of commercial ethanol production in April 2011. The India segment funded the purchase of refined glycerin inventories and biofuel feedstock inventories in support of a large biodiesel order by increasing borrowings under our working capital facility with Secunderabad Oils Limited and by negotiation of increased vendor payment terms.  The secured related party note decreased as a result of the conversion of interest and fees into common stock.
Equity.  We issued 1,750,000 shares of common stock pursuant to the sale of the $3.5 million in additional notes.  We issued an additional 700,000 to cure certain defaults under the secured term notes held by Third Eye Capital.  In July our senior term note matured with the provision that the note could be automatically extended through the payment of a $75,000 per month fee payable in cash or stock.  We elected to pay this fee in stock, and issued 498,035 shares during the three months ended September 30, 2011.  In addition, we issued 393,518 shares to our senior lender in consideration for waivers of certain loan defaults.  In July we acquired Zymetis, Inc. through the issuance of 6,673,557 shares of common stock.  Additionally, we issued 29,056,356 shares as part of a conversion right with our secured related party note.  The issuance of this equity resulted in an increase to additional paid in capital.
28

Quarterly Results of Operations
  For the three months ended  For the three months ended 
                   
  March 31, 2011  June 30, 2011  September 30, 2011  March 31, 2010  June 30, 2010  September 30, 2010 
Revenues $738,469  $27,253,190  $56,571,595  $2,236,838  $1,805,710  $1,592,932 
                         
Cost of goods sold  787,472   27,567,654   55,789,374   2,209,593   1,941,674   1,671,989 
                         
Gross profit/(loss)  (49,003)  (314,464)  782,221   27,245   (135,964)  (79,057)
                         
Research and development expenses  32,569   71,400   337,229   144,530   109,847   29,206 
Selling, general and administrative expenses  2,103,409   1,989,282   2,212,510   1,009,982   1,101,128   903,680 
                         
Operating loss  (2,184,981)  (2,375,146)  (1,767,518)  (1,127,267)  (1,346,939)  (1,011,943)
                         
Other income/(expense)                        
Interest income  4,021   2,796   351   180   1,914   147 
Interest expense  (2,103,163)  (3,649,359)  (3,785,857)  (909,018)  (917,037)  (726,564)
Other income, net of expenses  24,031   54,207   4,070   27,974   18,810   15,789 
Loss on asset sales  -   (401,407)  -   -   -   - 
Loss before income taxes  (4,260,092)  (6,368,909)  (5,548,954)  (2,008,131)  (2,243,252)  (1,722,571)
                         
Income taxes benefit/(expense)  (3,200)  -   98,479   (3,200)  -   - 
                         
Net loss  (4,263,292)  (6,368,909)  (5,450,475)  (2,011,331)  (2,243,252)  (1,722,571)
Less: Net loss attributable to the noncontrolling interest  -   -   -   (70,820)  (53,825)  (14,311)
Net loss attributable to Aemetis, Inc. $(4,263,292) $(6,368,909) $(5,450,475) $(1,940,511) $(2,189,427) $(1,708,260)
                         
Other comprehensive loss                        
Foreign currency translation adjustment  20,286   (16,031)  (727,992)  427,800   (309,086)  33,782 
Comprehensive loss  (4,243,006)  (6,384,940)  (6,178,467)  (1,583,531)  (2,552,338)  (1,688,789)
Comprehensive loss attributable to the noncontrolling interest  -   -   -   -   -   - 
Comprehensive loss attributable to Aemetis, Inc. $(4,243,006) $(6,384,940) $(6,178,467) $(1,512,711) $(2,498,513) $(1,674,478)
                         
Loss per common share attributable to Aemetis, Inc.                        
Basic and diluted $(0.05) $(0.07) $(0.05) $(0.02) $(0.03) $(0.02)
Weighted average shares outstanding                        
Basic and diluted  90,789,254   92,384,340   100,446,788   86,182,765   86,566,702   86,987,032 
The accompanying notes are an integral part of the financial statements
29

Three Months Ended March 31, 2011 Compared to Three Months Ended March 31, 2010

Revenues
Substantially all of our revenues for the three months ended March 31, 2011 and 2010 were derived from the sale of biodiesel and glycerin, and the resale of feedstock inventory by our India segment.
Three Months Ended March 31 (in thousands) 
  
  2011  2010  Increase/(Decrease) 
North America  -   -   - 
India $738  $2,237  $(1,499)
Total $738  $2,237  $(1,499)
During the three months ended March 31, 2011, we could not economically produce biodiesel due to high feedstock prices.  Therefore, we elected to suspend production and resell our feedstock inventory.  For the three months ended March 31, 2011, we sold 138 tons of biodiesel, and 23 tons of crude glycerin compared to 2,696 tons of biodiesel and 369 tons of crude glycerin for the three months ended March 31, 2010.
Cost of Goods Sold
Three Months Ended March 31 (in thousands) 
  
  2011  2010  Increase/(Decrease) 
North America  -   -   - 
India $787  $2,210  $(1,423)
Total $787  $2,210  $(1,423)
The decrease in costs of goods sold was attributable to lower biodiesel production.  During the three months ended March 31, 2011, we could not economically produce biodiesel due to high feedstock prices and elected to resell our feedstock inventory.  For the three months ended March 31, 2011 and 2010, we processed 1,284 and 3,408 metric tons of NRPO, respectively.
Operating Expenses
Three Months Ended March 31 (in thousands) 
  
  2011  2010  Increase/(Decrease) 
R&D         
North America
 $33  $145  $(112)
India
  -   -   - 
Total R&D  33   145   (112)
             
SG&A            
North America
  2,001   767   1,234 
India
  114   162   (48)
Other
  (12)  81   (93)
Total SG&A  2,103   1,010   1,093 
             
Other Expense            
North America
  1,030   469   561 
India
  1,045   412   633 
Total Other Expense $2,075  $881  $1,194 
30

R&D. Lower R&D costs reflect the fact that during the three months ended March 31, 2011, we were winding down operations at our Butte, MT pilot plant.
SG&A
North America. The increase in SG&A in the three months ended March 31, 2011 was primarily attributable to the costs incurred to restart the Keyes plant.
India. Our single largest expense in SG&A is the operational support fees paid to Secunderabad Oils Limited.  These fees are computed as a percentage of operating profits.  For the three months ended March 30, 2011 and 2010, we incurred approximately $42,000 and $32,000, respectively in operational support fees.
Other SG&A. Resources associated with the Biofuels Marketing subsidiary were reassigned to other segments during 2010 resulting in a decrease in Other SG&A..
Other Income/Expense
Other income (expense) consisted of the following items:
Interest expense attributable to debt facilities acquired by our parent company, our subsidiaries Universal Biofuels Pvt. Ltd., International Biofuels, Inc., AE Advanced Fuels Keyes, Inc. and interest accrued on the complaint filed by Cordillera Fund, L.P. These debt facilities included warrants issued as fees and the payment of other fees and discount fees, which are amortized as part of interest expense. During the three months ended March 31, 2011 and 2010, the debt facility for Universal Biofuels Pvt. Ltd. accrued interest at the default rate of interest. We incurred interest expense of approximately $2.1 million for the three months ended March 31, 2011 ($1.1 million from India loans and $1.0 from North America loans), compared to approximately $909,000 for the three months ended March 31, 2010 ($280,000 from India loans and $629,000 from North America loans). We capitalized interest in the amount of approximately $185,000 and zero, respectively, during the three months ended March 31, 2011 and 2010.
Interest income is earned on excess cash, principally in India. Due to low levels of cash during the three months ended March 31, 2011, and 2010, our interest income remained at low levels of $4,021 and $180, respectively.
Other income of $24,031 in 2011 and $27,974 in 2010 is attributable to rent income from portions our land holdings in Sutton, NE and Danville, IL leased to local farmers.
31

Three Months Ended June 30, 2011 Compared to Three Months Ended June 30, 2010
Revenues
Our revenues in the three months ended June 30, 2011 and 2010 were derived primarily from sales of ethanol and WDG in North America and biodiesel$0.1 million was held in our Indian subsidiary. Our current ratio at December 31, 2014 was 0.29 compared to a current ratio of 0.35 at December 31, 2013.  We expect that our future available capital resources will consist primarily of cash generated from operations, remaining cash balances, EB-5 program borrowings, amounts available for borrowing, if any, under our senior debt facilities and glycerin in India.our subordinated debt facilities, and any additional funds raised through sales of equity.
 
Three Months Ended June 30 (in thousands) 
  
  2011  2010  Increase/(Decrease) 
North America $27,253   -  $27,253 
India  -  $1,806   (1,806)
Total $27,253  $1,806  $25,447 
North America.  The increase in revenues in our North America segment for the three months ended June 30, 2011 reflects the operation of the Keyes, CA plant beginning in April 2011.  We generated 82% of revenue from sales of ethanol, 17% from sales of WDG, and less than 1% from the sale of syrup.  For the three months ended March 31, 2011 plant production, during its period of operation, averaged 85% of nameplate capacity.
India.  During the quarter ended June 30, 2011 we did not produce and sell any biodiesel due to high feedstock prices, compared to 2,114 tons of biodiesel and 32 tons of glycerin for the three months ended June 30, 2010.
Cost of Goods Sold
Three Months Ended June 30 (in thousands) 
  
  2011  2010  Increase/(Decrease) 
North America $27,550   -  $27,550 
India  17  $1,942   (1,925)
Total $27,567  $1,942  $25,625 
North America.  The increase in costs of goods sold in our North America segment for the three months ended June 30, 2011 reflects the operation of the Keyes, CA plant beginning April 2011.  For the three months ended June 30, 2011, we ground 86,788 tons of corn.
India.  For the three months ended June 30, 2010, feedstock costs rose above the price of biodiesel.  For the three months ended June 30, 2011 and 2010, we processed 0 and 1,353 metric tons of NRPO, respectively.The high cost of NRPO caused us to cease production and sales of biodiesel during the three months ended June 30, 2011.
Operating Expenses
Three Months Ended June 30 (in thousands) 
  2011  2010  Increase/(Decrease) 
R&D         
North America
 $71  $110  $(39)
India
  -   -   - 
Total R&D  71   110   (39)
             
SG&A            
North America
  1,651   948   703 
India
  338   75   263 
Other
  -   78   (78)
Total SG&A  1,989   1,101   888 
             
Other Expense            
North America
  2,591   583   2,008 
India
  1,403   313   1,090 
Total $3,994  $896  $3,098 
32

R&D. We made minimal expenditures on R&D during the three months ended June 30, 2011 as our landlord sold the building that housed our demonstration facility in Butte, MT and terminated the lease.  As a result, we moved our equipment from our commercial demonstration facility in Butte, MT into storage.  During the second quarter of 2012, we moved the equipment to our Keyes plant.  In comparison, our principal area of spending for R&D during the three months ended June 30, 2010 was our integrated cellulose and starch ethanol commercial demonstration facility in Butte, MT. We incurred expenses of $109,847 during the three months ended June 30, 2010 to operate the commercial demonstration facility. During the three months ended June 30, 2011, we incurred charges of $56,438 related to disposal of equipment from the disassembly of our facility in Butte, MT and storage of the equipment.
SG&A
North America. The increase in SG&A in the three months ended June 30, 2011 compared to 2010 was primarily attributable to (i) an increase in compensation expense related to the addition of management and administrative personnel at the Keyes plant; and (ii) an increase in ethanol and WDG sales and marketing expenses.  Compensation expense rose from $510,000 for the three months ended June 30, 2010 to approximately $699,000 for the three months ended June 30, 2011.  Marketing fees of $447,000 were incurred during the three months ended June 30, 2011 in connection with sales of ethanol and WDG.
India. Our single largest expense in SG&A is the operational support fees paid to Secunderabad Oils Limited.  These fees are computed as a percentage of operating profits.  Since there were minimal sales in the three months ended June 30, 2011, we reclassed overhead spending usually associated with cost of goods sold to SG&A. The activities of personnel focused on administrative, maintenance and marketing activities during this period.
Other Income/Expense
Other income (expense) consisted of the following items:
Interest expense is attributable to debt facilities acquired by our parent company, our subsidiaries Universal Biofuels Pvt. Ltd., International Biofuels, Inc., AE Advanced Fuels Keyes, Inc. and interest accrued on the complaint filed by Cordillera Fund, L.P. These debt facilities included warrants issued as fees and the payment of other fees and discount fees, which are amortized as part of interest expense. We incurred interest expense of approximately $3.6 million for the three months ended June 30, 2011 ($1.4 million from India loans and $2.2 million from North America loans) compared to approximately $917,000for the three months ended June 30, 2010 ($300,000 from India loans and $617,000from North America loans).  Interest expense increased in North American from the borrowings made during November 2010 and March 2011 to retrofit and restart the Keyes plant.  Interest expense decreased in India as our minimal level of sales did not require working capital funding during the three months ended June 30, 2011.
Interest income is earned on excess cash, principally in India. Due to low levels of cash during the three months ended June 30, 2011, and 2010, our interest income remained at low levels of $2,796 and $1,914, respectively.
Other income, for both years, is attributable to renting portions our land holdings in Sutton, NE and Danville, IL to local farmers.  During the three months ended June 30, 2011 we recorded $33,000 from renting portions of our tank storage at our plant in India.
During the three months ended June 30, 2011, we realized a loss of $401,407 on the sale of land holdings in Danville, IL.
33

Three Months Ended September 30, 2011 Compared to Three Months Ended September 30, 2010
Revenues
Substantially all of our revenues for the three months ended September 30, 2011 were derived from the sale of ethanol and WDG by our North America segment.
Three Months Ended September 30 (in thousands) 
  
  2011  2010  Increase/(Decrease) 
North America $52,178  $-  $52,178 
India  4,394   1,593   2,801 
Total $56,572  $1,593  $54,979 
North America.  The increase in revenues in our North America segment for the three months ended September 30, 2011 reflects the operation of the Keyes, CA plant beginning April 2011.  We generated 83% of North America revenue from sales of ethanol,16% of North America revenue from sales of WDG, and less than 1% from the sale of syrup.  For the three months ended September 30, 2011 plant production averaged 103% of nameplate capacity.
India.  The increase in revenues in our India segment for the three months September 30, 2011 reflects the resumption of biodiesel production and sales.  For the three months ended September 30, 2011, we sold 3,996 tons of biodiesel, no crude glycerin and 116 tons of refined glycerin.  For the three months ended September 30, 2010, we sold 1,486 tons of biodiesel, 111 tons of glycerin and no refined glycerin,
Cost of Goods Sold
Three Months Ended September 30 (in thousands) 
  
  2011  2010  Increase/(Decrease) 
North America $51,617  $-  $51,617 
India  4,172   1,672   2,500 
Total $55,789  $1,672  $54,117 
North America.  The increase in cost of goods sold for the three months ended September 30, 2011 reflects the operation of the Keyes, CA plant beginning April 2011.  For the three months ended September 30, 2011, we ground 141,451 tons of corn.
India.  The increase in cost of goods sold for the three months ended September 30, 2011 reflects the resumption of biodiesel production and sales due to the decline in feedstock prices.  For the three months ended September 30, 2011 and 2010, we processed 1,284 and 1,862 metric tons of NRPO, respectively.
Operating Expenses
Three Months Ended September 30 (in thousands) 
  2011  2010  Increase/(Decrease) 
R&D         
North America
 $337  $29  $308 
India
  -   -   - 
Total R&D  337   29   308 
             
SG&A            
North America
  2,066   746   1,320 
India
  147   86   61 
Other
  -   72   (72)
Total SG&A  2,213   904   1,309 
             
Other Expense            
North America
  3,136   361   2,775 
India
  646   350   296 
Total Other Expense $3,782  $711  $3,071 
34

R&D. In July 2011 we acquired Zymetis, Inc., an R&D company. Our R&D expense during the three months ended September 30, 2011 was attributable to the ongoing R&D activities at the facility in College Park.
SG&A
North America. The increase in SG&A in the three months ended September 30, 2011 compared to the same period of 2010 was primarily attributable to (i) an increase in compensation expense related to an increase in management and administrative personnel at the Keyes plant; and (ii) an increase in ethanol and WDG sales and marketing expenses.  Compensation expense rose from $417,000 for the three months ended September 30, 2010 to approximately $656,000 for the three months ended September 30, 2011.  Marketing fees of $804,000 were also incurred during the three months ended September 30, 2011 in connection with sales of ethanol and WDG.
India. Our single largest expense in SG&A is the operational support fees paid to Secunderabad Oils Limited.  These fees are computed as a percentage of operating profits.  For the three months ended September 30, 2011 and 2010, we incurred approximately $47,000 and $2,400, respectively in operational support fees.
Other Income/Expense (in thousands)
Other income (expense) consisted of the following items:
Interest expense is attributable to debt facilities acquired by our parent company, our subsidiaries Universal Biofuels Pvt. Ltd., International Biofuels, Inc., AE Advanced Fuels Keyes, Inc. and interest accrued on the complaint filed by Cordillera Fund, L.P. These debt facilities included warrants issued as fees and the payment of other fees and discount fees, which are amortized as part of interest expense. We incurred interest expense of approximately $3.8 million for the three months ended September 30, 2011 ($646,000 from India loans and $3.1 million from North America loans) compared to approximately $727,000 for the three months ended September 30, 2010 ($330,000 from India and $397,000 from North America).  Interest expense increased in North American from the borrowings made during November 2010 and March 2011 to retrofit and restart the Keyes plant.  Interest expense decreased in India due to lower levels of sales, which required lower levels of borrowing under the working capital loan during the three months ended September 30, 2011 compared to 2010.
Other income, $4,070 and $15,789 for the three months ended September 30, 2011 and 2010, respectively, is attributable to renting portions our land holdings in Sutton, NE and Danville, IL to local farmers.  The decrease in other income is a result of our sale of the Danville, IL landholding during the three months ended June 30, 2011.

 
 
35

 
Results of Operations
  2011  2010 
  For the six  For the nine  For the six  For the nine 
  months ended  months ended  months ended  months ended 
  June 30, 2011  September 30, 2011  June 30, 2010  September 30, 2010 
Revenues $27,991,659  $84,563,254  $4,042,548  $5,635,480 
                 
Cost of goods sold  28,355,126   84,144,500   4,151,267   5,823,256 
                 
Gross profit (loss)  (363,467)  418,754   (108,719)  (187,776)
                 
Research and development expenses  103,969   441,198   254,377   283,583 
Selling, general and administrative expenses  4,092,691   6,305,201   2,111,110   3,014,790 
                 
Operating loss  (4,560,127)  (6,327,645)  (2,474,206)  (3,486,149)
                 
Other income / (expense)                
Interest income  6,817   7,168   2,094   2,241 
Interest expense  (5,752,522)  (9,538,379)  (1,826,055)  (2,552,619)
Other income, net of expenses  78,238   82,308   46,784   62,573 
Loss on land sale  (401,407)  (401,407)  -   - 
                 
Loss before income taxes  (10,629,001)  (16,177,955)  (4,251,383)  (5,973,954)
                 
Income tax benefit/(expense)  (3,200)  95,279   (3,200)  (3,200)
                 
Net loss  (10,632,201)  (16,082,676)  (4,254,583)  (5,977,154)
Less: Net loss attributable to the noncontrolling interest  -   -   (124,645)  (138,956)
Net loss attributable to Aemetis, Inc.  (10,632,201)  (16,082,676)  (4,129,938)  (5,838,198)
                 
                 
Other comprehensive loss, net of tax                
Foreign currency translation adjustment  4,255   (723,737)  118,714   152,496 
Comprehensive loss, net of tax  (10,627,946)  (16,806,413)  (4,135,869)  (5,824,658)
Comprehensive loss attributable to the noncontrolling interest  -   -   -   - 
Comprehensive loss attributable to Aemetis, Inc. $(10,627,946) $(16,806,413) $(4,011,224) $(5,685,702)
                 
Loss per common share attributable to Aemetis, Inc.                
Basic and diluted  (0.12)  (0.17)  (0.05)  (0.07)
Weighted average shares outstanding                
Basic and diluted  91,591,203   94,575,503   86,375,794   86,581,779 
36

Six Months Ended June 30, 2011 Compared to Six Months Ended June 30, 2010
Revenues
Substantially all of our revenues for the six months ended June 30, 2011 were derived from the sale of ethanol and WDG by our North America segment while substantially all of our revenues for the same period of 2010 were derived from the sale of biodiesel by our India segment.
Six Months Ended June 30 (in thousands) 
  2011  2010  Increase/(Decrease) 
North America $27,253   -  $27,253 
India  738   4,043   (3,305)
Total $27,991  $4,043  $23,948 
Liquidity
North AmericaCash and cash equivalents, current a.  The increase in revenues forssets, current liabilities and debt at the six months ended June 30, 2011 reflects the operationend of the Keyes, CA plant beginning April 2011.  We generated 82% of revenue from sales of ethanol, 17% of revenue from sales of WDG, and less than 1% from the sale of syrup.  For the six months ended June 30, 2011 plant production, during itseach period of operation, averaged 85% of nameplate capacity.
India.  During the six months ended June 30, 2011, we could not economically produce biodiesel due to high feedstock prices.  Therefore, we elected to suspend production and resell our feedstock inventory. During the six months ended June 30, 2011, we sold 138 tons of biodiesel and 23 tons of crude glycerin compared to 4,810 tons of biodiesel and 401 tons of crude glycerin during the six months ended June 30, 2010.
Cost of Goods Sold
Six Months Ended June 30 (in thousands) 
  2011  2010  Increase/(Decrease) 
North America $27,550   -  $27,550 
India  805   4,151   (3,346)
Total $28,355  $4,151  $24,204 
North America.  The increase in cost of goods sold for the six months ended June 30, 2011 reflects the operation of the Keyes, CA plant beginning April 2011. During the six months ended June 30, 2011, we ground 86,788 tons of corn.
India.  The decrease in costs of goods sold was attributable to lower biodiesel production.  During this period, we could not economically produce biodiesel due to high feedstock prices and elected to resell our feedstock inventory. During the six months ended June 30, 2011 and 2010, we processed 1,284 and 4,761 metric tons of NRPO, respectively. The high cost of NRPO caused us to cease production from February to July 2011.were as follows (in thousands):
 
  December 31, 2014  December 31, 2013 
       
Cash and cash equivalents $332  $4,926 
Current assets (including cash, cash equivalents, and deposits)  7,933   12,707 
Current liabilities (excluding short term debt)  14,570   18,151 
Short & long term debt and other long term liabilities  77,578   91,758 
37

 
Operating Expenses
Six Months Ended June 30 (in thousands) 
  2011  2010  Increase/(Decrease) 
R&D         
North America
 $104  $255  $(151)
India
  -   -   - 
Total R&D  104   255   (151)
             
SG&A            
North America
  3,653   1,714   1,939 
India
  452   238   214 
Other
  (12)  159   (171)
Total SG&A  4,093   2,111   1,982 
             
Other Expense            
North America
  3,621   1,052   2,569 
India
  2,448   725   1,723 
Total $6,069  $1,777  $4,292 
R&D.We made minimal expenditures on R&D during the six months ended June 30, 2011 as we were moving our equipment from our commercial demonstration facility in Butte, MT into storage.  In comparison, ourOur principal areasources of spending for R&D during the six months ended June 30, 2010 was our integrated cellulose and starch ethanol commercial demonstration facility in Butte, MT. We incurred expenses of $110,000 during the six months ended June 30, 2010, from operating the commercial demonstration facility. During the six months ended June 30, 2011 we incurred charges of $56,000 related to disposal of equipment from the disassembly and storage of our facility in Butte, MT.
SG&A
North America. The increase in SG&A in the six months ended June 30, 2011 compared to 2010 was primarily attributable to (i) an increase in compensation expense related to in the addition of management and administrative personnel at the Keyes plant; and (ii) an increase in ethanol and WDG sales and marketing expenses.  Compensation expense rose from approximately $151,000 for the six months ended June 30, 2010 to approximately $1.4 million for the six months ended June 30, 2011.  Marketing fees of approximately $447,000 were incurred during the six months ended June 30, 2011 in connection with sales of ethanol and WDG.
India. The increase in SG&A for the six months ending June 30, 2011 resulted from a reclassification of excess overhead cost to SG&A for a period when there were minimal sales and personnel focused on maintenance and administrative tasks. Our single largest expense in SG&A is the operational support fees paid to Secunderabad Oils Limited.  These fees are computed as a percentage of operating profits.  For the six months ended June 30, 2011 and 2010, we incurred approximately $42,000 and $30,000, respectively in operational support fees.
38

Other Income/Expense
Other income (expense) consisted of the following items:
Interest expense is attributable to debt facilities acquired by our parent company, our subsidiaries Universal Biofuels Pvt. Ltd., International Biofuels, Inc., AE Advanced Fuels Keyes, Inc. and interest accrued on the complaint filed by Cordillera Fund, L.P. These debt facilities included warrants issued as fees and the payment of other fees and discount fees, which are amortized as part of interest expense. We incurred interest expense of approximately $5.7 million for the six months ended June 30, 2011 ($2.5 million from India loans and $3.2 million from North America loans) compared to approximately $1.8 million for the six months ended June 30, 2010 ($580,000 from India loans and $1.2 million from North America loans). Interest expense increase in North American from the borrowings made during November 2010 and March 2011 to retrofit and restart the Keyes plant.  Interest expense decreased in India due to lower levels of sales, which required lower levels of borrowing under the working capital loan during the six months ended June30, 2011 compared to 2010.
Other income, for both years, is attributable to renting portions our land holdings in Sutton, NE and Danville, IL to local farmers.  During the six months ended June 30, 2011 we recorded $33,000 from renting portions of our tank storage at our plant in India.
During the six months ended June 30, 2011, we realized a loss of approximately $401,000 on the sale of land holdings in Danville, IL.
39

Nine Months Ended September 30, 2011 Compared to Nine Months Ended September 30, 2010
Revenues
Nine Months Ended September 30 (in thousands) 
  
  2011  2010  Increase/(Decrease) 
North America $79,431   -  $79,431 
India  5,132  $5,636   (504)
Total $84,563  $5,636  $78,927 
North America.  The increase in revenues segment for the nine months ended September 30, 2011 reflects the operation of the Keyes, CA plant beginning April 2011. We generated 82% ofrevenue from sales of ethanol,17% from sales of WDG, and less than 1% from the sale of syrup. For the nine months ended September 30, 2011 plant production, during its period of operation, averaged 96% of nameplate capacity.
India.  During August, 2011 we delivered one large shipment, generating approximately $3.8 million in revenues, to an international customer. Additionally, we purchased an order for 1,000 metric tons of refined glycerin to resell in support of developing the market for this product in advance of the commissioning of our glycerin refining unit. For the nine months ended September 30, 2011, we sold 4,135 tons of biodiesel and 23 tons of crude glycerin and 116 tons of refined glycerin compared to 6,296 tons of biodiesel, and 512 tons of crude glycerin for the nine months ended September 30, 2010.
Cost of Goods Sold
Nine Months Ended September 30 (in thousands) 
  2011  2010  Increase/(Decrease) 
North America $79,168   -  $79,168 
India  4,977   5,823   (846)
Total $84,145  $5,823  $78,322 
North America.  The increase in cost of goods sold for the nine months ended September 30, 2011 reflects the operation of the Keyes, CA plant beginning April 2011. During the nine months ended September 30, 2011, we ground 228,240 tons of corn.
India.  The most significant component of cost of goods sold is feedstock.  For the nine months ended September 30, 2011 and 2010 our cost of goods decreased proportionately with revenue due to the significance of the feedstock component in this category and our strategy in this thin market to price biodiesel at a price that would offset a portion of our allocated overhead costs. For the nine months ended September 30, 2011 and 2010, we processed 5,925 and 6,623 metric tons of NRPO, respectively.
40

Operating Expenses
Nine Months Ended September 30 (in thousands) 
  2011  2010  Increase/(Decrease) 
R&D         
North America
 $441  $284  $157 
India
  -   -   - 
Total R&D  441   284   157 
             
SG&A            
North America
  5,717   2,460   3,257 
India
  600   324   276 
Other
  (12)  231   (243)
Total SG&A  6,305   3,015   3,290 
             
Other Expense            
North America
  6,757   1,414   5,343 
India
  3,093   1,074   2,019 
Total $9,850  $2,488  $7,362 
R&D. R&D expense was approximately $441,000 for the nine months ended September 30, 2011, compared to $284,000 for the same period in 2010. We spent $204,000 during the first nine months of 2011 in support of the technologies acquired through the purchase of Zymetis, Inc.  In comparison, R&D expense was $284,000 for the nine months ended September 30, 2010, all of which was attributable to operating our integrated cellulose and starch ethanol commercial demonstration facility in Butte, MT.
SG&A
North America. The increase in SG&A in the nine months ended September 30, 2011 was primarily attributable to (i) an increase in compensation expense and (ii) an increase in ethanol and WDG sales and marketing expenses.  Compensation expense increased by approximately $1.5 million for the nine months ended September 30, 2011when compared to the same period in 2010. Marketing expenses increased $1.2 million over the same period in 2010 due to the 2011 activity supporting the sales of ethanol and distiller’s grains for the Keyes plant. Rent,included in SG&A prior to the Keyes plant going into production, and corporate rent combined increased approximately $1 million for the nine months ended September 30, 2011over the same period in 2010. SG&A was partially reduced by a $(0.2) million decrease in office services for the same periods.
India.  The increase in SG&A for the nine months ending September 30, 2011 resulted from a reclassification of excess overhead cost in to SG&A for a period when there were minimal sales and personnel focused on maintenance and administrative tasks. SG&A operational support fees paid to Secunderabad Oils Limited are computed as a percentage of operating profits.  For the nine months ended September 30, 2011 and 2010, we incurred approximately $89,000 and $33,000, respectively in operational support fees.
41

Other SG&A.  Resources associated with the Biofuels Marketing subsidiary were reassigned to other segments during 2010 resulting in a decrease in Other SG&A.
Other Income/Expense
Other income (expense) consisted of the following items:
Interest expense is attributable to debt facilities acquired by our parent company, our subsidiaries Universal Biofuels Pvt. Ltd., International Biofuels, Inc., AE Advanced Fuels Keyes, Inc. and interest accrued on the complaint filed by Cordillera Fund, L.P. These debt facilities included warrants issued as fees and the payment of other fees and discount fees, which are amortized as part of interest expense. We incurred interest expense of approximately $9.4 million for the nine months ended September 30, 2011 ($3.1 million from India loans and $6.3 million from North America loans) compared to approximately $2.5 million for the nine months ended September 30, 2010 ($0.9 million from India loans and $1.6 from North America loans). The increase in interest expense in North America was from an increase in borrowings made during November 2010 and March 2011 to retrofit and restart the Keyes plant.  Decreases in interest expense in India were due to lower sales and a corresponding decrease in borrowings under our working capital facility during the nine months ended September 30, 2011 compared to 2010.
Other income, for both years, is attributable to renting portions our land holdings in Sutton, NE and Danville, IL to local farmers.  During the nine months ended September 30, 2011 we recorded $33,000 from renting portions of our tank storage at our plant in India.
During the nine months ended September 30, 2011, we realized a loss of approximately $401,000 on the sale of land holdings in Danville, IL.
42

Liquidity and Capital Resources
2010
In 2010, we were primarily engaged in three activities: (i) fundraising for the retrofit of the Keyes plant; (ii) operating our biodiesel production facility in Kakinada, India; and (iii) continuing to develop our proprietary, patent pending microbial and enzyme technology. During 2010, we funded our operations primarily from cash provided by borrowings under our credit facilities. To fund the retrofit of the Keyes plant and to fund general working capital requirements in North America, we borrowed (i) $1.6 million from a related party in January 2010; (ii) an aggregate of $8 million from Third Eye Capital in November 2010 and March 2011; and (iii) an aggregate of $1.0 million under our line of credit provided by a related party. We repaid the $1.6 million credit facility on May 11, 2010 and issued 600,000 shares of Aemetis, Inc.’s common stock as consideration for the borrowing.
2011
We completed the retrofit of the Keyes plant and commenced operations in late April 2011. During 2011, we funded our operations primarily fromliquidity have been cash provided by operations and borrowings under various debt arrangements. During the first quarter of 2015, funding from the EB-5 program began, and to the date of this report, funds from 37 investors, representing $18.5 million of funding have been authorized for release from the escrow account thus providing an additional source of liquidity for 2015. Our principal uses of cash have been to service indebtedness and capital expenditures.  We anticipate these uses will continue to be our principal uses of cash in the future. Global financial and credit facilities.markets have been volatile in recent years, and future adverse conditions of these markets could negatively affect our ability to secure funds or raise capital at a reasonable cost or at all. For additional discussion of our various debt arrangements see Note 5.  Notes Payable of the Notes to Consolidated Financial Statements in Part IV of this Form 10-K.

During the months representing the second half of 2013 and the first three quarters of 2014, we experienced a strong positive spread between the prices of ethanol and WDG and the prices of feedstock and natural gas, which improved our results of operations.  This favorable spread was driven by a strong corn harvest in the fall of 2013 resulting in lower corn costs, strong domestic gasoline demand, domestic export of ethanol into the international market and favorable logistics for ethanol producers in our region. However, ethanol prices have declined significantly since October 2014 reducing our spread as of December 31, 2014. We operate in a volatile market in which we have little control over the major components of production costs and product revenues.  As such, we expect that cash provided by operating activities mayto fluctuate in future periods primarily as a result of changes in the prices for corn, ethanol, WDG, corn oil, CDS, biodiesel, waste fats and oils, NPRO, and natural gas. DuringTo the extent that we experience periods in which the spread between ethanol prices and corn and energy costs narrow or the spread between biodiesel prices and NPROwaste fats and oils or palm oil and energy costs narrow, we may require additional working capital to fund operations. For additional discussion, see “Part I—Item 1A. Risk Factors.”
 
CashManagement believes that through:  (i) operating the Keyes plant, (ii) continuing to incorporate lower-cost non-food advanced biofuels feedstock at the Keyes plant when economical, thereby increasing operating margins, (iii) selling additional EB-5 Notes, (iv) refinancing senior debt on terms more commensurate with the long-term financing of capital assets, (v)  securing higher volumes of international shipments from the Kakinada plant, (vi) continuing to expand the domestic India markets, and Cash Equivalents(vii) using the availability on the existing working capital credit line, the Company will be able to obtain the liquidity necessary to fund company operations for the foreseeable future, however there is no assurance that our operations will generate significant positive cash flow, or that additional funds will be available to us, through borrowings  or otherwise, on favorable terms when required, or at all. 
 
Cash and cash equivalents were $249,466 atAt December 31, 2011,2014, the outstanding balance of which $117,748 was heldprincipal, interest and fees, net of discounts, on all Third Eye Capital Notes equaled $57.6 million.  On November 7, 2014, Third Eye Capital agreed to Amendment No. 8 to the Note Purchase Agreement to extend a line of credit in our North American entitiesthe amount of $6.0 million available for advance to Aemetis, such advance to be added to the outstanding principal balance of the existing notes under the Note Purchase Agreement. In November 2014, we drew $1.7 million on this advance to pay the amendment fees and $131,718 was heldfor use in our Indian subsidiary. Our current ratio atthe operations. As of December 31, 2011 was 0.24 compared2014, $4.3 million remains available to be drawn under the Third Eye Capital notes. The current maturity date for all of the Third Eye Capital Notes is July 1, 2015. We intend to pay the Notes through operational cash flow, EB-5 subordinated debt, a current ratio of 0.11 at December 31, 2010.senior debt refinancing and/or equity financing.  We expecthave engaged an investment bank to assist with exploring financing alternatives.  We believe that our future available capital resources will consist primarily of our remaining cash balances, amounts available for borrowing, if any, underwe should be able to refinance our senior debt facilities and our subordinated debt facilities, cash generated from operations, and any additional funds raised through sales of equity.
In July 2012 we acquired the Keyes plant and refinanced the project to include a revolving credit linefacility with commercial rates commensurate with our senior lender.  Our lender required repayment of certain obligations and fees under other agreements, and we closed the purchase with $3 million available under the $18 millioncurrent credit facility. profile.

Our senior lender has collateralized all significant assetsprovided a series of ours, which limits our abilityaccommodating amendments to obtain working capital through commercial banks or through other means.  We are therefore dependent onthe existing and previous loan facilities in the past as described in further detail in Note 5. Notes Payable of the Notes to Consolidated Financial Statements in Part IV of this Form 10-K.  However, there can be no assurance that our senior lender for future debt financing.will continue to provide further amendments or accommodations or will fund additional amounts in the future.
 
Liquidity

Cash and cash equivalents, current assets, current liabilities and debt at the end of each period were as follows:
  
December 31,
2011
  
December 31,
2010
 
Cash and cash equivalents $249,466  $683,016 
Current assets (including cash, cash equivalents, and deposits)  7,128,916   2,082,388 
Current liabilities (including short term debt)  29,428,067   18,300,160 
Short and long term debt  29,646,435   21,391,348 
 
 
4336

 
 
During the year ended December 31, 2014, we used cash flows from operations to fund our operations and made principal payments of $23.0 million against the Revolving Credit Facility with our senior lender.

We also rely on our working capital lines with J.D. Heiskell in California and Secunderabad Oil Limited, in India to fund our commercial arrangements for the acquisitions of feedstock.  J.D. Heiskell currently provides us with working capital for our California ethanol plant and Secunderabad Oil Limited currently provides us with working capital for our Kakinada facility.  The ability of both J.D. Heiskell and Secunderabad Oil Limited to continue to provide us with working capital depends in part on both of their respective financial strength and banking relationships.

Change in Working Capital and Cash Flows

Debt increased primarily due to accrued fees and interest in the amount of $6.8 million associated with borrowings to retrofit the Keyes plant and due to increased borrowings to purchase inventory in the amount of $1.6 million associated with borrowings from our working capital loan with Secunderabad Oils Limited.
Current liabilities increased primarily due to vendor trade credit received in connection with the restart of the Keyes plant and operating losses,which generated an incremental $9.6 million increase in accounts payable. A $1.0 million increase in short term borrowings also caused liabilities to rise. Current assets increased in accounts receivable, inventory,prepaid expenses and other assets primarily as a result of the ramping of production and operations at the Keyes ethanol plant.
Cash used in operating activities of $1.2 million resulted primarily from (i) consolidated net loss of $17.3 million, (ii) non-cash adjustments to net loss of $6.5 million, (iii)account receivable increase of $1.3 million, (iv) inventory increase of $3.7 million, (v) trade payable credit increase of $9.6 million, and (vi) accrued interest expense increase of $9.0 million.
Cash used in our investing activities of $1.0 million resulted primarily from $2.6 million in additions to property and equipment to retrofit the Keyes plant offset by $1.6 million received from the sale of land holdings.
Cash provided by our financing activities of $1.9 million resulted primarily from $1.3 million in net proceeds from our working capital line of credit, and $0.5 million in net proceeds from our secured debt facility borrowings.
Available Credit Facilities
On July 6, 2012, we entered into a new revolving credit facility in the aggregate amount of up to $18.0 million. The credit facility expires on July 5, 2013, provided, however, that the facility may be extended for up to two additional periods of one year upon certain conditions, including the payment of a renewal fee.  Interest accrues at a fluctuating rate of interest determined by reference to the Prime Rate and the amount outstanding. We are also required to pay customary fees and expenses associated with the credit facility.
We are required to (i) maintain a minimum amount of Free Cash Flow of not less than $1.5 million at the end of each fiscal quarter, (ii) debt to value ratio of 75% tested semi-annually, (iii) minimum quarterly ethanol production of not less than 14 million gallons per quarter, and (iv) limit purchases of capital expendituresto not more than $50,000 per quarter.  In addition, we are prohibited from incurring any additional indebtedness (other than specific intercompany indebtedness or specific subordinated indebtedness) absent the lender’s prior consent. Our obligations under the credit facility are secured by a first-priority security interest in all of its assets in favor of the lender.
On October 18, 2012, Third Eye Capital agreed to (i) extend the maturity date of the Existing Notes to July 6, 2014; (ii) to increase the amount of the Revolving Loan Facility by $6,000,000, to a total of $24,000,000; (iii) to modify the redemption waterfall so that any payments would be applied first to the increase in the Revolving notes; (iv) granted waivers to the Borrowers’ obligation to pay or comply, and any event of default which has occurred or may occur as a result of such failures of the Borrowers to pay or comply with certain financial covenants and principal payments, including financial covenants for the quarter ended September 30 and December 31, 2012; and (v) agreed to accrue interest until the earlier of certain events described in the Limited Waiver or February 1, 2013.  In consideration for the Limited Waiver and Amendment, the Borrowers, among other things, agreed to pay the Lenders a waiver fee in the amount of $4,000,000; and (ii) cash in the amount of $28,377for certain unreimbursed costs. After paying the $4 million waiver fee, $2 million remained available for future draw on the Revolving Loan Facility.
44

Notes Payable to Related Parties
In 2008, we entered into a Revolving Line of Credit Agreement with Laird Cagan, in the amount of $5,000,000 secured by certain, investments, intellectual property, securities and other collateral of ours, excluding the collateral securing our obligations with Third Eye Capital and the collateral securing our obligations with the State Bank of India. The Revolving Line of Credit bears interest at the rate of 10% per annum and matures on July 1, 2012. As of December 31, 2011, the remaining amount due and payable was $5,165,205.
On October 16, 2012, Aemetis International, Inc. (AII), a subsidiary of Aemetis, Inc. Entered into an amendment to the Revolving Line of Credit Agreement with Laird Q. Cagan and co-owners in the financing arrangement, pursuant to which AII extended the maturity date of the loan until July 1, 2014 and placed an average trailing daily closing price minimum of $0.05 per share for conversion of fees and accrued interest.  In exchange for the extension, the Company agreed to pay a $262,919 fee reflecting 5% of the outstanding balance of the Revolving Line of Credit, payable in cash or stock, at the same conversion price and terms as the accrued interest conversion terms.
Issuance of Convertible Promissory Notes
On March 4, 2011, and amended January 19, 2012, and July 24, 2012, the Company entered into a Note Purchase Agreement with Advanced BioEnergy, LP, a California limited Partnership for the issuance of up to 72 subordinated convertible promissory notes bearing interest at 3%, each note in the principal amount of $500,000 due and payable four years from the date of the note for a total aggregate principal amount of up to $36,000,000.
Advanced BioEnergy, LP arranges investments with foreign investors, who each make investments in the Keyes plant project in investment increments of $500,000.  The Company sold notes in the amount of $1,000,000 to the first two investors.  The availability of the remaining $35,000,000 will be determined by the ability of Advanced BioEnergy, LP to attract additional qualified investors.
45

Historical Sources and Uses of Cash
  For the three  For the six  For the nine  For the three  For the six  For the nine 
  months ended  months ended  months ended  months ended  months ended  months ended 
  March 31, 2011  June 30, 2011  September 30, 2011  March 31, 2010  June 30, 2010  September 30, 2010 
Operating activities:                  
Net loss  (4,263,292)  (10,632,201)  (16,082,676)  (2,011,331)  (4,254,583)  (5,977,154)
Adjustments to reconcile net loss to                        
  net cash provided/(used) in operating activities:                        
Stock-based compensation  53,421   104,468   221,124   100,512   169,687   245,776 
Depreciation and amortization  189,789   544,676   885,811   140,761   377,033   569,337 
Inventory provision  -   239,446   -   44,310   230,204   282,700 
Amortization of debt issuance discount  1,483,786   3,066,693   3,737,320   278,772   583,985   583,985 
Loss on extinguishment of debt  33,926   33,926   33,926   -   -   - 
Loss on sale or disposal of assets  -   401,407   401,407   -   -   - 
Deferred tax liability  -   -   (98,479)  -   -   - 
Changes in assets and liabilities:                        
Accounts receivable  96,013   (1,584,636)  (702,608)  (141,638)  26,830   (78,777)
Inventory  477,841   (2,387,855)  (4,436,268)  (363,571)  (50,494)  (916,303)
Prepaid expenses  117,113   121,521   (101,669)  (26,701)  (12,987)  964 
Other current assets and other assets  (29,817)  (345,794)  (764,533)  (50,034)  (42,368)  26,039 
Accounts payable  1,307,362   5,736,068   9,649,206   767,555   1,226,994   1,793,911 
Accrued interest expense and fees, net of payments  536,478   2,803,608   4,603,570   398,429   1,013,704   1,658,442 
Other liabilities  56,794   693,521   596,752   560,865   127,753   293,639 
Net cash provided by/(used in) operating activities  59,414  $(1,205,152) $(2,057,117) $(302,071) $(604,242) $(1,517,442)
                         
Investing activities:                        
Purchase of property, plant and equipment, net  (1,708,729)  (2,040,661)  (2,517,883)  (12,043)  (32,071)  (52,435)
Proceeds from sale of assets  -   1,598,593   1,598,593   -   -   - 
Cash obtained through merger  -   -   1,451   -   -   - 
Net cash used in investing activities  (1,708,729)  (442,068)  (917,839)  (12,043)  (32,071)  (52,435)
                         
Financing activities:                        
Proceeds from borrowings under secured debt facilities  1,750,776   3,500,000   3,500,000   -   -   - 
Repayments of borrowings under secured debt facilities  -   (920,000)  (1,944,994)  -   -   - 
Proceeds from borrowings under related party credit arrangements  -   -   -   2,100,000   2,373,000   2,612,000 
Payments of borrowings under related party credit arrangements  -   -   -   (1,600,000)  (1,600,000)  (1,600,000)
Proceeds from borrowings under short term debt facilities  -   -   5,658,030   1,196,528   1,770,248   3,189,946 
Repayments of borrowings under short term facilities  (538,614)  (1,051,541)  (4,762,790)  (1,089,343)  (2,049,874)  (2,752,368)
Net cash provided by financing activities  1,212,162   1,528,459   2,450,246   607,185   493,374   1,449,578 
                         
Effect of exchange rate changes on cash and cash equivalents  (7,746)  (5,635)  54,830   (13,200)  113,905   110,073 
Net increase (decrease) in cash and cash equivalents  (444,899)  (124,396)  (469,880)  279,871   (29,034)  (10,226)
Cash and cash equivalents at beginning of period  683,016   683,016   683,016   52,178   52,178   52,178 
Cash and cash equivalents at end of period  238,117  $558,620  $213,136  $332,049  $23,144  $41,952 
46

Operating Activities
Net cash used in operating activities forDuring the twelve months ended December 31, 20112014, current and long term debt decreased $14.5 million primarily due to (i) payments of ($1,246,899) was less thanprincipal of $23.0 million to our senior lender, $1.0 million to subordinated lenders and $0.5 million to the net useState Bank of cash inIndia, (ii) the twelve months ended December 31, 2010reclassification of ($3,682,089). The 2010 use$0.4 million from debt to other liabilities pursuant to settlement agreement with DBED (Department of cash wentBusiness and Economic Development) investors, (iii) a conversion of  $47 thousand of principal plus interest of a promissory note into the Company’s common stock at $2.50 a share, (iv) $8.3 million of principal payments to start-up expenses related to getting the ethanol plant ready. In 2011 the startup of the ethanol plant requiredour working capital partners in India and (v) payments of interest of $6.8 million.  The decrease in current and long term debt was offset by increases due to:  (i) accrued interest of $9.7 million, and (ii) additional borrowings net of payments of $0.5 million received from an EB-5 investor and $7.7 million in working capital loans from our working capital arrangement with Secunderabad Oils Limited.  Current assets decreased by $4.8 million due to  fund(i) a $4.6 million decrease in cash due to repayments of working capital in India, (ii) a $1.5 million decrease in accounts receivable, and inventories.  Through the corn procurement and working capital agreement with J.D. Heiskell, we funded the accounts receivable and inventory with accounts payable for corn purchases.  The balance of the(iii) a  $0.9 million increase in accounts payable arose from payment terms extended by trade vendorsprepaid expenses and accrued lease payment owing to our landlord.other assets and (iv) a $0.4 million increase in inventory.
Investing Activities

Net cash used in investingprovided by operating activities during the twelve months ended December 31, 20112014 was $20.1 million consisting of non-cash charges of $13.0 million, net changes in operating assets and 2010 was $967,957,liabilities of $24 thousand, and $672,965, respectively, whichnet income of $7.1 million. The non-cash charges consisted of: (i) $6.2 million in amortization of debt issuance costs and patents, (ii) $4.7 million in depreciation expenses, (iii) a $0.6 million in stock-based compensation expense, (iv) $1.3 million in loss on extinguishment of debt, and (v) $0.2 million in each of fair value changes in warrant liability and loss on sale of assets. Net changes in operating assets and liabilities consisted primarily of purchasesa decrease in accounts receivable of property, plant$1.5 million partially offset by a: (i) a $1.0 million decrease in accounts payable, (ii) a $3.0 million decrease in other liabilities, (iii) a $0.3 million increase in other assets and equipmentprepaids, (iv) a $0.5 million increase in inventory, and a $3.1 million increase in accrued interest.

Cash used by investing activities was $1.9 million primarily for the retrofit and restartpurchase of the Keyes plant.  In addition, in May 2011we generated $1,598,593 fromcapital equipment of $2.0 million offset by proceeds received of $0.1 million on the sale of our land holding in Danville, Illinois.equipment.

Financing Activities
Net cash providedCash used by financing activities duringwas $22.8 million primarily from proceeds from borrowings of $9.9 million, offset by payments in principal on long-term term loans of $32.7 million.

Contractual Obligations and Commitments

In addition to our long term debt obligations to our senior lender and subordinated lender, we have certain other contractual working capital obligations, including lease obligations related to our office spaces in the twelve months endedUS and India.

The following table summarizes our contractual obligations as of December 31, 2011 and 2010 was $1,865,307 and $4,859,286, respectively, which consisted in 2011 of proceeds, net of repayments, from our working capital line with Secunderabad Oils Limited, and borrowings under secured debt facilities with Third Eye Capital. In 2010 we borrowed $3,650,044, net of payments, and in 2011 we borrowed $568,074, net of payments, from Third Eye Capital. During 2010, we borrowed a net amount of $1,012,000 under the Revolving Line of Credit with related party Laird Cagan.  We made no additional borrowings under the Cagan Revolving Line of Credit during 2011. In 2011 and 2010 our India and Zymetis subsidiaries borrowed $1,297,233 and $197,242, respectively, net of payments from our working capital line of credit with Secunderabad Oils Limited. Zymetis borrowings only occurred after July 2011, when we acquired $414,558 in short-term debt from our acquisition of the subsidiary.2014:
 
Three Months Ended March 31, 2011 Compared to Three Months Ended March 31, 2010
     Payments due by Period ( In thousands) 
Contractual Obligations Total  Less than 1 year  1-3 years  3 - 5 years  More than 5 years 
                
Long-term debt obligations $78,377  $12,746  $65,131  $500  $- 
                     
Operating lease obligations  2,502   410   909   974   209 
                     
Other Long-term liabilities  365   88   175   102   - 
                     
Total Contractual obligations $81,244  $13,244  $66,215  $1,576  $209 
Operating Activities
Net cash provided by operating activities for the three months ended March 31, 2011 of $59,414 represents an increase over the net cash used in operating activity of ($302,071) for the same period in 2010.  The difference between periods is due primarily to the trade payable terms offered by vendors of our Keyes plant as part of the restart and commencement of operations of this facility.
Investing Activities
Net cash used in investing activities during the three months ended March 31, 2011 and 2010 was ($1,708,729) and ($12,043), respectively.  The difference consisted primarily of purchases of property, plant and equipment and tenant improvement expenditures relating to the retrofit of our ethanol facility in Keyes, California.
Financing Activities
Net cash provided by financing activities during the three months ended March 31, 2011 and 2010 was $1,212,162 and $607,185, respectively.  Net cash provided by financing activities during the three months ended March 31, 2011 consisted primarily of $1,750,776 in borrowings under short-term notes with Third Eye Capital to complete the retrofit of the Keyes plant. During the three months ended March 31, 2011 and 2010 we paid ($538,614) and borrowed $107,185 net of payments, respectively, on outstanding credit arrangements with Secunderabad Oils Limited in India.
 
 
4737

 

Six Months Ended June 30, 2011 Compared to Six Months Ended June 30, 2010Off-Balance Sheet Arrangements
 
Operating Activities
Net cash used in operating activities for the six months ended June 30, 2011 was ($1,205,152) primarily from losses incurred by the retrofit and initial operationsWe had no outstanding off-balance sheet arrangements as of the Keyes plant. Working capital requirements for accounts receivable and inventory associated with the restart of the Keyes plant were partially offset by the working capital relationship with J.D. Heiskell and the vendor terms reflected in the accounts payable.  A secondary component of the decrease in working capital was an increase in accrued interest and accruing fees on our debt facilities. Net cash used in operating activities for the same six months of fiscal 2010 was ($604,242), caused primarily by negative gross margins in the ethanol business.
Investing Activities
Net cash used in investing activities during the six months ended June 30, 2011 and 2010 was ($442,068), and ($32,071) respectively, which consisted of the capitalization of leasehold improvement costs incurred to retrofit the Keyes plant.  The capitalized costs were partially funded through the sale of our Danville land holding in 2011.
Financing Activities
Net cash provided by financing activities during the six months ended June 30, 2011 and 2010 was $1,528,459, and $493,374, respectively, which consisted in 2011 primarily of the proceeds from our borrowings from Third Eye Capital under a secured term note facility.  We remitted $920,000 of the proceeds from the Danville land sale to Third Eye Capital as a principal payment on outstanding notes. During the six months ended June 30, 2011 and 2010 we made payments net of borrowings of($1,051,541) and ($279,626), respectively, on outstanding loans under our working capital facility with Secunderabad Oils Limited in India.
Nine Months Ended September 30, 2011 Compared to Nine Months Ended September 30, 2010
Operating Activities
Net cash used in operating activities for the nine months ended September 30, 2011 was ($2,057,117).  Our year-to-date losses were funded through the extension of credit from trade vendors, working capital credit arrangement with J.D. Heiskell, lease payment credit by our landlord, and the accrual of certain interest expense and fees associated principally with our loan at the Keyes plant. This extension of credit was partially offset by an increase in inventories required to restart the Keyes plant and the preparation of an international order in India.  Net cash used in operating activities for the same nine months of fiscal 2010 was ($1,517,442). Net cash used in operating activities was higher in the current year as compared to the prior year period primarily due to an increased need for working capital from the operation of our ethanol business in Keyes, CA at higher production levels.
Investing Activities
Net cash used in investing activities during the nine months ended September 30, 2011 and 2010 was ($917,839), and ($52,435), respectively, which consisted primarily of purchases of property, plant and equipment for continued construction of our glycerin refining capacity in our India plant and for tenant improvements relating to the retrofit of the Keyes plant. Proceeds from the sale of the Danville, Illinois land partially offset the September 2011 period net investing amount.
Financing Activities
Net cash provided by financing activities during the nine months ended September 30, 2011 and 2010 was $2,450,246, and $1,449,578, respectively, which consisted in 2011 primarily of the proceeds from our secured term loan with Third Eye Capital, offset by mandatory principal reductions and working capital funding from Secunderabad Oils Limited in support of an international biodiesel sale.
48

December 31, 2014.
 
Critical Accounting Policies
 
Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the U.S.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses for each period.  The following represents a summary of our critical accounting policies, defined as those policies that we believe are the most important to the portrayal of our financial condition and results of operations and that require management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effects of matters that are inherently uncertain.
 
Revenue Recognition
 
We recognize revenue when it is realized or realizable and earned.  We consider revenue realized or realizable and earned when there is persuasive evidence of an arrangement, delivery has occurred, the sales price is fixed or determinable, and collection is reasonably assured.  We derive revenue primarily from sales of ethanol and related co-products, biodiesel, refined glycerin, and refined palm oil.  We recognize revenue when title transfers to our customers, which is generally upon the delivery of these products to a customer’s designated location.  These deliveries are made in accordance with sales commitments and related sales orders entered into with customers and our working capital partner J.D. Heiskell for our Keyes plant and Secunderabad Oils Limited for our Kakinada plant.  Commitments can be offered either verbally or in written form.  The sales commitments and related sales orders provide quantities, pricing and conditions of sales.  In this regard, sales consist of inventory produced at our Keyes or Kakinada plant.
 
Revenues from sales of ethanol and its co-products are billed net of the related transportation and marketing charges.  The transportation component is accounted for in cost of goods sold and the marketing component is accounted for in sales, general and administrative expense.  Revenues are recorded at the gross invoiced amount.  Deductions taken by our customer for transportation and marketing are recorded as cost of goods sold and marketing, respectively.  Additionally, our working capital partner leases our finished goods tank and requires us to transfer legal title to the product upon transfer of our finished ethanol to this location.  We consider the purchase of corn as a cost of goods sold and the sale of ethanol upon transfer to the finished goods tank as revenue on the basis that (i) we bear the risk of gain or loss on the processing of corn into ethanol and (ii) we have legal title to the goods during the processing time. Revenue from nonmonetary transactions, principally in-kind by-products received in exchange for material processing where the by-product is contemplated by contract to provide value, is recognized at the quoted market price of those goods received or by-products.
 
Recoverability of Our Long-Lived Assets
 
Property and Equipment
 
Property, plant and equipment are statedcarried at cost less accumulated depreciation. Depreciation on our biodiesel production facilitydepreciation after assets are placed in service and our leasehold improvements to the Keyesare comprised primarily of buildings, furniture, machinery, equipment, land, and plants in North America and India. When property, plant computer equipment and software, office furniture and equipment vehicles, and other fixed assets has been providedare acquired as part of an acquisition, the items are recorded at fair value on the straight-line methodpurchase date. It is the Company policy to depreciate capital assets over thetheir estimated useful lives ofusing the assets, which currently range from three to 25 years.  Expenditures for property betterments and renewals are capitalized. Costs of repairs and maintenance are charged to expense as incurred.  We periodically evaluate whether events and circumstances have occurred that may warrant revision of the estimated useful life of fixed assets, which is accounted for prospectively.straight-line method.
 
Impairment of Long-Lived Assets and Goodwill
 
Our long-lived assets consist of property and equipment.  We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable.  We measure recoverability of assets to be held and used by comparing the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset.  If the carrying amount of an asset exceeds its estimated future cash flows, we record an impairment charge in the amount by which the carrying amount of the asset exceeds the fair value of the asset.  No impairment charges have been recorded during the periods presented.
 
49

Our goodwill consists of amounts relating to our acquisitions of Zymetis, Inc. in 2011.  We review goodwill at an individual plant or subsidiary level for impairment at least annually, or more frequently whenever events or changes in circumstances indicate that impairment may have occurred.  We perform a two-step impairment test to evaluate goodwill.  Under the first step, we compare the estimated fair value of the reporting unit with its carrying value (including goodwill).  If the estimated fair value of the reporting unit is less than its carrying value, we would complete a second step to determine the amount of the goodwill impairment that we should record.  In the second step, we would determine an implied fair value of the reporting unit’s goodwill by allocating the reporting unit’s fair value to all of its assets and liabilities other than goodwill.  We would then compare the resulting implied fair value of the goodwill to the carrying amount and record an impairment charge for the difference.
 
38

The reviews of long-lived assets and goodwill require making estimates regarding amount and timing of projected cash flows to be generated by an asset or asset group over an extended period of time.  Management judgment regarding the existence of circumstances that indicate impairment is based on numerous potential factors including, but not limited to, a decline in our future projected cash flows, a decision to suspend operations at a plant for an extended period of time, adoption of our product by the market, a sustained decline in our market capitalization, a sustained decline in market prices for similar assets or businesses, or a significant adverse change in legal or regulatory factors or the business climate.  Significant management judgment is required in determining the fair value of our long-lived assets and goodwill to measure impairment, including projections of future cash flows.  Fair value is determined through various valuation techniques including discounted cash flow models, market values and third-party independent appraisals, as considered necessary.  Changes in estimates of fair value could result in a write-down of the asset in a future period.  Given the current economic and regulatory environment and uncertainties regarding the impact on our business, there are no assurances that our estimates and assumptions will prove to be an accurate prediction of the future. 
Business Combinations through Acquisitions – Purchase Price Allocation

We apply the acquisition method of accounting to account for business combinations. The cost of an acquisition is measured as the aggregate of the fair values at the date of exchange of the assets given, liabilities incurred, and equity instruments issued. Identifiable assets, liabilities, and contingent liabilities acquired or assumed are measured separately at their fair value as of the acquisition date. The excess of the cost of the acquisition over our interest in the fair value of the identifiable net assets acquired is recorded as goodwill. If our interest in the fair value of the identifiable net assets acquired in a business combination exceeds the cost of the acquisition, a gain is recognized in earnings on the acquisition date only after we have reassessed whether we have correctly identified all of the assets acquired and all of the liabilities assumed. For most acquisitions, we engage outside appraisal firms to assist in the fair value determination of identifiable intangible assets such as customer relationships, tradenames, property and equipment and any other significant assets or liabilities. We adjust the preliminary purchase price allocation, as necessary, after the acquisition closing date through the end of the measurement period (up to one year) as we finalize valuations for the assets acquired and liabilities assumed.
Convertible Instruments
During 2010, we modified our revolving line of credit with Laird Cagan to add a beneficial conversion feature (BCF) in exchange for Mr. Cagan agreeing to subordinate the line of credit to another lender.  The fee paid and BCF were recorded at fair value and amortized over the remaining term of the line of credit.  Since the BCF also included a conversion feature allowing for any future interest accrued to be convertible, interest was recorded on a daily valuation methodology at the commitment date and each day thereafter over the life of the loan.  The intrinsic value was calculated as the difference between the conversion price of $0.05 per share and the market price on each day multiplied by the number of shares convertible.  This difference is deferred as a debt discount and amortized over the remaining life of the debt.  The Company’s Board of Directors approved the conversion option on September 2, 2010, which became the commitment and measurement date for the outstanding interest and fees. Line of credit accrued daily interest through October 27, 2011 with a right to convert outstanding interest and fee at $0.05 per share. Beginning October 1, 2011, the BCF of daily interest was measured and recorded as a debt discount each day using the average of 22 days of trailing closing stock prices as quoted on the OTC markets. This fee was also treated as a fee and amortized over the remaining term of the line of credit, which at the time matured on June 30, 2011.  On July 1, 2011 the line of credit maturity was extended to July 1, 2012 by adding a five percent of loan balance waiver fee to the outstanding balance.
 
Testing for Modification or Extinguishment Accounting
 
During 20102014, 2013, and 20112012 we evaluated amendments to our debt under the FASBASC 470-50 guidance for modification and extinguishment accounting.  This evaluation included comparing the net present value of cash flows of the new debt to the old debt to determine if changes greater than 10 percent occurred.  In instances where our future cash flows changed more than 10 percent, we fair valued our debt based on factors available to us for similar borrowings and used the extinguishment accounting method to account for debt.
 
Warrant Liability Accounting
 
50

Certain common stock warrants issued in the Company’s equity financing are classified as liabilities under ASC 480.  The Company uses Black-Scholes option pricing model as its method of valuation for warrants subject to warrant liability accounting.  Warrants subject to liability accounting are valued on the date of issuance and re-measured at the end of each reporting period with the change in value reported in the Company’s consolidated statement of operations.  The determination of fair value as of the reporting date is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables.  These variables include, but are not limited to, expected stock price volatility over the term of the security and risk-free interest rate.  In addition, the Black-Scholes option pricing model requires the input of an expected life for the securities, which we estimated based upon the remaining term of the warrant.  The primary factors affecting the fair value of the warrant liability are the Company’s stock price and volatility.  The Black-Scholes option pricing model requires the input of highly subjective assumptions.  Other reasonable assumptions in the pricing model could provide differing results.
 
Recently Issued Accounting Pronouncements
 
EffectiveIn May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes all existing revenue recognition requirements, including most industry-specific guidance. The new standard requires a company to recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. The new standard will be effective for us on January 1, 2011, we adopted2017. We are currently evaluating the amended guidance in ASCpotential impact that Topic 805, Business Combinations, which, if we complete a material business combination during the reporting period, requires us to disclose our pro forma revenue and earnings as though the business combinations that occurred during the current period had occurred as of the beginning of the comparable prior annual reporting period. The amended guidance also requires us to include a description of the nature and amount of material, nonrecurring pro forma adjustments directly attributable to the business combination included in the reported pro forma revenue and earnings.
Effective January 1, 2011, we adopted the second phase of the amended guidance in ASC Topic 820, Fair Value Measurements and Disclosures, which requires us to disclose information in the reconciliation of recurring Level 3 measurements regarding purchases, sales, issuances and settlements on a gross basis, with a separate reconciliation for assets and liabilities. We did not experience an impact from the additional disclosure requirements as we do not606 may have any recurring Level 3 measurements.
Effective January 1, 2012, we will be required to adopt the third phase of amended guidance in ASC Topic 820, Fair Value Measurements and Disclosures. The purpose of the amendment is to achieve common fair value measurement and disclosure requirements by improving comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with GAAP and those prepared in conformity with International Financial Reporting Standards, or IFRS. The amended guidance clarifies the application of existing fair value measurement requirements and requires additional disclosure for Level 3 measurements regarding the sensitivity of fair value to changes in unobservable inputs and any interrelationships between those inputs. We currently would not be impacted by the additional disclosure requirements as we do not have any recurring Level 3 measurements.
Effective January 1, 2012, we will be required to adopt the amended guidance in ASC Topic 220, Comprehensive Income. This accounting standards update, which helps to facilitate the convergence of GAAP and IFRS, is aimed at increasing the prominence of other comprehensive income in the financial statement by eliminating the option to present other comprehensive income in the statement of stockholders’ equity, and requiring comprehensive income to be reported in either a single continuous statement or in two separate but consecutive statements reporting net income and other comprehensive income. This amended guidance will be implemented retroactively. We have determined that the changes to the accounting standards will affect the presentation of consolidated financial information but will not have a material effect on our financial position orand results of operations.
 
Effective January 1, 2012, we will be permitted to adopt the amended guidance in ASC Topic 350, Intangibles – Goodwill and Other. The amended guidance permits an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. The more-likely-than-not threshold is defined as having a likelihood of more than 50 percent. We have determined that the changes to the accounting standards will not impact our disclosure or reporting requirements.
39

 
ITEMItem 7A.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKQuantitative and Qualitative Disclosures About Market Risk
 
Not Applicable We are exposed to various market risks, including changes in interest rates, commodity prices and currency translation.  Market risk is the potential loss arising from adverse changes in market rates and prices.  In the ordinary course of business, we enter into various types of transactions involving financial instruments to manage and reduce the impact of changes in commodity prices and interest rates. We enter into no market risk sensitive instruments for trading purposes.
 
At the end of 2014 we did not have any open firm-price purchase commitments with our feedstock suppliers.  At times in our Indian biodiesel business, we reduce our exposure to fluctuations in feedstock prices and the price of biodiesel by entering into fixed price contracts to buy and sell commodities. At the time we enter into a purchase commitment for feedstock, our goal is to also enter into an off-take arrangement with our customer to purchase the biodiesel at a set price.
Commodity Price Risk
In our US operations we produce ethanol, distillers grains and corn oil from corn and our business is sensitive to changes in the prices of each of these commodities. The price of corn is subject to fluctuations due to unpredictable factors such as weather; corn planted and harvested acreage; changes in national and global supply and demand; and government programs and policies. We use natural gas in the ethanol production process and, as a result, our business is also sensitive to changes in the price of natural gas. The price of natural gas is influenced by such weather factors as extreme heat or cold in the summer and winter, or other natural events like hurricanes in the spring, summer and fall. Other natural gas price factors include North American exploration and production, and the amount of natural gas in underground storage during both the injection and withdrawal seasons. Ethanol prices are sensitive to world crude-oil supply and demand; crude oil refining capacity and utilization; government regulation; and consumer demand for alternative fuels. Distillers grains prices are sensitive to various demand factors such as numbers of livestock on feed, prices for feed alternatives, and supply factors, primarily production by ethanol plants and other sources. Even though our commodity outputs and input are sensitive to changes in market prices, we only opportunistically pursue fixed contract arrangements on a limited basis with regard to the various commodities used in our business.
Ethanol Production
A sensitivity analysis has been prepared to estimate our ethanol production exposure to ethanol, corn, distillers grains and natural gas price risk. Market risk related to these factors is estimated as the potential change in net income resulting from hypothetical 10% changes in prices of our expected corn and natural gas inputs, and ethanol and distillers grains outputs for a one-year period from December 31, 2014. The results of this analysis, which may differ from actual results, are as follows (in millions):
CommodityEstimated Total Volume Requirements for the Next 12 Months (1)Unit of Measure
Net Income Effect of Approximate 10% Change
in Price
 Ethanol55.0Gallons$9.4
 Corn19.6Bushels$11.4
 Distillers grains0.4Tons (2)$2.6
 Natural gas1.3MMBTU (3)$0.1
(1) Volume requirements assume production at full capacity.
(2) Distillers grains quantities are stated on an equivalent ton basis.
(3) Millions of Thermal Units

40

Corn Oil
A sensitivity analysis has been prepared to estimate our corn oil production segment exposure to corn oil price risk. Market risk related to these factors is estimated as the potential change in net income resulting from hypothetical 10% changes in prices of our expected corn oil output for a one-year period from December 31, 2014. The corn oil market risk at December 31, 2014, based on the estimated net income effect resulting from a hypothetical 10% change in such prices, was approximately $0.5 million.
In our India operations we are subject to market risk with respect to the price and availability of the main raw materials we use to produce our products including refined palm oil, palm stearin, animal fats, waste oils, crude glycerin, and chemicals. Unfavorable commodity margins result from a narrowing or surpassing of the feedstock costs over finish goods sales revenues, which represents an unfavorable market condition. This is especially true when market conditions do not allow us to pass along increased feedstock costs to our customers due to the commodity nature of our finished goods sales. The availability and pricing of feedstock for our biodiesel plant fluctuate with unpredictable factors such as global demand and supply of raw materials, weather conditions, governmental policies toward agriculture and biofuels, and international trade agreements.
Interest Rate Risk
We are exposed to market risk from changes in interest rates. Exposure to interest rate risk results primarily from issuing term and revolving loans that bear variable interest rates. Specifically, we had $56.6 million US Dollar denominated outstanding variable interest-rate debt as of December 31, 2014. Interest rates on our variable-rate debt are determined based upon the market interest rate of LIBOR. A 1% increase in LIBOR would increase our interest cost on such debt by approximately $0.6 million per year in the aggregate. Other details of our outstanding debt are discussed in the notes to the consolidated financial statements included as a part of this report.
The interest rate on our India operations debt facility is subject to adjustments based on the Reserve Bank of India advance rate. Based on the amount of our senior secured floating-rate term debt as of December 31, 2014, each 100 basis point increase or decrease in interest rates would increase or decrease our annual interest expense and cash outlay by approximately $60 thousand US dollars. This potential increase or decrease is based on the simplified assumption that the level of floating-rate debt remains constant with an immediate across-the-board increase or decrease as of December 31, 2014 with no subsequent change in rates for the remainder of the period.
Foreign Currency Exchange Rate Risk
We do expect to have exposure to foreign currency risk as we conduct most of our India business in Indian Rupees. Our India subsidiaries use the Indian Rupee local currency as their functional currency. Our primary exposure with respect to foreign currency exchange rate risk is the change in the Indian Rupee (INR) to US Dollar (USD) exchange rate.  For consolidation purposes, assets and liabilities are translated at month-end exchange rates. Items of income and expense are translated at average exchange rates. Translation gains and losses are not included in determining net income (loss), but are accumulated as a separate component of shareholders’ equity. Gains (losses) arising from foreign currency transactions are included in determining net income (loss). For the twelve months ended December 31, 2014 and 2013, we recognized a loss of $46 thousand and $0.6 million, respectively, associated with foreign currency translation adjustments to other comprehensive loss.  We prepared a foreign currency exchange rate risk sensitivity analysis to estimate our exposure to currency fluctuations. Using our 2014 Indian subsidiary financials and applying the appropriate actual weighted average or end exchange rate and then incrementing by 10 points each respective INR to USD exchange rate resulted in a $227 thousand impact to Net Income (loss), a $4.1 million change in Total Liabilities, a $2.0 million change in Stockholders’ equity (deficit), and a $2.1 million change in Total Assets in our Indian subsidiary.
As of December 31, 2014, we did not have any outstanding derivative financial instruments, off-balance sheet guarantees, interest rate swap transactions or foreign currency contracts.
ITEMItem 8.  FINANCIAL STATEMENTS AND SUPPLEMENTARY DATAFinancial Statements and Supplementary Data
 
Financial Statements are listed in the Index to Consolidated Financial Statements on page 6749 of this Report.
 
ITEMItem 9.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSUREChanges in and Disagreements with Accountants on Accounting and Financial Disclosure
 
None
 
51

ITEMItem 9A.  CONTROLS AND PROCEDURES
Management’s Annual Report on Internal Control over Financial Reporting.Controls and Procedures
 
The information contained in this section covers management’s evaluation of our disclosure controls and procedures and our assessment of our internal control over financial reporting for the periods since the date covered by our last periodic report (September 30, 2010) throughyear ended December 31, 2011.2014.
41

 
Evaluation of Disclosure Controls and Procedures.
 
Management with(with the participation of our Chief Executive Officer (CEO) and Chief Financial Officer (CFO), carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act).  Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of the end of the period covered in this report, our disclosure controls and procedures along with the related internal controls over financial reporting were not effective to provide reasonable assurance that the information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in Securities and Exchange Commission rules and forms, and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
 
Inherent Limitations on Effectiveness of Controls
 
Our management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all errorserror and all fraud.  A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met.  Our controls and procedures are designed to provide reasonable assurance that our control system’s objective will be met and our CEO and CFO have concluded that our disclosure controls and procedures are effective at the reasonable assurance level.  The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs.  Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the company have been detected.  These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake.  Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls.  The design of any system of controls is based in part on certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.  Projections of any evaluation of the effectiveness of controls in future periods are subject to risks.  Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.
 
Management’s Annual Report on Internal Control over Financial Reporting.
Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act).  Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external purposes in accordance with U.S. generally accepted accounting principles (GAAP).  Our internal control over financial reporting includes those policies and procedures that:  (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures by us are being made only in accordance with authorizations of our management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the consolidated financial statements.
 
Under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of the period covered by this report based on the criteria for effective internal control described in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). – 2013.  Based on the results of management’s assessment and evaluation, our chief executive officer and chief financial officer concluded that our internal control over financial reporting was not effective due to the material weaknesses described below.as of December 31, 2014.
 
52

McGladrey LLP, the independent registered accounting firm who audited our financial statements, has also audited the effectiveness of our internal control over financial reporting as of December 31, 2014 as described in their report on the next page.
 
Changes in Internal Control over Financial Reporting
Discussed below are changes made to our internal control over financial reporting since our last filing through December 31, 2011, in response to the identified material weaknesses.
 
Our efforts to improve our internal controls are ongoing and focused on expanding our organizational capabilities to improve our control environment and on implementing process changes to strengthen our internal control and monitoring activities. In addition, although we are implementing remedial measures to address all of the identified material weaknesses as discussed below, our assessment of the impact of these measures have not been completed as of the filing date of this report.
 
Material Weaknesses
42

 
A material weakness is a deficiency, or a combinationReport of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis.  The material weaknesses identified are:Independent Registered Public Accounting Firm
 
(1)  Inadequate number of personnel that could accurately and timely record and report the Company’s financial statements in accordance with GAAP;
To the Board of Directors and Stockholders
Aemetis, Inc.
 
●  We did not produce timely financial statements for the years ending December 31, 2010 and 2011 and did not employ an adequate number of people to ensure a control environment that would allow for the accurate and timely reporting of the financial statements. When we began to prepare these financial statements our auditors raised numerous items that required adjustments over a number of periods.
(2)  Ineffective controls to ensure that the accounting for complex accounting transactions are recorded in accordance with GAAP financial statements,
●  A number of significant audit adjustments were made to the general ledger, which collectively could have a material effect on the financial statements.
●  The number of revisions to our financial statements made by our auditor’s review of the financial statements indicated that our controls over disclosures were not effective.
Remediation
As part of our ongoing remedial efforts, we have audited Aemetis Inc. and will continue to, among other things:
(1)  Expand our accounting policy and controls organization by creating and filling new positions with qualified accounting and finance personnel;
(2)  Increase our efforts to educate both our existing and expanded accounting policy and control organization on the application of the internal control structure;
(3)  Emphasize with management the importance of our internal control structure;
(4)  Seek outside consulting services where our existing accounting policy and control organization believes the complexity of the existing exceeds our internal capabilities.
We believe that the foregoing actions have improved and will continue to improve oursubsidiaries’ internal control over financial reporting as wellof December 31, 2014, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013. Aemetis Inc. and subsidiaries’ management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our disclosure controlsaudit provides a reasonable basis for our opinion.

A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and procedures. We intendthe preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (a) pertain to perform such proceduresthe maintenance of records that, in reasonable detail, accurately and commit such resourcesfairly reflect the transactions and dispositions of the assets of the company; (b) provide reasonable assurance that transactions are recorded as necessary to continuepermit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (c) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to allow usfuture periods are subject to overcomethe risk that controls may become inadequate because of changes in conditions, or mitigate thesethat the degree of compliance with the policies or procedures may deteriorate.

In our opinion, Aemetis, Inc. and subsidiaries maintained, in all material weaknesses such that we can make timelyrespects, effective internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the financial statements of Aemetis Inc. as of December 31, 2014 and accurate quarterly2013 and annual financial filings until such time as those material weaknesses are fully addressedfor each of the three years in the period ended December 31, 2014, and remediated.our report dated March 12, 2015 expressed an unqualified opinion.

/s/ McGladrey LLP
Des Moines, Iowa
March 12, 2015

 
43

ITEM 9B.  OTHER INFORMATION
None.
Item 9B.  Other Information
 
53

Third Eye Capital Amendment
 
PART IIIOn March 12, 2015, Third Eye Capital agreed to Amendment No. 9 to the Note Purchase Agreement to allow for the repurchase of 1,000,000 shares of common stock of the Company held by the noteholders effective as of the date of Amendment No. 9, 573,347 shares of which were repurchased at a price per share equal to $6.00 per share and the remainder of which were repurchased at a price per share equal to the higher of $4.50 per share or the five-day volume weighted average price of the Company’s common stock on the NASDAQ Global Market immediately prior to the date of Amendment No. 9, for an aggregate purchase price of approximately $5.5 million.  An extension of the credit facility allows for the repurchase price to be added to the outstanding principal balance of the existing notes under the Note Purchase Agreement. In addition, Third Eye Capital agreed to remove the covenant that the Company must complete an equity offering of its preferred stock for net proceeds of not less than $20 million with all of such net proceeds to be used to repay the principal outstanding under the Note Purchase Agreement in accordance with the priorities set forth therein.  In addition, Third Eye Capital agreed that the Company will not be required to comply with the free cash flow financial covenant under the Note Purchase Agreement for the three months ending March 31, 2015.
 
ITEM 10.  DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Information aboutAs consideration for Amendment No. 9, the Directors
Set forth below is information regarding our directors:
Name Age Position Director Since
Eric A. McAfee 50 Chief Executive Officer and Chairman of the Board 2006
Fran Barton (1)
 65 Director 2012
John R. Block 77 Director 2008
Dr. Steven W. Hutcheson (2)
 58 Director 2011
Michael Peterson (1)
 50 Director 2006
Harold Sorgenti 78 Director 2007
(1) Mr. Peterson stepped downunconditional personal guaranty from the Company’s Board and Mr. Barton was appointed to the Company’s Board on August 2, 2012.
(2) Dr. Hutcheson was appointed to the Company’ Board in July 2011 in connection with the Company’s acquisition of Zymetis, Inc.
Eric A. McAfee co-founded Aemetis, Inc. in 2005 and has served as its Chairman of the Board since February 2006. Mr. McAfee was appointed Chief Executive Officer ofCompany, and the guaranties from the Company in February 2007. Mr. McAfee has been an entrepreneur, merchant banker, venture capitalistparties and farmer/dairyman for more than 20 years. Since 1995, Mr. McAfee has been the Chairman of McAfee Capital, and since 1998 has been a principal of BergLLC, owned by Mr. Eric McAfee, Companies, an investment company. Since 2000, Mr. McAfee has been a principal of Cagan McAfee Capital Partners (“CMCP”) through which Mr. McAfee has founded or acquired twelve energy and technology companies. In 2003, Mr. McAfee co-founded Pacific Ethanol, Inc. (Nasdaq PEIX), a West Coast ethanol producer and marketer. Mr. McAfee received a B.S. in Management from Fresno State University in 1986 and served as Entrepreneur in Residence of The Wharton Business School MBA Program in 2007. Mr. McAfee is a graduate of the Harvard Business School Private Equity and Venture Capital Program, and is a 1993 graduate of the Stanford Graduate School of Business Executive Program.
Francis Barton was appointed to the Company’s Board on August 2, 2012.  From 2008 to present, Mr. Barton served as Chief Executive Officer in the consulting firm Barton Business Consulting LLC. Prior to this, Mr. Barton served as the Executive Vice President and Chief Financial Officer of UTStarcom, Inc. from 2005 through 2008 and as a director from 2006 through 2008. From 2003 to 2005, Mr. Barton was Executive Vice President and Chief Financial Officer of Atmel Corporation. From 2001 to 2003, Mr. Barton was Executive Vice President and Chief Financial Officer of Broadvision Inc. From 1998 to 2001, Mr. Barton was Senior Vice President and Chief Financial Officer of Advanced Micro Devices, Inc. From 1996 to 1998, Mr. Barton was Vice President and Chief Financial Officer of Amdahl Corporation. From 1974 to 1996, Mr. Barton worked at Digital Equipment Corporation, beginning his career as a financial analyst and moving his way up through various financial roles to Vice President and Chief Financial Officer of Digital Equipment Corporation's Personal Computer Division. Mr. Barton holds a B.S. in Interdisciplinary Studies with a concentration in Chemical Engineering from Worcester Polytechnic Institute and an M.B.A. with a focus in finance from Northeastern University. Mr. Barton served on the board of directors of ON Semiconductor from 2008 to 2011. Mr. Barton will also serve as the Chair of the Audit Committee and as a member of the Governance, Compensation and Nominating Committee.  His experience as Executive Vice President and Chief Financial Officer as well as his extensive financial background qualify him for the appointment.
John R. Block has served as a member of the Company’s Board of Directors since October 16, 2008.  From 1981 to 1986, Mr. Block served as Secretary of Agriculture for the U.S. Department of Agriculture under President Ronald Reagan. He is currently an IL farmer and a Senior Policy Advisor to Olsson Frank Weeda Terman Bode Matz PC, an organization that represents the food industry, a position Mr. Block has held since January 2005. From January 2002 until January 2005, he served as Executive Vice President at the Food Marketing Institute, an organization representing food retailers and wholesalers. From February 1986 until January 2002, Mr. Block served as President of Food Distributors International. Mr. Block is currently a member of the board of directors of Digital Angel Corporation and Metamorphix, Inc.  During the past five years, Mr. Block has served on the board of directors of Deere and Co., Hormel Foods Corporation and Blast Energy Services, Inc. Mr. Block received his B.A. from the U.S. Military Academy.
54

Dr. Steven W. Hutcheson was appointed to the Company’s Board of Directors in July 2011.  From 1984 to present, Dr. Hutcheson served as a Professor for the University of Maryland in the Department of Molecular and Cell Biology. He also served as Founder, Chief Executive Officer from 2006-2008 and Chief Technical Officer of Zymetis, Inc. until its acquisition by AE Biofuels on July 1, 2011.  Dr. Hutcheson received his A.B. in Biology from the University of CA Santa Cruz and his Ph.D. in Plant Physiology from the University of CA Berkeley.  Dr. Hutcheson will also serve as a member of the Governance, Compensation and Nominating Committee.
Michael Peterson served as a member of the Company’s Board of Directors from February 2006 until August 2, 2012. Mr. Peterson has worked in the securities industry in various capacities for approximately 19 years. From 1989 to 2000, he was employed by Goldman Sachs & Co. including as a vice president with responsibility for a team of professionals that advised and managed over $7 billion in assets for high net worth individuals and institutions. Mr. Peterson joined Merrill Lynch in 2001 to form and help launch its Private Investment Group and was with Merrill Lynch until July 2004. From July 2004 until January 2005, Mr. Peterson was a self-employed financial consultant. In January 2005, Mr. Peterson joined American Institutional Partners, L.L.C. as a managing partner. On December 31, 2005, Mr. Peterson founded his own investment firm, Pascal Management LLC. Mr. Peterson received a B.S. in Computer Science and Statistics from Brigham Young University in 1985 and an M.B.A. from the Marriott School of Management at Brigham Young University in 1989.  Mr. Peterson is currently the Executive Vice President and CFO of Pedevco Corp.
Harold Sorgenti was appointed to the Company’s Board of Directors in November 2007. Since 1998, Mr. Sorgenti has been the principal of Sorgenti Investment Partners, a company engaged in pursuing chemical investment opportunities. Sorgenti Investment Partners acquired the French ethanol producer Societè d'Ethanol de Synthëse (SODES) in partnership with Donaldson, Lufkin & Jenrette in 1998. Prior to forming Sorgenti Investment Partners, Mr. Sorgenti served a distinguished career that included the presidency of ARCO Chemical Company, including leadership of the 1987 initial public offering of the company. Mr. Sorgenti is also the founder of Freedom Chemical Company. Mr. Sorgenti is a former member of the board of directors of Provident Mutual Life Insurance Co. and Crown Cork & Seal. Mr. Sorgenti received his B.S. in Chemical Engineering from City College of New York in 1956 and his M.S. from Ohio State University in 1959. Mr. Sorgenti is the recipient of honorary degrees from Villanova, St. Joseph's, Ohio State, and Drexel Universities.were all reaffirmed.
 
The Boardforegoing description of Amendment No. 9 is only a summary and does not purport to be complete and is qualified in its entirety by reference to the full text of Amendment No. 9, which is filed as Exhibit 10.65 hereto, and is incorporated, by reference herein.
PART III

Item 10.  Directors, held eleven (11) meetings during fiscal year 2010Executive Officers and twelve (12) meetings during fiscal year 2011. Each ofGovernance
The information under the foregoing directors attended at least 75% of the aggregate number of meetings ofcaption “Information about our Board of Directors, and the committees on which each director served during fiscal year 2010 and was eligible to attend.  No family relationship exists between any of the directors or executive officers of the Company.
Information about the Executive Officers
Set forth below is information regarding our executive officers (other than Eric A. McAfee):
NameAgePosition
Andrew B. Foster47Executive Vice President and Chief Operating Officer
Sanjeev Gupta53Executive Vice President and Managing Director, Chairman and President (Universal Biofuels Private, Ltd.)
Todd Waltz51Chief Financial Officer
Eric A. McAfee (50) Chief Executive Officer and Chairman of the Board (See Information About the Directors above).
Andrew B. Foster (47) joined American Ethanol in March 2006 and currently serves as Executive Vice President of Aemetis, Inc. and President and Chief Operating Officer of Aemetis Advanced Fuels, Inc. a wholly owned subsidiary.  Prior to joining the Company, Mr. Foster served as Vice President of Corporate Marketing for Marimba, Inc., an enterprise software company, which was acquired by BMC Software in July 2004. From July 2004 until April 2005, Mr. Foster served as Vice President of Corporate Marketing for the Marimba product line at BMC. In April 2005, Mr. Foster was appointed Director of Worldwide Public Relations for BMC and served in that capacity until December 2005. From May 2000 until March 2003, Mr. Foster served as Director of Corporate Marketing for eSilicon Corporation, a fabless semiconductor company. Mr. Foster also served as Associate Director of Political Affairs at the White House from 1989 to 1992, and Deputy Chief of Staff to Illinois Governor Jim Edgar from 1995 to 1998. Mr. Foster holds a B.A. in Political Science from Marquette University in Milwaukee, Wisconsin.
55

Sanjeev Gupta (53) joined Aemetis, Inc. in September 2007 as an executive with the Company’s marketing subsidiary, Biofuels Marketing, Inc. and managed the completion of construction of the Company’s biodiesel production facility in Kakinada, India. Mr. Gupta has served as the Managing Director, Chairman and President of the Company’s wholly-owned Indian biodiesel subsidiary, Universal Biofuels Private, Ltd. (“UBPL”) since 2009.
Todd A. Waltz (51) was appointed Chief Financial Officer on March 12, 2010.  From 2007 until March 12, 2010, Mr. Waltz served as the Company’s Corporate Controller.  From 1994 to 2007, Mr. Waltz served with increasing responsibility in a variety of senior financial management and business partner roles with Apple, Inc. in Cupertino, CA.  Prior to Apple, Mr. Waltz worked with Ernst & Young.  Mr. Waltz also serves as the Chief Executive Officer and sole Board member of Vision Global Solutions, Inc. (OTC:VIGS). Mr. Waltz is a Certified Public Accountant (inactive) in the state of California.  Mr. Waltz received his Bachelors Degree from Mount Union College in 1983, his MBA from Santa Clara University in 1997 and his Masters of Science in Taxation from San Jose State University in 2008.
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Securities Exchange Act of 1934, as amended, requires our executive officers and directors and persons who own more than 10% of a registered class of our equity securities to file with the Securities and Exchange Commission initial statements of beneficial ownership, reports of changes in ownership and annual reports concerning their ownership of our common stock and other equity securities, on Forms 3, 4 and 5 respectively. Executive officers, directors and greater than 10% shareholders are required by the Securities and Exchange Commission regulations to furnish our Company with copies of all Section 16(a) reports they file. Based upon a review of those forms and representations regarding the need for filing Forms 5, we believe during the year ended December 31, 2010 each of the following officers and directors filed a Form 5 related to one late Form 4 transaction reflecting the grant to each of these officers and directors of options and warrants on December 15, 2010: Andrew Foster, Sanjeev Gupta, Todd Waltz, John Block, Michael Peterson and Harold Sorgenti.  In addition, one 10% stockholder filed a Form 4 and Schedule 13G on September 19, 2012, which included transactions from 2008, 2010 and 2011.
Except as set forth above, we believe that, during fiscal 2010 and 2011, our directors, executive officers and 10% stockholders complied with all Section 16(a) filing requirements. In making this statement, we have relied upon examination of the copies of Forms 3, 4 and 5, and amendments thereto, provided to Aemetis, Inc. and the written representations of its directors and executive officers.
Committees of the Board of Directors
The Board of Directors has the following standing committees: (1) Audit and (2) Governance, Compensation and Nominating. The Board of Directors has adopted a written charter for each of these committees, copies of which can be found in the Investor Relations section of our website at www.aemetis.com. The Board of Directors has determined that all members of each committee of the Board of Directors are independent under the applicable rules and regulations of NASDAQ and the SEC, as currently in effect.
The following chart details the current membership of each committee:
Name of DirectorAudit
Governance, Compensation and
Nominating
Michael Peterson*CM
Harold SorgentiMC
Francis Barton*CM
John R. Block*M
Dr. Hutcheson*M
M = Member
C = Chair
*Mr. Peterson stepped down from the Company’s Board and Board Committees and Mr. Barton was appointed toRelated Matters” and “Section16(a) Beneficial Ownership Reporting Compliance,” aappearing in the Company’s Board and Audit Committees on August 2, 2012.
*Mr. Block was appointed to the Audit Committee on July 14, 2011.
*Dr. Hutcheson was appointed to the Governance, Compensation and Nominating Committee on July 14, 2011.Proxy Statement, is hereby incorporated by reference.
 
56

Audit Committee.
The Audit Committee (i) oversees our accounting, financial reporting and audit processes; (ii) appoints, determines the compensation of, and oversees, the independent auditors; (iii) pre-approves audit and non-audit services provided by the independent auditors; (iv) reviews the results and scope of audit and other services provided by the independent auditors; (v) reviews the accounting principles and practices and procedures used in preparing our financial statements; and (vi) reviews our internal controls.
The Audit Committee works closely with management and our independent auditors. The Audit Committee also meets with our independent auditors without members of management present, on a quarterly basis, following completion of our auditors’ quarterly reviews and annual audit and prior to our earnings announcements, to review the results of their work. The Audit Committee also meets with our independent auditors to approve the annual scope and fees for the audit services to be performed.
Each of the Audit Committee members is an independent director within the meaning set forth in the rules of the SEC, as currently in effect. In addition, the Board of Directors has determined that Mr. Barton is an “audit committee financial expert” as defined by SEC rules, as currently in effect.
A copy of the Audit Committee’s written charter is available in the Investor Relations section of our website at www.aemetis.com.  The Audit Committee held five (5) meetings during fiscal year 2010, and zero (0) meetings during fiscal year 2011.  Each director who is a member of the Audit Committee attended at least 75% of the aggregate number of meetings of the Audit Committee during fiscal year 2010 and 2011.
AUDIT COMMITTEE REPORT
The following is the report of the Audit Committee of the Board of Directors. The Audit Committee has reviewed and discussed our audited financial statements for the fiscal year ended December 31, 2010 and 2011 with our management. In addition, the Audit Committee has discussed with, our independent auditors, the matters required to be discussed by Statement on Auditing Standards No. 61, as amended (Communications with Audit Committee). The Audit Committee also has received the written disclosures and the letter from as required by the Public Company Accounting Oversight Board Rule 3526 “Communications with Audit Committees Concerning Independence” and the Audit Committee has discussed the independence of that firm.
Based on the Audit Committee’s review of the matters noted above and its discussions with our independent auditors and our management, the Audit Committee recommended to the Board of Directors that the financial statements be included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2010 and 2011.
Respectfully submitted by:
Francis Barton (Chair)
Harold Sorgenti
John R. Block
Governance, Compensation and Nominating Committee
The Governance, Compensation and Nominating Committee (i) reviews and approves corporate goals and objectives relevant to the CEO’s compensation, evaluates the CEO’s performance relative to goals and objectives and sets the CEO’s compensation annually; (ii) makes recommendations annually to the Board of Directors with respect to non-CEO compensation; (iii) considers and periodically reports on matters relating to the identification, selection and qualification of the Board of Directors and candidates nominated to the Board of Directors and its committees; (iv) develops and recommends governance principles applicable to the Company; (v) oversees the evaluation of the Board of Directors and management from a corporate governance perspective; and (vi) oversees, considers and approves related party transactions.
During 2010 and 2011 Michael Peterson and Harold Sorgenti served as members of the Governance, Compensation and Nominating Committee with Mr. Sorgenti serving as Chairman.  In August 2012, Mr. Peterson stepped down from the Committee and Mr. Francis Barton was appointed in his place.  Each current member of the Governance, Compensation and Nominating Committee is an independent director within the meaning set forth in the rules of the Nasdaq Stock Market, as currently in effect.
57

The Governance, Compensation and Nominating Committee considers properly submitted stockholder recommendations for candidates for membership on the Board of Directors as described below under “Identification and Evaluation of Nominees for Directors.” In evaluating such recommendations, the Governance, Compensation and Nominating Committee seeks to achieve a balance of knowledge, experience and capability on the Board of Directors and to address the membership criteria set forth under “Director Qualifications.” Any stockholder recommendations proposed for consideration by the Governance, Compensation and Nominating Committee should include the candidate’s name and qualifications for membership on the Board of Directors and should be addressed to the attention of our Corporate Secretary — Re: stockholder director recommendation.
Director Qualifications.  The Governance, Compensation and Nominating Committee does not have any specific, minimum qualifications that must be met by a Governance, Compensation and Nominating Committee-recommended nominee, but uses a variety of criteria to evaluate the qualifications and skills necessary for members of our Board of Directors. Under these criteria, members of the Board of Directors should have the highest professional and personal ethics and values. A director should have broad experience at the policy-making level in business, government, education, technology or public interest. A director should be committed to enhancing stockholder value and should have sufficient time to carry out their duties, and to provide insight and practical wisdom based on their past experience. A director’s service on other boards of public companies should be limited to a number that permits them, given their individual circumstances, to perform their director duties responsibly. Each director must represent the interests of Aemetis stockholders.
In addition to the foregoing, prior to any meeting of stockholders at which directors will be elected, as a condition to re-nomination, incumbent directors will be required to submit a resignation of their directorships in writing to the Chairman of the Governance, Compensation and Nominating Committee of the Board. The resignation will become effective only if the director fails to receive a sufficient number of votes for re-election at the meeting of stockholders, as described in the Company’s bylaws as recently amended and the Board accepts the resignation.
Identification and Evaluation of Nominees for Directors.  The Governance, Compensation and Nominating Committee utilize a variety of methods for identifying and evaluating nominees for director. The Governance, Compensation and Nominating Committee regularly assess the appropriate size of the Board of Directors, and whether any vacancies on the Board of Directors are expected due to retirement or otherwise. In the event that vacancies are anticipated, or otherwise arise, the Governance, Compensation and Nominating Committee considers various potential candidates for director. Candidates may come to the attention of the Governance, Compensation and Nominating Committee through current members of the Board of Directors, professional search firms, stockholders or other persons. These candidates are evaluated at regular or special meetings of the Governance, Compensation and Nominating Committee, and may be considered at any point during the year. The Governance, Compensation and Nominating Committee consider properly submitted stockholder recommendations for candidates for the Board of Directors. In evaluating such recommendations, the Governance, Compensation and Nominating Committee uses the qualifications standards discussed above and seeks to achieve a balance of knowledge, experience and capability on the Board of Directors.
A copy of the Committee’s written charter is available in the Investor Relations section of our website at www.aemetis.com.
In 2010, the Governance, Compensation and Nominating Committee held five (5) meetings, one (1) of which was a regularly scheduled meeting and four (4) of which were special meetings. Each director who is a member of the Governance, Compensation and Nominating Committee attended at least 75% of the aggregate number of meetings of the Committee during fiscal year 2010. In 2011, the Governance, Compensation and Nominating Committee held one regular meeting, which was attended by all Committee members.
Code of Business Conduct and Ethics
The Board of Directors has adopted a Code of Business Conduct and Ethics, which applies to our Board of Directors and all of our employees, including our Chief Executive Officer, Chief Financial Officer and any other principal financial officer, Controller and any other principal accounting officer, and any other person performing similar functions. The Code of Business Conduct and Ethics is posted on our website at www.aemetis.com in the Governance section of our investor relations webpage. Aemetis will disclose any amendment to the Code of Ethics or waiver of a provision of the Code of Ethics that applies to the Company’s Chief Executive Officer, Chief Financial Officer and any other principal financial officer, Controller and any other principal accounting officer, and any other person performing similar functions and relates to certain elements of the Code of Business Conduct and Ethics, including the name of the officer to whom the waiver was granted, on our website at www.aemetis.com, on our investor relations webpage.
58

Legal Proceedings
Mr. McAfee is a founding shareholder or principal investor in 12 publicly traded companies and approximately 20 private companies. Mr. McAfee served as the vice chairman of the Board of Directors of Verdisys, Inc., a publicly traded company, in 2003. To resolve potential litigation and to provide resolution of any issues, on July 28, 2006 Mr. McAfee and the SEC entered into a settlement agreement under which Mr. McAfee neither admitted nor denied causing any action by Verdisys, Inc. to fail to comply with Section 10(b) of the Exchange Act and Rule 10b-5 and agreed to a payment of $25,000.
Annual Meeting Attendance
We do not have a formal policy regarding attendance by members of the Board of Directors at our annual meetings of stockholders although directors are encouraged to attend annual meetings of Aemetis’ stockholders.
Communications with the Board of Directors
Although we do not have a formal policy regarding communications with the Board of Directors, stockholders may communicate with the Board of Directors by submitting an email to investors@aemetis.com or by writing to us at Aemetis, Inc., Attention: Investor Relations, 20400 Stevens Creek Blvd., Suite 700, Cupertino, CA 95014. Stockholders who would like their submission directed to a member of the Board of Directors may so specify. The General Counsel and Director of Investor Relations will review all communications. All appropriate business-related communications as reasonably determined by the General Counsel or Director of Investor Relations will be forwarded to the Board of Directors or, if applicable, to the individual director.
Code of Business Conduct and Ethics Policy
Our board of directors adopted a code of ethics that applies to all of our directors, officers and employees, including our principal executive officer, principal financial officer, and principal accounting officer. The code of ethics addresses, among other things, honesty and ethical conduct, conflicts of interest, compliance with laws, regulations and policies, including disclosure requirements under the federal securities laws, confidentiality, trading on inside information, and reporting of violations of the code.
Insider Trading Policy
Our board of directors adopted an insider trading policy that applies to all of its directors, officers and employees including our principal executive officer, principal financial officer, and principal accounting officer that applies to all trading except the exercise of stock options for cash under our stock option plan and the purchase of shares under an employee stock purchase plan, should we adopt such a plan. The insider trading policy addresses trading on material nonpublic information, tipping, confidentiality, 10b5-1 programs, disciplinary actions, trading windows, pre-clearance of trades, prohibition against short swing profits and individual responsibilities under the policy.
Compensation Committee Interlocks and Insider Participation
During fiscal year 2010, Messrs. Sorgenti and Peterson served as members of the Governance, Compensation and Nominating Committee.  During fiscal year 2011, Messrs. Sorgenti, Peterson and Hutcheson served as members.  No member of the Committee was an officer or employee of the Company. In addition, no member of the Committee or executive officer of the Company served as a member of the Board of Directors or Compensation Committee of any entity that has an executive officer serving as a member of our Board of Directors or Governance, Compensation and Nominating Committee.
59

ITEMItem 11.  EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION
The following table sets forth summary information concerning compensation paid or accrued for services rendered to the Company in all capacities for the fiscal years 2010 and 2011 to (i) the Company’s Chief Executive Officer, and (ii) the Company’s other two most highly compensated executive officers who were serving as executive officers at the end of fiscal year 2011.
Summary Compensation Table
Name and Principal Position  Year  
Salary
$
  
Option/
Warrant Awards(1)
$
  
Total
Compensation
$
 
              
Eric A. McAfee, Chief Executive Officer  2011   140,000   -   140,000 
   2010   120,000   -   120,000 
                 
Andrew B. Foster, Executive Vice President  2011   180,000   -   180,000 
   2010   180,000   9,050   189,050 
                 
Sanjeev Gupta, Executive Vice President  2011   180,000   -   180,000 
   2010   180,000   28,567   208,567 
                 
Todd A. Waltz, Chief Financial Officer  2011   180,000   -   180,000 
   2010   173,750   77,182   250,932 
(1)  
These amounts reflect the value determined by the Company for accounting purposes for these awards with respect to the current fiscal year and do not reflect whether the recipient has actually realized a financial benefit from the awards (such as by exercising stock options). This column represents the aggregate grant date fair value of stock options and warrants granted during fiscal year 2010 and 2011 to each of the named executive officers, in accordance with ASC Topic 718 Compensation. Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions.
60

Outstanding Equity Awards at 2011 Fiscal Year End
The following table shows all outstanding equity awards held by the named executive officers at the end of fiscal year 2011:
     Option/Warrant Awards 
Name 
Award
Date
  
No. of
Securities
underlying unexercised
options (#)
exercisable
  
No. of
securities underlying unexercised
options (#)
unexercisable
  
Equity incentive
plan awards:
# of securities underlying unexercised
unearned options
(#)
  
Option
exercise
price
$ (  )
  
Option
expiration
date
 
Andrew B. Foster 12/09/10   2,946(2)          0.12  12/08/15 
  12/15/10   41,163(4)          0.13  12/15/15 
  3/17/10   29,167(2)          0.21  3/17/15 
  5/21/09   440,000(3)          0.16  5/20/14 
  7/17/07   300,000(1)          3.00  7/16/17 
  11/26/07   90,000(2)          3.00  11/26/12 
                         
Sanjeev Gupta 12/09/10   2,964(2)          0.12  12/08/15 
  12/15/10   164,650(4)          0.13  12/15/15 
  3/17/10   58,333(2)          0.21  3/17/15 
  5/21/09   291,667(3)          0.16  5/20/14 
  11/26/07   45,000(1)          3.00  11/26/12 
  6/17/08   20,000(1)          3.70  6/16/13 
                         
Todd A. Waltz 12/09/10   17,675(2)          0.12  12/08/15 
  12/15/10   246,976(4)          0.13  12/15/15 
  3/17/10   475,000(3)          0.21  3/17/15 
  5/21/09   201,667(3)          0.16  5/20/14 
  11/26/07   90,000(1)          3.00  11/26/12 
  6/17/08   20,000(1)          3.70  6/16/13 
(1)Fifty percent (50%) of the shares subject to the option were exercisable on the date of grant and twenty-five percent (25%) of the shares subject to the option vest on the anniversary of the date of grant.
(2)One-twelfth (1/12) of the shares subject to the option vest every three months from the date of grant.
(3)Fifty percent (50%) of the shares subject to the option were exercisable on the date of grant and one-twenty-fourth (1/24) of the shares subject to the option vest every three months from the date of grant.
(4)Fully vested on the date of grant.
61

EMPLOYMENT CONTRACTS AND TERMINATION OF EMPLOYMENT AND CHANGE-IN-CONTROL ARRANGEMENTS
We are party to the following agreements with our named executive officers:
Eric A. McAfee
Effective September 1, 2011, the Company entered into a three year Employment Agreement with Mr. Eric A. McAfee in connection with his continuing responsibilities as Chief Executive Officer providing compensation of $180,000 per year. In addition, Mr. McAfee is entitled to an annual cash bonus in an amount determined by the Board of Directors based upon attainment of certain performance milestones. The Company will pay up to six months of severance and health benefits in the event Mr. McAfee is terminated without “cause” or “constructively terminated” (as defined in the Employment Agreement”).
Andrew B. Foster
In May 2007, the Company entered into an Executive Employment Contract with Mr. Foster to serve as the Company’s Executive Vice President and Chief Operating Officer. Under Mr. Foster’s employment contract, Mr. Foster receives an annual salary of $180,000 and a discretionary annual bonus of up to $50,000. The initial term of the Executive Employment Contract was for three years with automatic one-year renewals, currently October 18, 2013, unless terminated by either party on sixty days notice prior to the end of the term.
If, prior to a Change in Control (as defined in the agreement), Mr. Foster is terminated other than for Cause or as a result of his death or total disability or is Constructively Terminated (as defined in the agreement), then provided he signs a release of claims, Mr. Foster is entitled to severance benefits of (i) cash payments equal to his monthly base salary for a period of three months, and (ii) company-paid health, dental, and vision insurance coverage for him and his dependents until the earlier of three (3) months or until such time as Mr. Foster is covered under another employer’s group policy for such benefits. If, following a Change of Control, Mr. Foster is terminated other than for Cause or as a result of his death or total disability or is Constructively Terminated, then provided he signs a release of claims, in addition to the severance benefits provided above, all of his then unvested restricted stock or stock options shall be immediately vested.
Sanjeev Gupta
In September 2007, the Company entered into an Executive Employment Contract with Mr. Gupta to serve as the Company’s Executive Vice President and Chief Operating Officer. Under Mr. Gupta’s employment contract, Mr. Gupta receives an annual salary of $180,000 and a discretionary annual bonus of up to $50,000.  The initial term of the Executive Employment Contract was for three years with automatic one-year renewals, currently September 5, 2013, unless terminated by either party on sixty days notice prior to the end of the term.
If, prior to a Change in Control (as defined in the agreement), Mr. Gupta is terminated other than for Cause or as a result of his death or total disability or is Constructively Terminated (as defined in the agreement), then provided he signs a release of claims, Mr. Gupta is entitled to severance benefits of (i) cash payments equal to his monthly base salary for a period of three months, and (ii) company-paid health, dental, and vision insurance coverage for him and his dependents until the earlier of three (3) months or until such time as Mr. Gupta is covered under another employer’s group policy for such benefits. If, following a Change of Control, Mr. Gupta is terminated other than for Cause or as a result of his death or total disability or is Constructively Terminated, then provided he signs a release of claims, in addition to the severance benefits provided above, all of his then unvested restricted stock or stock options shall be immediately vested.
Todd A. Waltz
In March 2010, the Company entered into an Executive Employment Contract with Mr. Waltz to serve as the Company’s Chief Financial Officer. Under Mr. Waltz’ employment contract, Mr. Waltz receives an annual salary of $180,000 and a discretionary annual bonus of up to $50,000. The initial term of the Executive Employment Contract was for three years with automatic one-year renewals, currently March 15, 2013, unless terminated by either party on sixty days’ notice prior to the end of the term.
If, prior to a Change in Control (as defined in the agreement), Mr. Waltz is terminated other than for Cause or as a result of his death or total disability or is Constructively Terminated (as defined in the agreement), then provided he signs a release of claims, Mr. Waltz is entitled to severance benefits of (i) cash payments equal to his monthly base salary for a period of three months, and (ii) company-paid health, dental, and vision insurance coverage for him and his dependents until the earlier of three (3) months or until such time as Mr. Waltz is covered under another employer’s group policy for such benefits. If, following a Change of Control, Mr. Waltz is terminated other than for Cause or as a result of his death or total disability or is Constructively Terminated, then provided he signs a release of claims, in addition to the severance benefits provided above, all of his then unvested restricted stock or stock options shall be immediately vested.
62

Director Compensation
 
The following table provides information regarding all compensation awarded to, earned by or paid to each person who served as a director of Aemetis, Inc. for some portion or all of 2010under the caption “Executive Compensation and 2011. Other than as set forthRelated Information,” appearing in the table and described more fully below, Aemetis, Inc. did not pay any fees, made any equity or non-equity awards, or paid any other compensation, to its non-employee directors. All compensation paid to its employee directorsProxy Statement, is set forth in the tables summarizing executive officer compensation below.hereby incorporated by reference.
 
Name 
Fees Earned
or Paid in
Cash ($)
  
Option
Awards (1)
($)
  
Total
($)
 
          
2010         
Michael Peterson  110,000   18,097   128,097 
Harold Sorgenti  85,000   18,097   103,097 
John R. Block  77,750   18,097   95,847 
             
2011            
Michael Peterson  107,750      107,750 
Harold Sorgenti  82,750      82,750 
John R. Block  58,500      58,500 
Dr. Steven Hutcheson  37,500      37,500 
(1)  The amounts in this column represent the aggregate grant date fair value under ASC Topic 718. The assumptions made when calculating the amounts in this table are found in Note 11 (Stock Based Compensation) of the Notes to Consolidated Financial Statements in Part II, Item 8 of this Form 10-K .
In 2007, the Board of Directors of the Company adopted a director compensation policy pursuant to which each non-employee director is paid an annual cash retainer of $75,000 and a cash payment of $250 per Board or committee meeting attended telephonically and a cash payment of $500 per Board or committee meeting attended in person. In addition, each non-employee director is initially granted an option exercisable for 100,000 shares of the Company’s common stock, which vests quarterly over two years subject to continuing services to the Company.  In addition, an annual cash retainer of $10,000 is paid to the chairman of the Governance, Compensation and Nominating Committee and an annual cash retainer of $20,000 is paid to the chairman of the Audit Committee.
ITEMItem 12.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERSSecurity Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
 
The following table sets forth information asunder the caption “Security Ownership of October 25, 2012, regardingCertain Beneficial Owners and Management” and “Equity Compensation Plan Information,” appearing in the beneficial ownership of each class of our voting stock, including (a) each stockholder whoProxy Statement, is knownhereby incorporated by the Company to own beneficially in excess of 5% of each class of our voting stock; (b) each director; (c) the Company’s named executive officers; and (d) the Company’s named executive officers and directors as a group. Except as otherwise indicated, all persons listed below have (i) sole voting power and investment power with respect to their shares of stock, except to the extent that authority is shared by spouses under applicable law, and (ii) record and beneficial ownership with respect to their shares of stock. The percentage of beneficial ownership of common stock is based upon 170,548,507 shares of common stock outstanding as of October 25, 2012. The percentage of beneficial ownership of Series B preferred stock is based upon 3,097,725 shares of Series B preferred stock outstanding as of October 25, 2012. Unless otherwise identified, the address of the directors and officers of the Company is 20400 Stevens Creek Blvd., Suite 700, Cupertino, CA 95014.
reference.
 
63

  Common Stock  Series B Preferred Stock 
  
Amount and Nature of
Beneficial Ownership
  
Percentage
of Class
  
Beneficial
Ownership
  
Percentage
of Class
 
Officers & Directors            
Eric A. McAfee (1)
  27,885,000   16.35%      
John R. Block (2)
  485,775   *%      
Dr. Steven Hutcheson (3)
  2,057,570   1.21%      
Harold Sorgenti (4)
  485,775   *%      
Andrew Foster (5)
  1,012,887   *%      
Sanjeev Gupta (6)
  1,079,884   *%      
Todd A. Waltz (7)
  2,187,325   1.28%      
Francis Barton  100,000   -       
All officers and directors as a group (8 persons)  35,294,216   20.69%      
               
5% or more Holders              
               
Third Eye Capital (9)
  24,921,865   14.61%      
161 Bay Street, Suite 3930              
Toronto, Ontario, M5J 2S1              
               
Laird Cagan (8)
  22,014,496   12.91%      
20400 Stevens Creek Blvd., Suite 700              
Cupertino, CA 95014              
               
Michael Orsak  2,178,333   1.28%  166,667   5.38%
1125 San Mateo Drive,                
Menlo Park, California 94025                
                 
David J. Lies  1,606,587   0.94%  200,000   6.46%
1210 Sheridan Road                
Wilmette, Illinois 60091                
                 
Michael C Brown Trust dated June 30, 2000  481,676   0.28%  599,999   19.37%
34 Meadowview Drive                
Northfield, Illinois 60093                
                 
Mahesh Pawani  535,358   0.31%  400,000   12.91%
Villa No. 6, Street 29, Community 317, Al Mankhool,                
Dubai, United Arab Emirates                
                 
Frederick WB Vogel  440,678   0.26%  408,332   13.18%
1660 N. La Salle Drive, Apt 2411                
Chicago, Illinois 60614                
                 
Fred Mancheski  -   -   300,000   9.68%
1060 Vegas Valley Dr                
Las Vegas, NV  89109                
                 
Crestview Capital, LLC  -   -   166,667   5.38%
95 Revere Dr., Ste A                
Northbrook, Illinois 60062                
*Less than 1%                
64

(1) Includes (i) 27,885,000 shares held by McAfee Capital, LLC, a company owned by Mr. McAfee.
(2) Includes 403,451shares issuable pursuant to options exercisable within 60 days of October 25, 2012, and 82,324 common stock warrants fully exercisable.
(3)  Includes 1,957,570 shares held by Mr. Hutcheson and 100,000 shares issuable to Mr. Hutcheson pursuant to fully vested options.
(4)  Includes 403,451 shares issuable pursuant to options exercisable within 60 days of October 25, 2012, and 82,324 common stock warrants fully exercisable.
(5) Includes (i) 50,000 shares held by the Andrew B. Foster and Catherine H. Foster Trust;  (ii) 921,724 shares issuable pursuant to options exercisable within 60 days of October 25, 2012, and (iii) 41,163 fully exercisable common stock warrants.
(6)Includes 715,234 shares issuable pursuant to options exercisable within 60 days of October 25, 2012, and 164,650 fully exercisable common stock warrants.
(7) Includes 940,349 shares issuable pursuant to options exercisable within 60 days of October 25, 2012 and 246,976 fully exercisable common stock warrants.
(8) Includes (i) 18,366,760 shares held by Cagan Capital, LLC, a company owned by Mr. Cagan; (ii) 400,000 shares owned by the KRC Trust and 400,000 owned by the KQC Trust, trusts for Mr. Cagan's daughters for which Mr. Cagan is trustee and (iii) 2,847,736 shares held by Mr. Cagan individually.
(9) Includes 17,227,750 shares held by RBC Dexia Investor Services Trust, held in Trust for Account 110-455-262 and Sprott Private Credit Fund, LP, a corporation residing in Canada. Third Eye Capital beneficially owns 7,310,782 common shares and 383,333 common stock warrants fully exercisable.
Securities Authorized for Issuance under Equity Compensation Plans
The Company’s shareholders approved the Company’s Amended and Restated 2007 Stock Plan at the Company’s 2010 Annual Shareholders Meeting.  On December 15, 2010, the Company issued compensatory warrants to officers, directors and employees.  The warrants are exercisable at $0.13 per share and expire on December 15, 2015.  On July 1, 2011, the Company acquired the Zymetis 2006 Stock Plan pursuant to the acquisition of Zymetis, Inc. and gave Zymetis option holders the right to convert shares into Aemetis common stock at the same terms as the Zymetis plan.The following table provides information about our Amended and Restated 2007 Stock Plan and the compensatory warrants as of December 31, 2011:
Plan category 
Number of
securities
to be issued
upon exercise
of outstanding
options
 (a)
  
Weighted
average
exercise price
of outstanding
options
 (b)
  
Number of
securities remaining
available for future
issuance under equity
compensation plans
 (excluding securities
reflected in column
(a)) (c)
 
Equity compensation plans approved by security holders (1)
  6,803,701  $0.94   1,656,148(2)
Equity in the form of warrants issued to officers, directors and employees not approved by security holders  950,856   0.13   - 
(1)  Shares from the 2006 Stock Option Plan and the Amended and Restated 2007 Stock Option Plan.
(2)  Amount consists of shares available for future issuance under the 2006 and 2007 Plan.
65

ITEM 13.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
Item 13.  Certain Relationships and Related Transactions, and Director Independence
 
The following are transactions entered intoinformation under the caption “Certain Relationships and Related Transactions” and “Information about our Board of Directors, Board Committees and Related Matters—Director Independence”  appearing in fiscal 2010 and 2011 and any currently proposed transaction, (i) in which the registrant was orProxy Statement, is to be a participant, (ii) the amount involved exceeds the lesser of $120,000 or one percent of the average of the registrant’s company's total assets at year end for the last two completed fiscal years, and (iii) in which any director, executive officer, five percent stockholder or any member of the immediate family of any of the foregoing persons had or will have a direct or indirect material interest.hereby incorporated by reference.
 
On August 17, 2009, we entered into a $5 million secured revolving line of credit with Laird Cagan, a former member of the Company’s board of directors and a significant stockholder. The credit facility accrues interest at 10% per annum and was due and payable on July 1, 2011.  At December 31, 2010, $4,854,992 in principal, plus accrued interest of $810,728 and extension fee of $278,963 was outstanding under this credit facility. On September 30, 2011, Laird Cagan with co-investors exercised theirright to convert $1,452,818 in outstanding interest and fees to stock at a rate of 5 cents per share resulting in the Company issuing 29,056,356 shares of common stock in exchange for the payment. In October 2011, in connection with the extension of the line, the Company implemented a new conversion feature based on the average closing price on the previous twenty-two days of trading. At October 16, 2012, the remaining principal, interest and fees due under the Credit Agreement have a balance of $5,538,696.  See Note 15. Subsequent Events, of the Notes to Consolidated Financial Statements in Part II, Item 8 of this Form 10-K.
On January 30, 2010, AE Advanced Fuels Keyes, Inc., a wholly owned subsidiary of Aemetis, Inc., borrowed $1.6 million from Mr. Cagan pursuant to an unsecured promissory note.  The note bears no interest.  In consideration for this loan, we agreed to issue 600,000 shares of common stock to Mr. Cagan.  The note was redeemed in March 2010.
ITEM 14.  PRINCIPAL ACCOUNTING FEES AND SERVICES
Item 14.  Principal Accounting Fees and Services
 
AuditorThe information under the caption “Audit Matters—Principal Accountant Fees and Services,” appearing in Our 2011 and 2010 Fiscal Yearsthe Proxy Statement, is hereby incorporated by reference.
 
During fiscal 2010 our registered independent public accounting firm was BDO Seidman, LLP through the third quarter of 2010. Our relationship with BDO Seidman, LLP was terminated on June 23, 2011.  The fees billed by BDO Seidman, LLP in 2010 and 2011 were as follows:
  2011  2010 
Audit Fees $52,500  $163,925 
Audit-Related Fees  ––   –– 
Total Audit and Audit-Related Fees  52,500   163,925 
Tax Fees  2,747   17,747 
All Other Fees  ––   –– 
         
Total $55,247  $181,672 
Audit Fees consist of fees billed for professional services rendered for the audit of the Company's consolidated annual financial statements, and review of the interim consolidated financial statements included in quarterly reports and services that are normally provided by BDO Seidman, LLP in connection with statutory and regulatory filings or engagements.
Tax Fees include tax compliance, tax advice and tax planning services. These services related to the preparation of various state and federal tax returns and review of Section 409A compliance.
66

McGladrey LLP was appointed as our registered independent public accountant on May 21, 2012.  The fees billed by McGladrey, LLP for audits of the 2010 and 2011 financial statements are as follows:
  2011  2010 
Audit Fees $245,000  $140,000 
Audit-Related Fees  35,000   20,000 
Total Audit and Audit-Related Fees  280,000   160,000 
Tax Fees  ––   –– 
All Other Fees  ––   –– 
         
Total $280,000  $160,000 
PART IV


Audit Fees consist of fees billed for professional services rendered for the audit of the Company's consolidated annual financial statements, and review of the interim consolidated financial statements included in quarterly reports and services that are normally provided by McGladrey LLP in connection with statutory and regulatory filings or engagements.
Audit-Related Fees consist of assistance provided on various accounting matters.
Audit Committee's Pre-Approval Policies and Procedures
Consistent with policies of the SEC regarding auditor independence and the Audit Committee Charter, the Audit Committee has the responsibility for appointing, setting compensation and overseeing the work of the registered independent public accounting firm (the “Firm”). The Audit Committee's policy is to pre-approve all audit and permissible non-audit services provided by the Firm. Pre-approval is detailed as to the particular service or category of services and is generally subject to a specific budget. The Audit Committee may also pre-approve particular services on a case-by-case basis. In assessing requests for services by the Firm, the Audit Committee considers whether such services are consistent with the Firm’s independence, whether the Firm is likely to provide the most effective and efficient service based upon their familiarity with the Company, and whether the service could enhance the Company's ability to manage or control risk or improve audit quality.
In fiscal year 2011 and 2010, all fees identified above under the captions “Audit Fees,” “Audit-Related Fees,” “Tax Fees” and “All Other Fees” that were billed by BDO Seidman, LLP and McGladrey, LLP were approved by the Audit Committee in accordance with SEC requirements.
ITEM 15.  EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
Item 15.  Exhibits and Financial Statement Schedules
 
(a) The following documents are filed as a part of this Form 10-K:
 
1. Financial Statements:
 
The following financial statements of Aemetis, Inc. are filed as a part of this Annual Report:
 
●  Report of Independent Registered Public Accounting Firm
●  Consolidated Balance Sheets
●  Consolidated Statements of Operations and Comprehensive LossIncome (Loss)
●  Consolidated Statements of Cash Flows
●  Consolidated Statements of Stockholders' DeficitStockholders’ Equity (Deficit)
●  Notes to Consolidated Financial Statements
 
2. Financial Statement Schedules:
 
All schedules have been omitted as the required information is inapplicable or the information is presented in the Consolidated Financial Statements and notes thereto under Item 8 in Part II of this Form 10-K.
 
 
6744

 
 
3. Exhibits:
INDEX TO EXHIBITS
INDEX TO EXHIBITS
  Incorporated by Reference Filed
Exhibit No. Description Form Film No. Exhibit Filing Date Herewith
3.1.1 Articles of Incorporation 10-Q 000-51354 3.1 Nov. 14, 2008  
3.1.2 Certificate of Amendment  to Articles of Incorporation 10-Q 000-51354 3.1.1 Nov. 14, 2008  
3.1.3 Certificate of Designation of Series B Preferred Stock 8-K 000-51354 3.2 Dec. 13, 2007  
3.1.4 Certificate of Amendment to Articles of Incorporation 8-K 000-51354 3.3 Dec. 13, 2007  
3.1.5 Certificate of Amendment to Articles of Incorporation Pre14C 111136140   October 26, 2011  
3.2.1 Bylaws 8-K 000-51354 3.4 Dec. 13, 2007  
4.1 Specimen Common Stock Certificate 8-K 000-51354 4.1 Dec. 13, 2007  
4.2 Specimen Series B Preferred Stock Certificate 8-K 000-51354 4.2 Dec. 13, 2007  
4.3 Form of Common Stock Warrant 8-K 000-51354 4.3 Dec. 13, 2007  
4.4 Form of Series B Preferred Stock Warrant 8-K 000-51354 4.4 Dec. 13, 2007  
10.1 Amended and Restated 2007 Stock Plan 14A 000-51354   Apr. 15, 2008  
10.2 Amended and Restated 2007 Stock Plan form of Stock Option Award Agreement 14A 000-51354   Apr. 15, 2008  
10.4 Eric McAfee Executive Chairman Agreement dated January 30, 2006 8-K 000-51354 10.4 Dec. 13, 2007  
10.7 Andrew Foster Executive Employment Agreement, dated May 22, 2007 8-K 000-51354 10.7 Dec. 13, 2007  
10.10 Todd Waltz Executive Employment Agreement, dated March 15, 2010 8-K 000-51354   May 20, 2009 X
10.11 Sanjeev Gupta Executive Employment Agreement, dated September 1, 2007 10-K 000-51354 10.11 May 20, 2009  
10.12 Agreement of Loan for Overall Limit dated June 26, 2008 between Universal Biofuels Pvt Limited and State Bank of India 10-Q 000-51354 10.12 Aug. 14, 2008  
10.14 $5 million Note and Warrant Purchase Agreement dated May 16, 2008 among Third Eye Capital Corporation, as Agent; the Purchasers; and Aemetis, Inc., including the form of Note 8-K 000-51354 10.1 May 21, 2008  
10.16 Revolving Line of Credit Agreement dated August 17, 2009 between International Biodiesel, Inc. and Laird Cagan 10-K 000-51354 10.16 Mar. 15, 2010  
10.17 Project Agreement dated December 1, 2009 among Cilion, Inc., Aemetis, Inc., AE Advanced Fuels, Inc., and AE Advanced Fuels Keyes, Inc. 8-K 
000-51354
 
 10.1 Dec. 2, 2009  
10.18 Lease Agreement dated December 1, 2009, among Cilion Inc., AE Advanced Fuels Keyes, Inc., and AE Advanced Fuels, Inc., a Delaware corporation 8-K 000-51354 10.2 Dec. 2, 2009  
10.19 Amendment No. 4 and Limited Waiver to Note and Warrant Purchase Agreement dated December 10, 2009, between Aemetis, Inc. and Third Eye Capital Corporation 8-K 000-51354 10.1 Dec. 22, 2009  
10.20 Assignment of Proceeds Agreement dated December 10, 2009, between Aemetis, Inc. and Third Eye Capital Corporation 8-K 000-51354 10.2 Dec. 22, 2009  
10.21 Guaranty Agreement dated December 10, 2009, between AE Advanced Fuels Keyes, Inc. and Third Eye Capital Corporation 8-K 000-51354 10.3 Dec. 22, 2009  
10.24 Note Purchase Agreement dated October 18, 2010, among Third Eye Capital Corporation, the Purchasers and AE Advanced Fuels Keyes, Inc., including the Form of Note 8-K 000-51354 10.1 Nov. 3, 2010  
10.25 Amendment No. 5 and Limited Waiver to Note and Warrant Purchase Agreement dated October 18, 2010, between Aemetis, Inc. and Third Eye Capital Corporation 8-K 000-51354 10.1 Nov. 3, 2010  
10.27 Amendment #1 to Project Agreement dated October 29, 2010 among Cilion, Inc., Aemetis, Inc., AE Advanced Fuels, Inc., and AE Advanced Fuels Keyes, Inc. 10-Q 000-51354 10.3 Dec. 1, 2010  
10.28 Amendment #1 to Lease Agreement dated October 29, 2010, among Cilion, Inc., AE Advanced Fuels Keyes, Inc., and AE Advanced Fuels, Inc. 10-Q 000-51354 10.4 Dec. 1, 2010  
10.29 Subordination Agreement, dated October 29, 2010 among Laird Cagan, Aemetis, Inc., AE Advanced Fuels Keyes, Inc., and Third Eye Capital Corporation 10-Q 000-51354 10.5 Dec. 1, 2010  
10.30 Ethanol Marketing Agreement, dated October 29, 2010 between AE Advanced Fuels Keyes, Inc. and Kinergy Marketing, LLC 10-Q 000-51354 10.6 Dec. 1, 2010  
  Incorporated by Reference Filed Herewith
Exhibit No.DescriptionFormFile No.ExhibitFiling Date 
3.1.1Articles of Incorporation10-Q000-513543.1Nov. 14, 2008 
3.1.2Certificate of Amendment to Articles of Incorporation10-Q000-513543.1.1Nov. 14, 2008 
3.1.3Certificate of Designation of Series B Preferred Stock8-K000-513543.2Dec. 13, 2007 
3.1.4Certificate of Amendment to Articles of Incorporation8-K000-513543.3 Dec. 13, 2007 
3.1.5Certificate of Amendment to Articles of IncorporationPre14C111136140 26-Oct-11 
3.2.1Bylaws8-K000-513543.4Dec. 13, 2007 
3.2.2Certificate of Change in Articles of Incorporation are a result of 1 for 10 reverse split to Authorized Shares and Common Shares Outstanding on May 5, 201410-Q000-513543.131-May-14 
4.1Specimen Common Stock Certificate8-K000-513544.1  Dec. 13, 2007 
4.2Specimen Series B Preferred Stock Certificate8-K000-513544.2  Dec. 13, 2007 
4.3Form of Common Stock Warrant8-K000-513544.3  Dec. 13, 2007 
4.4Form of Series B Preferred Stock Warrant8-K000-513544.4 Dec. 13, 2007 
10.1Amended and Restated 2007 Stock Plan14A000-51354 Apr. 15, 2008 
10.2Amended and Restated 2007 Stock Plan form of Stock Option Award Agreement14A000-51354  Apr. 15, 2008 
10.3Eric McAfee Executive Employment Agreement dated September 1, 20118-K000-5135410.2Sep. 8, 2011 
10.4Andrew Foster Executive Employment Agreement, dated May 22, 20078-K000-5135410.7  Dec. 13, 2007 
10.5Todd Waltz Executive Employment Agreement, dated March 15, 20108-K000-51354 20-May-09 
10.6Sanjeev Gupta Executive Employment Agreement, dated September 1, 200710-K000-5135410.1120-May-09 
10.7Agreement of Loan for Overall Limit dated June 26, 2008 between Universal Biofuels Private Limited and State Bank of India10-Q000-5135410.12  Aug. 14, 2008 
10.8Ethanol Marketing Agreement, dated October 29, 2010 between AE Advanced Fuels Keyes, Inc. and Kinergy Marketing, LLC10-Q000-5135410.6Dec. 1, 2010 
10.9Zymetis, Inc. 2006 Stock Incentive Plan10-K000-5135410.3131-Oct-12 
10.1Zymetis Inc.  Incentive Stock Option Agreement10-K000-5135410.3231-Oct-12 
10.11Zymetis Inc. Non-Incentive Stock Option Agreement10-K000-5135410.3331-Oct-12 
10.12First Amendment to Ethanol Marketing Agreement dated September 6, 2011, between AE Advanced Fuels Keyes, Inc. and Kinergy Energy Marketing8-K000-5135410.18-Sep-11 
10.13Form of Note and Warrant Purchase Agreement8-K000-5135410.11-Jan-12 
10.14Form of 5% Subordinated Note8-K000-5135410.21-Jan-12 
10.15Form of Common Stock Warrant8-K000-5135410.31-Jan-12 
10.16Amendment No. 6 to Note Purchase Agreement dated April 13, 2012 among Aemetis Advanced Fuels Keyes, Inc., Third Eye Capital Corporation, as agent, and the Purchasers8-K000-5135410.119-Apr-12 
10.17Limited Waiver to Note Purchase Agreement dated March 31, 2012 among Aemetis Advanced Fuels Keyes, Inc., and Third Eye Capital Corporation, an Ontario corporation, as agent8-K000-5135410.119-Apr-12
 
 
68

10.31 Zymetis, Inc. 2006 Stock Incentive Plan         X
10.32 Zymetis Inc.  Incentive  Stock Option Agreement         X
10.33 Zymetis Inc. Non-Incentive Stock Option Agreement         X
10.34 Amendment No. 1 to Note Purchase Agreement dated March 10, 2011 among Third Eye Capital Corporation, as Agent; the Purchasers; and AE Advanced Fuels Keyes, Inc. 8-K 000-51354 10.1 March 16, 2011  
10.35 Amendment No. 2 to Project Agreement dated March 9, 2011 among Cilion, Inc., AE Biofuels, Inc., AE Advanced Fuels, Inc., and AE Advanced Fuels Keyes, Inc. 8-K 000-51354 10.2 March 16, 2011  
10.36 Amendment No. 2 to Lease Agreement dated March 9, 2011 among Cilion, Inc., AE Advanced Fuels Keyes, Inc., and AE Advanced Fuels, Inc. 8-K 000-51354 10.3 March 16, 2011  
10.37 Limited Waiver to Note and Warrant Purchase Agreement dated May 24, 2011, between Third Eye Capital Corporation, as Agent and AE Biofuels, Inc. 8-K 000-51354 10.1 June 1, 2011  
10.38 Limited Waiver and Amendment No. 2 to Note Purchase Agreement dated June 20, 2011, among Third Eye Capital Corporation, as Agent; the Purchasers; and AE Advanced Fuels Keyes, Inc. 8-K 000-51354 10.1 June 24, 2011  
10.39 First Amendment to Ethanol Marketing Agreement dated September 6, 2011, between AE Advanced Fuels Keyes, Inc. and Kinergy Energy Marketing 8-K 000-51354 10.1 September 8, 2011  
10.40 Limited Waiver and Amendment No. 4 to Note Purchase Agreement dated as of November 8, 2011 and effective as of October 18, 2011 among AE Advanced Fuels Keyes, Inc., Third Eye Capital Corporation, and the Purchasers 8-K 000-51354 10.1 November 15, 2011  
10.41 Form of Note and Warrant Purchase Agreement 8-K 000-51354 10.1 January 1, 2012  
10.42 Form of 5% Subordinated Note 8-K 000-51354 10.2 January 1, 2012  
10.43 Form of Common Stock Warrant 8-K 000-51354 10.3 January 1, 2012  
10.44 Limited Waiver, Consent and Amendment No. 5 to Note Purchase Agreement dated January 31, 2012 among Aemetis Advanced Fuels Keyes, Inc., Third Eye Capital Corporation, as agent and the Purchasers 8-K 000-51354 10.1 February 6, 2012  
10.45 Amendment No. 6 to Note Purchase Agreement dated April 13, 2012 among Aemetis Advanced Fuels Keyes, Inc., Third Eye Capital Corporation, as agent, and the Purchasers 8-K 000-51354 10.1 April 19, 2012  
10.46 Limited Waiver to Note Purchase Agreement dated March 31, 2012 among Aemetis Advanced Fuels Keyes, Inc., and Third Eye Capital Corporation, an Ontario corporation, as agent 8-K 000-51354 10.1 April 19, 2012  
10.47 Limited Waiver to Note and Warrant Purchase Agreement dated March 31, 2012 among Aemetis, Inc., Third Eye Capital Corporation, an Ontario corporation, as agent, and the Purchasers 8-K 000-51354 10.1 April 19, 2012  
10.48 Amendment No. 7 to Note Purchase Agreement dated May 15, 2012 among Aemetis Advanced Fuels Keyes, Inc., Third Eye Capital Corporation, as agent, and the Purchasers 8-K 000-51354 10.1 May 22, 2012  
10.49 Form of Note and Warrant Purchase Agreement 8-K 000-51354 10.1 June 6, 2012  
10.50 Form of 5% Subordinated Note 8-K 000-51354 10.1 June 6, 2012  
10.51 Form of Common Stock Warrant 8-K 000-51354 10.1 June 6, 2012  
10.52 Note and Warrant Purchase Agreement dated June 21, 2012 among Third Eye Capital Corporation, Aemetis Advanced Fuels Keyes, Inc., and Aemetis, Inc. 8-K 000-51354 10.1 June 28, 2012  
10.53 5% Subordinated Promissory Note dated June 21, 2012 among Third Eye Capital Corporation, Aemetis Advanced Fuels Keyes, Inc., and Aemetis, Inc. 8-K 000-51354 10.2 June 28, 2012  
10.54 Form of Warrant to Purchase Common Stock 8-K 000-51354 10.3 June 28, 2012  
10.55 Note Purchase Agreement dated June 27, 2012 among Third Eye Capital Corporation, Aemetis Advanced Fuels Keyes, Inc., and Aemetis, Inc. 8-K 000-51354 10.1 July 3, 2012  
10.56 15% Subordinated Promissory Note dated June 27, 2012 among Third Eye Capital Corporation, Aemetis Advanced Fuels Keyes, Inc., and Aemetis, Inc. 8-K 000-51354 10.2 July 3, 2012  
10.57 Agreement and Plan of Merger, dated July 6, 2012, among Aemetis, Inc., AE Advanced Fuels, Inc., Keyes Facility Acquisition Corp., and Cilion, Inc. 8-K 000-51354 2.1 July 10, 2012  
10.58 Stockholders’ Agreement, dated July 6, 2012, among Aemetis, Inc., and Western Milling Investors, LLC, as Securityholders’ Representative. 8-K 000-51354 10.1 July 10, 2012  
10.59 Amended and Restated Note Purchase Agreement, dated July 6, 2012 among Aemetis Advanced Fuels Keyes, Inc., Keyes Facility Acquisition Corp., Aemetis, Inc., Third Eye Capital Corporation, as Administrative Agent, and the Noteholders 8-K 000-51354 10.2 July 10, 2012  
6945

 
 
10.60 Amended and Restated Guaranty, dated July 6, 2012 among Aemetis, Inc., certain subsidiaries of Aemetis and Third Eye Capital Corporation, as Agent. 8-K 000-51354 10.3 July 10, 2012  
10.61 Amended and Restated Security Agreement, dated July 6, 2012 among Aemetis, Inc., certain subsidiaries of Aemetis and Third Eye Capital Corporation, as Agent. 8-K 000-51354 10.4 July 10, 2012  
10.62 Investors’ Rights Agreement, dated July 6, 2012, by and among Aemetis, Inc., and the investors listed on Schedule A thereto. 8-K 000-51354 10.5 July 10, 2012  
10.63 Technology License Agreement dated August 9, 2012 between Chevron Lummus Global LLC and Aemetis Advanced Fuels, Inc. 8-K 000-51354 10.1 August 22, 2012  
10.64 Corn Procurement and Working Capital Agreement dated March 9, 2011 between J.D. Heiskell Holdings LLC and Aemetis Advanced Fuels Keyes, Inc.**         X
10.65 Purchasing Agreement dated March  9, 2011 between J.D. Heiskell Holdings LLC and Aemetis Advanced Fuels Keyes, Inc.**         X
10.66 WDG Purchase and Sale Agreement dated March 23, 2011 between A.L. Gilbert Company and Aemetis Advanced Fuels Keyes, Inc.         X
10.67 Keyes Corn Handling Agreement dated March 23, 2011 among  A. L. Gilbert Company, AE Advanced Fuels Keyes, Inc., and J.D. Heiskell Holdings, LLC**         X
10.68 Limited Waiver and Amendment No. 1 to Amended and Restated Note Purchase Agreement dated as of October 18, 2012 by and among Aemetis Advanced Fuels Keyes, Inc., a Delaware corporation, Aemetis Facility Keyes, Inc., a Delaware corporation, Third Eye Capital Corporation, an Ontario corporation as agent, Third Eye Capital Credit Opportunities Fund – Insight Fund, and Sprott PC Trust. 8-K 000-51354 10.1 October 23, 2012  
10.69 Amendment No. 1 to Revolving Line of Credit Agreement dated October 16, 2012 by and among Aemetis International, Inc., a Nevada corporation, and Laird Q. Cagan 8-K 000-51354 10.2 October 23, 2012  
10.70 Note Purchase Agreement effective as of March 4, 2011, amended January 19, 2012 and July 24, 2012 by and among AE Advanced Fuels, Inc., a Delaware corporation, and Advanced BioEnergy, LP a California limited partnership and Advanced BioEnergy GP, LLC, a California limited liability company. 8-K 000-51354 10.3 October 23, 2012  
10.71 Form of Convertible Subordinated Promissory Note by and among AE Advanced Fuels, Inc., a Delaware corporation and Advanced FioEnergy, LP, a California limited partnership. 8-K 000-51354 10.4 October 23, 2012  
14 Code of Ethics 10-K 000-51354 14 May 20, 2009  
 Subsidiaries of the Registrant         X
24 Power of Attorney (see signature page)         X
 Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Section 302 of the Sarbanes-Oxley Act of 2002         X
 Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Section 302 of the Sarbanes-Oxley Act of 2002         X
32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002         X
32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002         X
10.18Limited Waiver to Note and Warrant Purchase Agreement dated March 31, 2012 among Aemetis, Inc., Third Eye Capital Corporation, an Ontario corporation, as agent, and the Purchasers8-K000-5135410.119-Apr-12 
10.19Amendment No. 7 to Note Purchase Agreement dated May 15, 2012 among Aemetis Advanced Fuels Keyes, Inc., Third Eye Capital Corporation, as agent, and the Purchasers8-K000-5135410.122-May-12 
10.2Form of Note and Warrant Purchase Agreement8-K000-5135410.16-Jun-12 
10.21Form of 5% Subordinated Note8-K000-5135410.16-Jun-12 
10.22Form of Common Stock Warrant8-K000-5135410.16-Jun-12 
10.23Note and Warrant Purchase Agreement dated June 21, 2012 among Third Eye Capital Corporation, Aemetis Advanced Fuels Keyes, Inc., and Aemetis, Inc.8-K000-5135410.128-Jun-12 
10.245% Subordinated Promissory Note dated June 21, 2012 among Third Eye Capital Corporation, Aemetis Advanced Fuels Keyes, Inc., and Aemetis, Inc.8-K000-5135410.228-Jun-12 
10.25Form of Warrant to Purchase Common Stock8-K000-5135410.328-Jun-12 
10.26Note Purchase Agreement dated June 27, 2012 among Third Eye Capital Corporation, Aemetis Advanced Fuels Keyes, Inc., and Aemetis, Inc.8-K000-5135410.13-Jul-12 
10.2715% Subordinated Promissory Note dated June 27, 2012 among Third Eye Capital Corporation, Aemetis Advanced Fuels Keyes, Inc., and Aemetis, Inc.8-K000-5135410.23-Jul-12 
10.28Agreement and Plan of Merger, dated July 6, 2012, among Aemetis, Inc., AE Advanced Fuels, Inc., Keyes Facility Acquisition Corp., and Cilion, Inc.8-K000-513542.110-Jul-12 
10.29Stockholders’ Agreement dated July 6, 2012, among Aemetis, Inc., and Western Milling Investors, LLC, as Security holders’ Representative.8-K000-5135410.110-Jul-12 
10.3Amended and Restated Note Purchase Agreement, dated July 6, 2012 among Aemetis Advanced Fuels Keyes, Inc., Keyes Facility Acquisition Corp., Aemetis, Inc., Third Eye Capital Corporation, as Administrative Agent, and the Note holders8-K000-5135410.210-Jul-12 
10.31Amended and Restated Guaranty, dated July 6, 2012 among Aemetis, Inc., certain subsidiaries of Aemetis and Third Eye Capital Corporation, as Agent.8-K000-5135410.310-Jul-12 
10.32Amended and Restated Security Agreement, dated July 6, 2012 among Aemetis, Inc., certain subsidiaries of Aemetis and Third Eye Capital Corporation, as Agent.8-K000-5135410.410-Jul-12 
10.33Investors’ Rights Agreement dated July 6, 2012, by and among Aemetis, Inc., and the investors listed on Schedule A thereto.8-K000-5135410.510-Jul-12 
10.34Technology License Agreement dated August 9, 2012 between Chevron Lummus Global LLC and Aemetis Advanced Fuels, Inc.8-K000-5135410.122-Aug-12 
10.35Corn Procurement and Working Capital Agreement dated March 9, 2011 between J.D. Heiskell Holdings LLC and Aemetis Advanced Fuels Keyes, Inc.*10-K000-5135410.6431-Oct-12 
10.36Purchasing Agreement dated March 9, 2011 between J.D. Heiskell Holdings LLC and Aemetis Advanced Fuels Keyes, Inc.*10-K000-5135410.6531-Oct-12 
10.37WDG Purchase and Sale Agreement dated March 23, 2011 between A.L. Gilbert Company and Aemetis Advanced Fuels Keyes, Inc.10-K000-5135410.6631-Oct-12
46

 
*
10.38Keyes Corn Handling Agreement dated March 23, 2011 among A. L. Gilbert Company, AE Advanced Fuels Keyes, Inc., and J.D. Heiskell Holdings, LLC**10-K000-5135410.6731-Oct-12 
10.39Limited Waiver and Amendment No. 1 to Amended and Restated Note Purchase Agreement dated as of October 18, 2012 by and among Aemetis Advanced Fuels Keyes, Inc., a Delaware corporation, Aemetis Facility Keyes, Inc., a Delaware corporation, Third Eye Capital Corporation, an Ontario corporation as agent, Third Eye Capital Credit Opportunities Fund – Insight Fund, and Sprott PC Trust.8-K000-5135410.123-Oct-12 
10.4Amendment No. 1 to Revolving Line of Credit Agreement dated October 16, 2012 by and among Aemetis International, Inc., a Nevada corporation, and Laird Q. Cagan8-K000-5135410.223-Oct-12 
10.41Note Purchase Agreement effective as of March 4, 2011, amended January 19, 2012 and July 24, 2012 by and among AE Advanced Fuels, Inc., a Delaware corporation, and Advanced BioEnergy, LP a California limited partnership and Advanced BioEnergy GP, LLC, a California limited liability company.8-K000-5135410.323-Oct-12 
10.42Form of Convertible Subordinated Promissory Note by and among AE Advanced Fuels, Inc., a Delaware corporation and Advanced BioEnergy, LP, a California limited partnership.8-K000-5135410.423-Oct-12 
10.43Amendment to the Purchasing Agreement dated March 9, 2011 between J.D. Heiskell Holdings LLC and Aemetis Advanced Fuels Keyes, Inc. dated September 29, 201210-K000-5135410.724-Apr-13 
10.44Agreement for Repayment of Note by Share Issuance dated as of December 31, 2012 by and among Aemetis, Inc., Aemetis International, Inc., (formerly known as “International Biodiesel, Inc.”), a Nevada corporation and wholly-owned subsidiary of the Company, and Laird Q. Cagan for himself and on behalf of all other holders of interests in the Revolving Line of Credit (as defined in the Agreement).8-K000-5135410.17-Jan-13 
10.45Agreement for Repayment of Note by Share Issuance dated as of December 31, 2012 by and among Aemetis, Inc., Aemetis International, Inc., (formerly known as “International Biodiesel, Inc.”), a Nevada corporation and wholly-owned subsidiary of the Company, and Laird Q. Cagan for himself and on behalf of all other holders of interests in the Revolving Line of Credit (as defined in the Agreement).8-K/A000-5135410.1Feb. 27, 2013 
10.46Limited Waiver and Amendment No. 2 to Amended and Restated Note Purchase Agreement dated as of February 27, 2013 by and among Aemetis Advanced Fuels Keyes, Inc., a Delaware corporation, Aemetis Facility Keyes, Inc., a Delaware corporation, Third Eye Capital Corporation, an Ontario corporation as agent, Third Eye Capital Credit Opportunities Fund – Insight Fund, and Sprott PC Trust.8-K000-5135410.111-Mar-13 
10.47Amendment No. 1 to Agreement for Repayment of Note by Share Issuance dated as of April 10, 2013 by and among Aemetis, Inc., Aemetis International, Inc., a Nevada corporation and wholly-owned subsidiary of the Company, and Laird Q. Cagan for himself and on behalf of all other holders of interests in the Revolving Line of Credit (as defined in the Agreement).10-K000-5135410.774-Apr-13 
47

10.48Amendment to the Purchasing Agreement dated March 9, 2011 between J.D. Heiskell Holdings LLC and Aemetis Advanced Fuels Keyes, Inc. dated January 2, 2013.10-K000-5135410.764-Apr-13 
10.49Limited Waiver and Amendment No.3 to Amended and Restated Note Purchase Agreement dated as of April 15, 2013 by and among Aemetis Advanced Fuels Keyes, Inc., a Delaware corporation, Aemetis Facility Keyes, Inc., a Delaware corporation, Third Eye Capital Corporation, an Ontario corporation as agent, Third Eye Capital Credit Opportunities Fund – Insight Fund, and Sprott PC Trust.8-K000-5135410.116-Apr-13 
10.505Amendment No. 4 to Amended and Restated Note Purchase Agreement dated as of April 19, 2013 by and among Aemetis Advanced Fuels Keyes, Inc., a Delaware corporation, Aemetis Facility Keyes, Inc., a Delaware corporation, Aemetis, Inc., a Nevada corporation, and Third Eye Capital Corporation, an Ontario corporation, as agent for Third Eye Capital Insight Fund8-K/A000-5135410.2May 14, 2013 
10.5Special Bridge Advance dated as of March 29, 2013 by and among Aemetis Advanced Fuels Keyes, Inc., a Delaware corporation, Aemetis, Inc., a Nevada corporation, Third Eye Capital Corporation, an Ontario corporation, as agent for Third Eye Capital Insight Fund8-K000-5135410.216-Apr-13 
10.51Agreement For Satisfaction of Note by Share and Note Issuance dated as of April 18, 2013 between Aemetis, Inc., Aemetis International, Inc. and Laird Q. Cagan for himself and on behalf of all other holders of interests in the Revolving Line of Credit dated August 17, 2009 as amended.8-K000-5135410.124-Apr-13 
10.52Amended and Restated Heiskell Purchasing Agreement dated May 16, 2013, by and between Aemetis Advanced Fuels Keyes, Inc., a Delaware corporation and a wholly-owned subsidiary of Aemetis, Inc. and J.D. Heiskell Holdings, LLC, a California limited liability company doing business as J.D. Heiskell & Co.*8-K000-5135410.123-May-13 
10.53Amended and Restated Aemetis Keyes Grain Procurement and Working Capital Agreement, dated May 2, 2013, by and between Aemetis Advanced Fuels Keyes, Inc., and J.D. Heiskell Holdings, LLC8-K000-5135410.223-May-13 
10.54Limited Waiver and Amendment No.5 to Amended and Restated Note Purchase Agreement, dated as of July 26, 2013 by and among Aemetis, Inc., Aemetis Advanced Fuels Keyes, Inc. Aemetis Facility Keyes, Inc., Third Eye Capital Corporation, an Ontario corporation, as agent, Third Eye Capital Credit Opportunities Fund - Insight Fund, and Sprott PC Trust8-K000-5135410.131-Jul-13 
10.55Limited Waiver and Amendment No.6 to Amended and Restated Note Purchase Agreement, dated as of October 28, 2013 by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; Third Eye Capital Corporation, an Ontario corporation, as agent for Third Eye Capital Credit Opportunities Fund - Insight Fund, and Sprott PC Trust.8-K000-5135410.11-Nov-13 
10.62Limited Waiver and Amendment No.7 to Amended and Restated Note Purchase Agreement, dated as of May 14, 2014 by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; Third Eye Capital Corporation, an Ontario corporation, as agent for Third Eye Capital Credit Opportunities Fund - Insight Fund, and Sprott PC Trust.10-Q000-5135410.131-Mar-14
48

10.64Limited Waiver and Amendment No. 8 to Amended and Restated Note Purchase Agreement, dated as of November 7, 2014 by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; Third Eye Capital Corporation, an Ontario corporation, as agent for Third Eye Capital Credit Opportunities Fund - Insight Fund, and Sprott PC Trust.10-Q/A000-5135410.113-Nov-14 
 10.65Limited Waiver and Amendment No. 9 to Amended and Restated Note Purchase Agreement, dated as of  March 12, 2015 by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; Third Eye Capital Corporation, an Ontario corporation, as agent for Third Eye Capital Credit Opportunities Fund - Insight Fund, and Sprott PC Trust. 10K000-5135410.1March 12,201510.65
14Code of Ethics10-K000-513541420-May-09 
21Subsidiaries of the Registrant  X
23Consent of Independent Registered Public Accounting FirmX
24Power of Attorney (see signature page)  X
31.1Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Section 302 of the Sarbanes-Oxley Act of 2002X
31.2Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Section 302 of the Sarbanes-Oxley Act of 2002X
32.1Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002X
32.2Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002X
*Confidential treatment has been requested for portions of this exhibit. Omitted portions have been filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
 
 
70

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Aemetis, Inc.
Date: October 31, 2012/s/ Eric A. McAfee
Eric A. McAfee
Chief Executive Officer
(Principal Executive Officer)
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Eric A. McAfee and Todd A. Waltz, and each of them, his true and lawful attorneys-in-fact, each with full power of substitution, for him in any and all capacities, to sign any amendments to this report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact or their substitute or substitutes may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:
NameTitleDate
/s/ Eric A. McAfee
Chairman/Chief Executive OfficerOctober 30, 2012
Eric A. McAfee(Principal Executive Officer and Director)
/s/Todd WaltzChief Financial OfficerOctober 30, 2012
Todd Waltz(Principal Financial and Accounting Officer)
/s/ Francis BartonDirectorOctober 30, 2012
Francis Barton
/s/ John R. Block
DirectorOctober 29, 2012
John R. Block
/s/ Dr. Steven HutchesonDirectorOctober 31, 2012
Dr. Steven Hutcheson
/s/ Harold Sorgenti______DirectorOctober 29, 2012
Harold Sorgenti

7149

 
 
AEMETIS, INC.
Consolidated Financial Statements
Index To Financial Statements
 
Index To Financial Statements
  
Page
Number
Report of Independent Registered Public Accounting Firm 73
51
Consolidated Financial Statements  
Consolidated Balance Sheets
 74
52
Consolidated Statements of Operations and Comprehensive LossIncome (Loss)
 75
53
Consolidated Statements of Cash Flows
 76
54
Consolidated Statements of Stockholders' DeficitEquity (Deficit)
 77
55
Notes to Consolidated Financial Statements
 78-11056-85
 
 
7250

 
 
Report of Independent Registered Public Accounting Firm
 
October 31, 2012
 
To the Board of Directors and Stockholders
Aemetis, Inc.
Cupertino, CA

We have audited the accompanying consolidated balance sheets of Aemetis, Inc. and subsidiaries as of December 31, 20112014 and 2010,2013, and the related consolidated statements of operations and comprehensive loss,income (loss), stockholders’ deficit,equity (deficit), and cash flows for each of the three years then ended.in the period ended December 31, 2014.  These consolidated financial statements are the responsibility of the Company’s management.  Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).  Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.  The Company is not required to have, nor were we engaged to perform an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements,statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall consolidated financial statement presentation.  We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Aemetis, Inc. and subsidiaries as of December 31, 20112014 and 2010,2013, and the results of itstheir operations and itstheir cash flows for each of the three years thenin the period ended December 31, 2014, in conformity with U.S. generally accepted accounting principles.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States). Aemetis, Inc. and subsidiaries’ internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013, and our report dated  March 12, 2015 expressed an unqualified opinion on the effectiveness of Aemetis, Inc.’s internal control over financial reporting.



/s/ McGladrey LLP
Des Moines, Iowa
March 12, 2015
 
 
7351

 

AEMETIS, INC.
CONSOLIDATED BALANCE SHEETS
AS OF DECEMBER 31, 20112014 AND 20102013

(In thousands except for par value)
 2011  2010  2014  2013 
Assets             
Current assets:             
Cash and cash equivalents $249,466  $683,016  $332  $4,926 
Accounts receivable, less allowance of $143,089 and $0  1,379,668   113,583 
Accounts receivable  1,262   2,764 
Inventories  3,981,997   666,854   4,491   4,098 
Prepaid expenses  491,308   228,040   1,392   584 
Other current assets  1,026,477   390,891   456   335 
Total current assets  7,128,916   2,082,384   7,933   12,707 
                
Property, plant and equipment, net  15,530,905   16,404,550   75,810   78,928 
Assets held for sale  885,000   2,885,000 
Intangible assets and goodwill  2,767,994   - 
Goodwill  968   968 
Intangible assets, net of accumulated amortization of $264 and $184, as of 2014 and 2013 respectively  1,536   1,616 
Other assets  905,106   222,101   2,929   2,923 
Total assets $27,217,921  $21,594,035  $89,176  $97,142 
                
Liabilities and stockholders' deficit        
Liabilities and stockholders' equity (deficit)        
Current liabilities:                
Accounts payable $14,337,536  $4,689,420  $8,339  $9,366 
Current portion of long term secured notes  2,425,588   2,793,427 
Secured notes, net of discount for issuance costs  5,161,191   5,306,742 
Short term notes and unsecured working capital lines of credit  2,066,720   547,596 
Current portion of long term debt  6,032   10,257 
Short term borrowings  6,714   7,709 
Mandatorily redeemable Series B convertible preferred stock  2,320,164   2,221,872   2,641   2,540 
Other current liabilities  3,116,868   2,741,103   3,590   6,245 
Total current liabilities  29,428,067   18,300,160   27,316   36,117 
                
Long term liabilities:        
Long term portion of secured notes, net of discount for issuance costs  15,701,023   8,168,980 
Long term debt (related party), net of discount for issuance costs  4,291,913   4,574,603 
Long term debt  64,555   73,792 
Other long term liability  277   - 
Total long term liabilities  19,992,936   12,743,583   64,832   73,792 
                
Commitments and contingencies        
        
Stockholders' deficit:                
Series B convertible preferred stock, $0.001 par value, 7,235,565 authorized, 3,115,225 and 3,165,225 shares issued and outstanding in 2011 and 2010, respectively (aggregate liquidation preference of $9,345,675 and $9,495,675 in 2011 and 2010, respectively)  3,115   3,165 
Common stock, $0.001 par value, 400,000,000 authorized, 130,746,890 and 90,342,032 shares issued and outstanding in 2011 and 2010, respectively  130,747   90,342 
Additional paid-in capital  45,432,447   38,557,376 
Series B convertible preferred stock, $0.001 par value; 7,235 authorized; 1,665 and 2,401 shares issued and outstanding each period, respectively (aggregate liquidation preference of $4,995 and $7,203, respectively)  2   2 
Common stock, $0.001 par value; 40,000 authorized; 20,650 and 19,974 shares issued and outstanding, respectively *  21   20 
Additional paid-in capital *  87,080   84,373 
Accumulated deficit  (65,526,029)  (47,229,670)  (87,113)  (94,246)
Accumulated other comprehensive loss  (2,243,362)  (870,921)  (2,962)  (2,916)
Total stockholders' deficit  (22,203,082)  (9,449,708)
        
Total liabilities and stockholders' deficit $27,217,921  $21,594,035 
Total stockholders' (deficit)  (2,972)  (12,767)
Total liabilities and stockholders'(deficit)  $89,176   $97,142 
* The Common Stock and Additional paid-in capital for all periods presented reflect the one-for-ten reverse split, which took effect May 15, 2014.
 
The accompanying notes are an integral part of the financial statements

 
7452

 

AEMETIS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSSINCOME (LOSS)
FOR THE YEARS ENDED DECEMBER 31, 20112014, 2013 AND 20102012
(In thousands, except for earnings per share)
 
   2011   2010 
         
Revenues $141,857,914  $8,132,108 
         
Cost of goods sold  137,216,040   8,254,123 
         
Gross profit/(loss)  4,641,874   (122,015)
         
Research and development expenses  576,625   322,561 
Selling, general and administrative expenses  8,570,591   4,709,744 
         
Operating loss  (4,505,342)  (5,154,320)
         
Other income/(expense)        
Interest income  23,436   24,464 
Interest expense  (13,561,285)  (4,034,447)
Other income, net of expenses  52,960   603,294 
Loss on land sale  (401,407)  - 
         
Loss before income taxes  (18,391,638)  (8,561,009)
         
Income taxes benefit/(expense)  95,279   (3,200)
         
Net loss  (18,296,359)  (8,564,209)
Less: Net loss attributable to noncontrolling interest  -   (138,956)
Net loss attributable to Aemetis, Inc. $(18,296,359) $(8,425,253)
         
         
Other comprehensive loss        
Foreign currency translation adjustment  (1,372,441)  505,461 
Comprehensive loss $(19,668,800) $(7,919,792)
         
Loss per common share attributable to Aemetis, Inc. 
Basic and diluted $(0.18) $(0.10)
Weighted average shares outstanding        
Basic and diluted  103,536,643   87,403,213 
  2014  2013  2012 
Revenues $207,683  $177,514  $189,048 
             
Cost of goods sold  170,539   159,220   197,975 
             
Gross profit (loss)  37,144   18,294   (8,927)
             
Research and development expenses  459   539   620 
Selling, general and administrative expenses  12,595   15,275   11,613 
             
Operating income (loss)  24,090   2,480   (21,160)
             
Other income (expense)            
             
Interest expense            
Interest rate expense  (10,052)  (11,808)  (10,114)
Amortization expense  (6,038)  (12,467)  (7,544)
Loss on debt extinguishment  (1,346)  (3,709)  (9,069)
Gain on bargain purchase  -       42,336 
Gain (loss) on sale or disposal  of assets  (119)  329   350 
Other income (expense)  604   744   (162)
             
Income (loss) before income taxes  7,139   (24,431)  (5,363)
             
Income tax (expense) benefit  (6)  (6)  1,081 
             
Net  income (loss)  7,133   (24,437)  (4,282)
             
Other comprehensive income            
Foreign currency translation adjustment  (46)  (598)  (75)
Comprehensive income (loss) $7,087  $(25,035) $(4,357)
             
Net income(loss) per common share * 
Basic $0.35  $(1.28) $(0.28)
Diluted $0.34  $(1.28) $(0.28)
             
Weighted average shares outstanding *         
Basic  20,371   19,101   15,102 
Diluted  21,047   19,101   15,102 
* The Earnings per share and Weighted average shares outstanding for all periods presented reflect the one-for-ten reverse split, which took effect May 15, 2014.
 
The accompanying notes are an integral part of the financial statement
 
 
7553

 

AEMETIS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED DECEMBER 31, 20112014, 2013 AND 20102012
(In thousands)

  2014  2013  2012 
Operating activities:         
Net income (loss) $7,133  $(24,437) $(4,282)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activitites:     
Share-based compensation  624   1,760   686 
Stock issued in connection with consultant services  645   -   - 
Depreciation  4,681   4,636   3,042 
Inventory provision  -   -   105 
Debt related amortization expense  6,038   12,467   7,544 
Intangibles and other amortization expense  126   254     
Change in fair value of warrant liability  48   (197)  97 
Loss on extinguishment of debt  1,346   3,709   9,069 
(Gain) loss on sale/ Disposal of assets  119   (329)  (350)
Gain on acquisition bargain purchase  -   -   (42,336)
Deferred tax asset  -   -   (1,085)
Changes in operating assets and liabilities:            
Accounts receivable  1,498   (1,487)  3,114 
Inventory  (457)  211   (740)
Prepaid expenses  (311)  14   148 
Other current assets and other assets  (187)  (694)  476 
Accounts payable  (879)  (5,412)  800 
Accrued interest expense and fees, net of payments  3,124   7,008   4,006 
Other liabilities  (2,956)  814   2,775 
Net cash provided by (used in) operating activities  20,592   (1,683)  (16,931)
Investing activities:            
Capital expenditures  (1,965)  (1,276)  (1,368)
Proceeds from the sale of assets  -   1,500   1,404 
Acquisition of Cilion  -   -   (16,500)
Net cash provided by  (used in) investing activities  (1,965)  224   (16,464)
             
Financing activities:            
Proceeds from borrowings  9,884   10,541   47,165 
Repayments of borrowings  (32,688)  (5,374)  (13,830)
Issuance of common stock for services, option and warrant exercises  5   1,083   1 
Payment of debt gaurantee fee  (172)        
Payment of financing costs  (255)        
Net cash provided by (used in) financing activities  (23,226)  6,250   33,336 
             
Effect of exchange rate changes on cash and cash equivalents  5   (156)  101 
Net cash and cash equivalents (decrease) increase for period  (4,594)  4,635   42 
Cash and cash equivalents at beginning of period  4,926   291   249 
Cash and cash equivalents at end of period $332  $4,926  $291 
Supplemental disclosures of cash flow information, cash paid:            
Interest payments $6,824  $4,522  $2,085 
Income tax expense  6   6   4 
       -     
Supplemental disclosures of cash flow information, non-cash transactions:         
Proceeds from exercise of stock options applied to accounts payable  16   -   - 
Issuance of warrants to subordinated debt holders  1,301   1,127   - 
Transfer between debt and other liabilities  438   -   - 
Payments of principal, fees and interest paid in stock  -   3,616   11,886 
Issuance of shares to related party for repayment of line of credit  -   822   4,107 
Issuance of warrants to non-employees to secure procurement and working capital  -   336   - 
Other asset transferred to related party  -   170   - 
Warrant liability transferred to equity upon exercise  -   1,007   - 
Exercise of conversion feature on note to equity  47   -   - 
Issuance of shares for acquisition  -   -   12,511 
Beneficial conversion discount on related party debt  -   -   885 
Seller note payable at fair value  -   -   3,584 
Settlement of accounts payable through transfer of equipment  99   -   - 
 
  2011  2010 
Operating activities:      
Net loss $(18,296,359) $(8,564,209)
Adjustments to reconcile net loss to net cash used in operating activities:
        
Stock-based compensation  177,278   377,669 
Depreciation and amortization  1,141,007   760,051 
Inventory provision  201,887   283,176 
Amortization of debt issuance discount  4,624,705   1,343,004 
Loss/(gain) on extinguishment of debt  33,926   (14,757)
Loss on sale of assets and disposal  401,407   56,378 
Deferred tax liability  (98,479)  - 
Changes in assets and liabilities:        
Accounts receivable  (1,316,028)  (78,711)
Inventory  (3,724,088)  (331,519)
Prepaid expenses  (172,840)  (205,869)
Other current assets and other assets  (1,476,557)  (158,649)
Accounts payable  9,597,694   1,056,939 
Accrued interest expense  7,470,040   2,384,300 
Other liabilities  189,508   (589,892)
Net cash used in operating activities  (1,246,899)  (3,682,089)
         
Investing activities:        
Purchase of property, plant and equipment, net  (2,568,001)  (672,965)
Proceeds from land sale  1,598,593   - 
Cash obtained through merger  1,451   - 
Net cash used in investing activities  (967,957)  (672,965)
         
Financing activities:        
Proceeds from borrowings under secured debt facilities  3,621,500   4,500,044 
Repayments of borrowings under secured debt facilities  (3,053,426)  (850,000)
Proceeds from borrowings under related party credit arrangements  -   2,612,000 
Payments of borrowings under related party credit arrangements  -   (1,600,000)
Proceeds from borrowings under short term debt facilities  8,773,415   4,457,667 
Repayments of borrowings under short term facilities  (7,476,182)  (4,260,425)
Net cash provided by financing activities  1,865,307   4,859,286 
         
Effect of exchange rate changes on cash and cash equivalents  (84,001)  126,606 
Net increase (decrease) in cash and cash equivalents  (433,550)  630,838 
         
Cash and cash equivalents at beginning of period  683,016   52,178 
Cash and cash equivalents at end of period $249,466  $683,016 
         
Supplemental disclosures of cash flow information, cash paid:        
         
Interest payments, net of capitalized interest of $184,933 in 2011 and $53,724 in 2010  1,021,188   151,572 
Income taxes  3,200   3,200 
         
Supplemental disclosures of cash flow information, non-cash transactions:     
         
Issuance of shares for acquisition  1,890,135   - 
Stock issued to pay interest and fees on borrowings  1,662,323   202,500 
Payment of loans and fees by issuance of stock to related party  1,452,818   162,000 
Beneficial conversion discount on related party debt  1,732,872   1,556,559 
Property, plant & equipment purchases included in accounts payable  -   466,493 

The accompanying notes are an integral part of the financial statement
 
 
7654

 

AEMETIS, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICITEQUITY (DEFICIT)
FOR THE YEARS ENDED DECEMBER 31, 20112014, 2013, AND 20102012
(In thousands)

                    Accumulated Other 
  Series B Preferred Stock  Common Stock  Additional  Accumulated  Comprehensive    
  Shares  Dollars  Shares  Dollars  Paid-in Capital  Deficit  loss  Total 
                         
Balance at December 31, 2011  3,115  $3   13,075  $13  $45,550  $(65,527) $(2,243)  (22,204)
                                 
Conversion of Series B preferred to common stock  (17)  -   2   -               - 
Options exercised & stock-based compensation          32   -   257           257 
Shares issued to consultants and other services         100   -   423           423 
Issuance and exercise of warrants          143   1   1,020           1,021 
Shares issued to secured lender          1,770   2   10,866           10,868 
Conversion of related party note          906   1   4,107           4,108 
Beneficial conversion feature on related party note                  885           885 
Shares issued in connection to acquisition          2,000   2   12,511           12,513 
Other comprehensive loss                          (75)  (75)
Net loss                      (4,282)      (4,282)
                                 
Balance at December 31, 2012  3,098   3   18,028   19   75,619   (69,809)  (2,318)  3,514 
                                 
Conversion of Series B preferred to common stock  (697)  (1)  70   -   -   -   -   (1)
Options exercised & stock-based compensation          26   -   1,161   -   -   1,161 
Shares issued to consultants and other services          177   -   599   -   -   599 
Issuance and exercise of warrants
          264   -   1,482   -   -   1,482 
Shares issued to secured lender          987   1   3,616   -   -   3,617 
Conversion of related party note          183   -   821   -   -   821 
Issuance of common stock through equity offering          239   -   1,075   -   -   1,075 
Other comprehensive loss              -   -   -   (598)  (598)
Net loss              -   -   (24,437)  -   (24,437)
                                 
Balance at December 31, 2013  2,401   2   19,974   20   84,373   (94,246)  (2,916)  (12,767)
                                 
Conversion of Series B preferred to common stock  (736)  -   74   -   -   -   -   - 
Options exercised & stock-based compensation  -   -   161   -   643   -   -   643 
Shares issued to consultants and other services  -   -   205   -   715   -   -   715 
Issuance and exercise of warrants
  -   -   217   1   1,302   -   -   1,303 
Conversion of note by note holder  -   -   19   -   47   -   -   47 
Other comprehensive loss  -   -   -   -   -   -   (46)  (46)
Net income  -   -   -   -   -   7,133   -   7,133 
                                 
Balance at December 31, 2014  1,665   2   20,650   21   87,080   (87,113)  (2,962)  (2,972)
 
                    Accumulated Other       
  Series B Preferred Stock  Common Stock     Additional  Accumulated  Comprehensive  Noncontrolling  Total 
  Shares  Dollars  Shares  Dollars  Paid-in Capital  Deficit  Income/(Loss)  Interest  Dollars 
                                     
Balance at December 31, 2009  3,320,725  $3,321   86,181,532  $86,181  $36,763,984  $(38,804,417) $(1,376,382) $(362,375) $(3,689,688)
                                     
Stock-based compensation  -   -   -   -   259,691   -   -   -   259,691 
Shares issued to consultants  -   -   155,000   155   14,895   -   -   -   15,050 
Debt issuance discount  -   -   2,250,000   2,250   200,250   -   -   -   202,500 
Energy Enzymes, Inc. merger  -   -   1,000,000   1,000   (502,331)  -   -   501,331   - 
Issuance of shares to related party  -   -   600,000   600   161,400   -   -   -   162,000 
Issuance of warrants  -   -   -   -   102,928   -   -   -   102,928 
Series B to Common conversion  (155,500)  (156)  155,500   156       -   -   -   - 
Beneficial conversion feature on related party notes    -   -   1,556,559   -   -   -   1,556,559 
Other comprehensive income  -   -   -   -   -   -   505,461   -   505,461 
Net loss  -   -   -   -   -   (8,425,253)  -   (138,956)  (8,564,209)
                                     
Balance at December 31, 2010  3,165,225  $3,165   90,342,032  $90,342  $38,557,376  $(47,229,670) $(870,921) $-  $(9,449,708)
                                     
Stock-based compensation  -   -   5,585   6   152,736   -   -   -   152,742 
Shares issued to consultants  -   -   30,000   30   24,506   -   -   -   24,536 
Debt issuance discount and waiver shares  -   -   4,589,360   4,589   1,657,734   -   -   -   1,662,323 
Issuance of shares to related party  -   -   29,056,356   29,056   1,423,762   -   -   -   1,452,818 
Beneficial conversion feature on related party notes                1,732,872             1,732,872  
Conversion of Series B preferred to common stock  (50,000 )  (50 )  50,000    50   -   -   -   -   - 
Zymetis Inc. merger  -   -   6,673,557   6,674   1,883,461   -   -   -   1,890,135 
Other comprehensive loss  -   -   -   -   -   -   (1,372,441)  -   (1,372,441)
Net loss  -   -   -   -   -   (18,296,359)  -   -   (18,296,359)
                                     
Balance at December 31, 2011  3,115,225  $3,115   130,746,890  $130,747  $45,432,447  $(65,526,029) $(2,243,362) $-  $(22,203,082)
The accompanying notes are an integral part of the financial statements.
 
 
7755

 

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
 
1. Nature of Activities and Summary of Significant Accounting Policies
 
Nature of Activities. These consolidated financial statements include the accounts of Aemetis, Inc. (formerly AE Biofuels, Inc.), a Nevada corporation, and its wholly owned subsidiaries (collectively, “Aemetis” or the “Company”):
 
Aemetis Americas, Inc. (formerly “American Ethanol, Inc.”), a Nevada corporation and its subsidiaries Sutton Ethanol, LLC, a Nebraska limited liability company, Illinois Valley Ethanol, LLC, an Illinois limited liability company, Danville Ethanol, Inc., an Illinois corporation, andsubsidiary AE Biofuels, Inc., a Delaware corporation;
Biofuels Marketing, Inc., a Delaware corporation;
Aemetis International, Inc. (formerly International Biodiesel, Inc.), a Nevada corporation and its subsidiary International Biofuels, Ltd., a Mauritius corporation and its subsidiary Universal Biofuels Private, Ltd., an India company;
Aemetis Technologies, Inc. (formerly AE Zymetis, Inc.), a Delaware corporation;
Aemetis Biochemicals, Inc., a Nevada corporation;
Aemetis Biofuels, Inc. (formerly AE Biofuels Technologies, Inc.), a Delaware corporation and its subsidiary Energy Enzymes, Inc., a Delaware corporation;
AE Advanced Fuels, Inc., a Delaware corporation and its subsidiaries Aemetis Advanced Fuels Keyes, Inc., a Delaware corporation and Aemetis Facility Keyes, Inc., a Delaware corporation;
Aemetis Advanced Fuels, Inc., a Nevada corporation; and,
Aemetis Advanced FuelsProducts Keyes, Inc. (formerly AE Advanced Fuels Keyes, Inc.), a Delaware corporation.
 
Aemetis Inc. is an international advanced renewable fuels and specialty chemicalbiochemicals company focused on the production of renewable fuels and chemicals and the acquisition, development and commercialization of innovative technologies that are substitutes forreplace traditional petroleum-based products.  In 2010,products by the conversion of first generation ethanol and biodiesel plants into advanced biorefineries.  The Company began retrofitting an ethanol production facilityowns and operates a plant in Keyes, California where the Company manufactures and produces ethanol, wet distillers’ grain (WDG), condensed distillers solubles (CDS) and corn oil and a manufacturing and refining facility in Kakinada, India where the Company manufactures and produces fatty acid methyl ester (biodiesel), crude and refined glycerin and refined palm oil.  In September 2013, the Company received approval by the US Environmental Protection Agency to produce ethanol using grain sorghum and biogas along with the Keyes plant existing combined heat and power systems to generate higher value D5 Advanced Biofuel Renewable Identification Numbers (RIN’s).  In April 2011 began high volume2014, the Company received the International Sustainability and Carbon Certification for the production of ethanolbiodiesel at the India plant from certain oils and wet distiller’s grain (WDG).fats for sale into European markets.  The Company completed the EPA Process for importation of our India biodiesel into the United States. In addition, the Company is continuing research and development focused on microbial technologies for the commercialization of renewable industrial biofuels and biochemicals.
 
Principles of Consolidation. The consolidated financial statements include the accounts of the Company and its subsidiaries. All material inter-company accounts and transactions are eliminated in consolidation.
Reverse Stock Split. In April 2014, our board of directors approved, and submitted a proposal to our stockholders for approval of a 1 for 10 reverse split of our common stock (the “Reverse Stock Split”).  The Reverse Stock Split was intended to increase the market price of our common stock to enhance our ability to meet the initial listing requirements of the NASDAQ Global Market and to make our common stock more attractive to a broader range of institutional and other investors.  Our stockholders approved the Reverse Stock Split on May 9, 2014 and we filed a Certificate of Change with the Secretary of State of the State of Nevada to effect the Reverse Stock Split on May 9, 2014.  The Reverse Stock Split became effective with the Financial Industry Regulatory Authority (FINRA) on May 15, 2014. Trading on the NASDAQ Global Market commenced on June 5, 2014.
Upon the effectiveness of the Reverse Stock Split, every ten shares of issued and outstanding and authorized Aemetis common stock were automatically combined into one share of common stock with any fractional shares rounded up to the next whole share without any change in the per share par value.  The Reverse Stock Split reduced the number of outstanding shares of Aemetis common stock from approximately 201.7 million shares to approximately 20.2 million shares.  The authorized shares of Aemetis common stock were also proportionally reduced from 400 million shares to 40 million shares.

Unless otherwise indicated, all share amounts, per share data, share prices, exercise prices and conversion rates set forth in these notes and the accompanying consolidated financial statements have, where applicable, been adjusted to reflect the Reverse Stock Split.
56

AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
 
Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. To the extent there are material differences between these estimates and actual results, the Company’s consolidated financial statements will be affected.
 
78

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Revenue recognition. The Company recognizes revenue when there is persuasive evidence of an arrangement, delivery has occurred, the price is fixed or determinable and collection is reasonably assured. The Company records revenues based upon the gross amounts billed to its customers. Revenue from nonmonetary transactions, principally in-kind by-products received in exchange for material processing where the by-product is contemplated by contract to provide value, is recognized at the quoted market price of those goods received or by-products.

Cost of Goods Sold. Cost of goods sold include those costs directly associated with the production of revenues, such as raw material purchases,consumed, factory overhead, and other direct production costs.  During periods of idle plant capacity, costs otherwise charged to cost of goods sold are reclassified to selling, general and administrative expense. The Company had idled the plant in Keyes, CA from January 15, 2013 to April 22, 2013, as such approximately $2.5 million was reclassified from cost of goods sold to selling, general and administrative expense during the year ended December 31, 2013.
 
Shipping and Handling Costs. Shipping and handling costs are classified as a component of cost of goods sold in the accompanying consolidated statements of operations.
 
Research and Development. Research and development costs are expensed as incurred, unless they have alternative future uses to the Company.
 
Cash and Cash Equivalents. The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. The Company maintains cash balances at various financial institutions domestically and abroad. Domestic accounts are insured by the FDIC.The Federal Deposit Insurance Corporation (FDIC) insures domestic cash accounts. The Company’s accounts at these institutions may at times exceed federally insured limits. The Company has not experienced any losses in such accounts.
 
Accounts Receivable, net.Receivable.  The Company sells ethanol, and wet distillers grains, corn syrup and corn oil through third-party marketing arrangements generally without requiring collateral.  The Company sells biodiesel, glycerin, and glycerinprocessed natural oils to a variety of customers and may require advanced payment based on the size and credit worthinesscreditworthiness of the customer.  Accounts receivables consist of product sales made to large credit worthycreditworthy customers. Trade accounts receivable are presented at original invoice amount, net of the allowance for doubtful accounts. There is no allowance for doubtful account balance as of December 31, 2014 and 2013.
 
The Company maintains an allowance for doubtful accounts for balances that appear to have specific collection issues. The collection process is based on the age of the invoice and requires attempted contacts with the customer at specified intervals. If, after a specified number of days, the Company has been unsuccessful in its collection efforts, a bad debt allowance is recorded for the balance in question. Delinquent accounts receivable are charged against the allowance for doubtful accounts once uncollectibility has been determined. The factors considered in reaching this determination are the apparent financial condition of the customer and the Company’s success in contacting and negotiating with the customer. If the financial condition of the Company’s customers were to deteriorate additional allowances may be required.
 
Inventories. Inventories are stated at the lower of cost, using the first-in and first-out (FIFO) method, or market.
 
Property, Plant and Equipment. Property, plant and equipment are carried at cost less accumulated depreciation after assets are placed in service and are comprised primarily of buildings, furniture, machinery, equipment, land, acquired for development of production facilities, and the biodiesel plant in India. It is the Company policy to depreciate capital assets over their estimated useful lives using the straight-line method.
 
Goodwill and Intangible Assets. Intangible assets consist of intellectual property in the form of patents pending, in-process research and development and goodwill. Once the patents pending or in-process R&D have secured a definite life in the form of a patent or product, they will be carried at initial fair valuecost less accumulated amortization over thetheir estimated useful life. Amortization commences upon grantingthe commercial application or generation of the patentrevenue and is amortized over the shorter of the economic life or patent protection period or shorter period upon abandonment of the patent.period.
 
 
7957

 
 
AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
 
(Tabular data in thousands, except par value and per share data)
Company intangible assets such as goodwill have indefinite lives and as a result need to be evaluated at least annually, or more frequently, if impairment indicators arise. In the Company’s review, we determined the fair value of segmentthe reporting assetsunit using market indicators and discounted cash flow modeling and compare itmodeling. The Company compares the fair value to the net book value of the acquired assets. If the fair value is less than the carrying value of the asset, the Company then determined the fair value of the asset.reporting unit. An impairment loss would be recognized when the fair value is less than the related net book value, and an impairment expense would be recorded in the amount of the difference. Forecasts of future cash flows are judgments based on the Company’s experience and knowledge of the Company’s operations and the industries in which the Company operates. These forecasts could be significantly affected by future changes in market conditions, the economic environment, including inflation, and the purchasing decisions of the Company’s customers.
 
California Ethanol Producer Incentive Program.  The Company iswas eligible to participate in the California Ethanol Producer Incentive Program (“CEPIP”). Under the CEPIP, an eligible California ethanol facility maycould receive up to $3 million in cash per plant per year of operations through 2013 when current production corn crush spreads, measured as the difference between specified ethanol and corn index prices, drop below $0.55 per gallon.   For any month in which a payment is made by the CEPIP, the Company may be required to reimburse the funds within the subsequent five years from each payment date, if the corn crush spreads exceed $1.00 per gallon. Since these funds are provided to subsidize current production costs and encourage eligible facilities to either continue production or start up production in low margin environments, the Company records the proceeds, if any, as a credit to cost of goods sold. The Company will assess the likelihood of reimbursement in future periodsWith respect to CEPIP payments received and applied as corn crush spreads approach $1.00 per gallon. If it becomes likely that amounts may be reimbursable by the Company, the Company will accrue a liability for such payment and recognize the costs as an increase in cost of goods sold. The Company recorded $1,803,380 and $0 as a reductionreductions to cost of goods sold, the Company recorded none for the years ended December 31, 20112014, 2013, and 2010, respectively,2012. During  2013 and 2014, the strength of the crush spread resulted in respectthe accrual of, and obligation to repay, CEPIP payments received. To date,funding in the amount of $1.8 million, the entire remaining amount of funds received from the program. As of December 31, 2014 and December 31, 2013, the Company hasaccrued a liability of $0.8 million and $0.1 million, respectively.  At December 31, 2014, there are no further CEPIP funds received that are subject to repayment.

Warrant liability: The Company adopted guidance related to distinguishing liabilities from equity for certain warrants which contain a conditional obligation to repurchase feature. As of December 31, 2014 and 2013, there were 18,644 warrants with a conditional obligation to repurchase feature that require liability treatment. As a result, a warrant liability was recorded to recognize the fair value upon issuance of each warrant. The Company estimates the fair value of future liability on warrants using the Black-Scholes pricing model. Assumptions within the pricing model include: 1) the risk-free interest rate, which comes from the U.S. Treasury yield curve for periods within the contractual life of the warrant 2) the expected life of the warrants is assumed to be the contractual life of the warrants, and, 3) the volatility is estimated based on an average of the historical volatilities.
The Company computes the fair value of the warrant liability at each reporting period and the change in the fair value is recorded through earnings. The key component in the value of the warrant liability is the Company's stock price, which is subject to significant fluctuation and is not been requiredunder the Company's control. The resulting effect on the Company's net loss is therefore subject to reimburse any amounts.significant fluctuation and will continue to be so until the warrants are exercised, amended or expired. Assuming all other fair value inputs remain constant, the Company will record non-cash expense when the stock price increases and non-cash income when the stock price decreases.
 
Income Taxes. The Company recognizes income taxes in accordance with ASC 740 Income Taxes using an asset and liability approach. This approach requires the recognition of taxes payable or refundable for the current year and deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s consolidated financial statements or tax returns. The measurement of current and deferred taxes is based on provisions of enacted tax law.
 
ASC 740 provides for recognition of deferred tax assets if the realization of such assets is more likely than not to occur. Otherwise, a valuation allowance is established for the deferred tax assets, which may not be realized. As of December 31, 20112014 and 2010,2013, the Company recorded a full valuation allowance against its net deferred tax assets due to operating losses incurred since inception. Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the net deferred tax assets were fully offset by a valuation allowance.
 
We areThe Company is subject to income tax audits by the respective tax authorities in all of the jurisdictions in which it operates. The determination of tax liabilities in each of these jurisdictions requires the interpretation and application of complex and sometimes uncertain tax laws and regulations. The recognition and measurement of current taxes payable or refundable and deferred tax assets and liabilities requires that the Company make certain estimates and judgments. Changes to these estimates or a change in judgment may have a material impact on the Company’s tax provision in a future period.
58

AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
 
Long - Lived Assets. The Company evaluates the recoverability of long-lived assets with finite lives in accordance with ASC Subtopic 360-10-35 Property Plant and Equipment –Subsequent Measurements, which requires recognition of impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable, based on estimated undiscounted cash flows, the impairment loss would be measured as the difference between the carrying amount of the assets and its estimated fair value based on the present value of estimated future cash flows.value.
Assets held for sale. The Company analyzes land holdings, buildings and equipment for their strategic importance to the future of the company, and if determined asset is disposable, the asset will be sold opportunistically in the open market for the highest bidder.
80

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
 
Basic and Diluted Net Lossincome (Loss) per Share.  Basic lossincome (loss) per share is computed by dividing income or loss attributable to common shareholders by the weighted average number of common shares outstanding for the period, net of shares subject to repurchase.period.  Diluted lossincome (loss) per share reflects the dilution of common stock equivalents such as options, convertible preferred stock, debt and warrants to the extent the impact is dilutive.  As the Company incurred net lossesincome for the year ended December 31, 2014, potentially dilutive securities have been included in the diluted net income per share computations and any potentially anti-dilutive shares have been excluded and are shown below. As the Company incurred net loss for the years ended December 31, 20112013 and 2010,2012, potentially dilutive securities have been excluded from the diluted net loss per share computation,computations as their effect would be anti-dilutive.
 
The following table reconciles the number of shares utilized in the net income (loss) per share calculations for the years ended December 31, 2014, 2013 and 2012:
  Year ended 
  December 31, 2014  December 31, 2013  December 31, 2012 
  (In thousands, except per share amounts) 
          
Net income (loss) $7,133  $(24,437) $(4,282)
             
Shares:                                              
    Weighted average shares outstanding—basic  20,371   19,101   15,102 
             
    Weighted average dilutive share equivalents from preferred shares  220   -   - 
    Weighted average dilutive share equivalents from stock options  269   -   - 
    Weighted average dilutive share equivalents from common warrants             187   -   - 
             
Weighted average shares outstanding—diluted  21,047   19,101   15,102 
             
             
         Earnings (loss) per share—basic $0.35  $(1.28) $(0.28)
             
         Earnings (loss) per share—diluted $0.34  $(1.28) $(0.28)
The following table shows the weighted-average number of potentialpotentially dilutive shares excluded from the diluted net lossincome (loss) per share calculated for the year endedcalculation as of December 31, 2011,2014, 2013 and 2010:2012:
 
  For the year ended December 31, 
  2011  2010 
         
Aemetis Series B preferred stock  3,142,485   3,239,154 
Aemetis Series B warrants  427,396   443,853 
Aemetis Common stock options and warrants  8,519,855   5,985,691 
Convertible interest & fees on note  – related party  20,636,157   17,615,521 
Total weighted average number of potentially dilutive shares excluded from the diluted net loss per share calculation  32,725,893   27,284,219 
  As of
  December 31, 2014  December 31, 2013  December 31, 2012 
Series B preferred  -   2,401   3,098 
Common stock options and warrants  30   1,480   1,031 
Convertible promissory note  -   19   18 
Total number of potentially dilutive shares excluded from the basic and diluted net income (loss) per share calculation  30   3,900   4,147 
 
Comprehensive Income.Loss. ASC 220 Comprehensive IncomeLoss requires that an enterprise report, by major components and as a single total, the change in its net assets from non-owner sources. The Company’s other comprehensive income (loss) and accumulated other comprehensive incomeloss consists solely of cumulative currency translation adjustments resulting from the translation of the financial statements of its foreign subsidiaries.subsidiary. The investment in this subsidiary is considered indefinitely invested overseas, and as a result, deferred income taxes are not recorded related to the currency translation adjustments.
 
59

AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
Foreign Currency Translation/Transactions. Assets and liabilities of the Company’s non-U.S. subsidiariessubsidiary that operateoperates in a local currency environment, where that local currency is the functional currency, are translated into U.S. dollars at exchange rates in effect at the balance sheet date; with the resulting translation adjustments directly recorded to a separate component of accumulated other comprehensive income.loss. Income and expense accounts are translated at average exchange rates during the year. Gains and losses from foreign currency transactions are recorded in other income (loss), net.
 
Operating Segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (“CODM”), or decision-making group, in deciding how to allocate resources and in assessing performance. The operations in India as well as the retrofit of the Keyes, California ethanol plant resulted in the Company’s reevaluation of its management structure and reporting around business segments.
81

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Aemetis recognized threetwo reportable geographic segments: “India”, and  “North America” and “Other.America.
 
The “India” operating segment encompasses the Company’s 50 MGYmillion gallon per year nameplate capacity biodiesel plant in Kakinada, India, the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius.
The “North America” operating segment includes the Company’s leased 55 MGYmillion gallons per year nameplate capacity ethanol plant in Keyes, CACalifornia and the assets (principally land) held for saleresearch facilities in Sutton, NE and in Danville, IL.College Park, Maryland.
●  The “Other” segment encompasses the Company’s costs associated with new market development, company-wide fund raising, formation, executive compensation and other corporate expenses.

Fair Value of Financial Instruments. The Company’s financial instruments include cash and cash equivalents, accounts receivable, accounts payable, other current liabilities,  mandatorily redeemable Series B preferred stockwarrant liability, and debt. The fair value of the Company’s debt was unable to be determined based on the operating structure of the cross-collateralized debt and the short-term maturity of these instruments. The Company’s long-term debt carrying value approximates fair value based upon the borrowing rates currently available to the Company for bank loans in India with similar terms and maturities. The Company is also unable to estimate the fair value of the long-term debt (related party) due to the lack of comparable available credit facilities.  The fair value of all othercurrent financial instruments was estimated to approximate carrying value due to the short-termshort term nature of these instruments. The carrying amount of debt obligations, including discount issuance costs, held by our senior lender, subordinated debt and seller note payable, at December 31, 2014 amounted to an aggregate of approximately $ 68.2 million in outstanding obligations. The debts were determined to have an estimated fair value of $67.5 million based on interest rates for comparable debt.  The Company’s debt was valued using inputs from independent consultants evaluating external market inputs and internal financings to determine appropriate discount rates to determine fair value. The warrant liability fair value was estimated using the Black-Scholes valuation pricing model at the end of each reporting period.

Share-Based Compensation. The Company recognizes share based compensation in accordance with ASC 718 Stock Compensation requiring the Company to recognize expense related to the estimateestimated fair value of the Company’s share-based compensation awards at the time the awards are granted adjusted to reflect only those shares that are expected to vest.
In valuing shares issued to consultants, debt holders, or affiliated investors, the Company estimates the discount for lack of marketability on restricted stock issued, using the Black-Scholes model for pricing call options, which assists in deriving the implied price of put options using the put-call parity principle.  The price of the put option divided by the market price quoted on the NASDAQ market exchange implies the discount for lack of marketability (DLOM).
 
Commitments and Contingencies. The Company records and/or discloses commitments and contingencies in accordance with ASC 450 Contingencies.  ASC 450 applies to an existing condition, situation, or set of circumstances involving uncertainty as to possible loss that will ultimately be resolved when one or more future events occur or fail to occur.
 
Business Combinations.  The Company applies the acquisition method of accounting to account for business combinations. The cost of an acquisition is measured as the aggregate of the fair values at the date of exchange of the assets given, liabilities incurred, and equity instruments issued. Identifiable assets, liabilities, and contingent liabilities acquired or assumed are measured separately at their fair value as of the acquisition date. The excess of the cost of the acquisition over our interest in the fair value of the identifiable net assets acquired is recorded as goodwill. If our interest in the fair value of the identifiable net assets acquired in a business combination exceeds the cost of the acquisition, a gain is recognized in earnings on the acquisition date.  The Company will adjust the preliminary purchase price allocation, as necessary, after the acquisition closing date through the end of the measurement period (up to one year) as the valuations for the assets acquired and liabilities assumed are finalized.

Convertible Instruments.  The Company evaluates the impacts of convertible instruments based on the underlying conversion features.  Convertible Instruments are evaluated for treatment as derivatives that could be bifurcated and recorded separately.  Any beneficial conversion feature is recorded based on the intrinsic value difference at the commitment date.

60

AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
Debt Modification Accounting. The Company evaluates amendments to its debt under the FASB guidancein accordance with ASC 540-50 Debt – Modification and Extinguishments for modification and extinguishment accounting.  This evaluation includedincludes comparing the net present value of cash flows of the new debt to the old debt to determine if changes greater than 10 percent occurred.  In instances, where the net present value of future cash flows changed more than 10 percent, the Company applies extinguishment accounting and determines the fair value of its debt based on factors available to the Company for similar borrowings and applied extinguishment accounting method.
82

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Sequencing Policy. In the event partial reclassification of contracts subject to ASC 815-40-25 is necessary due to the Company’s inability to demonstrate it has sufficient authorized shares, Shares will be allocated on the basis of maturity dates of potentially dilutive instruments, with the latest maturity date receiving first allocation of shares.  If a reclassification of an instrument were required it would result in the earliest maturity instrument being reclassified first.Company.
 
RecentRecently Issued Accounting Pronouncements.
 
EffectiveIn May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes all existing revenue recognition requirements, including most industry-specific guidance. The new standard requires a company to recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. The new standard will be effective for us on January 1, 2011,2017. We are currently evaluating the Company adopted the amended guidance in ASCpotential impact that Topic 805, Business Combinations, which, if the Company completed a material business combination during the reporting period, requires the Company to disclose the Company’s pro forma revenue606 may have on our financial position and earnings as though the business combinations that occurred during the current period had occurred asresults of the beginning of the comparable prior annual reporting period. The amended guidance also requires the Company to include a description of the nature and amount of material, nonrecurring pro forma adjustments directly attributable to the business combination included in the reported pro forma revenue and earnings.
Effective January 1, 2011, the Company adopted the second phase of the amended guidance in ASC Topic 820, Fair Value Measurements and Disclosures, which requires the Company to disclose information in the reconciliation of recurring Level 3 measurements regarding purchases, sales, issuances and settlements on a gross basis, with a separate reconciliation for assets and liabilities. The Company did not experience an impact from the additional disclosure requirements, as the Company does not have any recurring Level 3 measurements.
Effective January 1, 2012, the Company will be required to adopt the third phase of amended guidance in ASC Topic 820, Fair Value Measurements and Disclosures. The purpose of the amendment is to achieve common fair value measurement and disclosure requirements by improving comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with GAAP and those prepared in conformity with International Financial Reporting Standards, or IFRS. The amended guidance clarifies the application of existing fair value measurement requirements and requires additional disclosure for Level 3 measurements regarding the sensitivity of fair value to changes in unobservable inputs and any interrelationships between those inputs. The Company currently would not be impacted by the additional disclosure requirements, as the Company does not have any recurring Level 3 measurements.
Effective January 1, 2012, the Company will be required to adopt the amended guidance in ASC Topic 220, Comprehensive Income. This accounting standards update, which helps to facilitate the convergence of GAAP and IFRS, is aimed at increasing the prominence of other comprehensive income in the financial statement by eliminating the option to present other comprehensive income in the statement of stockholders’ equity, and requiring comprehensive income to be reported in either a single continuous statement or in two separate but consecutive statements reporting net income and other comprehensive income. This amended guidance will be implemented retroactively. The Company has determined that the changes to the accounting standards will not materially affect the presentation of consolidated financial.
Effective January 1, 2012, the Company will be permitted to adopt the amended guidance in ASC Topic 350, Intangibles – Goodwill and Other. The amended guidance permits an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. The more-likely-than-not threshold is defined as having a likelihood of more than 50 percent. The Company has determined that the changes to the accounting standards will not impact the Company’s disclosure or reporting requirements.operations.
 
2. Inventory
 
Inventory consists of the following:
 
  As of December 31, 
  2011  2010 
         
Raw materials $628,366  $465,451 
Work-in-progress  2,056,771   60,873 
Finished goods  1,296,860   140,530 
Total inventory $3,981,997  $666,854 
As of December 31, 2011 and 2010, the Company has recognized a lower of cost or market reserve of $223,069 and $179,225 respectively, related to inventory.
83

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
  December 31, 2014  December 31, 2013 
Raw materials $1,522  $597 
Work-in-progress  1,453   1,724 
Finished goods  1,516   1,777 
Total inventory $4,491  $4,098 
 
3. Property, Plant and Equipment
 
Property, plant and equipment consist of the following:
 
 As of December 31, 
 2011  2010  As of 
         December 31, 2014  December 31, 2013 
Land $667,008  $792,036  $2,753  $2,765 
Buildings  10,429,402   12,237,853 
Plant and Buildings  82,338   82,355 
Furniture and fixtures  152,373   104,199   458   558 
Machinery and equipment  1,025,105   907,651   4,063   2,076 
Leasehold and tenant improvements  2,800,339   1,024,831 
Construction in progress  3,186,551   3,066,928   148   539 
Total gross property, plant & equipment  18,260,778   18,133,498   89,760   88,293 
Less accumulated depreciation  (2,729,873)  (1,728,948)  (13,950)  (9,365)
Total net property, plant & equipment $15,530,905  $16,404,550  $75,810  $78,928 
Depreciation on the components of the property, plant and equipment is calculated using the straight-line method to allocate their depreciable amounts over their estimated useful lives as follows:
Years
Plant and Buildings20 - 30
Machinery & Equipment5 - 7
Furniture & Fixtures3 - 5
 
The Company recorded depreciation expense for the years ended December 31, 20112014, 2013, and 20102012 of $1,141,007$4.7 million , $4.6 million, and $760,051,$3.0 million, respectively.
 
As of December 31, 2011 and 2010, the components of construction in progress include $3,186,551 and $3,066,928, respectively, related to the Company’s Kakinada, India biodiesel pre-treatment and glycerin units.
61

 
As of December 31, 2011
AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and 2010, leasehold improvements and tenant improvements relate to the Keyes, California ethanol plant.per share data)
 
Management is required to evaluate these long-lived assets for impairment whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. Based on the evaluation, management determined no assets required impairment as of December 31, 20112014 and 2010.2013.
4. Intangible Assets and Goodwill
Net intangible assets and goodwill consist of $0.9 million in patents, $0.6 million in in-process research and development and $1.0 in goodwill. Following ASC 350-20-35 guidance, goodwill and indefinite lived intangibles are tested annually in December for impairment at the Aemetis Technologies, Inc. reporting unit level.  During the December 2014 testing period, no impairment resulted from the analysis. During the twelve months ended December 31, 2014, 2013 and 2012, the Company recognized amortization expense of $80 thousand, $184 thousand, and none, respectively, related to patents.  During the twelve months ended December 31, 2014 and 2013, all pending patents were in-process R&D and accordingly, no amortization expense had been recognized.
At December 31, 2014, future patent and in-process research and development amortization for the next five years and beyond consists of the following:
For the twelve months ending December 31, 2014 Amortization 
2015 $80 
2016  80 
2017  112 
2018  112 
2019  202 
Thereafter  950 
     
Total $1536 
5. Notes Payable
Debt consists of the notes from the Company’s senior lender, Third Eye Capital, acting as Agent for the Purchasers (Third Eye Capital), other working capital lenders and subordinated lenders as follows:
  December 31, 2014  
December 31, 2013
 
Third Eye Capital term note $7,394  $7,193 
Third Eye Capital revolving credit facility  22,330   38,349 
Third Eye Capital revenue participation term note  10,195   9,465 
Third Eye Capital acquisition term note  17,728   17,280 
Cilion shareholder seller note payable  5,373   4,869 
State Bank of India secured term loan  6,032   5,857 
Subordinated notes  5,428   5,317 
EB-5 long term promissory notes  1,534   1,037 
Unsecured working capital loans and short-term notes  1,287   2,391 
Total debt $77,301  $91,758 
Less current portion of debt  12,746   17,966 
Total long term debt                      64,555                        73,792 

Third Eye Capital Note Purchase Agreement
On July 6, 2012, Aemetis, Inc. and Aemetis Advanced Fuels Keyes, Inc. (“AAFK”), entered into an Amended and Restated Note Purchase Agreement with Third Eye Capital (the “Note Purchase Agreement”).  Pursuant to the Note Purchase Agreement, Third Eye Capital extended credit in the form of (i) senior secured term loans in an aggregate principal amount of approximately $7.2 million to replace existing notes held by Third Eye Capital (the “Term Notes”); (ii) senior secured revolving loans in an aggregate principal amount of $18.0 million (“Revolving Credit Facility”); (iii) senior secured term loans in the principal amount of $10.0 million to convert the prior revenue participation agreement to a Note (“Revenue Participation Term Notes”); (iv) senior secured term loans in an aggregate principal amount of $15.0 million (“Acquisition Term Notes”) used to fund the cash portion of the acquisition of Cilion, Inc. After this financing transaction, Third Eye Capital obtained sufficient equity ownership in the Company to be considered a related party (the Term Notes, Revolving Credit Facility, Revenue Participation Term Notes and Acquisition Term Notes are referred to herein collectively as, the “Notes”).  Initially, the Acquisition Term Notes and the Revenue Participation Term Notes matured on July 6, 2014, the Term Notes matured on October 18, 2012 and the Revolving Credit Facility matured on July 6, 2013 with extension rights subject to satisfaction of certain conditions.  The Notes have all been amended to extend the maturity date to July 1, 2015, as described below.
In May 2014, Third Eye Capital agreed to the Limited Waiver and Amendment No. 7 to the Note Purchase Agreement to extend the maturity date of the Notes to July 1, 2015, to modify the waterfall table, to fix the interest rate of the Term Notes at 14%, and to redefine the operating cash available to the Company for operating expenses. As consideration, the Company paid an extension fee of $2.0 million which was capitalized into the revolving credit facility at the time of the amendment plus an escalating monitoring fee will be effective from the January 2015.
In November 2014, Third Eye Capital agreed to Amendment No. 8 to the Note Purchase Agreement to extend a line of credit in the amount of $6.0 million available for advance to Aemetis, such advance to be added to the outstanding principal balance of the existing notes under the Note Purchase Agreement. In addition, Third Eye Capital agreed to give Aemetis the right to extend the maturity date of the notes to January 1, 2016 upon notice and payment of a 3% extension fee.  Pursuant to the terms of Amendment No.8, Aemetis agreed to a covenant to complete an equity offering of its preferred stock for net proceeds of not less than $20 million with all of such net proceeds to be used to repay the principal outstanding under the Note Purchase Agreement in accordance with the priorities set forth there in.  As consideration for Amendment No.8, the unconditional personal Guaranty from the Chairman of the Company and the guaranties from Company parties and McAfee Capital, LLC owned by Mr. Eric McAfee were all reaffirmed. The Company also agreed to pay $0.2 million in consideration to Mr. McAfee and McAfee Capital in exchange for their willingness to provide the guaranties. In addition, Company agreed to an amendment fee to Third Eye Capital in the amount of $0.3 million which will be paid from the proceeds of the advance. As a result of Company’s ability to extend the maturity of the notes under Amendment No.8, the note balances have been classified as long term debt in the accompanying December 31, 2014 balance sheet.
 
 
8462

 
 
AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
 
4. Intangible Assets(Tabular data in thousands, except par value and Goodwillper share data)
 
Intangible assets consist of goodwill, patents, and in-process research and development. In July 2011 the Company acquired Zymetis, Inc., a biochemical research and development firm, with several patents pending and in-process R&D valued at $1,800,000 at the time of the acquisition. $967,994 in goodwill resulted from the excess in consideration paid over the fair value of the net assets acquired from the Zymetis acquisition. According to ASC 350-20-35 goodwill will be tested for impairment at the Zymetis reporting unit level, which has been named Aemetis Technologies, Inc.  Intangible assets will be measured for impairment and abandonment until fully amortized.
As of December 31, 2011 in process R&D is still in development and thus no amortization has been taken.
5. Notes Payable and Subsequent Events
  
December 31,
2011
  
December 31,
2010
 
         
Third Eye Capital senior secured term notes, including accrued interest of $1,593,378 and revenue participation of $5,277,753 less unamortized issuance discount of $513,943 for 12/31/2011 and accrued interest of $653,376 less unamortized issuance discount of $733,924 for 12/31/2010. For the years ending 12/31/2011 and 12/31/2010, the Company issued debt discount shares of 4,589,360 and 2,250,000, respectively. $18,126,611  $10,962,407 
State Bank of India secured term loan, including accrued interest of $1,485,614 and $949,336 less unamortized issuance discount of $14,902 and $24,838, respectively.  5,161,191   5,306,742 
Revolving line of credit (related party), including accrued interest and fees of $1,428,403 and $1,089,691 less unamortized issuance discount of $873,292 and $1,370,079, respectively.  4,291,913   4,574,603 
Unsecured working capital loans and short-term notes, including accrued interest of $103,382 and $10,931, respectively.  2,066,720   547,596 
Total debt  29,646,435   21,391,348 
Less current portion of debt  9,653,499   8,647,765 
Total long term debt $19,992,936  $12,743,583 
On January 13, 2015, Third Eye Capital Senior secured note.  The Company had $7,092,514, and $6,815,056 in principal and accrued interest outstanding netagreed to Limited Waiver to the Note Purchase Agreement to waive the cash flow covenant of $0 and $381,276 in debt discounts on a senior secured note$2.0 million as of December 31, 2011 and 2010, respectively.  The Note bears interest at 10% and matured in June 2011, but allowed for the continuation with the payment of monthly $75,000 extension fees settled in cash or stock.  During the year ending December 31, 2011,2014. As consideration, the Company issued 1,083,903 shares of stock for the extension or payment ofagreed to pay $0.1 million in waiver fees associated with this note.which were paid from the proceeds available under the Amendment No. 8.
Terms of Third Eye Capital Notes
Details about each portion of the Third Eye Capital financing facility are as follows:
A.
Term Notes.  As of December 31, 2014, AAFK had $7.4 million in principal and interest outstanding, net of unamortized fair value discounts of $138 thousand.  The Term Notes mature on July 1, 2015*.  Interest on the Term Notes accrues at 14% per annum.  The Term Notes contain various covenants, including but not limited to, minimum free cash flow and production requirements and restrictions on capital expenditures.  On July 26, 2013 and October 28, 2013, the Company received waivers for certain covenants by Amendment No. 5 and Amendment No. 6 to the Note Purchase Agreement, respectively.  Additionally, Amendment No. 5 waived the requirement for minimum monthly base payments, interest payments and mandatory tiered redemption payments in favor of a daily cash flow sweep equal to 20% of cash deposits from operating activities.
B.
Revolving Credit Facility.  On July 6, 2012 AAFK entered into a Revolving Credit Facility with a commitment of $18.0 million.  Through various amendments to the Note Purchase Agreement, the amount of the Revolving Loan Facility was increased to approximately $39.0 million.  Interest on the Revolving Credit Facility accrues at the prime rate plus 13.75% (17% as of December 31, 2014) payable monthly in arrears.  The Revolving Credit Facility matures on July 1, 2015*.  As of December 31, 2014, AAFK had $22.3 million in principal and interest outstanding, net of unamortized debt issuance costs of $447 thousand, on the Revolving Credit Facility.
C.
Revenue Participation Term Notes.  The Revenue Participation Note bears interest at 5% per annum and matures on July 1, 2015*.  As of December 31, 2014, AAFK had $10.2 million in principal and interest outstanding, net of unamortized discounts of $190 thousand, on the Revenue Participation Note.

D.
Acquisition Term Notes.  The Acquisition Term Notes accrue interest at prime rate plus 10.75% (14% per annum as of December 31, 2014) and mature on July 1, 2015*.  As of December 31, 2014, Aemetis Facility Keyes had $17.7 million in principal and interest outstanding, net of unamortized discounts of $302 thousand, on the Term Notes.
* The note maturity date can be extended by the Company to January 2016 during the month of May 2015. As a condition to any such extension, the Company would be required to pay a fee of 3% of the carrying value of the debt.
 
The Note is secured by first-lien deeds of trust on real property located in Nebraska and Illinois (Danville, IL property was sold in May 2011), by a first priority security interest in equipment located in Montana, pledge and assignment of 50% of all cash dividends, cash royalties and all other proceeds received from Aemetis Advanced Fuels Keyes, Inc. and initially a guarantee of $1 million, and later as part of the Cilion merger subsequent event occurring on July 6, 2012, a $10 million guarantee by McAfee Capital LLC (solely owned by Eric McAfee), plus all interest accrued and expenses to enforce Guaranty.  The note restricts the payment of dividends by the Company and any of its subsidiaries.
85

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Third Eye Capital Term notes.  The Company had $5,756,344 and $4,147,351 in principal and accrued interest outstanding, net of $513,943 and $352,649 in debt discounts, on the term notes as of December 31, 2011 and 2010, respectively.  The term notes accrues at 12% per annum, and at 14% per annum subsequent to June 2011, on the unpaid principal balance and is payable monthly in arrears.  The first two term notes provide for payment of an additional 2% of total revenues at the Keyes plant until repayment of the term notes after which time the amount was reduced to 1% over the lesser of 5 years or the term of the lease.  Upon the issuance of the additional term notes, in February 2011, the terms were revised to increase the additional payment to 4% of total revenues until repayment and 2% over the lesser of 7 years or the term of the lease.  In March 2011, the Company issued 1,750,000 shares of common stock to secure the sale of additional notes at a fair value of $175,000. As of December 31, 2011 and 2010, the 4% revenue participation fee totaled $5,277,753 and $0, respectively. The Term Notes and the Senior Secured Notes contain cross-collateral and cross-default provisions.

The Term notes contain various covenants, including but not limited to, minimum free cash flow and production requirements and restrictions on capital expenditures.  Throughout the year ending December 31, 2011, the Company was in violation of covenants, but was waived by the note holders through the payment of fees.  As a result during, the Company issued a total of 1,755,457 shares of common stock as waiver or extension fees at a fair market value on the dates of issuance of $964,436.  The payment requirements on the notes as of December 31, 2011 were $50,000 per week plus the greater of $0.05 per gallon of ethanol produced or 50% of free cash flows, as defined in the agreement.  In addition, a $300,000 principal payment shall be paid on the final business day of each fiscal quarter beginning the fourth quarter of 2011 until maturity.

The Term notes are secured by first-lien deeds of trust on all real and personal property, and assignment of proceeds offrom all government grants and guaranteeguarantees from Aemetis, Inc.  The Notes all contain cross-collateral and cross-default provisions.  McAfee Capital, LLC (“McAfee Capital”), owned by Eric McAfee, the Company’s Chairman and CEO, provided a guaranty of payment and performance up to the amount of $8 million plus interest, secured by 2.4 million shares of common stock of Aemetis Inc., a $5,000,000 guarantee fromthat it owns. McAfee Capital owns 3.4 million shares of common stock of Aemetis.  In addition, Mr. McAfee himself also pledged substantially all of his personal assets, and a personal guarantee from Eric McAfee equalguaranty of payment and performance up to $2,400,000 in principalthe amount of $15.0 million plus any interest and fees accrued.  Later as part of the interest.
Cilion shareholder seller note payable.  The Company’s merger subsequent event occurringwith Cilion on July 6, 2012 McAfee Capital LLC (solely owned by Eric McAfee) agreedprovided $5.0 million in notes payable to a $10 million guarantee against allCilion shareholders as merger compensation subordinated to the senior secured Third Eye Capital debt, plus allNotes.  The liability bears interest accruedat 3% per annum and expenses to enforce Guaranty.
As disclosed in the subsequent events footnote, the maturity ofis due and payable after the Third Eye Capital Senior securedNotes have been paid in full.  As of December 31, 2014, Aemetis Facility Keyes, Inc. had $5.4 million in principal and interest outstanding  under the Cilion shareholder seller note and the Term notes were refinanced subsequent to year-end to extend the maturities of these agreements.  The Company has revised the maturities of the related debt agreements based on these subsequent events.payable.
 
63

AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
State Bank of India Secured Term Loansecured term loan.  On July 17, 2008, Universal Biofuels Private Limited (“UBPL”), the Company’s India operating subsidiary, entered into a sixnine year $6 millionsecured term loan commitment with the State Bank of India.India in the amount of approximately $6.0 million.  The term loan maturesmatured in March 2014 and is secured by UBPL’s assets, consisting of the biodiesel plant and land in Kakinada with an asset value of approximately $15.6 million.
Kakinada. In July 2008, the Company drew approximately $4.6 million against the secured term loan.  The loan principal amount iswas repayable in 20 quarterly installments of approximately $270,000,$0.3 million, using exchange rates ascorresponding to the date of December 31, 2009,payment, with the first installment due in June 2009 and the last installment payment due in March 2014.  TheAs of December 31, 2014, the 12% interest rate under this facility is subject to adjustment every two years, based on 0.25% above the Reserve Bank of India advance rate of 7.5 percent during 2011.
rate.  The principal payments scheduled for June September and December in 2009 and quarters of 2010 and 2011through March 2014 were not made.  The term loan provides for liquidating damages at a rate of 2% per annum for the period of default. As of December 31, 2011 and 2010, UBPL had accrued interest of $1,485,614 and $949,336, respectively.

On October 7, 2009,March 10, 2011, UBPL received a demand notice from the State Bank of India.India with respect to the Agreement of Loan for Overall Limit dated as of June 26, 2008. The notice informedinforms UBPL that an event of default hadhas occurred for failure to make an installment payment on the loan due insince June 2009 and demandeddemands repayment of the entire outstanding indebtedness of 19.60 crorescrore rupees (approximately $4$3.2 million) together with all accrued interest thereon and any applicable fees and expenses.  As of December 31, 2011,2014, UBPL iswas in default on over twenty-eight months of interest elevenand principal repayments, and all financial covenants, including asset coverage and debt service coverage ratios.  Additional provisions of default include the bank having the unqualified right to disclose or publish the Company’s name and the Company’s Directors’its director’s names as defaulters ondefaulter in any communicationmedium or media.  At the bank’s option, it may also demand payment of the entire balance of the loan, since the principal payments have been in default since June 2009.  As a result, the Company has classified the entire loan amount as a current liability.current.  The State Bank of India has filed a legal case before the Debt Recovery Tribunal (DRT)(“DRT”), Hyderabad, for recovery of approximately $5$5.0 million against the companyCompany and also impleaded Andhra Pradesh Industrial Infrastructure Corporation (APIIC)(“APIIC”) to expedite the process of registration of Factorythe factory land for which counter reply is yet to be filed by APIIC.  UBPL asserts that the State Bank of India did not provide the committed funding of the working capital loan and only funded a portion of the term loan, thus requiring the Company to enter into a working capital facility at unfavorable terms which served to hinder the business from developing at the planned rate. The State Bank of India has additionally required the personal guarantee of a former Executive Officer and the registration of the land underlying the factory as conditions prior to restructure of the loan. Payments have recently been made against the facility; however, the State Bank of India has rejected these payments as a good faith effort. In January 2014, the Company made payment of $162 thousand (1 crore rupees) against principal on the facility which was accepted by the State Bank of India. UBPL filed for a stay against further collection efforts pending the development of sufficient business in a domestic or international market that would allow UBPL to make meaningful repayments against the facility.  In May 2014, UBPL obtained an interim stay subject to payments of 1 crore rupees (approximately $0.2 million) by each of May 15, 2014 and June 15, 2014. UBPL made these payments promptly.  In the caseevent that the Company is unable to prevail with itsthe aforementioned legal case, DRT may pass a Decreedecree for recovery of the amount due, amount, which will impact operations of the company including action up tocould include seizing companyCompany property for recovery of their dues.amounts due. As of December 31, 2014 and December 31, 2013, the State Bank of India loan had $2.6 million and $3.2 million, respectively, in principal outstanding and accrued interest plus default interest of $3.4 million and $2.7 million respectively.
Subordinated Notes.  On January 6 and January 9, 2012, AAFK entered into Note and Warrant Purchase Agreements with two accredited investors pursuant to which it issued $3.0 million in 5% annual interest rate notes to the investors (the “Sub Notes”).  An additional $0.6 million and $0.8 million in Sub Notes were issued to one of the existing accredited investor’s Sub Notes balance in May and December 2012, respectively.  This same accredited investor received payments of $0.6 million in principal and $3 thousand in interest in July 2012. The Sub Notes included 2 or 5 year warrants exercisable for 170 thousand shares of Aemetis common stock at a price of $0.01 per share, subject to adjustment.  Interest is due at maturity.  Neither AAFK nor Aemetis may make any principal payments under the Sub Notes until all loans made by Third Eye Capital to AAFK are paid in full, except for a few exceptions where Sub Note investors will receive funds from EB-5 investments or sale of equipment.
The Company agreed to an Amendment No.1 to the Sub Notes to extend the maturity of the January 2012 Sub Notes to July 1, 2014 and refinanced the additional December 2012 Sub Note as two Sub Notes dated December 2012 and January 2013, with principal amounts of $0.5 million and $0.1 million, respectively. Both the December 2012 Sub Note and the January 2013 Sub Note had a maturity date of April 30, 2013. On January 24, 2013, an additional $0.3 million Sub Note was issued with a maturity date of April 30, 2013. On May 23, 2013, all Sub Notes above with a maturity date of April 30, 2013 were refinanced as a $1.0 million Sub Note (“May 2013 Note”) with a maturity date of December 31, 2013.
On January 1, 2014, the May 2013 Sub Note was amended to extend the maturity date until the earlier of (i) June 30, 2014; (ii) completion of an equity financing by AAFK or Aemetis in an amount of not less than $25.0 million; (iii) the completion of an Initial Public Offering by AAFK or Aemetis; or (iv) after the occurrence of an Event of Default, including failure to pay interest or principal when due and breaches of note covenants. A 10 percent cash extension fee was paid by adding the fee to the balance of the new Note and 30 thousand in common stock warrants were granted with a term of two years and an exercise price of $0.01 per share.  These January 1, 2014 amendments and the refinancing terms of the Note were evaluated and it was determined, in accordance with ASC 470-50 Debt – Modification and Extinguishment, that the loan was extinguished and as a result a loss on debt extinguishment of approximately $0.1 million was recorded in January 2014.
In March 2014, the Company received $0.5 million from EB-5 investments and repaid one of the accredited investors holding a sub note of January 2012 $0.5 million.
 
 
8664

 
 
AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Revolving line of credit – related party.  The Company has a Revolving Line of Credit Agreement with Mr. Cagan, a significant shareholder and ex-board member, for $5,000,000 secured by certain accounts, investments, intellectual property, securities and other collateral of Aemetis, Inc., excluding the collateral securing the Company’s obligations with Third Eye Capital and the collateral securing the Company’s obligations with the State Bank of India.  The Revolving Line of Credit bears interest at the rate of 10% per annum and matured on July 1, 2012.  As of December 31, 2011, no additional borrowings were available on the line.
 
In September(Tabular data in thousands, except par value and October, 2010,per share data)
On July 1, 2014, the January 2014 Sub Note and two January 2013 Sub Notes with two accredited investors were amended to extend the maturity date until the earlier of (i) December 31, 2014; (ii) completion of an equity financing by AAFK or Aemetis Inc.’s Boardin an amount of Directorsnot less than $25.0 million; (iii) the completion of an Initial Public Offering by AAFK or Aemetis; or (iv) after the occurrence of an Event of Default, including failure to pay interest or principal when due and Mr. Cagan approvedbreaches of note covenants. A 10 percent cash extension fee was paid by adding the fee to the balance of the new Note and 118 thousand in common stock warrants were granted with a term of two years and an exercise price of $0.01 per share. We evaluated these July 1, 2014 amendments and the refinancing terms of the Notes and determined in accordance with ASC 470-50 Debt – Modification and Extinguishment that the loans were extinguished and as a result a loss on debt extinguishment of approximately $1.2 million was recorded in July 2014.

On January 1, 2015, the  Sub Notes above were amended to extend the maturity date until the earlier of (i) June 30, 2015; (ii) completion of an agreement subordinating collateralequity financing by AAFK or Aemetis in an amount of not less than $25.0 million; (iii) the completion of an Initial Public Offering by AAFK or Aemetis; or (iv) after the occurrence of an Event of Default, including failure to pay interest or principal when due and breaches of note covenants. A 10 percent cash extension fee was paid by adding the fee to the balance of the new Note and 116 thousand in common stock warrants were granted with a term of two years and an exercise price of $0.01 per share. We evaluated these January 1, 2015 amendments and the refinancing terms of the Notes and determined in accordance with ASC 470-50 Debt – Modification and Extinguishment that the loans were not extinguished and only modification accounting was applied.

On January 14, 2013, Laird Cagan, a related party, loaned $0.1 million through a promissory note maturing on the Revolving Line of Credit behind Third Eye Capital.  As an inducement to accept this subordination risk, Mr. Cagan was givenApril 30, 2013 with a five percent annualized interest rate and the right to convert accruedexercise 5 thousand warrants exercisable at $0.01 per share.

In February 2015, the Cagan related party promissory note was amended to extend the maturity date until the earlier of (i) December 31, 2016; (ii) completion of an equity financing by AAFK or Aemetis in an amount of not less than $25.0 million; (iii) the completion of an Initial Public Offering by AAFK or Aemetis; or (iv) after the occurrence of an Event of Default, including failure to pay interest or principal when due and feesbreaches of note covenants.

At December 31, 2014 and December 31, 2013, the Company owed, in aggregate, subordinated notes in the amount of $5.4 million and $5.3 million, respectively, for principal and interest outstanding, net of unamortized issuance and fair value discounts of none and $0.3 million, respectively.

EB-5 long-term promissory notes.  EB-5 is a US government program authorized by the Immigration and Nationality Act designed to foster employment-based visa preference for immigrant investors to encourage the flow of capital into the U.S. economy and to promote employment of U.S. workers. On March 4, 2011, and amended on January 19, 2012, and on July 24, 2012, the Revolving LineCompany entered into a Note Purchase Agreement with Advanced BioEnergy, LP, a California limited Partnership authorized as a Regional Center to receive EB-5 investments, for the issuance of Credit into sharesup to 72 subordinated convertible promissory notes bearing interest at 3%, each note in the principal amount of Aemetis common stock$0.5 million is due and payable four years from the date of the note for a total aggregate principal amount of up to $36.0 million. The notes are convertible after three years at a conversion price of $0.05$30.00 per share.  Additionally,

Advanced BioEnergy, LP arranges investments with foreign investors, who each make investments in the BoardKeyes plant project in investment increments of Directors approved$0.5 million.  The Company sold notes in the amount of $1.0 million to the first two investors during the fourth quarter of 2012 and sold a 5% subordination fee$0.5 million note to an investor during the first quarter of 2014. As of December 31, 2014, $34 thousand in accrued interest remained outstanding on the outstanding balance payable in cash or in stock.  On the maturity date of July 1, 2011, the Board of Directors approved the accrual of an additional 5% fee on the outstanding balance to extend the line of credit through July 2012.  For the years endingnotes.  After December 31, 20112014 and 2010, the Company recorded a debt discount related to the conversion feature on this related party debtas of $1,732,872 and $1,556,559, respectively.
On September 30, 2011, Mr. Cagan converted $1,452,818 of eligible accrued interest and fees into 29,056,356 shares of common stock. Future conversions of interest and fees are limited to a conversion price equal to the average closing stock price for the 22 trailing days prior to the date of conversion.
As disclosedthis report, we sold notes in the subsequent events footnote, the maturityamount of $17.0 million to 34 investors. The availability of the Revolving lineremaining $17.5 million will be determined by the ability of credit was extended and, as a result, the Company has revised the maturities schedule relatedAdvanced BioEnergy, LP to the line.attract additional qualified investors.

Note payable – related party.  On January 30, 2010, Aemetis Advanced Fuels Keyes, Inc., entered into an Unsecured Promissory Note with Mr. Cagan for $1,600,000 as bridge financing to repair and retrofit the Keyes plant.  The note bears no interest.  The Company repaid the $1,600,000 credit facility on May 11, 2010.  Fees in connection with this bridge financing were paid with the issuance of 600,000 shares of Aemetis, Inc.’s common stock to Mr. Cagan.working capital loans
Working Capital Operating Agreement.  In November 2008, the Company entered into an operating agreement with Secunderabad Oils Limited (“Secunderabad”).  Under this agreement Secunderabad agreed to provide the Company with working capital, on an as needed basis, to fund the purchase of feedstock and other raw materials for the Company’sits Kakinada biodiesel facility.  The working capital loans are unsecured. Secunderabad as the right to decide whether or not to extend additional loans.  Working capital advances bear interest at the actual bank borrowing rate of Secunderabad of fifteen percent (15%).  In return, the Company agreed to pay Secunderabad an amount equal to 30% of the plant’s monthly net operating loss.profit.  In the event that the Company’s biodiesel facility operates at a loss, Secunderabad owes the Company 30% of the losses.  The agreement can be terminated by either party at any time without penalty.
 
During the years ended December 31, 2011 and 2010, the Company paid Secunderabad $101,408 and $135,019, respectively, in connection with the profit sharing portion of this agreement. In addition, during the same periods  paid approximately $143,788 and $64,284 respectively, in interest for working capital funding. At December 30, 2011 and December 31, 2010 the Company had $1,652,162 and $547,596, respectively, outstanding under this agreement.
As noted above, the maturities schedule presented below have been adjusted for the subsequent amendments to the Third Eye Capital and Revolving loan agreements.  Scheduled debt repayments based on these amendments for the debt outstanding at December 31, 2011 are:
  
Debt
Repayments
 
    
2012 $9,653,499 
2013  9,964,111 
2014  10,028,825 
Total $29,646,435 
 
8765

 
 
AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
During the year ended December 31, 20112014, the Company received advances of approximately $7.7 million and made principal payments to Secunderabad of approximately $8.3 million under the agreement and interest payments of approximately $176 thousand respectively, for working capital funding.  During the year ended December 31, 2013, the Company received advances of approximately $5.2 million and made principal payments to Secunderabad of approximately $4.8 million under the agreement and interest payments of approximately $181 thousand respectively, for working capital funding.    At December 31, 2014 and December 31, 2013 the Company had approximately $1.3 million and $1.9 million outstanding under this agreement, respectively.

Short-term notes.  Aemetis Technologies, formerly Zymetis, Inc., carries certain debt obligations associated with a series of grants issued by the Maryland Department of Business and Economic Development to Zymetis prior to the merger.  These grants were converted to promissory notes with interest upon the achievement of certain objectives. In the first quarter of 2014, the Company entered into a payment settlement agreement to pay off the principal and interest of approximately $0.4 million in monthly installments. As part of this agreement, the long term debt of $0.4 million has been classified into other long term liabilities. At December 31, 2014, the Company had approximately $277 thousand and $88 thousand in the other long term liabilities and other current liabilities, respectively. The remaining promissory note with principal and interest of approximately $47 thousand was converted in May 2014 at $2.50 per share into 19 thousand shares of common stock of the Company.

Scheduled debt repayments as of December 31, 2014 are as follows:
 
Twelve months ended December 31, Debt Repayments 
2015 $12,746 
2016*  62,508 
2017  2,623 
2018  500 
Total debt  78,377 
Discounts  (1,076)
Total debt, net of discounts $77,301 
*Due to the Company’s ability to extend the maturity of the Third Eye Capital notes by six months from the scheduled maturity of July 2015, the amounts are reflected above as a 2016 maturity.
6. Commitments and Contingencies
Operating Leases
As of December 31, 2014, the Company, through its subsidiaries, has non-cancelable future minimum operating lease payments for various office space locations. Future minimum operating lease payments are as follows:

Twelve months ended December 31, Future Rent Payments 
2015 $410 
2016  447 
2017  462 
2018  479 
2019  495 
Thereafter  209 
Total $2,502 
The Cupertino facility office space consists of 9,238 rentable square feet.  The current lease is set to expire on May 31, 2015, but the Company extended the lease in February 2015 for an additional five years ending on May 31, 2020.  From July 2009 through July 2012, we sublet office space consisting of 3,104 rentable square feet to Solargen, Inc., then from June 1, 2013 through present, we sublet office space consisting of 3,104 rentable square feet to Splunk Inc., at a monthly rent rate equal to the rent charged to us by our landlord.
For the year ending December 31, 2014 and 2013, the Company received from Splunk Inc., approximately $124 thousand and $80 thousand in rent reimbursement respectively. For the years ended December 31, 2014, 2013, and 2012, the Company recognized rent expense of $426 thousand, $386 thousand, and $2.2 million, respectively.
66


AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
 
6. Operating Leases
(Tabular data in thousands, except par value and per share data)
 
The Company, through its subsidiaries, has non-cancelable operating leases for office space in Cupertino.
Subsequent future minimum operating lease payments as of December 31, 2011 as adjusted for subsequent acquisition are approximately $1,592,000 for the year ended December 31, 2012.In July 2009, the Company entered into a sublease agreement with Nevo Energy, Inc. (formerly known as Solargen Energy, Inc.) for approximately 3,000 square feet of leased space. For the year ended December 31, 2010, the Company invoiced, collected and offset as rent expense $85,670 under this agreement. For the year ending December 31, 2011, the Company invoiced Nevo Energy for $86,291 in rents due, but reserved all the payments due to Nevo Energy’s inability to pay. See Note 13. Related Party Transactions. On April 12, 2011, the Company agreed to convert $62,151 of its then outstanding rent bills to a promissory note bearing a 10 percent annual interest rate and a maturity date of April 12, 2018. As of December 31, 2011 a balance of $66,812 remains outstanding on the note. The Company has fully reserved for the Nevo Energy promissory note, due to the high probability of not being able to collect on the Note.Legal Proceedings
 
On DecemberMarch 10, 2011, UBPL received a demand notice from the State Bank of India under the Agreement of Loan for Overall Limit dated as of June 26, 2008. The notice informs UBPL that an event of default has occurred for failure to make an installment payment on the loan commencing June 2009 and demands repayment of the entire outstanding indebtedness of 19.60 crore rupees (approximately $3.2 million) together with all accrued interest thereon and any applicable fees and expenses.  Upon the occurrence and during the continuance of an Event of Default, interest accrues at the default interest rate of 2% above the State Bank of India Advance Rate. The default period began on July 1, 2009 when the principal payment was deemed past due; and we have accrued interest at the default rate since the beginning of the default period.  In addition, since the bank demanded payment of the balance, we have classified the entire loan amount as current. On March 12, 2011, the State Bank of India has filed a legal case before the Debt Recovery Tribunal (“DRT”), Hyderabad, for recovery of approximately $5.0 million against the Company and also impleaded Andhra Pradesh Industrial Infrastructure Corporation (“APIIC”) to expedite the process of registration of the factory land for which counter reply is yet to be filed by APIIC. UBPL asserts that the State Bank of India did not provide the committed funding of the working capital loan and only funded a portion of the term loan, thus requiring the Company to enter into a working capital facility at unfavorable terms which served to hinder the business from developing at the planned rate. The State Bank of India has additionally required the personal guarantee of our Executive Officer and the registration of the land underlying the factory as conditions prior to restructure of the loan. Payments have recently been made against the facility; however, the State Bank of India has rejected these payments as a good faith effort. In January 2014, the Company made payment of $162 thousand (1 crore rupees) against principal on the facility which was accepted by the State Bank of India. UBPL filed for a stay against further collection efforts pending the development of sufficient business in a domestic or international market that would allow UBPL to make meaningful repayments against the facility.  In May 2014, the Company obtained an interim stay subject to payments of 1 crore rupees (approximately $0.2 million) by each of May 15, 2014 and June 15, 2014. In the event that the Company is unable to prevail in the aforementioned legal case, DRT may pass a decree for recovery of the amount due, which could include seizing company property for recovery of amounts due.

On August 4, 2013, GS Cleantech Corporation, a subsidiary of Greenshift Corporation (“Greenshift”), filed a complaint in the United States District for the Eastern District of California – Fresno Division against the Company and its subsidiary, AAFK. The case was transferred to the Southern District of Indiana and joined as tag-along defendants to a pending Multidistrict Litigation with over a dozen original defendants. The complaint alleges infringement of patent rights assigned to Greenshift that pertain to certain corn oil extraction processes that the Company employs and seeks royalties, damages, treble damages, and attorney’s fees, along with injunctions precluding the Company from infringing its patent rights. The corn oil extraction process we use is licensed to us by Valicor Separation Technologies LLC, formerly called Solution Recovery Services LLC (“SRS”). The process provider has no obligations to indemnify us. On September 12, 2013, the Company, along with its subsidiary, filed its answer and counterclaims. In response to a motion for summary judgment filed by the original defendants, on October 23, 2014, the Court ruled that all the claims of all the patents at issue in the case are invalid. Further, in a January 16, 2015 decision, the District Court for the Southern District of Indiana ruled in favor of a stipulated motion for partial summary judgment for Company, along with its subsidiary, finding that all of the GS Cleantech patents in the suit were invalid and, therefore, not infringed.  GS Cleantech has said it will appeal this decision when the remaining claim in the suit has been decided. Regardless of when it may be appealed, we believe that the likelihood of Greenshift succeeding on appeal with that respect to patent invalidity findings is small since the Court’s findings included summary judgments on several grounds for each allegedly infringed patent. If Greenshift successfully appeals the District Court’s findings of invalidity, damages may be $1 million or more.

The only remaining claim alleges that GS Cleantech inequitably conducted itself before the United States Patent Office when obtaining the patents at issue. A trial in the District Court for the Southern District of Indiana on that single issue is anticipated but has not yet been scheduled. If the Defendants, including Company and its subsidiary, succeed in proving inequitable conduct, the patents at issue will be invalidated such that no damages will be awarded to GS Cleantech for infringement and the Court will be asked to determine whether GS Cleantech behavior makes this an “exceptional case”. A finding that this is an exceptional case would allow the Court to award to Company and its subsidiary the attorneys’ fees each has expended to date for defense in this case. It is unknown whether GS Cleantech would appeal such a ruling.
67

AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
On August 21, 2012, UBS Securities LLC (“UBS”) filed a complaint in the United States District Court for the Southern District of New York against the Company for damages based on a breach of contract theory in connection with the Cilion acquisition transaction (“UBS Federal Action”). UBS filed a motion for, and the District Court approved, a judgment against the Company in the liquidated amount of $2.3 million which has been accrued by the Company. UBS filed post-judgment discovery requests and pursued the enforcement of the judgment. Subsequently, on March 13, 2014, UBS also filed a complaint against one of our subsidiaries, Aemetis Advanced Fuels Keyes, Inc. in the state court in the State of New York, alleging breach of the same contract involved in the UBS Federal Action. The Company and AAFK entered into a lease for a 55 million gallon nameplate ethanol facility locatedsettlement agreement with UBS in Keyes, CA for a term of 36 months at a monthly lease payment of $250,000.  The Lease termSeptember 2014 and rental began upon substantial completion ofcomplied with the repair and retrofit of the plant on April 1, 2011, which was amended in April 2012 to a 60-month term ending March 2016.
On July 6, 2012, Aemetis, Inc. acquired the Keyes, CA ethanol plant. As a result, no additional lease obligations remain for the ethanol plant lease after the acquisition date. See Note 15. Subsequent Events.
For the year endedagreement by  December 31, 2011 and 2010, the Company recognized rent expense of $3,314,712 and $714,718, respectively.2014.
 
7. Stockholders’ DeficitEquity
 
The Company is authorized to issue up to 400,000,00040 million shares of common stock, $0.001 par value and 65,000,00065 million shares of preferred stock, $0.001 par value.
 
Convertible Preferred Stock
 
The following is a summary of the authorized, issued and outstanding convertible preferred stock:
 
    Shares Issued and 
 
Authorized
  Outstanding December 31,  Authorized  Shares Issued and 
 Shares  2011  2010  Shares  Outstanding December 31, 
             2014  2013 
Series B preferred stock  7,235,565   3,115,225   3,165,225   7,235   1,665   2,401 
Undesignated  57,764,435   -   -   57,765       
  65,000,000   3,115,225   3,165,225   65,000   1,665   2,401 
 
Our Articles of Incorporation authorize the Company’s board to issue up to 65,000,00065 million shares of preferred stock, $0.001 par value, in one or more classes or series within a class upon authority of the board without further stockholder approval.
 
88

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Significant terms of the designated preferred stock are as follows:
 
Voting. Holders of the Company’s Series B preferred stock are entitled to the number of votes equal to the number of shares of Common Stock into which the shares of Series B preferred stock held by such holder could be converted as of the record date. Cumulative voting with respect to the election of directors is not allowed. Currently each share of Series B preferred stock is entitled to one0.1 vote per share of Series B preferred stock. In addition, without obtaining the approval of the holders of a majority of the outstanding preferred stock, the Company cannot:
 
Increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series B preferred stock;
Effect an exchange, reclassification, or cancellation of all or a part of the Series B preferred stock, including a reverse stock split, but excluding a stock split;
Effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series B preferred stock; or
Alter or change the rights, preferences or privileges of the shares of Series B preferred stock so as to affect adversely the shares of such series.
 
68

AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
Dividends. Holders of all of the Company’s shares of Series B preferred stock are entitled to receive non-cumulative dividends payable in preference and before any declaration or payment of any dividend on common stock as may from time to time be declared by the board of directors out of funds legally available for that purpose at the rate of 5% of the original purchase price of such shares of preferred stock. No dividends may be made with respect to the Company’s common stock until all declared dividends on the preferred stock have been paid or set aside for payment to the preferred stock holders. To date, no dividends have been declared.
 
Liquidation Preference. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of the Series B preferred stock are entitled to receive, prior and in preference to any payment to the holders of the common stock, $3.00 per share plus all declared but unpaid dividends (if any) on the Series B preferred stock. If the Company’s assets legally available for distribution to the holders of the Series B preferred stock are insufficient to permit the payment to such holders of their full liquidation preference, then the Company’s entire assets legally available for distribution are to be distributed to the holders of the Series B preferred stock in proportion to their liquidation preferences. After the payment to the holders of the Series B preferred stock of their liquidation preference, the Company’s remaining assets legally available for distribution are distributed to the holders of the common stock in proportion to the number of shares of common stock held by them. A liquidation, dissolution or winding up includes (a) the acquisition of the Company by another entity by means of any transaction or series of related transactions to which the Company is party (including, without limitation, any stock acquisition, reorganization, merger or consolidation but excluding any sale of stock for capital raising purposes) that results in the voting securities of the Company outstanding immediately prior thereto failing to represent immediately after such transaction or series of transactions (either by remaining outstanding or by being converted into voting securities of the surviving entity or the entity that controls such surviving entity) a majority of the total voting power represented by the outstanding voting securities of the Company, such surviving entity or the entity that controls such surviving entity, or (b) a sale, lease or other conveyance of all or substantially all of the assets of the Company.
 
Conversion. Holders of Series B preferred stock have the right, at their option at any time, to convert any shares into common stock. Each shareEvery 10 shares of preferred stock will convert into one share of common stock, at the current conversion rate. The conversion ratio is subject to adjustment from time to time in the event of certain dilutive issuances and events, such as stock splits, stock dividends, stock combinations, reclassifications, exchanges and the like. In addition, at such time as the Registration Statement covering the resale of the shares of common stock is issuable,declared effective, then all outstanding Series B preferred stock shall be automatically converted into common stock at the then effective conversion rate.
 
Mandatorily Redeemable Series B preferred stock. In connection with the election of dissenters’ rights by the Cordillera Fund, L.P., at December 31, 2008 the Company reclassified 583,334583 thousand shares with an original purchase price of $1,750,002$1.8 million out of shareholders’ equity to a liability called “mandatorily redeemable Series B preferred stock” and accordingly reduced stockholdersstockholders’ equity by the same amount to reflect the Company’s obligations with respect to this matter.  At December 31, 2011 and 2010, the CompanyThe obligation was $2,320,164 and $2,221,872, respectively, which accrues interest at the rate of 5.25% per annum.  Theyear.  At December 31, 2014 and 2013, the Company had accrued an outstanding obligation of $2.6 million and $2.5 million, respectively.  Full cash payment to the Cordillera Fund is currently past due.  The Company expects to pay these obligationsthis obligation upon settlementavailability of funds after paying senior secured obligationsobligations.
8. Outstanding Warrants
During the year ended December 31, 2014, the Company granted 148 thousand common stock warrants, which had the potential to enhance returns for accredited investors who entered into additional Notes. The accredited investors received 2 year warrants exercisable at $0.01 per share as part of the note payment agreements.

For the twelve months ended December 31, 2014, Note investors exercised 217 thousand warrant shares at  exercise prices of $0.01 to $5.00 per share.
A summary of historical warrant activity for the years ended December 31, 2014 and 2013 follows:
  Warrants Outstanding & Exercisable  Weighted - Average Exercise Price  Average Remaining Term in Years 
 Outstanding December 31, 2012  181  $2.70   2.67 
 Granted  582   2.60     
 Exercised  (264)  0.10     
 Expired  (29)  11.80     
 Outstanding December 31, 2013  470  $3.40   4.85 
 Granted  148   0.01     
 Exercised  (217)  1.32     
 Expired  (50)  4.97     
 Outstanding December  31, 2014  351   3.05   2.69 
69

9. Fair Value of Warrants
The following tables summarize the availabilityassumptions used in computing the fair value of funds.liability warrants subject to fair value accounting at the December 31, 2014:.

Expected dividend yield  0% 
Risk-free interest rate  0. 89% - 1.1% 
Expected volatility  77.00% - 77.78% 
Expected Life (years)  2.5 - 3.0 
Exercise price $0.01 
Company stock price $5.79 
There were no warrants granted during the year ended December 31, 2014 that were recorded as liabilities on the date of grant.
 
 
8970

 
 
AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
 
8. Outstanding Warrants(Tabular data in thousands, except par value and per share data)
10. Fair Value Measurements
 
The Company complies with the fair value measurements and disclosures standard which defines fair value, establishes a framework for measuring fair value, and expands disclosure for those assets and liabilities carried on the balance sheet on a fair value basis.
The Company's balance sheet contains derivative financial instruments that are recorded at fair value on a recurring basis. Fair value measurements and disclosures require that assets and liabilities carried at fair value be classified and disclosed according to the process for determining fair value. There are three levels of determining fair value.

Level 1 uses quoted market prices in active markets for identical assets or liabilities.

Level 2 uses observable market based inputs or unobservable inputs that are corroborated by market data.

Level 3 uses unobservable inputs that are not corroborated by market data.

A summarydescription of the valuation methodologies used for instruments measured at fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy, is set forth below.

Warrant liability: The warrant liability consists of stock warrants issued by the Company that contain a conditional obligation to repurchase feature. In accordance with accounting for warrants as liabilities, the Company calculated the fair value of warrants under Level 3 using the assumptions described in “Fair Value of Warrants”. Realized and unrealized gains and losses related to the change in fair value of the warrant liability are included in other income (expense) in the Consolidated Statement of Operations.

The following table summarizes financial liabilities measured at fair value on a recurring basis as of December 31, 2014 and 2013, segregated by the level of the valuation inputs within the fair value hierarchy utilized to measure fair value:

  Total  Level 1  Level 2  Level 3 
2014            
Warrant liability $108  $-  $-  $108 
2013                
Warrant liability $60  $-  $-  $60 

The following table reflects the activity for liabilities measured at fair value using Level 3 inputs for the yearstwelve months ended December 31, 20112014 and 2010 is as follows:2013:
 
Balance as of December 31, 2012 $268 
     
Issuances of warrant liabilities  996 
Exercise of warrant liabilities  (1,007)
Related change in fair value  (197)
Balance as of December 31, 2013 $60 
     
Related change in fair value  48 
Balance as of December 31, 2014 $108 

 
Preferred Stock
 Warrants Issued & Outstanding Weighted - Average Exercise Price Warrants Issued & Exercisable Average Remaining Term in Years 
                 
Outstanding December 31, 2009  443,853  $3.00   443,853   2.18 
Granted  -   -   -   - 
Outstanding December 31, 2010  443,853   3.00   443,853   1.18 
Expired  (51,374)  3.00   (51,374)    
Outstanding December 31, 2011  392,479   3.00   392,479   0.25 
                 
                 
 
Common Stock
 
Warrants Issued & Outstanding
 Weighted - Average Exercise Price Warrants Issued & Exercisable Average Remaining Term in Years 
          
Outstanding December 31, 2009  477,734  $0.79   477,734   3.34 
Granted  950,856   0.13   950,856   - 
Outstanding December 31, 2010  1,428,590   0.35   1,428,590   4.08 
Expired  -   -   -   - 
Outstanding December 31, 2011  1,428,590   0.35   1,428,590   3.08 
                 
          
 
Total
 Warrants Issued & Outstanding Weighted - Average Exercise Price Warrants Issued & Exercisable Average Remaining Term in Years 
          
Outstanding December 31, 2009  921,587  $1.85   921,587   2.78 
Granted  950,856   0.13   950,856   - 
Outstanding December 31, 2010  1,872,443   0.98   1,872,443   3.39 
Expired  (51,374)  3.00   (51,374)    
Outstanding December 31, 2011  1,821,069   0.92   1,821,069   2.47 
Certain financial assets and financial liabilities are measured at fair value on a nonrecurring basis; that is, the instruments are not measured at fair value on an ongoing basis but are subject to fair value adjustments in certain circumstances (for example, when there is evidence of impairment). Financial assets and financial liabilities measured at fair value on a non-recurring basis were not significant at December 31, 2014.
 
 
9071

 
 
AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
 
9.(Tabular data in thousands, except par value and per share data)
11. Stock-Based Compensation
 
Common Stock Reserved for Issuance
 
Aemetis authorized the issuance of 8,600,4341.1 million shares under its 2006 and 2007 Stock PlanPlans and 0.1 million outside the former Zymetis, Inc. Stock Plan for stock option awards,plans, which includes both incentive and non-statutory stock options. These options generally expire five years from the date of grant with general vesting term of 1/12th every three months and are exercisable at any time after the date of the grant,vesting subject to vesting.continuation of employment.
 
The following is a summary of options granted under the employee stock plans:
 
  Shares Available  Number of Shares  Weighted-Average 
  For Grant  Outstanding  Exercise Price 
             
Balance as of December 31, 2009  185,410   4,697,000  $1.37 
Authorized  908,734   -   - 
Granted  (1,694,144)  1,694,144   0.19 
Forfeited  610,167   (610,167)  1.32 
Balance as of December 31, 2010  10,167   5,780,977   1.02 
Authorized  959,290   -   - 
Merger with Zymetis, Inc. Plan  323,817   1,421,183   0.41 
Exercised  -   (35,585)  0.06 
Forfeited/Expired/Shares from Cashless exercise  362,874   (362,874)  0.20 
Balance as of December 31, 2011  1,656,148   6,803,701   0.94 
  Shares Available for Grant  Number of Shares Outstanding  Weighted-Average Exercise Price 
          
Balance as of December 31, 2012  161   752  $5.90 
Authorized  100��      
Granted  (288)  288   5.80 
Exercised     (26)  3.30 
Forfeited/expired  101   (101)  15.31 
Balance as of December 31, 2013  74   913  $4.90 
Authorized  100       
Granted  (247)  247   4.38 
Exercised     (156)  1.69 
Forfeited/expired  78   (78)                 2.71 
Balance as of December 31, 2014  5   926  $ 5.52 
 
The weighted average remaining contractual term forDuring 2014, the Stock Plans at December 31, 2011 and 2010 were 2.59 and 3.41 years, respectively. The weighted average grant date fair value per share of the awards issued during the year ended 2010 was $0.07.
The 35,585156 thousand shares of common stock exercisedissued upon exercise of options under from the Company’s stock plans during 2011 had an intrinsic value of $24,041$712 thousand at time of exercise. The weighted average strike price for the shares exercised was $0.06$1.69 per share and the weighted average closing market price at time of exercise was $0.74. The exercised shares hold a restrictive legend.$6.24.
 
91

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
At December 31, 2011 and 2010 the weighted average remaining contractual term of shares issued to Aemetis consultants were 1.66 and 2.21 years, respectively. The Company recorded an expense for the years ended December 31, 2011 and 2010 in the amount of $24,533 and $4,553, respectively, which reflects periodic fair value re-measurement of outstanding consultant options under ASC 505-50-30 Equity Based Payments to Non Employees. The valuation using the Black-Scholes-Merton model is based upon the current market value of the Company’s common stock and other current assumptions, including the expected term (contractual term for consultant options). The Company records the expense related to consultant options using the accelerated expense pattern prescribed in ASC 505-50-30. Vested and unvested options outstanding under the Aemetis Stock Option Plans as of December 31, 20112014 and 20102013 follow:
 
     Weighted  Remaining    
     Average  Contractual  Aggregate 
  Number of  Exercise  Term  Intrinsic 
  Shares  Price  (In Years)  
Value1
 
             
2010            
Vested  4,027,916  $1.37   3.36  $- 
Unvested  1,753,061   0.23   4.01   - 
Total  5,780,977  $1.02   3.56  $- 
                 
2011                
Vested  5,960,116  $1.05   2.57  $316,388 
Unvested  843,585   0.17   3.15   - 
Total  6,803,701  $0.94   2.64  $316,388 

  Number of Shares  Weighted Average Exercise Price  Remaining Contractual Term (In Years)  
Average Intrinsic Value1
 
2014            
Vested  559  $5.89   2.41  $772 
Unvested  367   4.95   3.87   356 
Total  926  $5.52   2.99  $1,128 
                 
2013                
Vested  516  $4.40   1.77  $523 
Unvested  397   5.70   4.11   9 
Total  913  $4.90   2.79  $532 
———————
(1) BasedIntrinsic value calculation based on the $0.70$5.79 and $3.20 closing price of Aemetis stock on December 31, 2011,2014 and 2013, as reported on the Over-the-CounterNASDAQ exchange and Over the Counter Bulletin Board certain option holders of 946,050 shares from the 2006 Employee Option Plan had $316,388 in aggregate intrinsic value. The option holders under the 2007 Amended and Restated Stock Option Plan carried no aggregate intrinsic value on December 31, 2011. Based on the $0.14 closing price of Aemetis stock on December 31, 2010, as reported on the Over-the-Counter Bulletin Board, options had no aggregate intrinsic value.respectively.
 
 
9272

 

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
 
(Tabular data in thousands, except par value and per share data)
Non-Plan Stock Options
In November 2012, the Company issued 98 thousand stock options to board members and consultants outside of any Company stock option plan. None of the non-plan options have been exercised. As of December 31, 2014, all options vested at remaining contractual term of 2.9 years. 9 thousand options were exercised at a weighted average exercise price of $5.50 and 89 thousand options were outstanding as of December 31, 2014.
Following summarizes the options granted under outside the Company stock plans:
  Number of Shares  Weighted Average Exercise Price  Remaining Contractual Term (In Years)  
Average Intrinsic Value2
 
2014            
Vested  89  $5.50   2.85  $26 
Unvested  -   -   -   - 
Total  89  $5.50   2.85  $- 
                 
2013                
Vested  69  $5.50   3.85  $- 
Unvested  29   5.50   3.85   - 
Total  98  $5.50   3.85  $- 

(2)Intrinsic value based on the $5.79 and $3.20 closing price of Aemetis stock on December 31, 2014 and 2013 respectively, as reported on the NASDAQ Exchange and Over the Counter Bulletin Board respectively.
Stock-based compensation for employees
Stock-based compensation is accounted for in accordance with the provisions of ASC 718, Compensation-Stock Compensation, which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. We estimate the fair value of stock-based awards on the date of grant using the Black-Scholes option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method.
73

AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
For the year ended December 31, 2014, 2013, and 2012, the Company recorded option expense in the amount of $605 thousand, $512 thousand, and $206 thousand, respectively.
Valuation and Expense Information
All issuances of stock options or other issuances of equity instruments to employees as the consideration for services received by us are accounted for based on the fair value of the equity instrument issued. The fair value of options granted to employees is estimated on the grant date using the Black-Scholes option valuation model. This valuation model for stock based compensation expense requires us to make assumptions and judgments about the variables used in the calculation, including the fair value of our common stock, the expected term (the period of time that the options granted are expected to be outstanding), the volatility of our common stock, a risk-free interest rate, and expected dividends. We also estimate forfeitures of unvested stock options. To the extent actual forfeitures differ from the estimates, the difference will be recorded as a cumulative adjustment in the period estimates are revised. No compensation cost is recorded for options that do not vest. We use the simplified calculation of expected life described in the SEC’s Staff Accounting Bulletin No. 107, Share-Based Payment, and volatility is based on an average of the historical volatilities of the common stock of four entities with characteristics similar to those of the Company. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the option. We use an expected dividend yield of zero, as we do not anticipate paying any dividends in the foreseeable future. Expected forfeitures are assumed to be zero due to the small number of plan participants and the plan.
 
The weighted-average fair value calculations for options granted to employees within the period are based on the following weighted average assumptions:
 
  
Fiscal Year Ended
December 31
 
  2011  2010 
        
Dividend-yield  0% 0%
Risk-free interest rate  0.20-1.80% 1.22-2.37
Expected volatility  90.38-103.22%  58.88-120.90%
Expected life (years)  0.2-4.0   3.12 
Weighted average fair value per share of common stock $0.10  $0.07 
  For the year ended December 31 
  2014  2013  2012 
Dividend-yield  0%  0%  0%
Risk-free interest rate  0. 74 - 1.10%  0.42 - 0.63  0.28 - 0.38
Expected volatility  77.00 - 78.43%  73.20 - 75.55%  79.08%
Expected life (years)  3   3   2 - 3 
Market value per share on grant date $4.20 - $ 4.66  $4.00 - $6.50  $5.50 
Weighted average fair value per share on grant date $2.14 - $2.35  $1.92 - $3.19  $2.34 - $2.80 
 
The Company incurred non-cash stock compensation expense of $177,278 and $377,669 in fiscal 2011 and 2010, respectively, for options granted to employees and consultants. As of December 31, 2011 and 2010,2014, the Company had $38,690 and $16,325 respectively,$750 thousand of total unrecognized compensation expenses thatexpense for employees which the Company will amortize over the next five fiscal years.
10. Acquisitions, Divestitures and Material Agreements2.99 years of weighted remaining term.
 
TechnologyThe Company Formation.granted 500 options, 7,600 options, and 11,500 options in the years ended December 31, 2014, 2013, and 2012, respectively to the non-employees under the stock plans and non-plan stock options.  We account for stock-based compensation awards to non-employees in accordance with ASC 505-50, Equity Based Payments to Non-Employees On February 28, 2007,. Under ASC 505-50, we determine the fair value of the options using Black Scholes option pricing model on the grant date and we re-measure the fair value of these options to recognize expense for the vested options for every quarter. We recognized the total expense on these non-employee options of $19 thousand, $10 thousand, $49 thousand for the years ended December 31, 2014, 2013, and 2012, respectively. As of December 31, 2014, the Company acquired a 51% interest in Energy Enzymes, Inc. On October 14, 2010,had $6 thousand of total unrecognized compensation expense for non-employees which the Company issued 1,000,000 shareswill amortize over the 2.99 years of common stock in Aemetis in exchange for theweighted remaining 49% interest in Energy Enzymes. The acquisition of the remaining 49% interest was accounted for as an equity transaction as the Company already controlled Energy Enzymes, and therefore the non-controlling interest accumulated loss of ($501,331) was transferred to paid-in capital.  Losses of $138,956 from Energy Enzymes operations through October 14, 2010 were allocated to the non-controlling interest owner.term.
 
Alcamar Oil and Fats, Ltd. termination:  On January 23, 2008, International Biofuels, Ltd agreed to end the joint venture with Acalmar Oils and Fats, Ltd. including termination of Acalmar’s right to own or receive any ownership interestIn addition, Company issued 200 thousand shares in the joint venture. The total cancellationCompany’s restricted common stock for services provided by outside consulting firms at an exercise price payable by International Biofuels was $900,000between $4.20 and was expensed$5.00.  We determine the fair value of the these awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. Stock-based compensation awards issued to non-employees are recorded in 2008.  In 2010expense and additional paid-in capital in stockholders’ equity (deficit) over the Company negotiated the remaining balance of $600,000 to $150,000 and other income of $450,000 was recognized.
Technology Company Acquisition. On July 1, 2011, the Company completed the acquisition of Zymetis, Inc., a Delaware corporation in exchange for 6,673,557 shares of Aemetis common stock.  The acquisition was made as a strategic purchase related to the research and development work that Zymetis was performing.  The purchase price was determinedapplicable service periods based on an arms-length negotiatedthe fair value which resulted inof the recognition of goodwill.  See following for Zymetis merger Purchase Price Allocation and Goodwill Reconciliation:awards or consideration received at the vesting date.
 
 
9374

 
 
AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
 
  2011 
     
Issuance of Stock as merger consideration $1,801,860 
Fair Value of stock options attributable to the pre-combination service  88,275 
Consideration paid $1,890,135 
     
Working capital assets $11,201 
Property, Plant & Equipment  65,493 
Working capital liabilities  (509,078)
Debt assumed  (346,995)
  Deferred Taxes  (98,479)
     
Intangibles  1,800,000 
Net Assets Acquired $922,141 
     
Goodwill $967,994 

Post-merger, the Zymetis subsidiary was renamed Aemetis Technologies, Inc and continued its R&D development work. Aemetis Technologies generated $1,750 in consulting income and $174,488 in losses for the year ending December 31, 2011.  The proforma adjustments for this acquisition are not material.

12. Agreements
Working Capital Arrangement. On March 9, 2011,In May 2013 we extended the Company entered into a Purchasing Agreement and Cornannual Grain Procurement and Working Capital Agreement with J.D. Heiskell pursuantthat has been in place since March 2011.  Pursuant to which J.D. Heiskell agreesthe agreement we agreed to supply 100% of the Company’s requirements forprocure whole yellow corn untiland grain sorghum (also called “milo”) from J.D. Heiskell. The Company has the ability to obtain grain from other sources subject to certain conditions, however, in the past all of our grain purchases have been from Heiskell. Title and risk of loss of the corn pass to the Company when the corn is deposited into the weigh bin. The term of the Agreement expires on December 31, 2011 with automatic one year renewal2015 and is automatically renewed for additional one-year terms. Heiskell further agrees to sell all ethanol to Kinergy Marketing or other marketing purchaser designated by the Company and all WDG and syrupcondensed distillers solubles to A.L. Gilbert. Our relationships with J.D. Heiskell, Kinergy Marketing, and A.L. Gilbert are well established and the Company believes that the relationships are beneficial to all parties involved in utilizing the distribution logistics, reaching out to widespread customer base, managing inventory, and building working capital relationships. Revenue is recognized upon delivery of ethanol to J. D. Heiskell as revenue recognition criteria have been met and any performance required of the Company subsequent to the sale to J.D. Heiskell is inconsequential. These agreements are ordinary purchase and sale agency agreements for an ethanol plant. See following for
The J.D. Heiskell & Company sales purchasesactivity associated with the Purchasing Agreement, Grain Procurement and accounts receivable as of and forWorking Capital
Agreements during the year ended 2011.
J.D. Heiskell & Company:
  2011 
Sales    
Ethanol $105,447,012 
Distillers Grains  20,558,034 
Total Sales  126,005,046 
     
Corn Purchases  106,194,420 
     
Accounts Receivable $841,729 
December 31, 2014, 2013 and 2012 were as follows:
 
  Year ended December 31 
  2014  2013  2012 
Ethanol sales $148,408  $106,566   128,831 
Wet distiller's grains sales  32,689   26,490   35,469 
Corn oil sales  4,501   2,609   2,583 
Corn purchases  120,915   96,000   156,985 
Milo Purchases  -   11,523     
Accounts receivable  368   641   395 
Accounts payable  1,965   2,228   2,650 
94

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

Ethanol and Wet Distillers Grains Marketing Arrangement. The Company entered into an Ethanol Marketing Agreement with Kinergy Marketing.Marketing and a Wet Distillers Grains marketing agreement with A. L Gilbert. Under the terms of the agreement,agreements, subject to certain conditions, the agreement term isagreements with Kinergy Marketing matures on August 31, 20132015 and with A.L Gilbert on December 31, 2015 with automatic one-year renewals thereafter.  For the yearyears ended December 31. 2011, Kinergy Marketing earned $928,54831, 2014, 2013 and 2012, the Company expensed marketing costs of $2.9 million, $2.1 million and $2.4 million, respectively, under the terms of this agreement.both ethanol and wet distillers grains agreements.
 
11.13. Segment Information
 
Aemetis recognizes two reportable geographic segments: “India” and “North America.”
The “India” operating segment encompasses the Company’s 50 MGY name plate capacity biodiesel manufacturing plant in Kakinada, the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius. The Company’s biodiesel is marketed and sold primarily to customers in India through brokers and by the Company directly.
The “North America” operating segment includes the Company’s owned 55 MGY name plate capacity ethanol plant in Keyes, California and its technology lab in College Park, Maryland. As the Company’s technology gains market acceptance, this business segment will include its domestic commercial application of cellulosic ethanol technology, its plant construction projects and any acquisitions of ethanol or ethanol related technology facilities in North America.
75

AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
Summarized financial information by reportable segment for the years ended December 31, 20112014, 2013 and 2010, based on the internal management system, is as follows:

Statement of Operations Data Year ended December 31, 
  2011  2010 
Revenues      
India $9,911,616  $8,132,108 
North America  131,946,298   - 
Other  -   - 
Total revenues $141,857,914  $8,132,108 
         
Cost of goods sold        
India $9,494,395   8,254,123 
North America  127,721,645   - 
Other  -   - 
Total cost of goods sold $137,216,040  $8,254,123 
         
Gross profit (loss)        
India $417,221  $(122,015)
North America  4,224,653   - 
Other  -   - 
Total gross profit (loss) $4,641,874  $(122,015)
India: In 2010 all of the Company’s revenues were from sales to external customers in the Company’s India Segment. During 2010, customer Essar Steel Limited accounted for approximately 10% of the Company’s biodiesel sales, but no customer accounted for 10% or more of consolidated 2010 sales. In 2011, customer Gunvor International B.V.Amsterdam represented approximately 70% of total revenues by purchasing biodiesel for export to Europe.2012 follow:
 
95

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
  For the year ended December 31, 
  2014  2013  2012 
Revenues         
North America $195,416  $144,698  $175,501 
India  12,267   32,816   13,547 
    Total revenues $207,683  $177,514  $189,048 
             
Cost of goods sold            
North America $158,719  $130,498  $183,784 
India  11,820   28,722   14,191 
    Total cost of goods sold $170,539  $159,220  $197,975 
             
Gross profit (loss)            
North America $36,697  $14,200  $(8,283)
India  447   4,094   (644)
             
Total gross profit (loss) $37,144  $18,294  $(8,927)
 
North America: In 2011,2014, 2013 and 2012, all of the Company’s revenues from sales of ethanol, WDG and WDGcorn oil were sold to J.D. Heiskell pursuant to the Corn Procurement and Working Capital Agreement. Sales to J.D. Heiskell accounted for 93%95 %, 94% and 95% of the Company’s North American segment consolidated revenues.revenues in 2014, 2013 and 2012 respectively.
 
  Year Ended December 31 
Total Assets Data 2011  2010 
India $15,654,763  $16,349,504 
North America  11,563,132   5,244,421 
Other  26   110 
Total Assets $27,217,921  $21,594,035 
India:  During 2014, three customers accounted for 80% of India sales through their purchase of Refined Glycerin, and four customers accounted for 80% of India sales through its purchase of biodiesel. During 2013, three customers accounted for 79% of India sales through their purchase of Refined Glycerin, two customers accounted for 97% of India sales through their purchase of Refined Palm Oil, one customer accounted for 69% of India sales through its purchase of biodiesel.  In 2012, two customers accounted for 45.8% of sales through their purchase of Refined Palm Oil. One customer accounted for 10.7% of consolidated sales through its purchase of biodiesel.
 
12.Company total assets by segment follow:
  December 31,  December 31, 
  2014  2013 
       
North America $76,066  $83,183 
India  13,110   13,959 
    Total Assets $89,176  $97,142 
14. Quarterly Financial Data (Unaudited)
 
The following is aA summary of the unaudited quarterly results of operations for the years ended December 31, 20112014 and 2010:2013 is as follows:
 
 
96

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
2011
  For the three months ended  
For the year ended
 
  March 31, 2011  June 30, 2011  September 30, 2011  December 31, 2011  December 31, 2011 
                
Revenues $738,469  $27,253,190  $56,571,595  $57,294,660  $141,857,914 
                     
Cost of goods sold  787,472   27,567,654   55,789,374   53,071,540   137,216,040 
                     
Gross profit/(loss)  (49,003)  (314,464)  782,221   4,223,120   4,641,874 
                     
Research and development expenses  32,569   71,400   337,229   135,427   576,625 
Selling, general and administrative expenses  2,103,409   1,989,282   2,212,510   2,265,390   8,570,591 
                   - 
Operating loss  (2,184,981)  (2,375,146)  (1,767,518)  1,822,303   (4,505,342)
                     
Other income/(expense)                    
Interest income  4,021   2,796   351   16,268   23,436 
Interest expense  (2,103,163)  (3,649,359)  (3,785,857)  (4,022,906)  (13,561,285)
Other income, net of expenses  24,031   54,207   4,070   (29,348)  52,960 
Loss on asset sales  -   (401,407)  -   -   (401,407)
Loss before income taxes  (4,260,092)  (6,368,909)  (5,548,954)  (2,213,683)  (18,391,638)
                     
Income taxes benefit/(expense)  (3,200)  -   98,479   -   95,279 
                     
Net loss  (4,263,292)  (6,368,909)  (5,450,475)  (2,213,683)  (18,296,359)
Less: Net loss attributable to the noncontrolling interest  -   -   -   - 
Net loss attributable to Aemetis, Inc. $(4,263,292) $(6,368,909) $(5,450,475) $(2,213,683) $(18,296,359)
                     
Other comprehensive loss                    
Foreign currency translation adjustment  20,286   (16,031)  (727,992)  (648,704)  (1,372,441)
Comprehensive loss attributable to Aemetis, Inc. $(4,243,006) $(6,384,940) $(6,178,467) $(2,862,387) $(19,668,800)
                     
Loss per common share attributable to Aemetis, Inc. 
Basic and diluted $(0.05) $(0.07) $(0.05) $(0.02) $(0.18)
Weighted average shares outstanding                    
Basic and diluted  90,789,254   92,384,340   100,446,788   130,127,853   103,536,643 
97

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
2010
  For the three months ended  
For the year ended
 
  March 31, 2010 June 30, 2010  September 30, 2010  December 31, 2010  December 31, 2010 
                     
Revenues $2,236,838  $1,805,710  $1,592,932  $2,496,628  $8,132,108 
                     
Cost of goods sold  2,209,593   1,941,674   1,671,989   2,430,867   8,254,123 
                     
Gross profit/(loss)  27,245   (135,964)  (79,057)  65,761   (122,015)
                     
Research and development expenses  144,530   109,847   29,206   38,978   322,561 
Selling, general and administrative expenses  1,009,982   1,101,128   903,680   1,694,954   4,709,744 
                   - 
Operating loss  (1,127,267)  (1,346,939)  (1,011,943)  (1,668,171)  (5,154,320)
                     
Other income/(expense)                    
Interest income  180   1,914   147   22,223   24,464 
Interest expense  (909,018)  (917,037)  (726,564)  (1,481,828)  (4,034,447)
Other income, net of expenses  27,974   18,810   15,789   540,721   603,294 
Loss before income taxes  (2,008,131)  (2,243,252)  (1,722,571)  (2,587,055)  (8,561,009)
                     
Income taxes benefit/(expense)  (3,200)  -   -   -   (3,200)
                     
Net loss  (2,011,331)  (2,243,252)  (1,722,571)  (2,587,055)  (8,564,209)
Less: Net loss attributable to the noncontrolling interest   (70,820)  (53,825)  (14,311)  -   (138,956)
Net loss attributable to Aemetis, Inc. $(1,940,511) $(2,189,427) $(1,708,260) $(2,587,055) $(8,425,253)
                     
Other comprehensive loss                    
Foreign currency translation adjustment  427,800   (309,086)  33,782   352,965   505,461 
Comprehensive loss  (1,583,531)  (2,552,338)  (1,688,789)  (2,234,090)  (8,058,748)
Comprehensive loss attributable to the noncontrolling interest  -   -   -   -   - 
Comprehensive loss attributable to Aemetis, Inc. $(1,512,711) $(2,498,513) $(1,674,478) $(2,234,090) $(7,919,792)
                     
Loss per common share attributable to Aemetis, Inc. 
Basic and diluted $(0.02) $(0.03) $(0.02) $(0.03)  (0.10)
Weighted average shares outstanding                    
Basic and diluted  86,182,765   86,566,702   86,987,032   89,840,728   87,403,213 
9876

 

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
 
13.(Tabular data in thousands, except par value and per share data)
  2014 For the three months ended  For the year ended 
  March 31,  June 30,  September 30,  December 31,  December 31, 
  2014  2014  2014  2014  2014 
Revenues $60,665  $57,195  $48,348  $41,475  $207,683 
                     
Cost of goods sold  45,041   45,842   40,633   39,023   170,539 
                     
Gross profit  15,624   11,353   7,715   2,452   37,144 
                     
Research and development expenses  100   141   101   117   459 
Selling, general and administrative expenses  2,842   3,449   2,972   3,332   12,595 
                     
Operating income/(loss)  12,682   7,763   4,642   (997)  24,090 
                     
Other income/(expense)                    
                     
Interest expense                    
Interest rate expense  (2,920)  (2,530)  (2,287)  (2,315)  (10,052)
Amortization expense  (2,118)  (2,502)  (741)  (677)  (6,038)
Loss on debt extinguishment  (115)  -   (1,231)  -   (1,346)
Gain on sale of assets  -   (119)  -   -   (119)
Other income/(expense)  164   110   81   249   604 
                     
Income /(Loss) before income taxes  7,693   2,722   464   (3,740)  7,139 
                     
Income tax expense  (6)  -   -   -   (6)
                     
Net income /(loss)  7,687   2,722   464   (3,740)  7,133 
                     
Other comprehensive income (loss)                 
Foreign currency translation adjustment  108   -   (98)  (56)  (46)
Comprehensive income (loss) $7,795  $2,722  $366  $(3,796) $7,087 
                     
Net income (loss) per common share                 
Basic $0.38  $0.13  $0.02  $(0.18) $0.35 
Diluted $0.34  $0.13  $0.02  $(0.18) $0.34 
Weighted average shares outstanding                 
Basic  20,007   20,284   20,555   20,630   20,371 
Diluted  22,657   20,948   21,476   20,630   21,047 
77

AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
2013

Certain balances on the quarterly results of operations for the quarters ended March 31, 2013, June 30, 2013 and September 30, 2013 have been reclassified, with no effect on net income (loss), to be consistent with the classifications adopted for the year ended December 31, 2013. A summary of the unaudited quarterly results of operations incorporating these changes discussed above for the years ended December 31, 2013 and 2012 is as follows:

  For the three months ended  For the year ended 
  March 31,  June 30,  September 30,  December 31,  December 31, 
  2013  2013  2013  2013  2013 
Revenues $19,420  $47,353  $56,688  $54,053  $177,514 
                     
Cost of goods sold  19,173   43,602   53,652   42,793   159,220 
                     
Gross profit  247   3,751   3,036   11,260   18,294 
                     
Research and development expenses  229   124   115   71   539 
Selling, general and administrative expenses  4,215   3,984   3,879   3,197   15,275 
                     
Operating income/(loss)  (4,197)  (357)  (958)  7,992   2,480 
                     
Other income/(expense)                    
                     
Interest expense                    
Interest rate expense  (2,671)  (2,913)  (2,933)  (3,291)  (11,808)
Amortization expense  (2,273)  (6,071)  (2,020)  (2,103)  (12,467)
Loss on debt extinguishment  (956)  (232)  (2,521)  -   (3,709)
Gain on sale of assets  126   48   108   47   329 
Other income/(expense)  163   (67)  35   613   744 
                     
Income (Loss) before income taxes  (9,808)  (9,592)  (8,289)  3,258   (24,431)
                     
Income tax expense  (6)  -   -   -   (6)
                     
Net income /(loss)  (9,814)  (9,592)  (8,289)  3,258   (24,437)
                     
Other comprehensive income (loss)                    
Foreign currency translation adjustment  199   (600)  (275)  78   (598)
Comprehensive (loss)/income $(9,615) $(10,192) $(8,564) $3,336  $(25,035)
                     
Net (loss)/income per common share                    
Basic $(0.54) $(0.51) $(0.43) $0.16  $(1.28)
Diluted $(0.54) $(0.51) $(0.43) $0.16  $(1.28)
Weighted average shares outstanding                    
Basic  18,223   18,964   19,390   19,806   19,101 
Diluted  18,223   18,964   19,390   20,272   19,101 

78


AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
15. Related Party Transactions

The Company owes Eric McAfee and McAfee Capital, solely owned by Eric McAfee, amounts of $1,254,188$0.4 million and $803,370$1.0 million in connection with employment agreements and expense reimbursements, which are included in accrued expenses and accounts payable on the balance sheet as of December 31, 20112014 and 2010.2013.  For the years ended December 31, 20112014, 2013, and 2010,2012, the Company expensed $519,828$191 thousand, $110 thousand, and $608,874$65 thousand, respectively, to reimburse actual expenses incurred for McAfee Capital and related entities.
As consideration for Amendment No.8 with which we entered with Third Eye Capital on November 7, 2014, the unconditional personal Guaranty from Chairman of the Company, the guaranties from Company parties and McAfee Capital, LLC owned by Mr. Eric McAfee were all reaffirmed. The Company also agreed to pay $0.2 million in connectionconsideration to Mr. McAfee and McAfee Capital in exchange for their willingness to provide the guaranties. As part of this Guarantee fee agreement, $172 thousand was paid as of December 31, 2014 and $28 thousand is accrued in the balance sheet as of December 31, 2014.
For the years ending December 31, 2014, 2013 and 2012, Eric McAfee received payments from the Company of principal, interest and fees associated with compensationa revolving line of credit co-owned with Laird Cagan, a related party, and expense reimbursements.other investors, by converting part of the balance due for none, 1.2 million, and 6.2 million shares of common stock, respectively. Laird Cagan received none, 0.7 million and 2.6 million shares of common stock as part of the same payments-for-stock transactions with the same terms.
 
The Company owes various Board Members amounts of $638,563 and $490,658totaling $1.7 million each as of December 31, 20112014 and 2010,2013, respectively, in connection with board compensation fees, which are included in accounts payable on the balance sheet.  For each of the years ended December 31, 20112014, 2013, and 20102012, the Company expensed $228,654 and $188,198, respectively,$0.4 million each year then ended,  in connection with board compensation fees.
 
InOn July 2009,6, 2012, Aemetis, Inc. and Aemetis Advanced Fuels Keyes, Inc., entered into an Amended and Restated Note Purchase Agreement with Third Eye Capital.  Third Eye Capital extended credit in the form of (i) senior secured revolving loans in an aggregate principal amount of $18.0 million (“Revolving Credit Facility”); (ii) senior secured term loans in the principal amount of $10.0 million to convert the Revenue Participation agreement to a Note (“Revenue Participation Term Notes”); and (iii) senior secured term loans in an aggregate principal amount of $15.0 million (“Acquisition Term Notes”) used to fund the cash portion of the acquisition of Cilion, Inc. After this financing transaction, Third Eye Capital obtained sufficient equity ownership in the Company entered intoto be considered a sublease agreementrelated party. Please refer to Note Payable - Note 5 for more information on the transactions with Nevo Energy, Inc. (formerly known as Solargen Energy, Inc.) for approximately 3,000 square feet of leased space. For the year ended December 31, 2010, the Company invoiced, collected and offset as rent and utilities expense $125,858 under this agreement and collected a prepayment of $11,876, which the Company received for April 2010 rent.  For the year ending December 31, 2011, the Company invoiced Nevo Energy $86,291 in rents, but reserved all the payments during 2011 due to Nevo Energy’s inability to pay.  The future minimum lease payments above exclude collections of rents under this sublease agreement.  Eric McAfee is a member of the Board of Directors and a significant shareholder of Nevo Energy, Inc.  Michael Peterson, a former member of the Company’s Board of Directors, was also the Chief Executive Officer of Nevo Energy, Inc. during 2011.   See Note 6 Operating Leases.Third Eye Capital.
 
14.16. Income Tax
 
The Company files a consolidated federal income tax return. This return includesincluding all corporate companies 80% or more owned by the Company as well as the Company’s pro-rata share of taxable income from pass-through entities in which Company holds an ownership interest. On October 14, 2010 AE Biofuels acquired the remaining 49% interest in Energy Enzymes, Inc. During 2011 Energy Enzymes was included as a 100% consolidated entity for financial reporting purposes.its domestic subsidiaries. State tax returns are filed on a consolidated, combined or separate basis depending on the applicable laws relating to the Company and its subsidiaries.
 
Components of tax expense (benefit) consist of the following:
 
  Year Ended December 31, 
  2011  2010 
Current:      
Federal  -   - 
State and local $3,200  $3,200 
Foreign  -   - 
   3,200   3,200 
         
Deferred:        
Federal  (83,707)  - 
State and local  (14,772)  - 
Foreign  -   - 
Income tax expense/(benefit)  (95,279) $3,200 
  2014  2013  2012 
Current:         
Federal  -       
State and Local $6  $6  $4 
Foreign  -   -   - 
   6   6   4 
             
Deferred:            
Federal  -   -   (934)
State and Local  -   -   (151)
Foreign  -   -   - 
Income tax expense/(benefit) $6  $6  $(1,081)
 
 
9979

 
 
AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
 
(Tabular data in thousands, except par value and per share data)
During the year ended December 31, 2014, 2013, and 2012, there is minimal tax expense recognized. The deferred tax liability resulted in a reduction in the valuation allowance of the Company, as the Company believes the reversal of the deferred tax liability will occur prior to the expiration of the NOL carryforward. During the year ended December 31, 2014, 2013, and 2012, there is minimal tax expense recognized due to state minimum taxes and the Company's valuation allowance. U.S. loss and foreign loss before income taxes are as follows:
 
  Year Ended December 31,
  2011  2010 
         
United States $(17,188,080) $(7,635,366
Foreign  (1,203,558)  (925,643)3)
Loss before income taxes $(18,391,638) $ (8,561,009)
  Year Ended December 31, 
  2014  2013  2012 
          
United States $8,652  $(24,712) $(2,981)
Foreign  (1,513)  281   (2,382)
Pretax Income $7,139  $(24,431) $(5,363)
 
Income tax expensebenefit differs from the amounts computed by applying the statutory U.S. federal income tax rate (34%) to incomeloss before income taxes as a result of the following:
 
  Year Ended December 31, 
  2011  2010 
         
Income tax expense at the federal statutory rate $(6,253,156) $(2,910,743)
Increase (decrease) resulting from:        
State tax  (1,441,008)  (232,303)
Stock-based compensation  41,703   134,497 
Foreign loss  290,821   244,847 
Interest expense  404,972   10,089 
Credits  (990,000)   
Other  9,457   21,711 
Valuation allowance  7,841,932   2,735,102 
Income tax expense $(95,279) $3,200 
          
Effective tax rate  0.52%  (0.04)%
100

  Year Ended December 31, 
  2014  2013  2012 
Income tax expense (benefit) at the federal statutory rate  2,427   (8,307)  (1,824)
State tax expense (benefit)  1,089   (695)  (476)
Foreign tax rate differential  302   220   475 
Stock-based compensation  204   556   382 
Interest Expense  53   328   430 
Loss on Debt Extinguishment  -   1,162   3,708 
Gain on Bargain Purchase  -   -   (16,728)
Other  (147)  69   (160)
Cilion Transactions  -   -   302 
Credits  (25)  -   (150)
Valuation Allowance  (3,897)  6,673   12,960 
             
Income Tax Expense  6   6   (1,081)
             
Effective Tax Rate  0.08%  -0.02%  20.16%
 
AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
The components of the net deferred tax asset or (liability) are as follows:
  Year Ended December 31, 
  2014  2013 
Deferred Tax Assets & (Liabilities):      
Organization, start-up costs & intangible assets $8,750  $9,303 
Stock-based compensation  86   115 
Property, plant and equipment  (22,015)  (18,930)
Net operating loss carryforward and Credits  49,645   49,139 
Convertible debt  (5)  (5)
Ethanol Credits  1,500   1,500 
Debt Extinguishment  2,239   2,536 
Other, net  592   1,544 
Subtotal $40,792  $45,202 
         
Valuation Allowance  (40,792)  (45,202)
         
Deferred tax assets (liabilities) $-  $- 
80

 
  December 31, 
  2011  2010 
Deferred tax assets (liabilities):      
Organization, start-up costs & intangible assets $8,916,114  $9,113,611 
Stock-based compensation  588,192   749,458 
Property, plant and equipment  2,511,067   2,964,914 
Net operating loss carryforward  11,578,808   5,062,449 
Convertible debt  (103,127)  (462,471)
Credit carryforward  1,500,000    
Other, net  589,890   492,153 
Total deferred tax assets (liabilities)  25,580,944   17,920,114 
Less valuation allowance $(25,580,944) $(17,920,114)
Deferred tax assets (liabilities)      
AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
 
(Tabular data in thousands, except par value and per share data)
Based on the Company’s evaluation of current and anticipated future taxable income, the Company believes it is more likely than not that insufficient taxable income will be generated to realize the net deferred tax assets, and accordingly, a valuation allowance has been set against these net deferred tax assets.
 
We doThe Company does not provide for U.S. income taxes for any undistributed earnings of the Company’s foreign subsidiaries, as the Company considers these to be permanently reinvested in the operations of such subsidiaries and have a cumulative foreign loss.  At December 31, 20112014, 2013 and 2010,2012, these undistributed earnings (losses)losses totaled $(7,195,566),$10.7 million, $9.2 million and $(5,980,052),$9.5million, respectively. If any earnings were distributed, some countries may impose withholding taxes. However, due to the Company’s overall deficit in foreign cumulative earnings and its U.S. loss position, the Company does not believe a material net unrecognized U.S. deferred tax liability exists.
 
ASC 740 Income Taxes provides that the tax effects from an uncertain tax position can be recognized in the Company’s financial statements only if the position is more-likely-than-not of being sustained on audit, based on the technical merits of the position. Tax positions that meet the recognition threshold are reported at the largest amount that is more-likely-than-not to be realized. This determination requires a high degree of judgment and estimation. The Company periodically analyzes and adjusts amounts recorded for the Company’s uncertain tax positions, as events occur to warrant adjustment, such as when the statutory period for assessing tax on a given tax return or period expires or if tax authorities provide administrative guidance or a decision is rendered in the courts. The Company does not reasonably expect the total amount of uncertain tax positions to significantly increase or decrease within the next 12 months. As of December 31, 2011,2014, the Company’s uncertain tax positions were not significant for income tax purposes.
101

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
 
We conduct business globally and, as a result, one or more of the Company’s subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. In the normal course of business, the Company is subject to examination by taxing authorities throughout the world, including such major jurisdictions as India, Mauritius, and the United States. The Company files a U.S. federal income tax return and tax returns in ninethree U.S. states, as well as in two foreign jurisdictions. Penalties and interest are classified as general and administrative expenses.
 
The following describes the open tax years, by major tax jurisdiction, as of December 31, 2011:2014:
 
United States — Federal20062005 – present
United States — State2005 –2005– present
India2006 – present
Mauritius2006 – present
 
As of December 31, 2011,2014, the Company had federal net operating loss carryforwards of $20,809,989approximately $117.0 million and state net operating loss carryforwards of $23,075,789.approximately $114.0 million.  Included in the federal and state net operating loss carryovers are approximately $0.3 million and $0.2 million of excess stock based compensation related deductions that will be credited to additional paid in capital when the tax benefits realized. The Company also has approximately $1,500,000$1.5 million of alcohol and cellulosic biofuel credit carryforwards. The federal net operating loss and other tax credit carryforwards expire on various dates between 2027 and 2031.2032. The state net operating loss carryforwards expire on various dates between 2027 through 2030.2032. Under the current tax law, net operating loss and credit carryforwards available to offset future income in any given year may be limited by US or India statute regarding net operating loss carryovers and timing of expirations or upon the occurrence of certain events, including significant changes in ownership interests. The Company’s India subsidiary also haswill have net operating loss carryforwards as of March 31, 2012,2015, its tax fiscal year end, of ($7,272,501)approximately $10 million in US dollars, which expire from March 30, 20172016 to March 30, 2020.
15. Subsequent Events
Third Eye Capital Debt Agreements

Subsequent to year-end and prior to the acquisition of Cilion, the debt agreements with Third Eye Capital (“Existing Notes”) were amended to waive covenant violations, extend the terms of the debt and issue additional debt.  In connection with these agreements, the Company; (i) incurred fees of $588,000 of which $100,000 was paid in cash and the remainder was added to the principal balance of the notes, (ii) issued 1,340,000 shares of common stock as fees with a fair value on date of issuance of $801,200, and (iii) received additional loans of $2,640,000. 
In connection with the acquisition of Cilion, the financing agreement with Third Eye Capital was amended and restated to include three new credit facilities.  The new credit agreement provides for (i) a new senior secured term loan in the principal amount of $15 million, used to pay the cash portion of the Cilion acquisition (the “Term Loan”), (ii) a senior secured loan in the aggregate principal amount of $10 million to finance outstanding balance and terminate future liabilities under the Revenue Participation obligations (the “RevPar Loan”); (iii) a senior secured $18 million revolving credit facility (the “Revolving Loan”) used to redeem approximately $7.3 million in remaining outstanding debt with Third Eye Capital at time of acquisition, pay fees related to the transaction and provide working capital.  Upon the close of the Cilion acquisition, the amount of $3 million remained available on the Revolving Loan.  The Company issued 15,000,000 shares of its common stock in connection with this financing.  The notes bear interest at rates ranging from 5% to 17%.  The Revolving Notes mature on July 2013 and provide one-year extensions. The Term Loan and RevPar Loan mature on July 6, 2014. 2023.
 
 
10281

 
 
AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
17. Parent Company Financial Statements (Unaudited)
The following is a summary of the Parent Company financial statements for the years ended December 31, 2014, 2013 and 2012:
Aemetis, Inc. (Parent Company)
Consolidated Balance Sheets
As of December 31, 2014 and 2013

Assets 2014  2013 
Current assets      
Cash and cash equivalents  65   14 
Intercompany receivables  24,578   27,627 
Prepaid expenses  609   - 
Total current assets  25,252   27,641 
         
Investments in Subsidiaries, net of advances        
Investment in Aemetis International, Inc.  1,082   2,679 
Investment in Aemetis Americas, Inc  -   - 
Total investments in Subsidiaries, net of advances  1,082   2,679 
         
Other assets  23   23 
         
Total Assets $26,357  $30,343 
         
Liabilities & stockholders' deficit        
Current liabilities        
Accounts payable  2,869   3,397 
Outstanding checks in excess of cash  -   - 
Mandatorily redeemable Series B convertibe preferred  2,641   2,540 
Other current liabilities  996   1,678 
Total current liabilities  6,506   7,615 
         
         
Subsidiary obligation in excess of investment        
Investment in AE Advanced Fuels, Inc.  18,497   31,325 
Investment in Aemetis Americas, Inc  205   247 
Investment in Aemetis Biofuels, Inc.  2,741   2,741 
Investment in Aemetis Technologies, Inc.  1,031   833 
Investment in Biofuels Marketing, Inc.  349   349 
Total subsidiary obligation in excess of investment  22,823   35,495 
         
Total long term liabilities $22,823  $35,495 
         
Stockholders' deficit        
Series B Preferred convertible stock  2   2 
Common stock  21   20 
Additional paid-in capital  87,080   84,373 
Accumulated deficit  (87,113)  (94,246)
Accumulated other comprehensive loss  (2,962)  (2,916)
Total stockholders' deficit  (2,972)  (12,767)
Total liabilities & stockholders' deficit $26,357  $30,343 
         
         
82

AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
Aemetis, Inc. (Parent Company)
Consolidated Statements of Operations and Comprehensive Loss
For the Years Ended December 31, 2014, 2013 and 2012

  2014  2013  2012 
          
Equity in subsidiary gains (losses)  11,123   (22,134)  (12)
             
Selling, general and administrative expenses  3,942   2,687   2,303 
             
Operating  income (loss)  7,181   (24,821)  (2,315)
             
Other income (expense)            
Interest expense  (277)  (187)  (1,866)
Other income (expense)  235   577   (97)
             
 Income (loss) before income taxes  7,139   (24,431)  (4,278)
             
Income tax expense  (6)  (6)  (4)
             
Net gain (loss)  7,133   (24,437)  (4,282)
             
Other comprehensive loss            
Foreign currency translation adjustment  (46)  (598)  (75)
Comprehensive income (loss)  7,087   (25,035)  (4,357)

83

AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
Aemetis, Inc. (Parent Company)
Consolidated Statements of Cash Flows
For the years ended December 31, 2014, 2013 and 2012

  2014  2013  2012 
Operating activities:         
Net income (loss)  7,133   (24,437)  (4,282)
Adjustments to reconcile net income (loss) to net cash used in operating activities: 
             
Stock-based compensation  624   1,760   686 
Stock issued in connection with services  645   -   - 
Amortization of debt issuance discount  -   -   401 
Change in fair value of warrant liability  48   (197)  97 
Changes in assets and liabilities:            
Subsidiary portion of net (gains) losses  (11,123)  22,134   12 
Prepaid expenses  (539  -   5 
Accounts payable  (512)  (640)  237 
Accrued interest expense  -   -   683 
Other liabilities  (629)  (178)  288 
Net cash used in operating activities  (4,353)  (1,558)  (1,873)
             
Investing activities:            
Change in outstanding checks in excess of cash  -   (26)  26 
Subsidiary advances, net  4,399   515   9,417 
Net cash provided in investing activities  4,399   489   9,443 
             
Financing activities:            
Proceeds from borrowings under secured debt facilities  -   -   840 
Repayments of borrowings under secured debt facilities  -   -   (8,412)
Equity Offering  -   1,075   - 
Issuance of common stock for services, option and warrant exercises  5   8   1 
Net cash provided by (used in) financing activities  5   1,083   (7,571)
             
Net increase in cash and cash equivalents  51   14   (1)
             
Cash and cash equivalents at beginning of period  14   -   1 
Cash and cash equivalents at end of period $65  $14  $(0)
             
Supplemental disclosures of cash flow information, cash paid:     
             
Interest payments  6,824   4,522   2,085 
Income tax expense  6   6   4 
             
Supplemental disclosures of cash flow information, non-cash transactions: 
             
Proceeds from exercise of stock options applied to accounts payable  16   -   - 
Issuance of warrants to non-employees to secure procurement and working capital  -   336   - 
Issuance of warrants to subordinated debt holders  1,301   1,127   - 
Exercise of conversion feature on note to equity  47   -   - 
Issuance of shares for acquisition  -   -   12,511 
Payments of principal, fees and interest by issuance of stock  -   3,616   11,886 

84


AEMETIS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Tabular data in thousands, except par value and per share data)
18. Subsequent Events
Subordinated Notes
 
On October 18, 2012, Third Eye Capital agreed to (i) extendJanuary 1, 2015, the two accredited investors Subordinated Notes’ maturity date of the Existing Notes to July 6, 2014; (ii) to increase the amount of the Revolving Loan Facility by $6,000,000, to a total of $24,000,000; (iii) to modify the redemption waterfall so that any payments would be applied first to the increase in the Revolving notes; (iv) granted waivers to the Borrowers’ obligation to pay or comply, and any event of default which has occurred or may occur as a result of such failures of the Borrowers to pay or comply with certain financial covenants and principal payments, including financial covenants for the quarter ended September 30 and December 31, 2012; and (v) agreed to accrue interestwas extended until the earlier of certain events described in the Limited Waiver or February 1, 2013.  In consideration for the Limited Waiver and Amendment, the Borrowers, among other things, agreed to pay the Lenders a waiver fee in the amount of $4,000,000; and (ii) cash in the amount of $28,377 for certain unreimbursed costs. After paying the $4 million waiver fee, $2 million remained available for draw on the Revolving Loan Facility.
$3 Million Note and Warrant Purchase Agreement
On January 6 and January 9, 2012, Aemetis Advanced Fuels Keyes, Inc. sold to two accredited investors 5% Subordinated Promissory Notes in the aggregate principal amount of $3,000,000 and 5-year warrants exercisable for 1,000,000 shares of Aemetis common stock at an exercise price of $0.001 per share.  Interest is due at maturity.  The promissory notes are guaranteed by Aemetis and are due and payable upon the earlier of (i) December 31, 2013;June 30, 2015; (ii) completion of an equity financing by AAFK or Aemetis in an amount of not less than $25,000,000;$25 million; (iii) the completion of an Initial Public Offering by AAFK or Aemetis; or (iv) after the occurrence of an Event of Default, including failure to pay interest or principal when due and breaches of note covenants.  Neither AAFK nor Aemetis may make any principal payments underA 10 percent cash extension fee was paid by adding the Promissory Notes until all loans made by Third Eye Capitalfee to AAFK are paid in full.
Related Party Revolving Line of Credit Agreement

On October 16, 2012, Aemetis International, Inc. (AII), a subsidiary of Aemetis, Inc. entered into an amendment to the Revolving Line of Credit Agreement with Laird Q. Cagan and co-owners of financing arrangement, pursuant to which AII extended the maturity date of the loan until July 1, 2014 and placed an average trailing daily closing price minimum of $0.05 per share for conversion of fees and accrued interest.  In exchange for the extension, the Company agreed to pay a fee of 5% of the outstanding balance of the Revolving Line, payablenew Note and 116 thousand in cash orcommon stock atwarrants were granted with a term of two years and an exercise price of $0.01 per share.
In February 2015, the same conversion price and terms as the accrued interest conversion terms.

On October 16, 2012, the Company entered into Amendment No 1. to Revolving Line of Credit Agreement with Laird Q. Cagan related party promissory note was amended to extend the maturity date until the earlier of (i) December 31, 2016; (ii) completion of an equity financing by AAFK or Aemetis in an amount of not less than $25.0 million; (iii) the revolving linecompletion of credit until July 1, 2014an Initial Public Offering by AAFK or Aemetis; or (iv) after the occurrence of an Event of Default, including failure to pay interest or principal when due and placed an average trailing daily closing price minimumbreaches of $0.05 per share for conversion of fees and accrued interest.note covenants.
 
Issuance of Convertible Promissory NotesThird Eye Capital Amendment
 
On March 4, 2011, and amended January 19, 2012, and July 24, 2012,12, 2015, Third Eye Capital agreed to Amendment No. 9 to the Company entered into a Note Purchase Agreement with Advanced BioEnergy, LP, a California limited Partnershipto allow for the issuancerepurchase of up to 72 subordinated convertible promissory notes bearing interest at 3%, each note in1,000,000 shares of common stock of the principal amountCompany effective as of $500,000 due and payable four years from the date of the note for a total aggregate principal amount of up to $36,000,000.
Advanced BioEnergy, LP arranges investments with foreign investors, who each make investments in the Keyes plant project in investment increments of $500,000.  The Company sold notes in the amount of $1,000,000 to the first two investors.  The availability of the remaining $35,000,000 will be determined by the ability of Advanced BioEnergy, LP to attract additional qualified investors.
103

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Note and Warrant Purchase Agreement
On June 21, 2012, Aemetis Advanced Fuels Keyes, Inc. (AAFK), a subsidiary of Aemetis, Inc., entered into Note and Warrant Purchase Agreements with TEC pursuant to which AAFK sold 5% Subordinated Promissory Notes in the aggregate principal amount of $400,000 and 5-year warrants exercisable for 133,333Amendment No. 9, 573,347 shares of Aemetis common stock,which were repurchased at an exercisea price of $0.001per share equal to $6.00 per share and paidthe remainder of which were repurchased at a feeprice per share equal to the higher of $50,000.  These Notes were subsequently refinanced as part$4.50 per share or the five-day volume weighted average price of the restructuring in connection withCompany’s common stock on the Cilion acquisition discussed above.

Land HeldNASDAQ Global Market immediately prior to the date of Amendment No. 9, for Sale
On May 10, 2012,an aggregate purchase price of approximately $5.5 million.  An extension of the credit facility allows for the repurchase price to be added to the outstanding principal balance of the existing notes under the Note Purchase Agreement. In addition, Third Eye Capital agreed to remove the covenant that the Company soldmust complete an equity offering of its land heldpreferred stock for salenet proceeds of not less than $20 million with a carrying valueall of $885,000 for $1,126,867. Proceeds from the sale weresuch net proceeds to be used to repay a portion of the principal outstanding indebtedness owed to TEC.
Acquisition of Cilion (unaudited)
On July 6, 2012, the Company acquired Cilion, Inc. through a merger. The Company has been leasing the property owed by Cilion. The Company’s primary lender supported the financing of the acquisition in anticipation the merger will be accretive to earnings in the long term. Acquiring the real property and assets associated with the ethanol plant provides assets beneficial to the Company in securing additional financing and much needed flexibility not available under the lease in the development, testing, and commercialization of next generation biofuels technologies owed by the Company.
At the effective time of the Merger, each issued and outstanding share of Cilion Preferred Stock was automatically converted into the right to receive an aggregate of (a) $16,500,000 and (b) 20,000,000 shares of Aemetis common stock and (c) the right to receive an additional cash amount of $5,000,000 plus interest at the rate of 3% per annum, which is payable upon the satisfaction by the Company of certain conditions set forth in the merger agreement.
The fair value of the contingent consideration was determined by discounting the anticipated cash flow stream at an estimated market rate of interest based on potential payment timing. The merger agreement is the basis for determining the amount of the payment. The $5,000,000 contingent consideration is payable when theNote Purchase.  In addition, Third Eye Capital loans have been satisfied. The Company anticipateswaived the contingent consideration will be redeemed after satisfaction of amounts owedfree cash flow financial covenant under senior secured debt arrangements with Third Eye Capital. Management projects full satisfaction of the Third Eye Capital obligations will occur within the next two to three years.
The preliminary purchase price for Cilion, Inc. is recapped below based on the trading value of the stock at the time of the acquisition and the expected fair value of the contingent consideration (in thousands):

Cash $16,500 
Fair value of shares issued  15,600 
Contingent Consideration  3,824 
  $35,924 
104

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
The preliminary acquisition date fair value of consideration was allocated to Cilion’s net tangible and identifiable intangible assets based on their estimated fair values as of July 6, 2012 as set forth below (in thousands).

Tangible Assets:   
Accounts receivable $3,114 
Prepaid assets  5 
Equipment held for resale  1,367 
Property, plant and equipment  70,464 
Other assets  147 
Total Tangible Assets Acquired  75,097 
     
Liabilities Assumed    
Accounts payable  (6)
     
Identified Intangible Assets    
Permits  926 
Net Assets Acquired $76,017 

The Company believes the Cilion shareholders valued the equity component of the consideration higher than the current quoted market price.  The Company believes the lower market share price is due to the recent lack of information available to the market. Cilion shareholders valued Aemetis common stock at a value higher than the current trading price on the OTC market, which gave rise to the gain on bargain purchase accounting of approximately $40 million dollars.

The pro forma financial information below presents the combined revenue and net income for Cilion and the CompanyNote Purchase Agreement for the yearsthree months ending DecemberMarch 31, 2010 and 2011, as if the acquisition occurred as of January 1, 2010 (in thousands):2015.

  Historical  Pro Forma 
  Aemetis, Inc.  Cilion, Inc.  Adjustments  Combined 
2010            
Revenue $8,132  $500  $(500) $8,132 
Net loss  (8,425)  (44,218)  35,405   (17,238)
                 
2011                
Revenue  141,858   2,700   (2,700)  141,858 
Net loss $(18,296) $(3,487) $(4,365) $(26,148)

The adjustment columns above include the elimination of the intercompany rental activity received by Cilion from the Company, the recognition of the bargain purchase gain, adjustments necessary for the revaluation of the assets, and increase in financing costs associated with the acquisition.
105


AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
16. Parent Company Financial Statements (Unaudited)
The following is a summary of the Parent Company financial statements for the years ended December 31, 2011 and 2010:
106

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Aemetis, Inc. (Parent Company)
Consolidated Condensed Balance Sheets
As of December 31, 2011 and 2010

Assets 2011  2010 
Current assets      
Cash and cash equivalents $747  $17,631 
Intercompany receivables  3,168,587   - 
Prepaid expenses  88,000   5,827 
Total current assets  3,257,334   23,458 
         
Investments in Subsidiaries, net of advances    
Investment in Aemetis International, Inc.  5,979,020   9,831,430 
Investment in Aemetis Americas, Inc  -   259,473 
Total investments in Subsidiaries, net of advances  5,979,020   10,090,903 
         
Property, plant and equipment, net  -   2,193 
Other assets  23,095   23,096 
Total Assets $9,259,449  $10,139,650 
         
Liabilities & stockholders' deficit     
Current liabilities        
Accounts payable $3,800,250  $3,056,268 
Mandatorily redeemable Series B convertibe preferred  2,320,164   2,221,872 
Secured notes, net of discount for issuance cost  1,075,588   900,000 
Interecompany payables  -   233,717 
Other current liabilities  1,786,962   1,714,229 
Total current liabilities  8,982,964   8,126,086 
         
         
Parent Company long term debt portion of secured notes, net of discount for issuance cost  6,016,926   5,915,056 
         
Subsidiary obligation in excess of investment    
Investment in AE Advanced Fuels, Inc.  440   200 
Investment in Aemetis Advanced  Fuels Keyes, Inc.  13,252,571   2,699,096 
Investment in Aemetis Americas, Inc  118,252   - 
Investment in Aemetis Biofuels, Inc.  2,567,894   2,488,735 
Investment in Aemetis Technologies, Inc.  174,488   - 
Investment in Biofuels Marketing, Inc.  348,996   360,185 
Total subsidiary obligation in excess of investment  16,462,641   5,548,216 
         
Total long term liabilities  22,479,567   11,463,272 
         
Stockholders' deficit        
Series B Preferred convertible stock  3,115   3,165 
Common stock  130,747   90,342 
Additional paid-in capital  45,432,447   38,557,376 
Accumulated deficit  (65,526,029)  (47,229,670)
Accumulated other comprehensive loss  (2,243,362)  (870,921)
Total stockholders' deficit  (22,203,082)  (9,449,708)
Total liabilities & stockholders' deficit $9,259,449  $10,139,650 
107

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Aemetis, Inc. (Parent Company)
Consolidated Statements of Operations and Comprehensive Loss
For the Years Ended December 31, 2011 and 2010

   2011  2010 
        
Equity in subsidiary earnings (losses) $(15,386,811) $(4,970,719)
          
Selling, general and administrative expenses  1,003,879   1,673,873 
          
Operating loss  (16,390,690)  (6,644,592)
          
Other income/(expense)        
 Interest expense  (1,918,750)  (1,890,304)
 Other income, net of expenses  16,281   112,843 
          
Loss before income taxes  (18,293,159)  (8,422,053)
          
 Income taxes benefit/(expense)  (3,200)  (3,200)
          
Net loss  $(18,296,359) $(8,425,253)
108


AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Aemetis, Inc. (Parent Company)
Consolidated Statements of Cash Flows
For the years ended December 31, 2011 and 2010

  2011  2010 
Operating activities:      
Net loss $(18,296,359)  (8,564,209)
Adjustments to reconcile net loss to net cash used in operating activities:
        
Stock-based compensation  177,278   377,669 
Depreciation and amortization  2,193   11,386 
Amortization of debt issuance discount  1,177,413   717,466 
Loss/(gain) on extinguishment of debt  -   (14,757)
Changes in assets and liabilities:        
Subsidiary portion of net losses  15,386,811   5,109,675 
Prepaid expenses  1,160   (1,380)
Other current assets and other assets  1   15,504 
Accounts payable  743,982   1,044,483 
Accrued interest expense  894,475   1,350,501 
Other liabilities  72,733   209,657 
Net cash provided in operating activities  159,687   255,995 
         
Investing activities:        
Subsidiary advances, net  723,429   598,801 
Net cash used in investing activities  723,429   598,801 
         
Financing activities:        
Repayments of borrowings under secured debt facilities  (900,000)  (850,000)
Net cash provided by financing activities  (900,000)  (850,000)
         
Net increase (decrease) in cash and cash equivalents  (16,884)  4,796 
         
Cash and cash equivalents at beginning of period  17,631   12,835 
Cash and cash equivalents at end of period $747  $17,631 
109

AEMETIS, INC.
December 31, 2011
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
17.19.  Management’s Plan

The accompanying financial statements have been prepared on a going concern basis, which contemplatescontemplating the realization of assets and satisfaction of liabilities in the normal course of business. The Company has experienced lossesDuring 2014, the Company’ operations provided positive margins throughout the year and negative cash flow and currently has a working capital deficit and total stockholders’ deficit. The Company has been reliant on their senior secured lender to provide additional funding requirements whenstrong cash flows do not supportin the payment requirements on the Company’s debt.  Although the current agreements in place with this lender do not require any payments or covenant requirements through February 2013, the continuationfirst three quarters of the Company depends on management being able2014 which was used to maintain this relationship with thepay $23.0 million of senior lender or find other financing options to provide cash as the company expands its technologies.debt.   Management’s plans to continue to operatefor the Company include:

As discussed inOperating the subsequent event footnote, the acquisition of Cilion provided the Company with a substantial asset to use as collateral both with their current lender and with future financings.Keyes plant;

ContinueIncorporate lower-cost, non-food advanced biofuels feedstock at the Keyes plant when economical;
Attracting investors to work with the Company’s senior lender to provide financing as well as explore other financing arrangements including working with Advanced BioEnergy LP to attract investors for the remaining $35issue up to $34.5 million of additional EB-5 notes available under the program, or through the issuance of additional equity.at 3% interest rate;

Development of Joint Venture agreements forRefinance the expansionsenior debt with a lender who is able to offer terms conducive to the long term financing of the Company’s technologies.Keyes plant

Continued supportRestructuring or refinance the State Bank of India note to allow for additional working capital and reduce current financing costs;
Securing higher volumes of international shipments from major shareholdersthe Kakinada, India biodiesel and board of directorsrefined glycerin facility; and
Continuing to expand in providing cash financing.the India market as the diesel subsidy was reduced to zero by June 2014.

Management believes that through the above mentioned actions it will be able to sustainfund company operations and continue to operate the company as a going concern.secured assets for the foreseeable future. There can be no assurance that the existing credit facilities and cash from operations will be sufficient nor that wethe Company will be successful at maintaining adequate relationships with ourthe senior lenderlenders or significant shareholders that will result in additional financings.shareholders. Should the Company require additional financing, there can be no assurances that the additional financing will be available on terms satisfactory to the Company.
 
110
85

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Aemetis, Inc.
Date: March 12, 2015
By:/s/ Eric A. McAfee
Eric A. McAfee
Chief Executive Officer
(Principal Executive Officer)
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Eric A. McAfee and Todd A. Waltz, and each of them, his true and lawful attorneys-in-fact, each with full power of substitution, for him in any and all capacities, to sign any amendments to this report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact or their substitute or substitutes may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:
NameTitleDate
/s/ Eric A. McAfee
Chairman/Chief Executive OfficerMarch 12, 2015
Eric A. McAfee(Principal Executive Officer and Director)
/s/Todd Waltz
Chief Financial OfficerMarch 12, 2015
Todd Waltz(Principal Financial and Accounting Officer)
/s/ Francis Barton
DirectorMarch 12, 2015
Fran Barton
/s/ John R. Block
DirectorMarch 12, 2015
John R. Block
/s/ Dr. Steven Hutcheson
DirectorMarch 12, 2015
Dr. Steven Hutcheson
/s/ Harold Sorgenti
DirectorMarch 12, 2015
Harold Sorgenti
86